=== МЕТАДАННЫЕ ===
{
  "original_filename": "ehab364.pdf",
  "converted_date": "2026-01-31T14:50:36.928435",
  "file_size_bytes": 4507577,
  "original_format": "pdf",
  "document_type": "Guidelines",
  "source_folder": "Guidelines",
  "full_path": "00_RAW_CARDIOLOGY/Guidelines/ehab364.pdf"
}

=== СОДЕРЖАНИЕ ===

--- Страница 1 ---
ESC GUIDELINES
EuropeanHeartJournal(2021)00,1(cid:2)94
doi:10.1093/eurheartj/ehab364
2021 ESC Guidelines on cardiac pacing and
cardiac resynchronization therapy
Developed by the Task Force on cardiac pacing and cardiac
resynchronization therapy of the European Society of Cardiology (ESC)
With the special contribution of the European Heart Rhythm
Association (EHRA)
Authors/Task Force Members: Michael Glikson * (Chairperson) (Israel),
Jens Cosedis Nielsen* (Chairperson) (Denmark), Mads Brix Kronborg (Task Force
Coordinator) (Denmark), Yoav Michowitz (Task Force Coordinator) (Israel),
Angelo Auricchio (Switzerland), Israel Moshe Barbash (Israel), Jose´ A. Barrabe´s
(Spain), Giuseppe Boriani (Italy), Frieder Braunschweig (Sweden), Michele Brignole
(Italy), Haran Burri (Switzerland), Andrew J. S. Coats (United Kingdom),
Jean-Claude Deharo (France), Victoria Delgado (Netherlands), Gerhard-Paul Diller
(Germany), Carsten W. Israel (Germany), Andre Keren (Israel), Reinoud E. Knops
(Netherlands), Dipak Kotecha (United Kingdom), Christophe Leclercq (France),
*Correspondingauthors:MichaelGlikson,JesselsonIntegratedHeartCenter,ShaareZedekMedicalCenterandHebrewUniversityFacultyofMedicine,Jerusalem,Israel,
Tel:þ97226555975,Email:mglikson@szmc.org.il.
JensCosedisNielsen,DepartmentofClinicalMedicine,AarhusUniversityandDepartmentofCardiology,AarhusUniversityHospital,AarhusN,Denmark,
Tel:þ4578452039,Email:jenniels@rm.dk.
Author/TaskForceMemberaffiliations:listedinAuthorinformation.
ESCClinicalPracticeGuidelinesCommittee(CPG):listedintheAppendix.
ESCsubspecialtycommunitieshavingparticipatedinthedevelopmentofthisdocument:
Associations:AssociationforAcuteCardioVascularCare(ACVC),AssociationofCardiovascularNursing&AlliedProfessions(ACNAP),EuropeanAssociationof
CardiovascularImaging(EACVI),EuropeanAssociationofPercutaneousCardiovascularInterventions(EAPCI),EuropeanHeartRhythmAssociation(EHRA),HeartFailure
Association(HFA).
Councils:CouncilforCardiologyPractice,CouncilonBasicCardiovascularScience,CouncilonCardiovascularGenomics,CouncilonHypertension,CouncilonStroke.
WorkingGroups:AdultCongenitalHeartDisease,CardiacCellularElectrophysiology,CardiovascularRegenerativeandReparativeMedicine,CardiovascularSurgery,e-
Cardiology,MyocardialandPericardialDiseases.
PatientForum
ThecontentoftheseEuropeanSocietyofCardiology(ESC)Guidelineshasbeenpublishedforpersonalandeducationaluseonly.Nocommercialuseisauthorized.Nopartof
theESCGuidelinesmaybetranslatedorreproducedinanyformwithoutwrittenpermissionfromtheESC.Permissioncanbeobtaineduponsubmissionofawrittenrequestto
OxfordUniversityPress,thepublisheroftheEuropeanHeartJournalandthepartyauthorizedtohandlesuchpermissionsonbehalfoftheESC(journals.permissions@oup.com).
Disclaimer:TheESCGuidelinesrepresenttheviewsoftheESCandwereproducedaftercarefulconsiderationofthescientificandmedicalknowledgeandtheevidenceavailableat
thetimeoftheirpublication.TheESCisnotresponsibleintheeventofanycontradiction,discrepancy,and/orambiguitybetweentheESCGuidelinesandanyotherofficialrecommen-
dationsorguidelinesissuedbytherelevantpublichealthauthorities,inparticularinrelationtogooduseofhealthcareortherapeuticstrategies.Healthprofessionalsareencouraged
totaketheESCGuidelinesfullyintoaccountwhenexercisingtheirclinicaljudgement,aswellasinthedeterminationandtheimplementationofpreventive,diagnostic,ortherapeutic
medicalstrategies;however,theESCGuidelinesdonotoverride,inanywaywhatsoever,theindividualresponsibilityofhealthprofessionalstomakeappropriateandaccuratedeci-
sionsinconsiderationofeachpatient’shealthconditionandinconsultationwiththatpatientand,whereappropriateand/ornecessary,thepatient’scaregiver.NordotheESC
Guidelinesexempthealthprofessionalsfromtakingintofullandcarefulconsiderationtherelevantofficialupdatedrecommendationsorguidelinesissuedbythecompetentpublic
healthauthorities,inordertomanageeachpatient’scaseinlightofthescientificallyaccepteddatapursuanttotheirrespectiveethicalandprofessionalobligations.Itisalsothehealth
professional’sresponsibilitytoverifytheapplicablerulesandregulationsrelatingtodrugsandmedicaldevicesatthetimeofprescription.
Thisarticlehasbeenco-publishedwithpermissionintheEuropeanHeartJournalandEPEuropace.VC theEuropeanSocietyofCardiology2021.Allrightsreserved.
Thearticlesareidenticalexceptforminorstylisticandspellingdifferencesinkeepingwitheachjournal’sstyle.Eithercitationcanbeusedwhencitingthisarticle.Forpermissions,
pleaseemailjournals.permissions@oup.com.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 2 ---
2 ESCGuidelines
Be´la Merkely (Hungary), Christoph Starck (Germany), Ingela Thyle´n (Sweden),
Jose´ Maria Tolosana (Spain), ESC Scientific Document Group
DocumentReviewers:FranciscoLeyva (CPGReviewCoordinator)(UnitedKingdom),CeciliaLinde
(CPGReviewCoordinator)(Sweden),MagdyAbdelhamid(Egypt),VictorAboyans(France),ElenaArbelo
(Spain),RiccardoAsteggiano(Italy),GonzaloBaro(cid:2)n-Esquivias(Spain),JohannBauersachs(Germany),
MauroBiffi(Italy),UlrikaBirgersdotter-Green(UnitedStatesofAmerica),MariaGraziaBongiorni(Italy),
MichaelA.Borger(Germany),JelenaC(cid:3)elutkiene_ (Lithuania),MajaCikes(Croatia),Jean-ClaudeDaubert
(France),IngaDrossart(Belgium),KennethEllenbogen(UnitedStatesofAmerica),PerryM.Elliott
(UnitedKingdom),LarissaFabritz(UnitedKingdom),VolkmarFalk(Germany),LaurentFauchier(France),
FranciscoFerna(cid:2)ndez-Avile´s(Spain),DanFoldager(Denmark),FredrikGadler(Sweden),PastoraGallego
GarciaDeVinuesa(Spain),BulentGorenek(Turkey),JoseM.Guerra(Spain),KristinaHermannHaugaa
(Norway),JeroenHendriks(Netherlands),ThomasKahan(Sweden),HugoA.Katus(Germany),
AleksandraKonradi(Russia),KonstantinosC.Koskinas(Switzerland),HannahLaw(UnitedKingdom),
BasilS.Lewis(Israel),NicholasJohnLinker(UnitedKingdom),Maja-LisaLøchen(Norway),JoostLumens
(Netherlands),JuliaMascherbauer(Austria),WilfriedMullens(Belgium),KlaudiaVivienNagy(Hungary),
EvaPrescott(Denmark),PekkaRaatikainen(Finland),AminaRakisheva(Kazakhstan),TobiasReichlin
(Switzerland),RenatoPietroRicci(Italy),EvgenyShlyakhto(Russia),MartaSitges(Spain),MiguelSousa-Uva
(Portugal),RichardSutton(Monaco), PiotrSuwalski(Poland),JesperHastrupSvendsen(Denmark),
RhianM.Touyz(UnitedKingdom),IsabelleC.VanGelder(Netherlands),KevinVernooy(Netherlands),
JohannesWaltenberger(Germany),ZacharyWhinnett(UnitedKingdom),KlausK.Witte(UnitedKingdom)
Allexpertsinvolvedinthedevelopmentoftheseguidelineshavesubmitteddeclarationsofinterest.
Thesehavebeencompiledinareportandpublishedinasupplementarydocumentsimultaneouslytothe
guidelines.ThereportisalsoavailableontheESCwebsitewww.escardio.org/guidelines
FortheSupplementaryDatawhichincludebackgroundinformationanddetaileddiscussionofthedata
thathaveprovidedthebasisfortheguidelinesseeEuropeanHeartJournalonline
...................................................................................................................................................................................................
Keywords Guidelines • cardiacpacing • cardiacresynchronizationtherapy • pacemaker • heartfailure • syncope •
atrialfibrillation • conductionsystempacing • pacingindications • alternatesitepacing • complications •
pacinginTAVI • bradycardia • temporarypacing
.
Table of contents .. 3.4.3Cardiacresynchronizationtherapy(endo-and/or
. .
. epicardial)...................................................... 14
. .
1Preamble ......................................................... 6 . 3.4.4Alternativemethods(conductionsystempacing,
. .
2Introduction ...................................................... 8 . leadlesspacing) ............................................... 14
.
.
2.1Evidencereview .............................................. 8 . 3.4.4.1Conductionsystempacing ............................. 14
.
.
2.2Relationshipswithindustry.................................... 8 . 3.4.4.2Leadlesspacing ...................................... 14
.
.
2.3Whatisnewintheseguidelines ............................... 8 . 3.4.5Pacingmodes ........................................... 14
.
.
2.3.1Newconceptsandnewsections .......................... 8 . 3.4.6Rate-responsivepacing .................................. 14
.
.
2.3.2Newrecommendationsin2021........................... 9 . 3.5Sexdifferences .............................................. 14
.
.
2.3.3Changesincardiacpacingandcardiacresynchronization . 4Evaluationofthepatientwithsuspectedordocumented
.
.
therapyguidelinerecommendationssince2013 ................ 11 . bradycardiaorconductionsystemdisease .......................... 14
.
.
3Background ..................................................... 11 .. 4.1Historyandphysicalexamination............................. 14
.
3.1Epidemiology................................................ 11 .. 4.2Electrocardiogram........................................... 16
.
3.2Naturalhistory .............................................. 12 .. 4.3Non-invasiveevaluation ..................................... 16
.
3.3Pathophysiologyandclassificationofbradyarrhythmias .. 4.3.1Ambulatoryelectrocardiographicmonitoring............. 16
.
consideredforpermanentcardiacpacingtherapy ................ 12 .. 4.3.2Exercisetesting ......................................... 16
.
3.4Typesandmodesofpacing:generaldescription ............... 13 .. 4.3.3Imaging ................................................. 16
.
3.4.1Endocardialpacing ...................................... 13 .. 4.3.4Laboratorytests ........................................ 17
.
3.4.2Epicardialpacing ........................................ 13 . 4.3.5Genetictesting .......................................... 17
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 3 ---
ESCGuidelines 3
.
.
4.3.6Sleepevaluation ......................................... 19 . 6.5Pacinginpatientswithreducedleftventricularejection
.
.
4.3.7Tilttesting .............................................. 19 . fractionandaconventionalindicationforantibradycardia
.
.
4.4Implantablemonitors ........................................ 19 . pacing .......................................................... 36
.
.
4.5Electrophysiologystudy...................................... 20 . 6.6Benefitofaddingimplantablecardioverterdefibrillatorin
.
.
5Cardiacpacingforbradycardiaandconductionsystemdisease ..... 21 . patientswithindicationsforcardiacresynchronizationtherapy .... 36
.
.
5.1Pacingforsinusnodedysfunction ............................ 21 . 6.7Factorsinfluencingtheefficacyofcardiacresynchronization
.
.
5.1.1Indicationsforpacing .................................... 21 . therapy:roleofimagingtechniques .............................. 37
.
.
5.1.1.1Sinusnodedysfunction ................................ 21 . 7Alternativepacingstrategiesandsites ............................. 38
.
.
5.1.1.2Bradycardia—tachycardiaformofsinusnode .. 7.1Septalpacing ................................................ 38
.
dysfunction ................................................. 22 .. 7.2Hisbundlepacing ............................................ 38
.
5.1.2Pacingmodeandalgorithmselection ..................... 22 .. 7.2.1Implantationandfollow-up .............................. 38
.
5.2Pacingforatrioventricularblock .............................. 24 .. 7.2.2Indications .............................................. 40
. 5.2.1Indicationsforpacing .................................... 24 .. 7.2.2Pacingforbradycardia................................. 40
.
5.2.1.1First-degreeatrioventricularblock....................... 24 .. 7.2.2Paceandablate ....................................... 40
.
5.2.1.2Second-degreetypeIatrioventricularblock .. 7.2.2Roleincardiacresynchronizationtherapy .............. 40
.
(MobitztypeIorWenckebach) ............................... 24 .. 7.3Leftbundlebranchareapacing ............................... 41
. 5.2.1.3Second-degreeMobitztypeII,2:1,andadvanced .. 7.4Leadlesspacing .............................................. 41
.
atrioventricularblock(alsonamedhigh-gradeatrioventricular .. 8Indicationsforpacinginspecificconditions ........................ 42
.
block,wheretheP:QRSratiois3:1orhigher),third-degree .. 8.1Pacinginacutemyocardialinfarction ......................... 42
.
atrioventricularblock......................................... 24 .. 8.2Pacingaftercardiacsurgeryandhearttransplantation ......... 42
.
.
5.2.1.4Paroxysmalatrioventricularblock ....................... 24 . 8.2.1Pacingaftercoronaryarterybypassgraftandvalve
.
.
5.2.2Pacingmodeandalgorithmselection ..................... 25 . surgery ...................................................... 42
.
.
5.2.2.1Dual-chambervs.ventricularpacing .................... 25 . 8.2.2Pacingafterhearttransplantation ........................ 43
.
.
5.2.2.2Atrioventricularblockinthecaseofpermanentatrial . 8.2.3Pacingaftertricuspidvalvesurgery ....................... 43
.
.
fibrillation .................................................. 25 . 8.3Pacingaftertranscatheteraorticvalveimplantation............ 44
.
.
5.3Pacingforconductiondisorderswithoutatrioventricularblock ... 26 . 8.4Cardiacpacingandcardiacresynchronizationtherapyin
.
.
5.3.1Indicationsforpacing .................................... 26 . congenitalheartdisease ......................................... 46
.
.
5.3.1.1Bundlebranchblockandunexplainedsyncope ........... 26 . 8.4.1Sinusnodedysfunctionandbradycardia—tachycardia
.
.
5.3.1.2Bundlebranchblock,unexplainedsyncope,and . syndrome .................................................... 46
.
.
abnormalelectrophysiologicalstudy ........................... 26 . 8.4.1.1Indicationsforpacemakerimplantation ................. 46
.
.
5.3.1.3Alternatingbundlebranchblock ........................ 27 .. 8.4.2Congenitalatrioventricularblock ........................ 46
.
5.3.1Bundlebranchblockwithoutsymptoms ................... 27 .. 8.4.2.1Indicationsforpacemakerimplantation ................. 46
.
5.3.1.4Patientswithneuromusculardiseases ................... 27 .. 8.4.3Post-operativeatrioventricularblock ..................... 47
.
5.3.2Pacingmodeandalgorithmselection ..................... 27 .. 8.4.3.1Indicationsforpacemakerimplantation ................. 47
.
5.4Pacingforreflexsyncope .................................... 28 .. 8.4.4Cardiacresynchronization ............................... 47
.
5.4.1Indicationsforpacing .................................... 29 .. 8.5Pacinginhypertrophiccardiomyopathy....................... 47
.
5.4.2Pacingmodeandalgorithmselection ..................... 30 .. 8.5.1Bradyarrhythmia ........................................ 47
.
5.5Pacingforsuspected(undocumented)bradycardia ............ 30 .. 8.5.2Pacingforthemanagementofleftventricularoutflow
.
5.5.1Recurrentundiagnosedsyncope ......................... 30 .. tractobstruction ............................................. 47
. 5.5.2Recurrentfalls .......................................... 30 .. 8.5.3Pacemakerimplantationfollowingseptalmyectomy
. 6Cardiacresynchronizationtherapy ............................... 30 .. andalcoholseptalablation .................................... 48
. 6.1Epidemiology,prognosis,andpathophysiologyofheart .. 8.5.4Cardiacresynchronizationtherapyinend-stage
.
.
failuresuitableforcardiacresynchronizationtherapyby . hypertrophiccardiomyopathy ................................ 48
.
.
biventricularpacing ............................................. 30 . 8.6Pacinginrarediseases ....................................... 48
.
.
6.2Indicationforcardiacresynchronizationtherapy:patients . 8.6.1LongQTsyndrome ...................................... 48
.
.
insinusrhythm ................................................. 31 . 8.6.2Neuromusculardiseases................................. 48
.
.
6.3Patientsinatrialfibrillation ................................... 33 . 8.6.3DilatedcardiomyopathywithlaminA/Cmutation ........ 49
.
.
6.3.1Patientswithatrialfibrillationandheartfailurewho . 8.6.4Mitochondrialcytopathies ............................... 49
.
.
arecandidatesforcardiacresynchronizationtherapy ........... 33 . 8.6.5Infiltrativeandmetabolicdiseases ........................ 49
.
.
6.3.2Patientswithuncontrolledheartratewhoare . 8.6.6Inflammatorydiseases ................................... 49
.
.
candidatesforatrioventricularjunctionablation(irrespective . 8.6.6.1Sarcoidosis........................................... 50
.
.
ofQRSduration) ............................................. 33 . 8.7Cardiacpacinginpregnancy .................................. 50
.
.
6.3.3EmergingnovelmodalitiesforCRT:roleofconduction .. 9Specialconsiderationsondeviceimplantationsandperioperative
.
systempacing ................................................ 34 .. management ...................................................... 50
.
6.4Patientswithconventionalpacemakerorimplantable .. 9.1Generalconsiderations ...................................... 50
.
cardioverterdefibrillatorwhoneedupgradetocardiac .. 9.2Antibioticprophylaxis ....................................... 50
.
resynchronizationtherapy....................................... 35 . 9.3Operativeenvironmentandskinantisepsis ................... 50
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 4 ---
4 ESCGuidelines
.
.
9.4Managementofanticoagulation .............................. 51 . Recommendationsforcardiacpacinginpatients
.
.
9.5Venousaccess............................................... 51 . withsuspected(undocumented)syncopeandunexplainedfalls ...... 30
.
.
9.6Leadconsiderations ......................................... 52 . Recommendationsforcardiacresynchronizationtherapyin
.
.
9.7Leadposition................................................ 52 . patientsinsinusrhythm ............................................ 32
.
.
9.8Devicepocket............................................... 52 . Recommendationsforcardiacresynchronizationtherapyin
.
.
10Complicationsofcardiacpacingandcardiacresynchronization . patientswithpersistentorpermanentatrialfibrillation .............. 35
.
.
therapy ........................................................... 53 . Recommendationforupgradefromrightventricularpacingto
.
.
10.1Generalcomplications...................................... 53 . cardiacresynchronizationtherapy .................................. 35
.
.
10.2Specificcomplications ...................................... 54 . Recommendationforpatientswithheartfailureand
.
.
10.2.1Leadcomplications..................................... 54 . atrioventricularblock .............................................. 36
.
.
10.2.2Haematoma ........................................... 54 .. Recommendationsforaddingadefibrillatorwithcardiac
.
10.2.3Infection ............................................... 54 .. resynchronizationtherapy ......................................... 37
. 10.2.4Tricuspidvalveinterference ............................ 54 .. RecommendationsforusingHisbundlepacing ...................... 41
.
10.2.5Other ................................................. 55 .. Recommendationsforusingleadlesspacing(leadlesspacemaker) .... 42
.
11Managementconsiderations .................................... 55 .. Recommendationsforcardiacpacingafteracutemyocardial
.
11.1Magneticresonanceimaginginpatientswithimplanted .. infarction ......................................................... 42
. cardiacdevices.................................................. 55 .. Recommendationsforcardiacpacingaftercardiacsurgeryand
.
11.2Radiationtherapyinpacemakerpatients..................... 57 .. hearttransplantation .............................................. 44
.
11.3Temporarypacing .......................................... 58 .. Recommendationsforcardiacpacingaftertranscatheteraortic
.
11.4Peri-operativemanagementinpatientswithcardiovascular .. valveimplantation ................................................. 46
.
implantableelectronicdevices ................................... 59 .. Recommendationsforcardiacpacinginpatientswithcongenital
.
11.5Cardiovascularimplantableelectronicdevicesandsports .. heartdisease ...................................................... 47
.
.
activity ......................................................... 59 . Recommendationsforpacinginhypertrophicobstructive
.
.
11.6Whenpacingisnolongerindicated ......................... 60 . cardiomyopathy ................................................... 48
.
.
11.7Devicefollow-up ........................................... 60 . Recommendationsforcardiacpacinginrarediseases ............... 48
.
.
12Patient-centredcareandshareddecision-makingincardiac . RecommendationforpatientswithLMNAgenemutations .......... 49
.
.
pacingandcardiacresynchronizationtherapy ....................... 61 . RecommendationsforpacinginKearns—Sayresyndrome .......... 49
.
.
13Qualityindicators .............................................. 61 . Recommendationsforpacingincardiacsarcoidosis ................. 50
.
.
14Keymessages .................................................. 63 . Recommendationsregardingdeviceimplantationsand
.
.
15Gapsinevidence ............................................... 64 . peri-operativemanagement ........................................ 53
.
.
16‘Whattodo’and‘whatnottodo’messagesfromthe . Recommendationsforperformingmagneticresonanceimaging
.
.
guidelines ......................................................... 65 . inpacemakerpatients ............................................. 57
.
.
17Supplementarydata ............................................ 67 .. Recommendationsregardingtemporarycardiacpacing ............. 59
.
18AuthorInformation ............................................ 68 .. Recommendationwhenpacingisnolongerindicated ............... 60
.
19Appendix ...................................................... 70 .. Recommendationsforpacemakerandcardiacresynchronization
.
20References ..................................................... 70 .. therapy-pacemakerfollow-up ...................................... 61
.
.. Recommendationregardingpatient-centredcareincardiacpacing
.
.. andcardiacresynchronizationtherapy.............................. 61
.
.
Tables of Recommendations .
. .
.. List of tables
.
Recommendationsfornon-invasiveevaluation ...................... 16 .
.
.
Recommendationforambulatoryelectrocardiographic . Table1Classesofrecommendations ................................ 7
.
.
monitoring ........................................................ 17 . Table2Levelsofevidence .......................................... 7
.
.
Recommendationsforexercisetesting ............................. 17 . Table3Newconceptsandsectionsincurrentguidelines ............. 8
.
.
Recommendationsregardingimagingbeforeimplantation ........... 18 . Table4Newrecommendationsin2021 ............................. 9
.
.
Recommendationsforlaboratorytests ............................. 18 . Table5Changesincardiacpacingandcardiacresynchronization
.
.
Recommendationsforgenetictesting .............................. 19 .. therapyguidelinerecommendationssince2013 ..................... 11
.
Recommendationforsleepevaluation .............................. 19 .. Table6Drugsthatmaycausebradycardiaorconduction
.
Recommendationfortilttesting .................................... 19 .. disorders ......................................................... 15
.
Recommendationforimplantablelooprecorders ................... 19 .. Table7Intrinsicandextrinsiccausesofbradycardia ................. 16
.
Recommendationsforelectrophysiologystudy .....................21 .. Table8Choiceofambulatoryelectrocardiographicmonitoring
.
Recommendationsforpacinginsinusnodedysfunction ............. 24 .. dependingonsymptomfrequency ................................. 17
.
Recommendationsforpacingforatrioventricularblock ............. 25 .. Table9Advantagesanddisadvantagesofa‘backup’ventricular
.
Recommendationsforpacinginpatientswith .. leadwithHisbundlepacing ........................................ 40
.
bundlebranchblock ............................................... 27 .. Table10Predictorsforpermanentpacingaftertranscatheter
.
Recommendationsforpacingforreflexsyncope .................... 30 . aorticvalveimplantation ........................................... 45
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 5 ---
ESCGuidelines 5
.
Table11Managementofanticoagulationinpacemaker .. AVB Atrioventricularblock
.
procedures ....................................................... 51 .. AVJ Atrioventricularjunction
.
Table12Complicationsofpacemakerandcardiac .. AVN Atrioventricularnode
.
resynchronizationtherapyimplantation ............................ 54 .. BBB Bundlebranchblock
.
Table13Frequencyoffollow-upforroutinepacemakerand .. BLOCK-HF BiventricularversusRVpacinginpatients
.
cardiacresynchronizationtherapy,eitherinpersonaloneor .. withAVblock(trial)
.
combinedwithremotedevicemanagement ........................ 60 .. b.p.m. Beatsperminute
.
Table14Topicsandcontentthatmaybeincludedinpatient .. BRUISECONTROL BridgeorContinueCoumadinfor
.
education ......................................................... 62 .. DeviceSurgeryRandomizedControlled
.
Table15Aselectionofthedevelopedqualityindicatorsfor .. Trial
.
patientsundergoingcardiovascularimplantableelectronicdevice .. BRUISECONTROL-2 RandomizedControlledTrialof
.
implantation....................................................... 63 .. ContinuedVersusInterruptedDirect
. .
. OralAnti-CoagulantattheTimeof
List of figures ..
. DeviceSurgery
.
.
. CABG Coronaryarterybypassgraft
Figure1CentralIllustration ........................................ 12 ..
. CARE-HF CArdiacREsynchronizationinHeart
Figure2Classificationofdocumentedandsuspected ..
bradyarrhythmias.................................................. 13
... Failure(trial)
Figure3Initialevaluationofpatientswithsymptomssuggestiveof
... CHD Congenitalheartdisease
bradycardia ....................................................... 15
... CI Confidenceinterval
Figure4Evaluationofbradycardiaandconductiondisease
... CIED Cardiovascularimplantableelectronic
algorithm ......................................................... 20
... device
Figure5Optimalpacingmodeandalgorithmselectioninsinus
... CMR Cardiovascularmagneticresonance
nodedysfunctionandatrioventricularblock ........................ 23
... COMPANION COmparisonofMedicaltherapy,PAcing
Figure6Decisionalgorithmforpatientswithunexplainedsyncope
... aNddefibrillatION(trial)
.. CPAP Continuouspositiveairwaypressure
andbundlebranchblock ........................................... 26 .
.. CRT Cardiacresynchronizationtherapy
Figure7Decisionpathwayforcardiacpacinginpatientswith .
.. CRT-D Defibrillatorwithcardiac
reflexsyncope .................................................... 28 .
.. resynchronizationtherapy
Figure8Summaryofindicationsforpacinginpatients>40years .
.
. CRT-P Cardiacresynchronizationtherapy-
ofagewithreflexsyncope ......................................... 29 .
.
. pacemaker
Figure9Indicationforatrioventricularjunctionablationinpatients .
.
. CSM Carotidsinusmassage
withsymptomaticpermanentatrialfibrillationorpersistentatrial .
.
. CSS Carotidsinussyndrome
fibrillationunsuitableforatrialfibrillationablation ................... 34 .
.
. CT Computedtomography
Figure10Patient’sclinicalcharacteristicsandpreferencetobe .
.
. DANPACE DANishMulticenterRandomized
consideredforthedecision-makingbetweencardiac .
.
. TrialonSingleLeadAtrialPACingvs.
resynchronizationtherapypacemakerordefibrillator ............... 38 ..
. DualChamberPacinginSickSinus
Figure11Threepatientswithdifferenttypesoftransitionsin ..
. Syndrome
QRSmorphologywithHisbundlepacinganddecrementing ..
. DDD Dual-chamber,atrioventricularpacing
pacingoutput ..................................................... 39 ..
Figure12Managementofconductionabnormalitiesafter
... ECG Electrocardiogram/electrocardiographic
transcatheteraorticvalveimplantation ............................. 45
... Echo-CRT EchocardiographyGuidedCardiac
Figure13Integratedmanagementofpatientswithpacemakerand
... ResynchronizationTherapy(trial)
cardiacresynchronizationtherapy .................................. 56
... EF Ejectionfraction
Figure14Flowchartforevaluatingmagneticresonanceimagingin
... EHRA EuropeanHeartRhythmAssociation
pacemakerpatients ................................................ 57
... EMI Electromagneticinterference
Figure15Pacemakermanagementduringradiationtherapy ......... 58
... EORP EurObservationalResearchProgramme
Figure16Exampleofshareddecision-makinginpatients
... EPS Electrophysiologystudy
.. ESC EuropeanSocietyofCardiology
consideredforpacemaker/CRTimplantation ....................... 62 .
.. EuroHeart EuropeanUnifiedRegistriesOnHeart
.
.. CareEvaluationandRandomizedTrials
.
Abbreviations and acronyms .. HBP Hisbundlepacing
.
.
. HCM Hypertrophiccardiomyopathy
.
AF Atrialfibrillation .. HF Heartfailure
.
APAF AblateandPaceinAtrialFibrillation .. HFmrEF Heartfailurewithmildlyreducedejection
.
(trial) .. fraction
.
.
ATP Antitachycardiapacing . HFpEF Heartfailurewithpreservedejection
.
.
AV Atrioventricular . fraction
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 6 ---
6 ESCGuidelines
.
HFrEF Heartfailurewithreducedejection .. SAR Specificabsorptionrate
.
fraction .. SAS Sleepapnoeasyndrome
.
HOT-CRT His-optimizedcardiacresynchronization .. SCD Suddencardiacdeath
.
therapy .. SND Sinusnodedysfunction
.
HR Hazardratio .. SR Sinusrhythm
.
.
HV His(cid:2)ventricularinterval(timefromthe . TAVI Transcatheteraorticvalveimplantation
.
.
beginningoftheHdeflectiontothe . VKA VitaminKantagonist
.
.
earliestonsetofventricular . WRAP-IT World-wideRandomizedAntibiotic
.
.
depolarizationrecordedinanylead, . EnvelopeInfectionPreventionTrial
.
.
electrophysiologystudyoftheheart) .
.
.
ICD Implantablecardioverter-defibrillator .
.
ILR Implantablelooprecorder .. 1 Preamble
. .
LBBB Leftbundlebranchblock .
.
LGE Lategadoliniumcontrastenhanced .. Guidelinessummarizeandevaluateavailableevidencewiththeaimof
.
LQTS LongQTsyndrome .. assisting health professionals in proposing the best management
.
LV Leftventricular .. strategiesforanindividualpatientwithagivencondition.Guidelines
. .
LVEF Leftventricularejectionfraction .. and their recommendations should facilitate decision-making of
.
MADIT-CRT MulticenterAutomaticDefibrillator .. healthprofessionalsintheirdaily practice.However, thefinaldeci-
.
ImplantationwithCardiac .. sionsconcerninganindividualpatientmustbemadebytheresponsi-
.
ResynchronizationTherapy(trial) .. ble health professional(s) in consultation with the patient and
.
MI Myocardialinfarction .. caregiver,asappropriate.
.
MIRACLE MulticenterInsyncRAndomizedClinical .. Agreatnumberofguidelineshavebeenissuedinrecentyearsby
.
Evaluation(trial) .. theEuropeanSocietyofCardiology(ESC),aswellasbyothersoci-
.
MOST MOdeSelectionTrialinSinus-Node .. etiesandorganizations.Becauseoftheirimpactonclinicalpractice,
.
Dysfunction .. quality criteria for the development ofguidelines have been estab-
.
MRI Magneticresonanceimaging .. lishedinordertomakealldecisionstransparenttotheuser.Therec-
.
MUSTIC MUltisiteSTimulationIn .. ommendations for formulating and issuing ESC Guidelines can be
.
Cardiomyopathies(trial) .. found on the ESC website (https://www.escardio.org/Guidelines).
.
NOAC Non-vitaminKantagonistoral .. TheESCGuidelinesrepresenttheofficialpositionoftheESCona
.
anticoagulant .. giventopicandareregularlyupdated.
.
NYHA NewYorkHeartAssociation .. InadditiontothepublicationofClinicalPracticeGuidelines,theESC
.
OAC Oralanticoagulant .. carriesouttheEurObservationalResearchProgrammeofinternational
.
OMT Optimalmedicaltherapy .. registriesofcardiovasculardiseasesandinterventionswhichareessen-
.
OR Oddsratio .. tial toassessdiagnostic/therapeuticprocesses,use ofresources,and
.
PATH-CHF PAcingTHerapiesinCongestiveHeart .. adherence to guidelines. These registries aim at providing a better
.
Failure(trial) .. understanding of medical practice in Europe and around the world,
.
PCCD Progressivecardiacconductiondisease .. basedonhigh-qualitydatacollectedduringroutineclinicalpractice.
.
PCI Percutaneouscoronaryintervention .. Furthermore,theESChasdevelopedandembeddedinthisdocu-
.
.
PET Positronemissiontomography .. mentasetofqualityindicators(QIs),whicharetoolstoevaluatethe
.
PM Pacemaker .. level of implementation of the guidelines and may be used by the
.
RA Rightatrium/atrial .. ESC, hospitals, healthcare providers, and professionals to measure
.
RAFT Resynchronization(cid:2)Defibrillationfor .. clinicalpracticeaswellasineducationalprogrammes,alongsidethe
.
AmbulatoryHeartFailureTrial .. keymessagesfromtheguidelines,toimprovequalityofcareandclini-
.
RBBB Rightbundlebranchblock .. caloutcomes.
.
RCT Randomizedcontrolledtrial .. TheMembersofthisTaskForcewereselectedbytheESC,includ-
.
RESET-CRT Re-evaluationofOptimalRe- .. ingrepresentationfromitsrelevantESCsubspecialtygroups,inorder
.
synchronisationTherapyinPatientswith .. torepresentprofessionalsinvolvedwiththemedicalcareofpatients
.
ChronicHeartFailure(trial) .. withthispathology.Selectedexpertsinthefieldundertookacom-
.
REVERSE REsynchronizationreVErsesRemodelling .. prehensive review of the published evidence for management of a
.
inSystolicleftvEntriculardysfunction .. given condition according to ESC Clinical Practice Guidelines
.
(trial) .. Committee(CPG)policy.Acriticalevaluationofdiagnosticandther-
.
RV Rightventricular/rightventricle .. apeutic procedures was performed, including assessment of the
.
RVA Rightventricularapical .. risk(cid:2)benefitratio.Thelevelofevidenceandthestrengthoftherec-
.
RVOT Rightventricularoutflowtract .. ommendationofparticularmanagementoptionswereweighedand
.
RVS Rightventricularseptum .. gradedaccordingtopre-definedscales,asoutlinedbelow.
.
S.aureus Staphylococcusaureus .. Theexpertsofthewritingandreviewingpanelsprovideddeclara-
.
. tionofinterestformsforallrelationshipsthatmightbeperceivedas
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 7 ---
ESCGuidelines 7
Table1 Classesofrecommendations
Wording to use
Class I Evidence and/or general agreement Is recommended or is indicated
that a given treatment or procedure is
Class II
Class IIa Weight of evidence/opinion is in Should be considered
Class IIb May be considered
established by evidence/opinion.
Class III Evidence or general agreement that the Is not recommended
given treatment or procedure is not
useful/effective, and in some cases
may be harmful.
Table2 Levelsofevidence
Level of Data derived from multiple randomized clinical trials
evidence A or meta-analyses.
Level of Data derived from a single randomized clinical trial
evidence B or large non-randomized studies.
Level of Consensus of opinion of the experts and/or small studies,
evidence C retrospective studies, registries.
.
.
realorpotentialsourcesofconflictsofinterest.Theirdeclarationsof . endorsement process of these Guidelines. The ESC Guidelines
.
.
interestwerereviewedaccordingtotheESCdeclarationofinterest . undergoextensivereviewbytheCPGandexternalexperts.After
.
.
rulesandcanbefoundontheESCwebsite(http://www.escardio.org/ . appropriate revisions, the guidelines are signed-off by all the
.
.
guidelines) and have been compiled in a report and published in a . experts involved in the Task Force. The finalized document is
.
.
supplementarydocumentsimultaneouslywiththeguidelines. . signed-off by the CPG for publication in the European Heart
.
.
Thisprocessensurestransparencyandpreventspotentialbiasesin . Journal.Theguidelinesweredevelopedaftercarefulconsideration
.
.
thedevelopmentandreviewprocesses.Anychangesindeclarations . ofthescientificandmedicalknowledgeandtheevidenceavailable
.
.
ofinterestthataroseduringthewritingperiodwerenotifiedtothe . atthetimeoftheirdating.
.
.
ESCandupdated.TheTaskForcereceiveditsentirefinancialsupport . ThetaskofdevelopingESCGuidelinesalsoincludesthecreation
.
.
fromtheESCwithoutanyinvolvementfromthehealthcareindustry. .. ofeducationaltoolsandimplementationprogrammesfortherecom-
.
The ESC CPG supervises and coordinates the preparation of .. mendationsincludingcondensedpocketguidelineversions,summary
.
new guidelines. The Committee is also responsible for the . slides,summarycardsfornon-specialists,and anelectronicversion
snoitadnemmocer
fo
sessalC
1202
CSE©
1202
CSE©
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 8 ---
8 ESCGuidelines
.
.
for digital applications (smartphones, etc.). These versions are . Pericardial Diseases, as well as the Association of Cardiovascular
.
.
abridged and thus, for more detailed information, the user should . Nursing&AlliedProfessions.
.
.
alwaysaccesstothefulltextversionoftheguidelines,whichisfreely .
.
available via the ESC website and hosted on the EHJ website. The .. 2.1 Evidence review
.
.
NationalCardiacSocieties oftheESC are encouraged toendorse, .. Thisdocumentisdividedintosections,eachwithasectioncoordina-
.
adopt,translate,andimplementallESCGuidelines.Implementation .. torandseveralauthors.Theywereaskedtothoroughlyreviewthe
.
programmes are needed because it has been shown that the out- .. recentliteratureontheirtopics,andtocomeupwithrecommenda-
.
comeofdiseasemaybefavourablyinfluencedbythethoroughappli- .. tionsandgradethembyclassificationaswellasbylevelofevidence.
.
cationofclinicalrecommendations. .. Wheredataseemedcontroversial,amethodologist(DipakKotecha)
.
HealthprofessionalsareencouragedtotaketheESCGuidelines .. wasaskedtoevaluatethestrengthoftheevidenceandtoassistin
.
fullyintoaccountwhenexercisingtheirclinicaljudgement,aswellas .. determiningtheclassofrecommendationandlevelofevidence.All
.
inthedeterminationandtheimplementationofpreventive,diagnos- .. recommendationswerevotedonbyallauthorsofthedocumentand
. tic,ortherapeuticmedicalstrategies.However,theESCGuidelines .. wereacceptedonlyifsupportedbyatleast75%oftheco-authors.
.
donotoverrideinanywaywhatsoevertheindividualresponsibility .. The leaders(JensCosedisNielsenand Michael Glikson) and the
.
ofhealthprofessionalstomakeappropriateandaccuratedecisionsin .. coordinators of this document (Yoav Michowitz and Mads Brix
.
considerationofeachpatient’shealthconditionandinconsultation .. Kronborg)wereresponsibleforalignmentoftherecommendations
. withthatpatientorthepatient’scaregiverwhereappropriateand/or .. between sections, and several members of the writing committee
.
necessary. Itis alsothehealth professional’s responsibility to verify .. wereresponsibleforoverlapwithotherESCGuidelines,suchasthe
.
therulesandregulationsapplicableineachcountrytodrugsanddevi- .. HFguidelinesandthevalvularheartdiseaseguidelines.
.
cesatthetimeofprescription. ..
.
.
. 2.2 Relationships with industry
.
.
.
. All work in this document was voluntary and all co-authors were
.
2 Introduction .
. requiredtodeclareandprovethattheydonothaveconflictsofinter-
.
.
. ests,asdefinedrecentlybytheScientificGuidelineCommitteeofthe
.
Pacingisanimportantpartofelectrophysiologyandofcardiologyin .. ESCandtheESCboard.
.
general.Whereassomeofthesituationsrequiringpacingareclearand .
.
.
havenotchangedovertheyears,manyothershaveevolvedandhave .. 2.3 What is new in these guidelines
.
beenthesubjectofextensiverecentresearch,suchaspacingaftersyn- ... ...
2.3.1 Newconceptsandnewsections
cope(section5),pacingfollowingtranscatheteraorticvalveimplanta- .. ..
.
tion (TAVI; section 8), cardiac resynchronization therapy (CRT) for ...
Table3 Newconceptsandsectionsincurrent
heartfailure(HF)andforpreventionofpacing-inducedcardiomyop- ...
guidelines
athy(section6),andpacinginvariousinfiltrativeandinflammatorydis- ..
easesoftheheart,aswellasindifferentcardiomyopathies(section8).
... Concept/section Section
Othernoveltopicsincludenewdiagnostictoolsfordecision-making ... Newsectionontypesandmodesofpacing,includingcon- 3.4
.
onpacing(section4),aswellasawholenewareaofpacingtheHisbun- .. ductionsystempacingandleadlesspacing
.
dle and the left bundle branch (section 7). In addition, attention has .. Newsectiononsexdifferencesinpacing 3.5
.
increasedinotherareas,suchashowtosystematicallyminimizepro- .. Newsectiononevaluationofpatientsforpacing 4
.
ceduralriskandavoidcomplicationsofcardiacpacing(section9),how .. ExpandedandupdatedsectiononCRT 6
.
tomanagepatientswithpacemakersinspecialsituations,suchaswhen .. Newsectiononalternativepacingstrategiesandsites 7
. magneticresonanceimaging(MRI)orirradiationareneeded (section ...
Expandedandupdatedsectiononpacinginspecificcon- 8 11),howtofollowpatientswithapacemakerwithemphasisonthe ...
ditions,includingdetailednewsectionsonpostTAVI,
.
useofremotemonitoring,andhowtoincludeshareddecision-making .. postoperativeandpacinginthepresenceoftricuspid
.
incaringforthispatientpopulation(section12). .. valvediseases,andoperations
.
ThelastpacingguidelinesoftheEuropeanSocietyofCardiology .
. Anewsectiononimplantationandperioperativemanage- 9
.
(ESC)werepublishedin2013;therefore,anewsetofguidelineswas .
. ment,includingperioperativeanticoagulation
.
felttobetimelyandnecessary. .
.. AnexpandedrevisedsectiononCIEDcomplications 10
Toaddressthese topics,aTaskForcewasestablished tocreate .
.
. Anewsectiononvariousmanagementconsiderations, 11
thenewguidelines.Aswellasreceivingtheinputofleadingexpertsin .
.
. includingMRI,radiotherapy,temporarypacing,periopera- thefieldofpacing,theTaskForcewasenhancedbyrepresentatives .
.
. tivemanagement,sportactivity,andfollowup
from the Association for Acute CardioVascular Care, the Heart . .
. Anewsectiononpatient-centredcare 12
Failure Association, the European Association of Cardiothoracic .
.
.
Surgery, the EuropeanAssociationofPercutaneous Cardiovascular .. CIED=cardiovascularimplantableelectronicdevice;CRT=cardiacresynchroni-
. zationtherapy;MRI=magneticresonanceimaging;TAVI=transcatheteraortic
Interventions, the ESC Working Group on Myocardial and ..
valveimplantation.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 9 ---
ESCGuidelines 9
.
2.3.2 Newrecommendationsin2021 .
. Laboratorytests
.
.
.. Inadditiontopreimplantlaboratorytests,dspe-
Table4 Newrecommendationsin2021 ...
cificlaboratorytestsarerecommendedin
.
Recommendations Classa Levelb
... patientswithclinicalsuspicionforpotential
I C
.. causesofbradycardia(e.g.thyroidfunctiontests,
.
Evaluationofthepatientwithsuspectedordocumentedbrady- .. Lymetitre,digitalislevel,potassium,calcium,and
.
cardiaorconductionsystemdisease .. pH)todiagnoseandtreattheseconditions.
.
.
Monitoring . Sleepevaluation
.
.
Inpatientswithinfrequent(lessthanoncea . ScreeningforSASisrecommendedinpatients
.
.
month)unexplainedsyncopeorothersymp- . withsymptomsofSASandinthepresenceof
.. I C
tomssuspectedtobecausedbybradycardia,in
I A
... severebradycardiaoradvancedAVBduring
whomacomprehensiveevaluationdidnotdem- .. sleep.
.
onstrateacause,long-termambulatorymonitor- .. Electrophysiologicalstudy
.
ingwithanILRisrecommended. .. Inpatientswithsyncopeandbifascicularblock,
.
.
Ambulatoryelectrocardiographicmonitoringis . EPSshouldbeconsideredwhensyncope
.
. recommendedintheevaluationofpatientswith . remainsunexplainedafternon-invasiveevalua-
I C .
.
suspectedbradycardiatocorrelaterhythmdis- . tionorwhenanimmediatedecisionaboutpac- IIa B
.
.
turbanceswithsymptoms. . ingisneededduetoseverity,unlessempirical
.
.
Carotidmassage .. pacemakerimplantationispreferred(especially
.
Oncecarotidstenosisisruledoutc,carotidsinus .. inelderlyandfrailpatients).
.
massageisrecommendedinpatientswithsyn- .. Inpatientswithsyncopeandsinusbradycardia,
.
copeofunknownorigincompatiblewithareflex I B .. EPSmaybeconsideredwhennon-invasivetests
. IIb B
mechanismorwithsymptomsrelatedtopres- .. havefailedtoshowacorrelationbetweensyn-
.
.
sure/manipulationofthecarotidsinusarea. . copeandbradycardia.
.
.
Tilttest . Genetics
.
.
Tilttestingshouldbeconsideredinpatientswith .. Genetictestingshouldbeconsideredinpatients
IIa B .
suspectedrecurrentreflexsyncope. .. withearlyonset(age<50years)ofprogressive IIa C
.
Exercisetest .. cardiacconductiondisease.
.
.
Exercisetestingisrecommendedinpatients . Genetictestingshouldbeconsideredinfamily
.
.
whoexperiencesymptomssuspiciousofbrady- I C .. membersfollowingtheidentificationofapatho-
.
cardiaduringorimmediatelyafterexertion. .. genicgeneticvariantthatexplainstheclinical IIa C
.
Inpatientswithsuspectedchronotropicincom- .. phenotypeofcardiacconductiondiseaseinan
.
petence,exercisetestingshouldbeconsidered IIa B .. indexcase.
.
toconfirmthediagnosis. .. Cardiacpacingforbradycardiaandconductionsystemdisease
.
.
Inpatientswithintra-ventricularconductiondis- . Pacingisindicatedinsymptomaticpatientswith
. .
easeorAVBofunknownlevel,exercisetesting IIb C . thebradycardia-tachycardiaformofSNDtocor-
.
maybeconsideredtoexposeinfranodalblock. .. rectbradyarrhythmiasandenablepharmacologi- I B
.
.
Imaging .. caltreatment,unlessablationofthe
.
. tachyarrhythmiaispreferred. Cardiacimagingisrecommendedinpatients .
.
withsuspectedordocumentedsymptomatic .. Pacingisindicatedinpatientswithatrialarrhyth-
.
bradycardiatoevaluatethepresenceofstruc- .. mia(mainlyAF)andpermanentorparoxysmal
turalheartdisease,todetermineleftventricular
I C ...
third-orhigh-degreeAVBirrespectiveof
I C
.
systolicfunction,andtodiagnosepotential .. symptoms.
.
.
causesofconductiondisturbances. . InpatientswithSNDandDDDPM,minimiza-
.
Multimodalityimaging(CMR,CT,PET)should ... tionofunnecessaryventricularpacingthrough I A
.
beconsideredformyocardialtissuecharacter- .. programmingisrecommended.
.
izationinthediagnosisofspecificpathologies .. Dualchambercardiacpacingisindicatedto
IIa C .
associatedwithconductionabnormalitiesneed- .. reducerecurrentsyncopeinpatientsaged>40
.
ingpacemakerimplantation,particularlyin .. yearswithsevere,unpredictable,recurrentsyn-
.
patientsyoungerthan60years. .. copewhohave:
.
Continued .. • spontaneousdocumentedsymptomaticasys- I A
.
.. tolicpause/s>3sorasymptomaticpause/s
.
.. >6sduetosinusarrestorAVB;or
.
.. • cardioinhibitorycarotidsinussyndrome;or
.
.. • asystolicsyncopeduringtilttesting.
Continued
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 10 ---
10 ESCGuidelines
.
.
Inpatientswithrecurrentunexplainedfalls,the . HBPwithaventricularbackupleadmaybecon-
.
.
sameassessmentasforunexplainedsyncope IIa C . sideredinpatientsinwhoma“pace-and-ablate”
.
.
shouldbeconsidered. . strategyforrapidlyconductedsupraventricular IIb C
.
.
AFablationshouldbeconsideredasastrategy .. arrhythmiaisindicated,particularlywhenintrin-
.
toavoidpacemakerimplantationinpatientswith .. sicQRSisnarrow.
.
AF-relatedbradycardiaorsymptomaticpre- IIa C .. HBPmaybeconsideredasanalternativetoright
.
automaticitypauses,afterAFconversion,taking .. ventricularpacinginpatientswithAVBandLVEF
. IIb C
intoaccounttheclinicalsituation. .. >40%,whoareanticipatedtohave>20%ven-
.
Inpatientswiththebradycardia-tachycardiavar- .. tricularpacing.
.
.
iantofSND,programmingofatrialATPmaybe IIb B . Leadlesspacing
.
.
considered. .. Leadlesspacemakersshouldbeconsideredasan
.
Dual-chambercardiacpacingmaybeconsidered .. alternativetotransvenouspacemakerswhenno
.
toreducesyncoperecurrencesinpatientswith
IIb B
... upperextremityvenousaccessexistsorwhen
IIa B
theclinicalfeaturesofadenosine-sensitive .. riskofdevicepocketinfectionisparticularly
.
syncope. .. high,suchaspreviousinfectionandpatientson
.
Cardiacresynchronizationtherapy .. haemodialysis.
.
.
InpatientswhoarecandidatesforanICDand . Leadlesspacemakersmaybeconsideredasan
.
.
whohaveCRTindication,implantationofa I A . alternativetostandardsingleleadventricular
.. IIb C
CRT-Disrecommended. .. pacing,takingintoconsiderationlifeexpectancy
.
InpatientswhoarecandidatesforCRT,implan- .. andusingshareddecision-making.
.
tationofaCRT-Dshouldbeconsideredafter .. Indicationsforpacinginspecificconditions
IIa B .
individualriskassessmentandusingshareddeci- .. Pacinginacutemyocardialinfarction
.
sion-making. .. Implantationofapermanentpacemakerisindi-
.
.
InpatientswithsymptomaticAFandanuncon- . catedwiththesamerecommendationsasina
.
.
trolledheartratewhoarecandidatesforAVJ . generalpopulation(section5.2)whenAVBdoes I C
.
.
ablation(irrespectiveofQRSduration),CRT IIa C . notresolvewithinawaitingperiodofatleast5
.
.
ratherthanstandardRVpacingshouldbecon- . daysafterMI.
.
.
sideredinpatientswithHFmrEF. .. InselectedpatientswithAVBincontextofante-
.
InpatientswithsymptomaticAFandanuncon- .. riorwallMIandacuteHF,earlydeviceimplanta- IIb C
.
trolledheartratewhoarecandidatesforAVJ .. tion(CRT-D/CRT-P)maybeconsidered.
IIa B .
ablation(irrespectiveofQRSduration),RVpac- .. Pacingincardiacsurgery
.
ingshouldbeconsideredinpatientswithHFpEF. ... 1)High-degreeorcompleteAVBaftercardiac
.
InpatientswithsymptomaticAFandanuncon- .. surgery.Aperiodofclinicalobservationforat
.
trolledheartratewhoarecandidatesforAVJ
IIb B
... least5daysisindicatedinordertoassess
ablation(irrespectiveofQRSduration),CRT .. whethertherhythmdisturbanceistransientand
. I C maybeconsideredinpatientswithHFpEF. .. resolves.However,inthecaseofcompleteAVB
.
Alternatesitepacing .. withlowornoescaperhythmwhenresolution
.
Hisbundlepacing .. isunlikely,thisobservationperiodcanbe .
InpatientstreatedwithHBP,deviceprogram- ... shortened.
.
mingtailoredtospecificrequirementsofHis I C .. SNDaftercardiacsurgeryandhearttransplanta-
.
bundlepacingisrecommended. ... tion.Beforepermanentpacemakerimplantation,
IIa C
InCRTcandidatesinwhomcoronarysinuslead .. aperiodofobservationforupto6weeksshould
.
implantationisunsuccessful,HBPshouldbecon- .. beconsidered.
IIa B .
sideredasatreatmentoptionalongwithother .. Chronotropicincompetenceafterhearttrans-
.
techniquessuchassurgicalepicardiallead. .. plantation.Cardiacpacingshouldbeconsidered
.
InpatientstreatedwithHBP,implantationofa .. forchronotropicincompetencepersistingmore IIa C
.
rightventricularleadusedas“backup”forpacing ... than6weeksafterhearttransplantationto
shouldbeconsideredinspecificsituations(e.g. ... improvequalityoflife.
.
pacemaker-dependency,high-gradeAVB,infra-
IIa C
... Continued
nodalblock,highpacingthreshold,plannedAVJ ..
.
ablation),orforsensingincaseofissueswith ..
.
detection(e.g.riskofventricularundersensing ..
.
oroversensingofatrial/Hispotentials). ..
.
Continued ..
.
.
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 11 ---
ESCGuidelines 11
.
Surgeryforvalvularendocarditisandintraopera- .. AmbulatoryECGmonitoringgorelectrophysiol-
.
tivecompleteAVB.Immediateepicardialpace- .. ogystudyhmaybeconsideredforTAVIpatients
.
.
makerimplantationshouldbeconsideredin . withpre-existingconductionabnormalitywho IIb C
.
.
patientswithsurgeryforvalvularendocarditis . developfurtherprolongationofQRSorPR
.
.
andcompleteAVBifoneofthefollowingpredic- IIa C . >20ms.
.
.
torsofpersistenceispresent:preoperativecon- .. Prophylacticpermanentpacemakerimplantation
.
ductionabnormality,Staphylococcusaureus .. isnotindicatedbeforeTAVIinpatientswith III C
.
infection,intracardiacabscess,tricuspidvalve .. RBBBandnoindicationforpermanentpacing.
.
involvement,orpreviousvalvularsurgery. .. Varioussyndromes
.
Patientsrequiringpacingatthetimeoftricuspid .. Inpatientswithneuromusculardiseasessuchas
.
valvesurgery.Transvalvularleadsshouldbe .. myotonicdystrophytype1andanysecond-or
avoidedandepicardialventricularleadsused.
...
third-degreeAVBorHV>_70ms,withorwith-
I C
.
Duringtricuspidvalvesurgery,removalofpre- ... outsymptoms,permanentpacingisindicated.i
existingtransvalvularleadsshouldbeconsidered ...
InpatientswithLMNAgenemutations,including
andpreferredoversewing-intheleadbetween IIa C ...
Emery-Dreifussandlimbgirdlemusculardystro-
.
theannulusandabio-prosthesisorannuloplasty .. phieswhofulfilconventionalcriteriaforpace-
.
ring.Inthecaseofanisolatedtricuspidannulo- .. makerimplantationorwhohaveprolongedPR IIa C
.
plastybasedonanindividualrisk-benefitanalysis, .
. withLBBB,ICDimplantationwithpacingcapabil-
.
apre-existingrightventricularleadmaybeleftin .
. itiesshouldbeconsideredifatleast1-yearsur-
.
placewithoutjailingitbetweenringandannulus. .
. vivalisexpected.
.
Patientsrequiringpacingafterbiologicaltricuspid ..
InpatientswithKearns-Sayresyndromewho
.
v Walv he enre vp el nac tre im cue lan rt/ ptr ai cc iu ns gp ii sd inva dl iv ce atr ein dg ,tr re ap na si vr e.
-
......
h da leve brP aR ncp hro bl lo on cg ka ,t oio rn fa, sa cn icy ud lae rgr be loe co kf ,A peV rB m, ab nu en n-
t
IIa C
nousimplantationofacoronarysinusleador
IIa C
...
pacingshouldbeconsidered.
minimallyinvasiveplacementofanepicardial ...
Inpatientswithneuromusculardiseasesuchas
ventricularleadshouldbeconsideredandpre- ..
. myotonicdystrophytype1withPR>_240msor
ferredoveratransvenoustransvalvular .. IIb C
. QRSduration>_120ms,permanentpacemaker
approach. ...
implantationmaybeconsidered.i
.
Patientsrequiringpacingaftermechanicaltricus- .
. InpatientswithKearns-SayreSyndromewithout
.
pidvalvereplacement.Implantationofatrans- III C .
.. cardiacconductiondisorder,permanentpacing IIb C
valvularrightventricularleadshouldbeavoided. .
.. maybeconsideredprophylactically.
Pacingintranscatheteraorticvalveimplantation ...
Sarcoidosis
.
Permanentpacingisrecommendedinpatients .
. Inpatientswithcardiacsarcoidosiswhohave
withcompleteorhigh-degreeAVBthatpersists I B ..
. permanentortransientAVB,implantationofa
for24-48hafterTAVI. .. IIa C
. devicecapableofcardiacpacingshouldbe
.
Permanentpacingisrecommendedinpatients
I C
... considered.i
withnewonsetalternatingBBBafterTAVI. ...
Inpatientswithsarcoidosisandindicationfor
Earlyepermanentpacingshouldbeconsideredin ...
permanentpacingwhohaveLVEF<50%,implan- IIa C
patientswithpre-existingRBBBwhodevelop
IIa B
...
tationofaCRT-Dshouldbeconsidered. anyfurtherconductiondisturbanceduringor ..
. Specialconsiderationsondeviceimplantationsandperiopera-
afterTAVI.f ..
. tivemanagement
AmbulatoryECGmonitoringgoranelectro- ..
physiologystudyhshouldbeconsideredfor
... Administrationofpreoperativeantibioticpro-
.. phylaxiswithin1hofskinincisionisrecom- I A
patientswithnewLBBBwithQRS>150msor IIa C .
.. mendedtoreduceriskofCIEDinfection.
PR>240mswithnofurtherprolongationduring .
.. Chlorhexidinealcoholinsteadofpovidone-
>48hafterTAVI. ...
iodinealcoholshouldbeconsideredforskin IIa B
Continued ..
. antisepsis.
.
.
. Continued
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 12 ---
12 ESCGuidelines
.
.
Forvenousaccess,thecephalicoraxillaryvein
IIa B
... In-officeroutinefollow-upofsingle-anddual-
shouldbeconsideredasfirstchoice. ... chamberpacemakersmaybespacedbyupto24
IIa A
Forimplantationofcoronarysinusleads,quadri- .. monthsinpatientsonremotedevice
IIa C .
polarleadsshouldbeconsideredasfirstchoice. .. management.
.
.
Toconfirmtargetventricularleadposition,use . Temporarypacing
.
.
ofmultiplefluoroscopicviewsshouldbe IIa C . Temporarytransvenouspacingisrecommended
.
.
considered. . incasesofhaemodynamic-compromisingbra-
.. I C
Rinsingthedevicepocketwithnormalsalinesol- .. dyarrhythmiarefractorytointravenouschrono-
.
utionbeforewoundclosureshouldbe IIa C .. tropicdrugs.
.
considered. .. Transcutaneouspacingshouldbeconsideredin
.
InpatientsundergoingareinterventionCIED .. casesofhaemodynamiccompromisingbradyar-
. IIa C
procedure,theuseofanantibiotic-elutingenve- IIb B .. rhythmiawhentemporarytransvenouspacingis
.
lopemaybeconsidered. .. notpossibleoravailable.
.
.
Pacingofthemid-ventricularseptummaybe .. Temporarytransvenouspacingshouldbecon-
.
consideredinpatientswithahighriskofperfora- IIb C .. sideredwhenimmediatepacingisindicatedand
.
tion(elderly,previousperforation). ... pacingindicationsareexpectedtobereversible,
IIa C
Inpacemakerimplantationsinpatientswithpos- .. suchasinthecontextofmyocardialischaemia, .
siblepocketissuessuchasincreasedriskofero- .. myocarditis,electrolytedisturbances,toxic
.
sionduetolowbodymassindex,Twiddler’s IIb C .. exposure,oraftercardiacsurgery.
.
syndromeoraestheticreasons,asubmuscular .. Temporarytransvenouspacingshouldbecon-
.
devicepocketmaybeconsidered. .. sideredasabridgetopermanentpacemaker
.
Heparin-bridgingofanticoagulatedpatientsis ... implantation,whenthisprocedureisnotimme- IIa C
III A .
notrecommended. .. diatelyavailableorpossibleduetoconcomitant
.
. infection.
Permanentpacemakerimplantationisnotrec- .
.
ommendedinpatientswithfever.Pacemaker .. Forlong-termtemporarytransvenouspacing,an
III B .
implantationshouldbedelayeduntilthepatient ... activefixationleadinsertedthroughtheskinand
IIa C
hasbeenafebrileforatleast24h. .. connectedtoanexternalpacemakershouldbe
.
Managementconsiderations
... considered.
Remotemonitoring
... Miscellaneous
.
. Whenpacingisnolongerindicated,adecision
Remotedevicemanagementisrecommendedto .
.
. onthemanagementstrategyshouldbebasedon
reducenumberofin-officefollow-upinpatients .
.
. anindividualrisk-benefitanalysisinashared I C
withpacemakerswhohavedifficultiestoattend .
I A .. decision-makingprocesstogetherwiththe
in-officevisits(e.g.duetoreducedmobilityor .
.
. patient.
othercommitmentsoraccordingtopatient .
.
preference). .. MRImaybeconsideredinpacemakerpatients
.
Remotemonitoringisrecommendedincaseofa
... withabandonedtransvenousleadsifnoalterna- IIb C
devicecomponentthathasbeenrecalledoris
... tiveimagingmodalityisavailable.
.
onadvisory,toenableearlydetectionofaction- .. Continued
I C .
ableeventsinpatients,particularlythosewho ..
.
areatincreasedrisk(e.g.incaseofpacemaker- ..
.
dependency). ..
.
.
Continued .
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 13 ---
ESCGuidelines 13
.
.
Patient-centredcare . Cardiacresynchronizationtherapy
.
.
InpatientsconsideredforpacemakerorCRT, .. Patientswhohavereceivedaconventionalpace-
.
thedecisionshouldbebasedonthebest .. makeroranICDandwhosubsequentlydevelop
.
availableevidencewithconsiderationof .. symptomaticHFwithLVEF<_35%despiteOMT
. I IIa
individualrisk-benefitsofeachoption,the .. andwhohaveasignificantbproportionofRV
.
patient(cid:2)spreferences,andgoalsofcare,anditis I C .. pacingshouldbeconsideredforupgradeto
.
recommendedtofollowanintegratedcare .. CRT.
.
approachandusetheprinciplesofpatient- .. CRTratherthanRVpacingisrecommendedfor .
centredcareandshareddecisionmakingin .. patientswithHFrEF(<40%)regardlessofNYHA
.
theconsultation. .. classwhohaveanindicationforventricularpac- IIa I
.
.
. ingandhigh-degreeAVBinordertoreduce
AF=atrialfibrillation;ATP=antitachycardiapacing;AV=atrioventricular;AVB .
.
=atrioventricularblock;AVJ=atrioventricularjunction;BBB=bundlebranch .. morbidity.ThisincludespatientswithAF.
.
block; BMI = body mass index; CIED = cardiovascular implantable electronic .. CRTshouldbeconsideredforsymptomatic
device;CMR=cardiovascularmagneticresonance;CRT=cardiacresynchroniza- .
tion therapy; CRT-D = defibrillator with cardiac resynchronization therapy;
... patientswithHFinSRwithLVEF<_35%,aQRS
CRT-P = cardiac resynchronization therapy-pacemaker; CSM = carotid sinus .. durationof130(cid:2)149ms,andLBBBQRSmor- I IIa
.
massage;CT=computedtomography;DDD=dual-chamber,atrioventricular .. phologydespiteOMT,toimprovesymptoms
pacing; ECG = electrocardiogram; EPS = electrophysiology study; HBP = His .
bundlepacing;HF=heartfailure;HFmrEF=heartfailurewithmildlyreduced
... andreducemorbidityandmortality.
ejectionfraction;HFpEF=heartfailurewithpreservedejectionfraction;HV= .. InpatientswithsymptomaticAFanduncon-
.
His(cid:2)ventricular interval; ICD = implantable cardioverter-defibrillator; ILR = .
. trolledheartratewhoarecandidatesforAVJ
implantablelooprecorder;LBBB=leftbundlebranchblock;LV=leftventricular; .. IIa I
LVEF=leftventricularejectionfraction;MI=myocardialinfarction;MRI=mag- .. ablation(irrespectiveofQRSduration),CRTis
.
neticresonanceimaging;OMT=optimalmedicaltherapy;PET=positronemis- . recommendedinpatientswithHFrEF.
.
siontomography;PR=PRinterval;QRS=Q,R,andSwaves;RBBB=right .
bundlebranchblock;RV=rightventricular;SAS=sleepapnoeasyndrome;SND
... Specificindicationsforpacing
=sinusnodedysfunction;SR=sinusrhythm;TAVI=transcatheteraorticvalve .. Inpatientswithcongenitalheartdisease,pacing
.
implantation. .
. maybeconsideredforpersistentpostoperative
aClassofrecommendation. .. IIa IIb
bLevelofevidence. .. bifascicularblockassociatedwithtransientcom-
cCSM should not be undertaken in patients with previous transient ischaemic .. pleteAVB.
.
attack,stroke,orknowncarotidstenosis.Carotidauscultationshouldbeper- .
formedbeforecarotidsinusmassage.Ifacarotidbruitispresent,carotidultra-
... Managementconsiderations
soundshouldbeperformedtoexcludecarotiddisease .. InpatientswithMRI-conditionalpacemakersys-
dCompletebloodcounts,prothrombintime,partialthromboplastintime,serum ... temsc,MRIcanbeperformedsafelyfollowing IIa I
c eIr mea mti en din iae t, ea lynd afe tele rc ptr ro ol cy ete ds u.
reorwithin24h.
....
manufacturerinstructions.
fTransienthigh-degreeAVB,PRprolongation,orQRSaxischange. .. Inpatientswithnon-MRI-conditionalpacemaker
.
gAmbulatory continuous ECG monitoring (implantable or external) for 7(cid:2)30 .
. systems,MRIshouldbeconsideredifnoalterna-
days. ..
hElectrophysiologystudywithHV>_70msmaybeconsideredpositiveforperma- .. tiveimagingmodeisavailableandifnoepicardial IIb IIa
.
nentpacing. . leads,abandonedordamagedleads,orlead
. siW ideh re en dev ae ccr op ra dc inin gg ti os rin ed leic va at ne td guin idn ee liu nr eo s.musculardisease,anICDshouldbecon- ....
adaptors/extendersarepresent.
.
.. AF=atrialfibrillation;AVB=atrioventricularblock;AVJ=atrioventricularjunc-
.
. tion; CRT = cardiac resynchronization therapy; HFrEF = heart failure with
.
.. reducedejectionfraction;ICD=implantablecardioverter-defibrillator;LBBB=
2.3.3 Changesincardiacpacingandcardiac .. leftbundlebranchblock;LVEF=leftventricularejectionfraction;MRI=magnetic
. . resonanceimaging;NYHA=NewYorkHeartAssociation;OMT=optimalmed-
resynchronizationtherapyguidelinerecommendations .
. icaltherapy;RV=rightventricular;SR=sinusrhythm. .
since2013 .. aClassofrecommendation.
.. bAlimitof20%RVpacingforconsideringinterventionsforpacing-inducedHFis
.
. supportedbyobservationaldata.However,therearenodatatosupportthatany
.
.. percentageofRVpacingcanbeconsideredasdefiningatruelimitbelowwhich
Table5 Changesincardiacpacingandcardiac .. RVpacingissafeandbeyondwhichRVpacingisharmful.
resynchronizationtherapyguidelinerecommendations .. cCombination of MRI conditional generator and lead(s) from the same
.
since2013 .. manufacturer.
.
.
.
.
2013 2021 .. ..
. 3 Background
.
Classa ..
............................ ..
Cardiacpacingforbradycardiaandconductionsystemdisease .. 3.1 Epidemiology
.
Inpatientswithsyncope,cardiacpacingmaybe .. The prevalence and incidence of pacemaker implantation are
.
consideredtoreducerecurrentsyncopewhen IIa IIb ... unknowninmanycountries,yetseveralestimationshavebeenpub-
asymptomaticpause(s)>6sduetosinusarrest ... lishedbasedontheanalysisoflargeobservationalstudiesanddata-
aredocumented. ... bases. There is considerable variability in reported pacemaker
.
Continued .. implant rates between European countries, ranging from <25
1202
CSE
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 14 ---
14 ESCGuidelines
New in these guidelines
Pacing inTAVI
CRT indications
patients
HBP in bradycardia
Leadless pacing
or CRT
Minimizing Pacing in Pacing in
Preimplant Pacing for High risk
complication patients with patients after
evaluation bradycardia reflex syncope
risk rare diseases cardiac surgery
Figure1 The2021ESCGuidelinesoncardiacpacingandCRTpresentnewandupdatedrecommendationsforthesetreatmentsinrelevantpatient
populations.
.
pacemakerimplantationspermillionpeopleinAzerbaijan,Bosniaand .. pacemaker-treatedpatients.9(cid:2)12Incontrast,SNDfollowsanunpre-
.
.
Herzegovina, and Kyrgyzstan, to >1000 implantations per million . dictable course, and there is no evidence to show that pacemaker
. people in France, Italy, and Sweden.1 These differences may result .. therapyresultsinimprovedprognosis.13(cid:2)15
.
.
from under- or overtreatment with pacemaker therapy in some . Improving life expectancy is not, however, the only objective of
.
.
countries,orfromvariationsinsociodemographiccharacteristics . pacemakertherapy.Qualityoflifeisanessentialmetricformeasuring .
.
andpathologicalconditions.Thereisacontinuousgrowthinthe .. apatient’sclinicalstatusandoutcome,andprovidesaholisticpicture
.
useofpacemakersduetotheincreasinglifeexpectancyandage- .. ofclinicaltreatmenteffectiveness.16Studieshavebeenunanimousin
.
ingofpopulations.2(cid:2)8Theestimatednumberofpatientsglobally .. finding improved quality of life in patients receiving pacing
.
undergoing pacemaker implantation has increased steadily up to .. therapy.17(cid:2)22
.
anannualimplantrateof(cid:3)1milliondevices.2Degenerationofthe ..
.
cardiac conduction system and changes in intercellular conduc- .. 3.3 Pathophysiology and classification of
.
tion can be manifestations of cardiac pathology or non-cardiac .. bradyarrhythmias considered for
.
disease,andaremostprevalentinolderpatients.Therefore,most ... permanent cardiac pacing therapy
bradycardiasrequiringcardiacpacingareobservedintheelderly, ..
. Definitions of various conduction disturbances are presented in
with>80%ofpacemakersbeingimplantedinpatientsabove the ..
ageof65years.
... SupplementaryTable1.
.. Sinusbradycardiacanbeconsideredphysiologicalinresponseto
.
.. specificsituations,suchasinwell-conditionedathletes,youngindivid-
3.2 Natural history ...
uals,andduringsleep.Pathologicalbradyarrhythmiasaredependent
.
High-degreeatrioventricularblock(AVB)andsinusnodedysfunction .. ontheirunderlyingcauseandcanbebroadlycategorizedintointrin-
.
(SND)arethemostcommonindicationsforpermanentpacemaker .. sicandextrinsicaetiologies.Advancedageandage-relateddegenera-
.
therapy.Conservativelytreated (i.e. non-paced) patientswith high- .. tive changes are important intrinsic causes of modifications in
.
degree AVB have notably poorer survival compared with . electrical impulse initiation and propagation of the conduction
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 15 ---
ESCGuidelines 15
Patient with bradycardia-related symptoms
Y Persistent bradycardia
Sinus node disease
N
AV block
Sinus rhythm
Atrial fibrillation
Documented arrhythmia
(ECG/Holter/monitor)
Y N
(suspected)
Intrinsic
BBB
ParoxysmalAV block
Sino-atrial block and sinus arresta
Reflex syncope
Atrial fibrillation with slow ventricular condition
Carotid sinus
Extrinsic (functional) Tilt-induced
Vagally induced sinus arrest orAV block
Adenosine hypersensitivityb
IdiopathicAV block Unexplained syncope
Figure2 Classificationofdocumentedandsuspectedbradyarrhythmias.AV=atrioventricular;BBB=bundlebranchblock;ECG=electrocardiogram.
aIncludingthebradycardia(cid:2)tachycardiaformofsicksinussyndrome.bDeharoetal.32FigureadaptedfromBrignoleetal.33
.
system.Inaddition,geneticmutationshavebeenlinkedtoconduction . 3.4 Types and modes of pacing: general
.
.
disorders (see section 4.3.5), and atrial cardiomyopathy23 may be a .. description
.
specific disease that can result in supraventricular tachyarrhythmia, ...
3.4.1 Endocardialpacing
SND,andatrioventricularnode(AVN)disease.24 ...
Endocardiallead-basedpacemakersconsistofapulsegeneratorcom-
It is essential to differentiate reversible from non-reversible ...
monly placed in the pectoral region and transvenous lead(s)
causes of bradycardia. Potential reversible causes of bradycardia ..
. implantedintothemyocardiumwiththeabilitytosensecardiacactiv-
include adverse drug effects, myocardial infarction (MI), toxic ..
. ity and provide therapeutic cardiacstimulation.Sincetheintroduc- exposure,infections,surgery,andelectrolytedisorders.Inastudy ..
. tion of transvenous endocardial pacemakers in the 1960s, major including 277 patients referred to the emergency department ..
. technological advances have improved their efficacy and safety. In withbradycardia,electrolytedisordersweretheunderlyingcause ..
. general,pacemakerimplantationisconsideredalow-riskprocedure,
in4%,intoxicationin6%,acuteMIin14%,andadversedrugeffects ..
. yetitisnotexemptfromdevice-andprocedure-relatedcomplica-
in21%.25 ..
. tionsandmalfunction.Pacemakerimplantationiscoveredindetailin
.
Inthecaseofnon-reversiblepathologicalcausesofslowheart .
. a recent European Heart Rhythm Association (EHRA) consensus
.
rate,thepresenceandseverityofsymptomsplayanessentialrole .. document.34
.
in the consideration for permanent antibradycardia pacemaker .
.
.
therapy.Thismaybechallenginginpatientswithcompetingmech- .
.
.
anismsfortheirsymptoms.Ingeneral,candidatesforpacingther- . 3.4.2 Epicardialpacing
.
.
apy can be broadly classified into two groups: patients with .. Some clinical scenarios dictate implantation of an epicardial pace-
.
persistent bradycardia and patients with intermittent [with or .. makersystem.Theseincludepatientswithcongenitalanomaliesand
.
without electrocardiographic (ECG) documentation] bradycar- .. novenousaccesstotheheartorwithanopenshuntbetweenthe
.
dia.Persistentbradycardiausuallyindicatesanintrinsicdiseasein .. right and left sides of the circulation, recurrent device infections,
.
thesinusnodetissueortheatrioventricular(AV)conductionsys- .. occluded veins, and—most commonly today—in conjunction with
.
tem, whereas intermittent bradycardia can be a result of a wide .. opencardiacsurgery.Epicardialleadsarecurrentlyimplantedusing
.
variety of intrinsic and extrinsic pathological processes, as illus- .. various (minimally invasive) thoracotomy or thoracoscopy and
.
tratedinFigure2.26(cid:2)31 . robotictechniques.35
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 16 ---
16 ESCGuidelines
.
.
3.4.3 Cardiacresynchronizationtherapy(endo-and/or . heart rate during emotional or physical activity by sensing body
.
.
epicardial) . motion/acceleration, minute ventilation, intracardiac impedance, or
.
.
Cardiacdyssynchrony is a difference in the timingof electrical and . othersurrogatesofphysicalandmentalstress,andareindicatedin
.
mechanicalactivationoftheventricles,whichcanresultinimpaired .. casesofchronotropicincompetence.51(cid:2)57Dual-sensingrate-respon-
.
.
cardiacefficiency.CRTdeliversbiventricularpacingtocorrectelec- . sivepacing(e.g.accelerometerandminuteventilation)maybeused
.
tromechanicaldyssynchronyinordertoincreasecardiacoutput.36In .. inselectedpatients.58Abriefoverviewofthemostcommonlyused
.
.
multipletrials,CRThasshownasignificantmorbidityandmortality . rate-responsivepacingsensorsisgiveninSupplementaryTable3.
.
.
benefitinspecificpatientgroupswithreducedleftventricularejec- ..
.
tionfraction(LVEF).37(cid:2)40 ..
.. 3.5 Sex differences
.
.
3.4.4 Alternativemethods(conductionsystempacing,
... Pacing indications and complication rates differ between male and
leadlesspacing)
... femalepatients.Inmalepatients,primarypacemakerimplantationis
3.4.4.1 Conductionsystempacing
... moreoftenindicatedforAVBandlesssoforSNDandatrialfibrilla-
Compared with right ventricular (RV) pacing, His bundle pacing
... tion (AF) with bradycardia.59,60 In female patients, the rate of
(HBP)providesamorephysiologicalsimultaneouselectricalactiva-
... procedure-related adverse events is significantly higher, corrected
tionoftheventriclesviatheHis(cid:2)Purkinjesystem.HBPcanrestore
... forageandtypeofdevice.Thishigherrateisdrivenmostlybypneu-
conductioninasubsetofpatientswithhigh-degreeAVB,andshorten
... mothorax, pericardial effusion, and pocket haematomas.59(cid:2)61
.. Possibleexplanationsforthisareasmallerbodysizeinwomenand
QRSdurationinsomepatientswithleftbundlebranchblock(LBBB) .
orrightbundlebranchblock(RBBB).41(cid:2)44Morestudiesareongoing ... anatomical differences, such as smaller vein diameters and RV
.. diameters.
andrequiredtoevaluatewhetherHBPhasclinicalbenefitsoverCRT .
.
.
or RV pacing. In addition, left bundle branch area pacing is being .
.
.
studiedasapacingmodalityforpatientsinwhomtheconductiondis- .
.
.
easeistoodistalforHBP(seesection7.3). .. 4 Evaluation of the patient with
.
.
.. suspected or documented
3.4.4.2 Leadlesspacing .
.
.
Miniaturized,intracardiacleadlesspacemakershavebeenintroduced. . bradycardia or conduction system
.
.
Thesedevicesareinsertedpercutaneouslythroughthefemoralvein .
.. disease
and implanted directly in the RV wall using customized catheter- .
.
.
based delivery systems. The first-generation leadless pacemakers ...
4.1 Historyand physical examination
have been proven to provide effective single-chamber pacing ..
therapy.45(cid:2)50Albeitapromisingtechnology,potentialdifficultywith ... Acarefulhistoryandphysicalexaminationareessentialfortheevalu-
leadlesspacemakerretrievalattheendofserviceisalimitation.Thus
... ation of patients with suspected or documented bradycardia
far, thereare no randomized controlled data available to compare
... (Figure3).Currentguidelinesemphasizetheimportanceofthehis-
clinicaloutcomesbetweenleadlesspacingandsingle-chambertrans-
... toryandphysicalexaminationintheinitialevaluation,particularlyfor
venouspacing.
... identifyingpatientswithstructuralheartdisease.62,63
.. Acompletehistoryshouldincludefamilyhistory,comprehensive
.
.. cardiovascular risk assessment, and recent/historical diagnoses that
3.4.5 Pacingmodes ... maycausebradycardia.Thehistoryshouldbefocusedonfrequency,
Technologicaladvancesinpacemakertherapyhaveresultedinawide ..
. severity,anddurationofsymptomsthatmightsuggestbradycardiaor
. varietyofpacingmodalities.Pacemakerscansensetheheart’sintrin- .
. conductionsystemdisease.Therelationshipofsymptomstophysical
. sicelectricalactivityandrestoretherateandAVsequenceofcardiac .
. activity, emotional distress, positional changes, medical treatment
. activation. Abnormal cardiac automaticity and conduction may be .
. (Table6),andtypicaltriggers(e.g.urination,defecation,cough,pro-
.
treated by single-lead atrial sensing/pacing, single-lead ventricular .
. longedstanding,andshaving)shouldbeexploredtoo,aswellaspulse
.
sensing/pacing, single leads that pace the right ventricle (RV) and .
. rateifmeasuredduringanepisode.
.
senseboththeatriumandventricle,anddual-leadsystemsthatsense .
. Familyhistorymaybeespeciallyimportantinyoungpatientswith
.
andpacetherightatrium(RA)andRV.Forcommonpacingmodes, .
. progressivecardiacconductiondiseaseeitherisolatedorinassocia-
.
refer to Supplementary Table 2. The choice of the optimal pacing .. tionwithcardiomyopathiesand/ormyopathies.64,65
.
mode in the presence of conduction disturbances is driven by the .
. Physicalexaminationshouldfocusonmanifestationsofbradycar-
.
underlyingmorbidity,theimpactofpacingtherapyonmorbidity,and .
. diaandsignsofunderlyingstructuralheartdiseaseorsystemicdisor-
.
the potential harmful effect of the chosen pacing modality. The .
.. ders (Table 7). Symptomatic slow peripheral pulses should be
choiceofpacingmodesinspecificsituationsisdiscussedinsection5. ...
confirmed with cardiac auscultation or ECG to ensure that other
.
.. rhythmsarenotmisrepresentedasbradycardia(e.g.prematureven-
.
3.4.6 Rate-responsivepacing .. tricularcontractions).
.
Thesinusnodemodulatestheheartrateduringdifferenttypesand .. Autonomic regulation disorders are important in the differential
.
loads of exercise (i.e. physical exercise, emotions, postural change, .. diagnosis of syncope or near syncope, and, therefore, orthostatic
.
and fever) proportionalto the metabolic demand. Rate-responsive .. changesinheartrateandbloodpressuremayhelpintheevaluation
.
pacemakersystemsstrivetoproduceanappropriatecompensatory . ofthepatients.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 17 ---
ESCGuidelines 17
Initial evaluation of patients with symptoms suggestive of bradycardia (SND orAV block)
History Physical examination ECG Cardiac imaging
Cardiovascular risk
Complete history
focusing on symptoms
Family history
Medical treatment
Figure3 Initialevaluationofpatientswithsymptomssuggestiveofbradycardia.AVB=atrioventricularblock;ECG=electrocardiogram;SND=sinus
nodedysfunction.
.
.
Table6 Drugsthatmaycausebradycardiaorconduction .. Table6 Continued
.
disorders .
.
. Sinusnode AVB
.
Sinusnode AVB .. bradycardia
bradycardia ...
Others
Beta-blockers 1 1 ..
. Musclerelaxants 1 –
.
Antihypertensives .
.. Cannabis 1 –
Non-dihydropyridinecalciumchannel 1 1 ...
Propofol 1 –
blockers ..
. Ticagrelor 1 1
.
Methyldopa 1 – .
.. High-dosecorticosteroids 1 –
Clonidine 1 – ...
Chloroquine – 1
Antiarrhythmics ..
. H antagonists 1 1
. 2
Amiodarone 1 1 .
.. Protonpumpinhibitors 1 –
Dronedarone 1 1 ..
. Chemotherapy
Sotalol 1 1 ..
. Arsenictrioxide 1 1
.
Flecainide 1 1 .
.. Bortezomib 1 1
Propafenone 1 1 ..
. Capecitabine 1 –
Procainamide – 1 ..
. Cisplatin 1 –
.
Disopyramide 1 1 .
.. Cyclophosphamide 1 1
Adenosine 1 1 ..
. Doxorubicin 1 – Digoxin 1 1 ..
.. Epirubicin 1 –
Ivabradine 1 – .
.. 5-fluorouracil 1 1
Psychoactiveandneuroactivedrugs ..
. Ifosfamide 1 –
Donepezil 1 1 ..
.. Interleukin-2 1 –
Lithium 1 1 .
.. Methotrexate 1 –
Opioidanalgesics 1 – ..
. Mitroxantrone 1 1
.
Phenothiazine 1 1 .
.. Paclitaxel 1 –
Phenytoin 1 1 .
.. Rituximab 1 1
Selectiveserotoninreuptakeinhibitors – 1 ..
. Thalidomide 1 1
. Tricyclicantidepressants – 1 .
.. Anthracycline – 1
Carbamazepine 1 1 ...
Taxane – 1
Continued ..
. AVB=atrioventricularblock.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 18 ---
18 ESCGuidelines
.
.
Table7 Intrinsicandextrinsiccausesofbradycardia .. Table7 Continued
.
.
.
Sinus AVJ .. Sinus AVJ
bradycardia disturbances .. bradycardia disturbances
.
orSND .. orSND
.
Intrinsic .. Hypothermia 1 1
.
Idiopathic(ageing,degenerative) 1 1 .. Neurologicaldisorders
.
.
Infarction/ischaemia 1 1 .. Increasedintracranialpressure 1 1
.
Cardiomyopathies 1 1 .. Centralnervoussystemtumours 1 1
.
Geneticdisorders 1 1 .. Temporalepilepsy 1 1
. .
Infiltrativediseases .. Obstructivesleepapnoea 1 1
.
Sarcoidosis 1 1 .
. AV=atrioventricular;AVB=atrioventricularblock;AVJ=atrioventricularjunc- .
Amyloidosis 1 1 .. tion;SND=sinusnodedysfunction.
.. AdaptedfromMangrumetal.71andDaCostaetal.72a
Haemochromatosis 1 1 .
.
.
Collagenvasculardiseases ..
.
Rheumatoidarthritis 1 1 ..
.
.
Scleroderma 1 1 .
.. Carotid sinus massage (CSM) can be helpful in any patient >_40
Systemiclupuserythematosus 1 1 ..
. yearsoldwithsymptomssuggestiveofcarotidsinussyndrome(CSS):
Storagediseases 1 1 ..
. syncopeornearsyncopeelicitedbytightcollars,shaving,orturning
.
Neuromusculardiseases 1 1 .. the head.66,67Methodologyand responsetoCSM are described in
.
Infectiousdiseases .. section4.1intheSupplementarydata.DiagnosisofCSSrequiresboth
.
Endocarditis(perivalvularabscess) – 1 .. thereproductionofspontaneoussymptomsduringCSMandclinical
.
.
Chagasdisease 1 1 . features of spontaneous syncope compatible with a reflex
.
Myocarditis – 1 ... mechanism.68(cid:2)70
.
Lymedisease – 1 ..
.
Diphtheria – 1 .. 4.2 Electrocardiogram
.
.
Toxoplasmosis – 1 .. Togetherwiththehistoryandphysicalexamination,therestingECG
.
Congenitalheartdiseases 1 1 .. is an essential component of the initial evaluation of patients with
.
Cardiacsurgery .. documentedorsuspectedbradycardia.A12-leadECGorarhythm
.
.
Coronaryarterybypassgrafting 1 1 .. strip during the symptomatic episode provides the definitive
.
. diagnosis.
Valvesurgery(including 1 1 .
.
. Forthoseinwhomphysicalexaminationsuggestsabradycardia,a
transcatheteraorticvalve .
.
. 12-leadECGisusefultoconfirmtherhythm,rate,nature,andextent
replacement) .
.
. ofconductiondisturbance(SupplementaryTable1).Furthermore,an
Mazeoperation 1 – ..
. ECGmayprovideinformationaboutstructuralheartorsystemicill- Hearttransplant 1 1 ..
. ness(e.g.LVhypertrophy,Qwaves,prolongedQTinterval,andlow
.
Radiationtherapy 1 1 .. voltage)thatpredictadverseoutcomesinsymptomaticpatients.62
.
IntendedoriatrogenicAVB – 1 ..
.
Sinustachycardiaablation 1 – .. 4.3 Non-invasive evaluation
.
. Extrinsic .
.
.
Physicaltraining(sports) 1 1 .. Recommendationsfornon-invasiveevaluation
.
Vagalreflex 1 1 ..
.. Recommendations Classa Levelb
Drugeffects 1 1 .
.
.
IdiopathicparoxysmalAVB – 1 .. Oncecarotidstenosisisruledout,cCSMisrec-
.
Electrolyteimbalance .. ommendedinpatientswithsyncopeofunknown
.
Hypokalaemia 1 1 .. origincompatiblewithareflexmechanismor I B
.
Hyperkalaemia 1 1
... withsymptomsrelatedtopressure/manipulation
.. ofthecarotidsinusarea.68(cid:2)70
Hypercalcaemia 1 1 .
.
.
Hypermagnesaemia 1 1 . CSM=carotidsinusmassage.
.
Metabolicdisorders
.... a bC Lela vs es lo of fr ee vc ido em nm cee .ndation.
Hypothyroidism 1 1 .. cCSM should not be undertaken in patients with previous transient ischaemic
.
. attack,stroke,orknowncarotidstenosis.Carotidauscultationshouldbeper-
Anorexia 1 1 ...
formedbeforeCSM.Ifacarotidbruitispresent,carotidultrasoundshouldbe
Hypoxia 1 1 .. performedtoexcludethepresenceofcarotiddisease.
.
.
Acidosis 1 1
Continued
1202
CSE
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 19 ---
ESCGuidelines 19
.
.
4.3.1 Ambulatoryelectrocardiographic .. Exercise testing can be used to diagnose symptomatic chrono-
.
monitoring .. tropicincompetence,definedasaninabilitytoincreasetheheartrate
.
Theintermittentnatureofmostsymptomaticbradycardiasecondary .. commensurate with the increased metabolic demands of physical
.
toconductionsystemdiseaseoftenrequiresprolongedambulatory .. activity.74,75 The most commonly used definition of chronotropic
.
ECG monitoringto correlaterhythmdisturbances withsymptoms. .. incompetencehasbeenfailuretoreach80%oftheexpectedheart
.
ThismonitoringallowsdetectionofinterruptionofAVconduction .. ratereserve.Expectedheartratereserveisdefinedasthedifference
.
byeitherprimarydiseaseoftheconductivesystem,avagalorneuro- .. betweentheage-predictedmaximalheartrate(220(cid:2)age)andthe
.
cardiogenicmechanism,orreflexAVblock.72,72a .. restingheartrate.However,somemedicaltreatmentsandcomor-
.
Ambulatory ECG identifies defects of sinus automaticity, which .. biditiescauseexerciseintoleranceandmakethediagnosisofchrono-
.
includes sinus pauses, sinus bradycardia, bradycardia(cid:2)tachycardia .. tropicincompetencebyexercisetestingmoredifficult.
.
syndrome,asystolepost-conversionofatrialflutterorAF,andchro- .. Inpatients withexercise-related symptoms, thedevelopmentor
.
.
notropicincompetence. . progression of AVB may occasionally be the underlying cause.
.
.
Different versions of ambulatory ECG monitoring have been . Tachycardia-related exercise-induced second-degree and complete
.
.
reviewed recently in a comprehensive expert consensus . AVBhavebeenshowntobelocateddistaltotheAVNandpredict
.
(Supplementary Table 4).73 Ambulatory ECG selection depends on .. progression to permanent AVB.76(cid:2)78 Usually, these patients show
.
.
thefrequencyandnatureofthesymptoms(Table8). . intraventricularconductionabnormalitiesontherestingECG,buta
.
.. normal resting ECG has also been described in such cases.77,79
.
.
. Exercise testingmayexpose advanced infranodal AVB in the pres- .
.
. enceofconductionsystemdiseaseofuncertainlocation.
.
Table8 Choiceofambulatoryelectrocardiographic .. In rare cases, conduction disturbances induced by exercise are
.
monitoringdependingonsymptomfrequency .
. causedbymyocardialischaemiaorcoronaryvasospasm,andexercise
.
.
Frequencyof .. testingmayreproducethesymptoms.80,81
.
symptom .. Therearenodatasupportinganindicationforexercisetestingin
.
Daily 24-hHolterECGorin-hospitaltelemetric .. patientswithoutexercise-relatedsymptoms.Exercisetestingmaybe
.
monitoring .. usefulinselectedpatientstodistinguishAVNfromconductiondis-
.
Every48(cid:2)72h 24(cid:2)48(cid:2)72hHolterECG .. turbancesintheHis(cid:2)PurkinjesystembelowtheAVNinthesetting
.
Everyweek 7-dayHolterECG/externallooprecorder/ .. ofconductiondisturbanceatanunclearlevel.
.
externalpatchrecorder ..
.
.
Everymonth Externallooprecorder/externalpatch .. Recommendationsforexercisetesting
.
recorder/handheldECGrecorder .
. <1permonth ILR ... Recommendations Classa Levelb
.
.
ECG=electrocardiogram;ILR=implantablelooprecorder. .. Exercisetestingisrecommendedinpatients
AdaptedfromBrignoleetal.33 ...
whoexperiencesymptomssuspiciousofbrady-
. I C
.. cardiaduringorimmediatelyafter
.
.. exertion.62,74(cid:2)80
.
.
. Inpatientswithsuspectedchronotropicincom- .
.
Recommendationforambulatoryelectrocardiographic . petence,exercisetestingshouldbeconsidered IIa B .
monitoring .. toconfirmthediagnosis.74,75
.
.
Recommendation Classa Levelb
... Inpatientswithintraventricularconductiondis-
.. easeorAVBofunknownlevel,exercisetesting
. IIb C AmbulatoryECGmonitoringisrecommendedin .. maybeconsideredtoexposeinfranodal
.
theevaluationofpatientswithsuspectedbrady- .. block.76,77,79
I C .
.
cardiatocorrelaterhythmdisturbanceswith .
symptoms.73
.... A aCV laB ss= oa ftr ri eo cv oe mnt mri ec nu dla ar tib olo n.ck.
.. bLevelofevidence.
ECG=electrocardiogram. ..
aClassofrecommendation. ..
.
bLevelofevidence. .
.
.
.
.
.
. 4.3.3 Imaging
.
.
. Inpatientswithsuspectedordocumentedsymptomaticbradycardia,
.
.
4.3.2 Exercisetesting .. theuseofcardiacimagingisrecommendedtoevaluatethepresence
.
Exercise testing may be useful in selected patients with suspected .. ofstructuralheartdisease,todetermineLVsystolicfunction,andto
.
bradycardia during or shortly after exertion. Symptoms occurring .. diagnose potential reversible causes of conduction disturbances
.
duringexercisearelikelytobeduetocardiaccauses,whereassymp- .. (Table7).
.
toms occurring after exercise are usually caused by a reflex .. Echocardiographyisthemostcommonlyavailableimagingtechni-
.
mechanism. . que for evaluation of the above factors. It can also be used in the
1202
CSE
1202
CSE
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 20 ---
20 ESCGuidelines
contextofhaemodynamicinstability.Whencoronaryarterydisease ...
Recommendationsforlaboratorytests
issuspected,coronarycomputedtomography(CT),angiography,or ..
.
stress imaging is recommended.82 Cardiovascular magnetic reso- .. Recommendations Classa Levelb
.
nance(CMR)andnuclearimagingtechniquesprovideinformationon ..
tissue characterization (inflammation, fibrosis/scar) and should be
... Inadditiontopre-implantationlaboratorytests,c
consideredbeforepacemakerimplantationwhenspecificaetiologies
... specificlaboratorytestsarerecommendedin
associatedwithconductionabnormalitiesaresuspected(speciallyin
... patientswithclinicalsuspicionforpotential
young patients). Late gadolinium contrast enhanced (LGE) and T2
... underlyingcausesofreversiblebradycardia(e.g. I C
.. thyroidfunctiontests,Lymetitre,digitalislevel,
CMRtechniquesallowthediagnosisofspecificcausesofconduction .
.. potassium,calcium,andpH)todiagnoseand
disturbances(i.e.sarcoidosisandmyocarditis).Lategadoliniumcon- .
.. treattheseconditions.90(cid:2)94
trastenhancementCMRhelpsinthedecision-makingofindividuals .
.
.
witharrhythmicevents;thepresenceoflargeareasofLGE(scar/fib- .. aClassofrecommendation.
rosis)hasbeenlinkedtoanincreasedriskofventriculararrhythmias .. bLevelofevidence.
.. cCompletebloodcounts,prothrombintime,partialthromboplastintime,serum
regardless of LVEF and may indicate the need for an implantable .
cardioverter-defibrillator(ICD).83(cid:2)85T2CMRsequencesaresuited
... creatinine,andelectrolytes.
.
.
forthedetectionofmyocardialinflammation(i.e.oedemaandhyper- .
.
.
aemia) as a potential cause of transitory conduction abnormalities .
..
.
that may not need permanent pacemaker implantation.86 Similarly, . 4.3.5 Genetictesting .
.
positron emission tomography (PET) combined with CMR or CT .. Mostcardiacconductiondisordersareduetoeitherageingorstruc-
.
helpsinthediagnosisofinflammatoryactivitystatusofinfiltrativecar- .. tural abnormalities of the cardiac conduction system caused by
.
diomyopathies(i.e.sarcoidosis).87,88 .. underlyingstructuralheartdisease.Genesresponsibleforinherited
.
.. cardiacdiseases associated with cardiac conduction disorders have
.
Recommendationsregardingimagingbefore
... beenidentified.65,95,96
implantation .. Genetic mutations have been linked to a range of abnormalities
.
.. thatmaypresentinisolatedformsofcardiacconductiondisorderor
.
Recommendations Classa Levelb .. inassociationwithcardiomyopathy,congenitalcardiacanomalies,or
.
.. extra-cardiac disorders. Most genetically mediated cardiac conduc-
Cardiacimagingisrecommendedinpatients .
.. tiondisordershaveanautosomaldominantmodeofinheritance65,95
withsuspectedordocumentedsymptomatic .
.. (SupplementaryTable5).
bradycardiatoevaluatethepresenceofstruc- .
I C .. Progressive cardiac conduction disease (PCCD) may be
turalheartdisease,todetermineLVsystolic .
.. diagnosed in the presence of unexplained progressive conduction
function,andtodiagnosepotentialcausesof .
.. abnormalitiesinyoung(<50years)individualswithstructurallynor-
conductiondisturbances. .
.. malheartsintheabsenceofskeletalmyopathies,especiallyifthereis
Multimodalityimaging(CMR,CT,orPET)should ...
a family history of PCCD.97 Common PCCD-associated genes are
beconsideredformyocardialtissuecharacter- ..
. SCN5AandTRPM4forisolatedformsandLMNAforPCCDassoci-
izationinthediagnosisofspecificpathologies ..
IIa C . atedwithHF.
associatedwithconductionabnormalitiesneed- ..
. ThediagnosisofPCCDinanindexpatientisbasedonclinicaldata
ingpacemakerimplantation,particularlyin ..
. includinghistory,familyhistory,and12-leadECG.Thepotentialpres-
patientsyoungerthan60years.83(cid:2)86,88 ..
. enceofcongenitalheartdisease(CHD)and/orcardiomyopathymust
.
.
CMR=cardiovascularmagneticresonance;CT=computedtomography;LV= .. beinvestigatedwithcardiacimaging.
.
leftventricular;PET=positronemissiontomography. . Early-onsetPCCD,eitherisolatedorwithconcomitantstructural
.
aClassofrecommendation. .
. heartdisease,shouldpromptconsiderationofPCCDgenetictesting,
bLevelofevidence. ..
. particularly in patients with a positive family history of conduction
.
.
. abnormalities,pacemakerimplants,orsuddendeath.97 .
.
.. Aconsensuspanelhasendorsedmutation-specificgenetictesting
.
4.3.4 Laboratorytests .. forfamilymembersandappropriaterelativesaftertheidentification
.
Laboratorytests,includingfullbloodcounts,prothrombintime,par- .. ofaPCCDcausativemutationinanindexcase.Suchtestingcanbe
.
tial thromboplastin time, renal function, and electrolyte measure- .. deferred in asymptomatic children because of the age-dependent
.
ments, are warranted as part of pre-procedural planning for
.. natureofcardiacconductiondiseasesandincompletepenetrance.65
.
pacemakerimplantation. .. However,everycaseshouldbeindividuallyevaluateddependingof
.
Bradycardia or AVB may be secondary to other conditions .. theriskofthedetectedmutation.
.
(Table7).Whensuspected,laboratorydataareusefulforidentifying .. Asymptomatic family members who are positive for the family’s
.
and treating these conditions (e.g. thyroid function, Lyme titre to .. PCCD-associated mutationshouldberegularlyfollowedfor devel-
.
diagnose myocarditis in a young person with AVB, endocarditis, .. opmentofcardiacconductiondisease-relatedsymptoms,deteriora-
.
hyperkalaemia,digitalislevels,andhypercalcaemia).89(cid:2)94 .. tionofcardiacconduction,andbeginningofHF.
1202
CSE
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 21 ---
ESCGuidelines 21
.
Recommendationsforgenetictesting .. 4.3.7 Tilttesting
.
.
. Tilttestingshouldbeconsideredtoconfirmadiagnosisofreflexsyn-
.
Recommendations Classa Levelb .
. copeinpatientsinwhomthisdiagnosiswassuspectedbutnotcon-
.
.
Genetictestingshouldbeconsideredinpatients .. firmed by initial evaluation.62,107 The endpoint of tilt testing is the
.
withearlyonset(age<50years)ofprogressive IIa C .. reproductionofsymptomsalongwiththecharacteristiccirculatory
.
cardiacconductiondisease.c65,97 .. patternofthereflexsyncope.Themethodologyandclassificationof
.
Genetictestingshouldbeconsideredinfamily
.. responsesaredescribedinsection4.2intheSupplementarydataand
.
membersfollowingtheidentificationofapatho-
... inSupplementaryFigure1.
genicgeneticvariantthatexplainstheclinical IIa C ... A positive cardioinhibitory response to tilt testingpredicts, with
phenotypeofcardiacconductiondiseaseinan
... high probability, asystolic spontaneous syncope; this finding is rele-
indexcase.65 ... vantfortherapywhencardiacpacingisconsidered(seesection5.4).
.. Conversely, the presence of a positive vasodepressor, a mixed .
aClassofrecommendation. .. response,orevenanegativeresponsedoesnotexcludeasystoledur-
b cPL re ov ge rl eo sf se ivv eid ce an rc de ia.
cconductiondisease:prolongedPwaveduration,PRinterval,
....
ingspontaneoussyncope.62
.
andQRSwideningwithaxisdeviation.96 .
.
.
. . Recommendationfortilttesting
.
.
.
.
4.3.6 Sleepevaluation .. Recommendation Classa Levelb
.
.
Nocturnalbradyarrhythmiasarecommoninthegeneralpopulation. .
.. Tilttestingshouldbeconsideredinpatientswith
In most circumstances, these are physiological, vagally mediated ...
suspectedrecurrentreflexsyncope.62
IIa B
asymptomaticevents,whichdonotrequireintervention.98(cid:2)100 ..
.
Patientswithsleepapnoeasyndrome(SAS)haveahigherpreva- .. aClassofrecommendation.
lenceofsleep-relatedbradycardia(bothsinusandconductionsystem
... bLevelofevidence.
.
related)duringapnoeicepisodes.101,102SAS-inducedhypoxaemiaisa ..
.
key mechanism leading to an increased vagal tone and bradycardic ..
.
rhythm disorders.101,102 Another rare mechanism of sleep-related ..
.
bradycardia (usually inthe form ofprolonged sinus arrest) is rapid .. 4.4 Implantable monitors
.
eyemovementsleep-relatedbradycardia,unrelatedtoapnoea.This ... Patientswithinfrequentsymptomsofbradycardia(lessthanonceper
mechanismcanalsobediagnosedbypolysomnography.103Although ...
month) need a longer duration of ECG monitoring. For these
most cases quoted in the literature have been treated with pace- ... patients, the implantable loop recorder (ILR) is an ideal diagnostic
makers,theevidenceforthisisscant,andthereisnoconsensuson ... toolgivenitscapacityforprolongedmonitoring(upto3years)and
howtotreatthesepatients.103 ...
withouttheneedforactivepatientparticipation(Table8).
.
Treatmentwithcontinuouspositiveairwaypressure(CPAP)alle- .. In patients with unexplained syncope after the initial evaluation
.
viatesobstructivesleepapnoea-relatedsymptomsandimprovescar- .. andinfrequentsymptoms(lessthanonceamonth),severalstudies
.
diovascular outcomes. Appropriate treatment reduces episodes of .. havedemonstratedahigherefficacyofinitialILRimplantationcom-
bradycardia by 72(cid:2)89%,104 and patients are unlikely to develop ... pared with a conventional strategy. Many conditions diagnosed by
symptomaticbradycardiaatlong-termfollow-up.104(cid:2)106Therefore, ... ILRarebradycardiamediated.108(cid:2)112Forfurtherdiscussiononthe
.
patients with asymptomatic nocturnal bradyarrhythmias or cardiac .. diagnosticrolesofILRandambulatoryECG,andindicationsfortheir
. conductiondiseasesshouldbeevaluatedforSAS.Ifthediagnosisis .. use,refertotheESCGuidelinesforthediagnosisandmanagementof
. confirmed,treatmentofsleepapnoeawithCPAPandweightlosscan .. syncope.62
. be effective in improving bradyarrhythmias occurring during sleep, .
.
.
andpermanentpacingshouldbeavoided.Inpatientswithknownor ..
.
suspected SAS and symptomatic bradyarrhythmias not associated ..
Recommendationforimplantablelooprecorders
.
withsleep,amorecomplexassessmentoftherisksassociatedwith ..
.
bradyarrhythmiasvs.thebenefitofcardiacpacingisneeded. .. Recommendation Classa Levelb
.
.
.
.. Inpatientswithinfrequent(lessthanoncea
Recommendationforsleepevaluation .
.. month)unexplainedsyncopeorothersymp-
.
Recommendation Classa Levelb ... tomssuspectedtobecausedbybradycardia,in
.. whomacomprehensiveevaluationdidnot I A
.
ScreeningforSASisrecommendedinpatients .. demonstrateacause,long-termambulat
.
withsymptomsofSASandinthepresenceof I C ... orymonitoringwithanILRis
severebradycardiaoradvancedAVBduring .. recommended.108(cid:2)112
.
sleep.101(cid:2)106 ..
.. ILR=implantablelooprecorder.
AVB=atrioventricularblock;SAS=sleepapnoeasyndrome. .. aClassofrecommendation.
aClassofrecommendation. ... bLevelofevidence.
bLevelofevidence.
1202
CSE
1202
CSE
1202
CSE
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 22 ---
22 ESCGuidelines
.
4.5 Electrophysiology study .. In patients with syncope and sinus bradycardia, the pre-test
.
.
Thedevelopmentofnon-invasiveambulatoryECGtechnologieshas . probabilityofbradycardia-relatedsyncopeincreaseswhenthereisa
.
.
reducedtheneedfortheelectrophysiologystudy(EPS)asadiagnos- . sinus bradycardia (<50 b.p.m.) or sinoatrial block. Observational
.
.
tictest.EPSisgenerallyanadjunctivetoolintheevaluationofpatients . studies have shown a relationship between prolonged sinus node
.
.
with syncope in whom bradycardia is suspected but has not been . recovery time with syncope and the effect of pacing on
.
documentedafternon-invasiveevaluation(Figure4).Thegoalofan .. symptoms.113,114
.
.
EPSinthecontextofbradycardiaevaluationistoidentifyabnormal . In patients with syncope and bifascicular block, a prolonged
.
.
sinusnodefunctionortheanatomicallocationofthecardiacconduc- . His(cid:2)ventricularinterval(HV)>_70ms,orHV>_100msafterpharma-
.
.
tiondisorders(intheAVNorintheHis(cid:2)Purkinjesystemdistalto .. cologicalstress(ajmaline,procainamide,flecainide,ordisopyramide),
.
theAVN). . orinductionofsecond-orthird-degreeAVBbyatrialpacingorby
Patient with symptoms suggestive of bradycardia or conduction system disease
History, physical examination, 12-lead ECG and cardiac imaging
Early onset
of progressive
Bradycardia cardiac Clinical
Suspected Suspected
or cardiac conduction suspicion Syncope and Exercise
scar or recurrent
conduction disease or for potential bifascicular induced
infiltrative reflex
disorders family history causes of block symptoms
cardiomyopathy syncope
during sleep inherited cardiac bradycardia
conduction
disorder
EPS or ET for
exercised-
Further
induced block
Polysomnography Genetic Laboratory imaging CSM/ tilt
or empirical ET
/sleep study test test (CMR,CT, test
pacemaker in
PET etc.)
elderly and
frail patients
Diagnostic
Y N (non-diagnostic)
Symptoms
AECG
<1 per ILR
SND AV block monitoring
month
(See section 5.1) (See section 5.2)
CCD without
Reflex syncope
AV block
(See section 5.4) Non- Clinical
(See section 5.3)
diagnostic follow-up
Figure 4 Evaluationofbradycardiaandconductiondiseasealgorithm.AECG=ambulatoryelectrocardiographicmonitoring;AV=atrioventricular;
CCD=cardiacconductiondisease(ordisorder);CMR=cardiovascularmagneticresonance;CSM=carotidsinusmassage;CT=computedtomography;
ECG=electrocardiogram;EPS=electrophysiologystudy;ET=exercisetest;ILR=implantablelooprecorder;PET=positronemissiontomography;
SND=sinusnodedysfunction.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 23 ---
ESCGuidelines 23
.
.
pharmacologicalstress,identifiesagroupathigherriskofdeveloping . be considered as an appropriate indication for permanent pacing
.
AVB.115(cid:2)122 .. onlywhenbradycardiaduetoSNDissymptomatic.126Patientswith
.
.
The efficacy of EPS for the diagnosis of syncope is highest in . SNDmaymanifestsymptomsattributabletobradyarrhythmiaand/or
.
.
patients with sinus bradycardia, bifascicular block, and suspected . symptomsofaccompanyingatrialtachyarrhythmiasinthebradycar-
.
.
tachycardia,62andlowestinpatientswithsyncope,anormalECG,no .. dia(cid:2)tachycardia form of the disease. Symptoms may be present
.
structuralheartdisease,andnopalpitations.Therefore,EPSispre- .. eitheratrestorattheendofthetachyarrhythmicepisode(conver-
.
ferred over ILR in patients with syncope who have a highpre-test .. sion pause also named pre-automaticity pause), or develop during
.
probability for significant conduction disease (e.g. abnormal ECG, .. exercise,andmayrangefrommildfatiguetolight-headedness,dizzy
.
BBB, ischaemicheart disease, orscar-related cardiomyopathy). For .. spells, near-syncope, to syncope. Dyspnoea on exertion may be
.
patientswithalowpre-testprobability(nostructuralheartdisease, .. relatedtochronotropicincompetence.Syncopeisacommonmani-
.
normalECG),ILRispreferredoverEPS.EPSisalsopreferredwhen .. festation of SND and has been reported in 50% of patients who
.
thereisahighlikelihoodthatanothersyncopalepisodewillbedan- .. receiveapacemakerforSND.127
. gerousorlife-threateningandanimmediatediagnosisislikelyifEPSis .. Establishingacorrelationbetweensymptomsandbradyarrhyth-
.
performed. .. miaisacrucialstepindecision-making.However,age,concomitant
.
AnegativeEPSdoesnotexcludeanarrhythmicsyncope,andfur- .. heart disease, and other comorbidities may pose difficulties in
.
ther evaluation is warranted. Approximately one-third of patients .. establishing a clear cause(cid:2)effect relationship between SND and
. withanegativeEPSinwhomanILRisimplanteddevelopAVBatfol- .. symptoms.
.
low-up.123 .. Theeffectofcardiacpacingonthenaturalhistoryofbradyarrhyth-
.
.
. mias was evaluated in non-randomized studies undertaken at the
.
Recommendationsforelectrophysiologystudy .. beginning of the pacemaker era, which suggested a symptomatic
.
.. improvementwithcardiacpacing.128(cid:2)131Thiswasconfirmedbyone
Recommendations Classa Levelb ... randomizedcontrolledtrial(RCT)14inwhich107patients(aged73
.
.
Inpatientswithsyncopeandbifascicularblock, .. ±11years)withsymptomaticSNDwererandomizedtonotreat-
.
EPSshouldbeconsideredwhensyncope .. ment, oral theophylline, or dual-chamber (DDD) rate-responsive
.
remainsunexplainedafternon-invasiveevalua- .. pacemakertherapy.Inthisstudy,theoccurrenceofsyncopeandHF
.
tionorwhenanimmediatedecisionaboutpac- IIa B .. was lower in the pacemaker group during a follow-up of 19 ± 14
.
ingisneededduetoseverity,unlessempirical .. months.
.
pacemakerimplantationispreferred(especially .. Inpatientspresentingwithexerciseintoleranceinwhomchrono-
.
inelderlyandfrailpatients).115(cid:2)121 .. tropic incompetence has been identified, the usefulness of cardiac
.
Inpatientswithsyncopeandsinusbradycardia,
.. pacingisuncertain,andthedecisiontoimplantapacemakerinsuch
.
EPSmaybeconsideredwhennon-invasivetests
.. patientsshouldbemadeonacasebycasebasis.
havefailedtoshowacorrelationbetweensyn-
IIb B ....
Insomecases,symptomaticbradyarrhythmiasmayberelatedto
copeandbradycardia.113,114 ... transient, potentially reversible, or treatable conditions (section 4,
.. Table 7). In such cases, correction of these factors is required,
.
EPS=electrophysiologystudy. .. whereaspermanent pacingis notindicated. Inclinical practice, it is
a bC Lela vs es lo of fr ee vc ido em nm cee .ndation. ....
crucial to distinguish physiological bradycardia (due to autonomic
.. influences or training effects) from inappropriate bradycardia that
.
.. requirespermanentcardiacpacing.Forexample,sinusbradycardia,
.
.. evenwhenitis40(cid:2)50b.p.m.whileatrestorasslowas30b.p.m.
.
.
. whilesleeping,particularlyintrainedathletes,couldbeacceptedasa
. .
. physiological finding that does not require cardiac pacing.
. .
5 Cardiac pacing for bradycardia . Asymptomaticbradycardia(duetoeithersinuspausesorAVBepi-
.
.
. sodes)isnotuncommonandwarrantsinterpretationintheclinical
and conduction system disease .
.
. contextofthepatient:inhealthysubjects,pauses>2.5sareuncom-
.
.
. mon,butthispersedoesnotnecessarilyconstituteaclinicaldisorder;
5.1 Pacing for sinus node dysfunction ...
asymptomatic bradyarrhythmias are common in athletes.132 In the
.
SND,alsoknownassicksinussyndrome,comprisesawidespectrum ..
absence of published trials, no recommendations for bradycardia
.
of sinoatrial dysfunctions, ranging from sinus bradycardia, sinoatrial ..
detectedinasymptomaticpatientscanbemade.Ontheotherhand,
.
block,andsinusarresttobradycardia(cid:2)tachycardiasyndrome.124,125 ..
inpatientsinvestigatedforsyncopeinwhomasymptomaticpause(s)
.
An additional manifestation of SND is an inadequate chronotropic ..
>6sduetosinusarrestareeventuallydocumented,pacingmaybe
.
responsetoexercise,reportedaschronotropicincompetence. ...
indicated.Indeed,suchpatientsconstitutedasmallminorityofthose
.
.. includedinanobservationalstudyandarandomizedtrialonpacingin
.
5.1.1 Indicationsforpacing .. reflex syncope.133,134 In patients presenting with sleep-related
.
5.1.1.1 Sinusnodedysfunction .. asymptomatic intermittent bradycardia (sinus bradycardia orAVB),
.
Ingeneral,pacingforasymptomaticSNDhasneverbeenshownto .. sleep apnoea and rapid eye movement sleep-related bradycardia
.
affectprognosis,asopposedtopacingforAVB.Therefore,SNDcan . shouldbeconsideredaspossiblecauses.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 24 ---
24 ESCGuidelines
.
.
5.1.1.2 Bradycardia(cid:2)tachycardiaformofsinusnodedysfunction . Syndrome(DANPACE),whichenrolled1415patientsfollowedfora
.
.
Thebradycardia(cid:2)tachycardiavariantofSNDisthemostcommon . meanof5.4years,foundnodifferencebetweenDDD(R)andAAIR
.
.
form,andischaracterizedbyprogressive,age-related,degenerative . pacing in all-cause mortality.127 The DANPACE trial also found a
.
.
fibrosis of the sinus node tissue and atrial myocardium. .. higher incidence of paroxysmal AF [hazard ratio (HR) 1.27] and a
.
Bradyarrhythmias can be associated with various forms of atrial .. two-fold increased risk of pacemaker reoperation with AAIR, with
.
tachyarrhythmias,includingAF.125InthisformofSND,thebradyar- .. AVBdevelopingin0.6(cid:2)1.9%ofpatientseveryyear.127Thesefindings
.
rhythmiasmaycorrespondtoatrialpausesduetosinoatrialblocksor .. support the routine use of DDD(R) rather than AAIR pacing in
.
may be due to overdrive suppression after an atrial .. patientswithSND.
.
tachyarrhythmia.135 .. Inviewofthesedata,DDD(R)isthepacingmodeoffirstchoicein
.
Atrialtachyarrhythmias may be presentat thetimeofdiagnosis, .. SND (Figure 5). Unnecessary RV pacing should be systematically
.
typicallywithsinusarrestandasystolicpausesattheterminationof .. avoidedinpatientswithSND,becauseitmaycauseAFanddeteriora-
.
atrial tachyarrhythmias or after device implant. Control of atrial .. tion of HF, particularly if systolic function is impaired or border-
.
tachyarrhythmias in patients presenting with high ventricular rates .. line.144,148ThiscanbeachievedbyprogrammingoftheAVinterval
.
maybedifficultbeforeimplant,asdrugsprescribedforratecontrol .. orusingspecificalgorithmsforminimizingRVpacing.Programming
.
mayworsenbradyarrhythmias.Ablationoftheatrialtachyarrhythmia, .. anexcessivelylongAVintervaltoavoidRVpacinginpatientswith
.
mainlyAF,hasbeenproposedinlieuofpacingandcontinuingmedi- .. prolongedAVconductionmaybedisadvantageousfromahaemody-
. cations for selected patients,136(cid:2)138 butno data are availablefrom .. namic point ofview by causingdiastolic mitral regurgitation, which
.
RCTstoshowwhethercatheterablationofAFisnon-inferiortocar- .. mayleadtosymptomsand/orAF.144,149,150
.
.
diacpacingwithrespecttobradycardia-relatedsymptomsinpatients . Pacingalgorithmsforminimizingventricularpacingareoftenused
.
with bradycardia(cid:2)tachycardia syndrome.139 If drug treatment is .. inSND.144,151Ameta-analysisofalgorithmsforminimizingRVpacing
.
.
chosen,bradyarrhythmiasduringdrugtreatmentforrateorrhythm . failedtoshowasignificanteffectcomparedwithconventionalDDD
.
.
controlmaybemanagedbydosereductionordiscontinuationasan . pacing in patients with normal ventricular function with regard to
.
.
alternative to cardiac pacing, but in many cases bradyarrhythmias . endpoints such as incidence of persistent/permanent AF, all-cause
.
persist. .. hospitalization,andall-causemortality.152However,therationalefor
.
.
. reducingunnecessaryRVpacingremainsstrongandiscoupledwith
.
.
.. thebenefitsofextendingdevicelongevity.151,152Somemanufacturer-
.
5.1.2 Pacingmodeandalgorithmselection .. specificalgorithmsaremoreeffectiveinminimizingventricularpacing,
.
InpatientswithSND,controlledstudiesfoundthatDDDwassupe- .. but mayconfer disadvantages in allowing decouplingbetween atria
.
riortosingle-chamberventricularpacinginreducingtheincidenceof .. andventricles.153,154Rarely,algorithmsdesignedtominimizeventric-
.
AF.ThesestudiesalsoshowedsomeeffectofDDDpacingonthe .. ularpacingcancauselife-threateningventriculararrhythmiasthatare
.
occurrenceofstroke.140,141Dual-chamberpacingreducestheriskof .. pausedependentorpausetriggered.155(cid:2)158 No direct comparison
.
pacemaker syndrome, which mayoccur in more thana quarter of .. ofthesealgorithmshasbeenperformedsofar,butpooleddatafrom
.
patients with SND.21,142 Pacemaker syndrome is associated with a .. randomized trials donot show clear-cut superiority ofany specific
.
reduction in quality of life and usually justifies the preference for .. algorithminimprovingclinicaloutcome.152,159
.
DDD vs. ventricular rate-modulated pacing in SND, when reason- .. InpatientswithseverelyreducedLVEFandaSNDindicationfor
.
able.143 Potential exceptions are very elderly and/or frail patients .. pacing,inwhomahighpercentageofventricularpacingisexpected,
.
withinfrequentpauseswhohavelimitedfunctionalcapacityand/ora .. anindicationforCRTorHBPshouldbeevaluated(seesection6on
.
. shortexpectedsurvival.Inthesepatients,thebenefitofDDD(R)vs. . CRTandsection7onHBP).
.
.
VVIRpacingisexpectedtohavelimitedornoclinicalimpact,andthe . TheroleofpacingalgorithmsforpreventingAFhasbeenthesub-
.
.
incremental risk of complications related to the second atrial lead . jectofcontroversy.Aseriesofalgorithmsforpreventing/suppressing
. .
required in DDD(R) implants should also be considered when . AF has been tested, such as dynamic atrial overdrive pacing, atrial
. .
choosingthepacingmode.InpatientswithSNDtreatedwithaDDD . pacinginresponsetoatrialprematurebeats,pacinginresponseto
.
.
pacemaker,programmingoftheAVintervalandspecificalgorithms . exercise, and post-mode-switch pacing. The clinical evaluation of
.
.
forminimizingRVpacingmayfurtherreducetheriskofAFandpar- . these algorithms, also applied at different atrial pacing sites, is not .
ticularlyofpersistentAF.144Dual-chamberpacingissaferandmore .. convincingandnoclinicalbenefitwithregardtomajorclinicalend-
.
sustainable than atrial-only pacing modes used in the past,127 even .. pointshasbeendemonstrated.160,161
.
.
thoughsingle-leadatrialpacingwasfound tobe superiortosingle- . Atrialantitachycardiapacing[ATP;i.e.deliveryofatrialstimuliat
.
.
leadventricularpacing.145,146Theresultsofstudiesthatevaluateddif- .. highfrequenciestoconvertanatrialtachyarrhythmiatosinusrhythm
.
ferent pacing modes in bradyarrhythmias, including in some cases .. (SR)] has also been tested for reducing the atrial tachyarrhythmia
.
bothSNDandAVB,areshowninSupplementaryTable6. .. burdenandcounteractingthetendencyovertimetowardsprogres-
.
With regard to the choice between DDD(R) and atrial pacing .. sion to permanent AF.162 Conventional delivery of atrial ATP in a
.
atrialsensinginhibited-responserate-adaptive(AAIR)pacing,anRCT .. way that mirrors the delivery of ventricular ATP (bursts/ramp at
.
withonly177patientssuggestedareducedriskofAFwithAAIR.147 .. arrhythmiaonset)hasarelativelylowsuccessrate,andindeedthetri-
.
However,themostrecentDANishMulticenterRandomizedTrialon .. alsbasedonconventionalatrialATPshowednobenefitonAFbur-
.
Single Lead Atrial PACing vs. Dual Chamber Pacing in Sick Sinus . den or clinical events.163 A new form of ATP delivery has been
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 25 ---
ESCGuidelines 25
Optimal pacing mode in sinus node dysfunction and atrio-ventricular block
SND AV block
Persistent or Persistent or
paroxysmal paroxysmal
Persistent Paroxysmal Persistent Paroxysmal
Chronotropic
incompetence?
SND no SND AF
Y N
Sinus rhythm:
Default DDDR DDD DDD(R)a DDD +AVM
DDD(R)a DDD VVIR
option +AVM +AVM +AVM AF:VVI +
rate hysteresis
Single
Any reason Single Single
chamber
to avoid 2 chamber chamber VVI(R)a VDD VDD
AAI(R)a
leadsb AAIR AAI
VVI(R)a
Significant VVI + rate VVI +
VVIR VVI VVI
comorbidity hysteresis rate hysteresis
Figure5Optimalpacingmodeandalgorithmselectioninsinusnodedysfunctionandatrioventricularblock.AF=atrialfibrillation;AV=atrioventricular;
AVM=atrioventricularmanagement[i.e.AVdelayprogramming(avoidingvalues>230ms)orspecificalgorithmstoavoid/reduceunnecessaryventricular
pacing];CRT=cardiacresynchronizationtherapy;SND=sinusnodedysfunction.a(R)indicatesthattheprogrammingofsuchapacingmodeispreferred
onlyinthecaseofchronotropicincompetence.bReasonstoavoidtwoleadsincludeyoungageandlimitedvenousaccess.Note:inpatientswhoarecandi-
datesforaVVI/VDDpacemaker,aleadlesspacemakermaybeconsidered(seesection7).ForcombinedCRTindications,seesection6.Adaptedfrom
Brignoleetal.62
.
.
proposed,specificallyaimedatreducingatrialtachyarrhythmias,and . conventionalDDD(R)].Thepositiveeffectontheprimaryendpoint
.
.
its efficacy in reducing the progression to permanent AF was vali- . wasduetoalowerrateofprogressiontopermanentAF.Apost-hoc
.
datedinanRCT.162,164 .. analysis indicated that this form of atrial ATP was an independent
.
Inthistrial,164theprimarycompositeoutcomeat2years(death, .. predictor of permanent or persistent AF reduction.162,164,165 In
.
.
cardiovascular hospitalizations, or permanent AF) was significantly . CHD,wherere-entrantatrialarrhythmiasareverycommon,useof
.
.
reducedinpatientswithadevicecombiningATPandalgorithmsfor . DDD(R)pacemakerswithatrialATPmaybeconsidered(seesection
.
.
minimizing RV pacing [36% relative risk reduction compared with . 8onpacinginCHD).
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 26 ---
26 ESCGuidelines
.
.
. AVB, manifestations of fatigue, exertional intolerance, and HF are
Recommendationsforpacinginsinusnodedysfunction .
.
. sometimes underestimated. Deterioration of cognitive functions is
.
.
Recommendations Classa Levelb .. oftenonlyspeculativesothatthepossibilitiesofimprovementafter
.
. implantationofapacemakerareunpredictableandunlikely.Deathin
.
InpatientswithSNDandaDDDpacemaker, .
. patientswithuntreatedAVBisduenotonlytoHFsecondarytolow
.
minimizationofunnecessaryventricular .
I A .. cardiac output, but also to SCD caused by prolonged asystole or
pacingthroughprogrammingis .
. bradycardia-triggeredventriculartachyarrhythmia.AlthoughRCTsof
recommended.144,151,159,164,166(cid:2)169 ..
. pacing in AVB have not been performed, it is clear from several
.
PacingisindicatedinSNDwhensymptomscan ...
observationalstudiesthatpacingpreventsrecurrenceofsyncopeand
clearlybeattributedto I B ... improvessurvival.10(cid:2)12
bradyarrhythmias.14,128(cid:2)131 ..
.
.
Pacingisindicatedinsymptomaticpatientswith .. 5.2.1.1First-degreeatrioventricularblock
. thebradycardia(cid:2)tachycardiaformofSNDin .. Usually the prognosis is good in the absence of structural heart
.
ordertocorrectbradyarrhythmiasandenable
I B
... disease,andprogressiontohigh-degreeblockisuncommon.175The
pharmacologicaltreatment,unlessablationof .. indication for pacing relies on an established correlation between
.
thetachyarrhythmiais .. symptomsandAVB.ThereisweakevidencetoshowthatmarkedPR
preferred.17,20,21,136(cid:2)138,170,171 ...
prolongation(i.e. >_300 ms), particularlywhen it persists oris pro-
.
Inpatientswhopresentchronotropicincompe- .. longedduringexercise,canleadtosymptomssimilartopacemaker
.
tenceandhaveclearsymptomsduringexercise, .. syndrome and/or that thesecan improve with pacing.176 Symptom
IIa B .
DDDwithrate-responsivepacingshouldbe .. correlation is crucial, although it may be difficult if these are non-
.
considered.172,173 .. specificandsubtle.Intheabsenceofaclearcorrelation,apacemaker
.
.
AFablationshouldbeconsideredasastrategy . isgenerallynotindicated.
.
.
toavoidpacemakerimplantationinpatientswith .
.
.
AF-relatedbradycardiaorsymptomaticpre- IIa C . 5.2.1.2Second-degreetypeIatrioventricularblock(MobitztypeIor
.
.
automaticitypauses,afterAFconversion,taking . Wenckebach)
.
.
intoaccounttheclinicalsituation.136(cid:2)139,174 . Inadditiontothepresenceorabsenceofsymptoms,theriskofpro-
.
.
Inpatientswiththebradycardia(cid:2)tachycardia .. gressiontohigherdegreesofAVBshouldbeconsidered.Supranodal
.
variantofSND,programmingofatrialATPmay IIb B .. blockhasabenigncourse,andtheriskofprogressiontotypeIIora
.
beconsidered.164,165 .. higherdegreeofAVblockislow.Small,retrospectivestudieshave
.
Inpatientswithsyncope,cardiacpacingmaybe .. suggestedthat,overthelongterm,thistypeofAVBcarriesahigher
.
consideredtoreducerecurrentsyncopewhen .. riskofdeathinpatientsaged>_45yearsintheabsenceofpacemaker
asymptomaticpause(s)>6sduetosinusarrest
IIb C ... implantation.177,178Infranodalblock(rareinthisformofblock)car-
.
isdocumented.133,134 .. riesahighriskofprogressiontocompleteheartblock,syncope,and
.
PacingmaybeconsideredinSNDwhensymp-
... sudden death, and warrants pacing even in the absence of
tomsarelikelytobeduetobradyarrhythmias, IIb C
... symptoms.179,180
.
whentheevidenceisnotconclusive. ..
.. 5.2.1.3Second-degreeMobitztypeII,2:1,andadvancedatrioventricular
Pacingisnotrecommendedinpatientswithbra- .
.. block(alsonamedhigh-gradeatrioventricularblock,wheretheP:QRS
dyarrhythmiasrelatedtoSNDthatareasympto- .
III C .. ratiois3:1orhigher),third-degreeatrioventricularblock
maticorduetotransientcausesthatcanbe .
correctedandprevented.33
... Intheabsenceofareversiblecause,duetotheriskofoccurrenceof
.. severe symptoms and/or possible progression towards a more
. ATP = antitachycardia pacing; DDD = dual-chamber, atrioventricular pacing; .. severeorcompleteAVB,patientsshouldreceiveapacemakereven
.
SND=sinusnodedysfunction. .. intheabsenceofsymptoms.Inasymptomaticpatientsinwhoma2:1
aClassofrecommendation. ..
bLevelofevidence. .. AVB is found incidentally, the decision for implantation should be
.
. madeonacasebycasebasisincludingdistinctionbetweennodaland
.
.
. infranodalAVB.Thisdistinctionmaybebasedonobservationssuch
.
.
. asPRorPPintervalprolongationbeforeAVB,theeffectofexercise
.
.
. onAVconduction,andanEPS.
.
5.2 Pacing for atrioventricular block ..
.
.
5.2.1 Indicationsforpacing . 5.2.1.4Paroxysmalatrioventricularblock
.
.
Treatment of AVB aims at ameliorating symptoms and preventing . BecauseoftheriskofsyncopeandSCDandofthepotentialprogres-
.
.
syncopeandsuddencardiacdeath(SCD).First-degreeAVBisusually . siontopermanentAVB,theindicationsforpacingarethesamefor
.
.
asymptomatic. Syncope and dizziness are mainly observed in high- .. paroxysmalasforpermanentAVB.Itiscrucialtoruleoutareversible
.
degree and complete AVB, especially in the paroxysmal forms. HF .. causeandtorecognizethereflexformsofAVB,whichmaynotneed
.
symptomsaremorecommoninchronicAVBwithpermanentbrady- .. pacing.DocumentationofinfranodalblockbyEPSorthedocumenta-
.
cardia,butcanalsobeobservedinfirst-degreeAVBwithaverypro- .. tionofinitiationoftheblockbyatrialorventricularprematurebeats,
.
longed PR interval. Given the commonly advanced age at onset of . orincreasedheartrate(tachy-dependentAVB)ordecreasedheart
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 27 ---
ESCGuidelines 27
.
.
rate(brady-dependentAVB),supportadiagnosisofintrinsicinfrano- . symptomsduetobradycardiaandofhigh-degreeorinfranodalblock,
.
dalAVB.27 .. pacingisunlikelytobebeneficialandisnotindicated.
.
.
. In patients with AF who undergo atrioventricular junction (AVJ)
.
.
. ablationtocontrolrapidventricularrates,thereisevidencetoshow
5.2.2 Pacingmodeandalgorithmselection ..
5.2.2.1 Dual-chambervs.ventricularpacing
... thatAVJablationplusRVpacingimprovessymptomsandqualityof
Large, randomized, parallel trials that included patients with only
... life.192Incontrast,neutralresultswerefoundregardingtheprogres-
AVB181 or with AVB and/or SND140 failed to show superiority of
... sionofHF,hospitalization,andmortality,193exceptinonestudy.194
.. Comparedwithpharmacologicalratecontrol,AVJablationandCRT
DDDoverventricularpacingwithregardtomortality,andhavenot .
.. reducedtherisksofdeathduetoHF,hospitalizationduetoHF,or
consistentlyshownsuperiorityintermsofqualityoflifeormorbidity .
(includingstrokeortransientischaemicattackandAF).20,140,181Dual-
... worsening HF by 62%, and improved specific symptoms of AF by
.. 36%inelderlypatientswith permanentAFand narrowQRS.195In
chamberpacingisbeneficialoverventricularpacingduetotheavoid- .
.. otherstudies,thisbeneficialeffectwaslimitedtopatientswithHFor
anceofpacemakersyndrome,whichoccurredinuptoaquarterof . .. reduced ejection fraction (EF).166,196 For further discussion of the
patientswithAVBinthesetrials.Inameta-analysisof20crossover .
.. roleofCRTfollowingAVJablation,refertosection6.Thereisweak
trials,DDDwasassociatedwithanimprovedexercisecapacitycom- .
.. evidence to support a benefit from para-Hisian and Hisian pacing
pared with ventricular pacing. However, the effect was driven by .
.. after AVJ ablation for refractory AF.197(cid:2)200 For further discussion,
non-rate-modulated ventricular pacemakers, and no benefit was . .
. refertosection7.
observed from the comparison of DDD with VVIR pacing.182 .
.
.
Pacemaker syndrome is associated with reduction in quality of life .
.
. Recommendationsforpacingforatrioventricularblock
andmayrequireareinterventionforupgrading,justifyingtheprefer- .
.
.
enceforDDDwhenreasonable(i.e.inpatientswhodonotpresent .
.. Recommendations Classa Levelb
with significant frailty, very advanced age, significant comorbidities .
.
.
limitingtheirlifeexpectancy,oraverylimitedmobility).Anothercon- . PacingisindicatedinpatientsinSRwithperma-
.
.
siderationisthediagnosisofAF,whichismorereliablefromdevice . nentorparoxysmalthird-orsecond-degree
.. I C
datainpatientswithDDDpacemakers.Onacasebycasebasis,in . type2,infranodal2:1,orhigh-degreeAVB,irre-
.
.
frail elderly patients, and/or when AVB is paroxysmal and pacing . spectiveofsymptoms.c9(cid:2)12
.
.
anticipated to be infrequent, VVIR pacing may be considered as it .. Pacingisindicatedinpatientswithatrialarrhyth-
.
carriesalowercomplicationrate.140 .. mia(mainlyAF)andpermanentorparoxysmal
. I C
There is strong evidence to show that chronic conventional RV .. third-orhigh-degreeAVBirrespectiveof
.
pacingmaybedeleteriousinsomepatientsandmayleadtoLVdys- .. symptoms.
.
functionandHF,148evenwhenAVsynchronyismaintained.183This ..
InpatientswithpermanentAFinneedofapace-
.
effectisonlypartlyexplained bytheabnormalactivationsequence .. maker,ventricularpacingwithrateresponse I C
.
and may involve myocardial perfusion, and humoral, cellular, and .. functionisrecommended.201(cid:2)204
.
molecularchanges.184,185Comparedwithamatchedcontrolcohort, ...
Pacingshouldbeconsideredinpatientswithsec-
patientswithapacemakerandanRVleadhaveanincreasedriskof ...
ond-degreetype1AVBthatcausessymptoms
HF,whichisalsoassociatedwitholderage,previousMI,kidneydis- ...
orisfoundtobelocatedatintra-orinfra-His
IIa C
ease, and male sex.186 Pacing-induced cardiomyopathy occurs in ... levelsatEPS.177(cid:2)180
10(cid:2)20%ofpatientsafter2(cid:2)4yearsofRVpacing.186(cid:2)188Itisassoci- ..
. InpatientswithAVB,DDDshouldbepreferred
atedwitha>20%RVpacingburden.187(cid:2)190However,thereareno ..
. oversingle-chamberventricularpacingtoavoid
datatosupportthatanypercentageofRVpacingcanbeconsidered .. IIa A . pacemakersyndromeandtoimprovequalityof
.
as defining a true limit below which RV pacing is safe and beyond .. life.20,140,181,182
.
whichRVpacingisharmful.Fordiscussionofpotentialindicationsfor .
.. Permanentpacemakerimplantationshouldbe
CRTand/orHBPtopreventpacing-inducedcardiomyopathy,please .
.. consideredforpatientswithpersistentsymp-
refertosections6and7. .
.. tomssimilartothoseofpacemakersyndrome IIa C
.
.. andclearlyattributabletofirst-degreeAVB(PR
5.2.2.2 Atrioventricularblockinthecaseofpermanentatrialfibrillation .
.. >0.3s).205(cid:2)207
In the presence of AF, AVB should be suspected if the ventricular .
.
. PacingisnotrecommendedinpatientswithAVB rate is slow and the ventricular rhythm regular. During prolonged .
.
. duetotransientcausesthatcanbecorrected III C
monitoring,longventricularpausesmaybedetected.191Inpatients ..
. andprevented.
withAFandnopermanentAVBorsymptoms,thereisnoidentifiable, ..
.
minimumpausedurationasanindicationforpacing.Intheabsenceof .. AF=atrialfibrillation;AVB=atrioventricularblock;DDD=dual-chamber,atrio-
.
apotentiallyreversiblecause,bradycardiaorinappropriatechrono- .. ventricularpacing;EPS=electrophysiologystudy;SR=sinusrhythm.
tropicresponse(duetoeitherintermittentorcompleteAVB)associ-
.... a bC Lela vs es lo of fr ee vc ido em nm cee .ndation.
ated or reasonably correlated with symptoms is an indication for .. cInasymptomaticnarrowQRScomplexand2:1AVB,pacingmaybeavoidedif
.
cardiacpacing.Anyhigh-degreeorinfranodalblockisalsoanindica- .. supra-Hisianblockisclinicallysuspected(concomitantWenckebachisobserved
tionforpacing,evenintheabsenceofsymptoms.Intheabsenceof
.. andblockdisappearswithexercise)ordemonstratedatEPS.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 28 ---
28 ESCGuidelines
.
.
In patients with AF, compared with fixed rate pacing, rate- . IsolatedfascicularblockandBBBarerarelyassociatedwithsymp-
.
.
responsive pacing is associated with better exercise performance, . toms;however,theirpresencemaybeamarkerforunderlyingstruc-
.
.
improved daily activities, a decrease in symptoms of shortness of . turalheartdisease.Thepresenceorabsenceofsymptomsreferable
.
.
breath, chest pain, and palpitations, and improved quality of . tointermittentbradycardiawillguidetheevaluationofthesepatients.
.
life.201(cid:2)203Ithasalsobeenshowntoimproveheartrateandblood ..
.
.
pressure response to mental stress compared with fixed rate pac- .. 5.3.1 Indicationsforpacing
.
ing.204 Therefore, rate-adaptive pacing is the pacing mode of first .. 5.3.1.1Bundlebranchblockandunexplainedsyncope
.
choice.Fixed-rateVVIpacingshouldbereservedforoldersedentary .. Althoughsyncope is not associated with an increased incidence of
.
patients who have very limited activity. Commonly, the minimum .. suddendeathinpatientswithpreservedcardiacfunction,ahighinci-
.
rateisprogrammedhigher(e.g.70b.p.m.)thanforpatientsinSRin .. dence of total deaths (about one-third sudden) was observed in
.
anattempttocompensateforlossofactiveatrialfilling. .. patientswithBBBandHF,previousMI,orlowEF.208(cid:2)210Indeed,in
.
.. those with low EF, syncope is a risk factor for death.211
. .. Unfortunately, ventricular-programmed stimulation does not seem
5.3 Pacing forconduction disorders .
.
. toidentifythesepatientscorrectly;therefore,anICDoradefibrilla-
without atrioventricular block ..
. torwithCRT(CRT-D) isindicated in patients with BBB and LVEF
.
This sectionfocuses onpatients with1:1 AV conductionand QRS .. <35%forthepreventionofSCD(Figure6).63
. abnormalities caused by delayed or blocked conduction of the ..
.
His(cid:2)Purkinjesystem:BBB,fascicularblockinisolationorincombina- .. 5.3.1.2Bundlebranchblock,unexplainedsyncope,andabnormalelec-
.
tion with BBB, and non-specific intraventricular delay. Bifascicular .. trophysiologicalstudy
.
blockisdefinedasLBBBorthecombinationofRBBBandwithleft .. Electrophysiological assessment includes measurement of the
.
anteriororposteriorfascicularblock. . HV at baseline, with stress by incremental atrial pacing or by
Decision algorithm for patients with unexplained syncope and BBB
Bifascicular block
Y LVEF ≤ 35%
N
Elderly and frail patients
at risk of traumatic Y
recurrrences
N
EPS/CSM
No diagnosis Diagnosis
ILR
No diagnosis Diagnosis
ICD/CRT-D Clinical follow-up Adapted therapy Pacemaker implant
Figure6 Decisionalgorithmforpatientswithunexplainedsyncopeandbundlebranchblock.BBB=bundlebranchblock;CRT-D=defibrillatorwith
cardiac resynchronization therapy;CSM = carotid sinusmassage;EPS = electrophysiology study;ICD = implantable cardioverter-defibrillator; ILR=
implantablelooprecorder;LVEF=leftventricularejectionfraction.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 29 ---
ESCGuidelines 29
pharmacologicalprovocation(ajmaline,procainamide,orflecainide). .. Recommendationsforpacinginpatientswithbundle
.
Scheinmanetal.studiedtheprognosticvalueoftheHV:theprogres- .. branchblock
.
sionratetoAVBat4yearswas4%inpatientswithHV<70ms,12% ..
inpatientswithHVbetween70and100ms,and24%inpatientswith
... Recommendations Classa Levelb
.
HV>100ms.121Developmentofintra-orinfra-Hisblockatincre- ..
Inpatientswithunexplainedsyncopeandbifas-
.
.
mentalatrialpacingorbypharmacologicalstresstestincreasesthe . cicularblock,apacemakerisindicatedinthe
.
.
s we hn osit wiv ii lt ly dean ved lop pos Ait Viv Be .1p 1r 6e (cid:2)d 1i 1c 8t ,i 1v 2e 0,1v 2a 2lu ,2e 12o Aft ph oe siE tiP vS et Eo PSid ye in et ldify edpa at pie on st is
-
..... p or ne ds -e on rce tho irf de -i dth ee gr rea eb ia ns te rali -ne orH inV fro af -H>_ i7 s0 ianm bs, lose ckc-
I B
.
tivepredictivevalueashighas80%toidentifypatientswhodevelop .. duringincrementalatrialpacing,oranabnormal
.
AVB. This finding has been indirectly confirmed by a study that .. responsetopharmacologicalchallenge.119,120
.
showed a significant reduction in syncopal recurrences in patients .. Pacingisindicatedinpatientswithalternating
. I C
withpositiveEPStreatedwithapacemaker,comparedwithacontrol .. BBBwithorwithoutsymptoms.
groupofuntreatedpatientswithanegativeEPS.119Inpatientswith ..
. Pacingmaybeconsideredinselectedpatients
.
unexplainedsyncopeandbifascicularblock,EPSishighlysensitivein .
. withunexplainedsyncopeandbifascicularblock
identifyingpatientswithintermittentorimpendinghigh-degreeAVB. .. IIb B
. withoutEPS(elderly,frailpatients,high-riskand/
.
However, a negative EPS cannot rule out intermittent/paroxysmal ... orrecurrentsyncope).213
AVBasthecauseofsyncope.Indeed,inpatientswithanegativeEPS, ...
Pacingisnotrecommendedforasymptomatic
intermittentorstableAVBwasdocumentedbyILRin(cid:3)50%ofcases. ... BBBorbifascicularblock.115,121,215 III B
Therefore, elderly patients with bifascicular block and unexplained ..
.
syncope might benefit from an empirical pacemaker, especially in .. BBB = bundle branch block; EPS = electrophysiology study; HV =
unpredictableandrecurrentsyncopethatexposesthe patienttoa .... H aCis la(cid:2) ssve on ft rr eic cu ol mar min et ne drv aa til o.
n.
highriskoftraumaticrecurrences.The decisiontoimplantapace- ... bLevelofevidence.
makerinthesepatientsshouldbebasedonindividualrisk(cid:2)benefit ..
.
evaluation.213 ..
.
..
.. 5.3.2 Pacingmodeandalgorithmselection
5.3.1.3 Alternatingbundlebranchblock ...
In intermittent bradycardia, pacing may be required only for short
.
ThisrareconditionreferstosituationsinwhichthereisclearECG .. periods.Inthissituation,thebenefitsofbradycardiaandpausepre-
.
evidenceforblockinallthreefasciclesonsuccessiveECGs;examples .. vention must be weighed against thedetrimentaleffects of perma-
.
are LBBB and RBBB morphologies on successive ECGs, or RBBB .. nent pacing, particularly pacing-induced HF. Low base-rate
.
with associated left anterior fascicular block on one ECG and left .. programmingtoachievebackuppacing,andmanualadaptationofAV
posteriorfascicularblockonanotherECG.214Thereisgeneralcon- ..
. interval, programming AV hysteresis, or other specific algorithms
.
sensusthatthisphenomenonisassociatedwithsignificantinfranodal .
. preventingunnecessaryRVpacing,playaparticularlyimportantrole
.
disease and that patients will progress rapidly toward AVB. .. inthispatientgroup.144,148
.
Therefore,apacemakershouldbeimplantedassoonasthealternat- .
. InpatientsinSR,theoptimalpacingmodeisDDD.Thestrongevi-
.
ingBBBisdetected,evenintheabsenceofsymptoms. .
. denceofsuperiorityofDDDvs.VVIpacingislimitedtoimprovement
.
.
. insymptomsandqualityoflife.Conversely,thereisstrongevidence
.
5.3.1.4 Bundlebranchblockwithoutsymptoms .. of non-superiority with regard to survival and morbidity.20
.
PermanentpacemakerimplantationisnotindicatedforBBBwithout ..
Therefore,inelderlyorfrailpatientswithintermittentbradycardia,
.
symptoms, with the exception of alternating BBB, because only a ..
thedecisionregardingthepacingmodeshouldbemadeonanindivid-
. minority of these patients will develop AVB (1(cid:2)2% per ..
ual basis, taking into consideration the increased complication risk
.
year).115,121,215 The risks of pacemaker implantation and long-term ...
andcostsofDDD(Figure5).
transvenousleadcomplicationsarehigherthanthebenefitsofpace- ...
VDDmaybeapacingmodealternativeforpatientswithadvanced
makerimplantation.216,217 ...
AV conduction abnormalities and spared sinus node function. In
.
.. comparisonwithDDD,VDDsystemimplantationisassociatedwith
5.3.1.5 Patientswithneuromusculardiseases ...
fewercomplications,shorterprocedureandfluoroscopytimes,anda
In patients with neuromuscular diseases, cardiac pacing should be ... highincidenceofatrialundersensing.218Potentialatrialundersensing
considered,asanydegreeoffascicularblockcanprogressunpredict- ...
iscontributingtothelowuseofthissystemasmostoperatorsare
ably,evenintheabsenceofsymptoms(seesection8.5). ..
aimingforAVsynchrony.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 30 ---
30 ESCGuidelines
.
5.4 Pacing for reflex syncope .. rate of syncope with pacing of 15% at 2 years, significantly lower
.
Permanentpacemakertherapymaybeeffectiveifasystoleisadomi-
... than the 37% rate observed in unpaced controls.219 The 3-year
nant feature of reflex syncope. Establishing a relationship between
... recurrenceratewassimilarinpatientswithcardioinhibitorycarotid
symptomsandbradycardiashouldbethegoaloftheclinicalevalua-
... sinussyndrome(16%),asystolictiltresponse(23%),andspontane-
tionofpatientswithsyncopeandanormalbaselineECG.Theefficacy
... ous asystole documented by ILR (24%), suggesting similar indica-
ofpacingdependsontheclinicalsetting.Thefactthatpacingiseffec-
... tions andsimilarresultsfor thethreeforms ofreflex syncope.220
.
tivedoesnotmeanitisalwaysnecessary.Inpatientswithreflexsyn- .. Whilstsomescepticismprevailsoverthediagnosticaccuracyoftilt
.
cope, cardiac pacing should be the last resort and should only be .. testing for the diagnosis of syncope, emerging evidence supports
.
considered in highly selected patients [i.e. those >40 years of age .. theuseoftilttestingintheassessmentofreflexhypotensivesus-
.. ceptibility.107,221 Thus, tilt testing may be considered to identify
(mostly>60years),affectedbysevereformsofreflexsyncopewith .
.
. patients with an associated usually antecedent hypotensive
frequentrecurrencesassociatedwithahighriskofinjury,oftenwith- .
.
out a prodrome]. The 2018 ESC Guidelines on syncope62 give a .. responsethatwouldbelesslikelytorespondtopermanentcardiac
.
. pacing. Patients with hypotensive susceptibility need measures
detailed description of the diagnostic pathway and indications for .
.
. directedtocounteracthypotensivesusceptibilityinadditiontocar-
pacing,andprovidetheevidencefromtrialsthatsupportsuchrec- .
.
. diacpacing(e.g.physicalcounterpressuremanoeuvres,discontinu-
ommendations.Figure7summarizesthesuggesteddecisionpathway. .
.
. ation/reduction of hypotensive drugs, and administration of
ThealgorithmshowninFigure7hasbeenprospectivelyvalidated .
.
inamulticentrepragmaticstudy,whichshowedalowrecurrence
.. fludrocortisoneormidodrine).
.
.
Management of cardiac pacing in patients with reflex syncope
Y Severe,recurrent, unpredictable syncopes, age > 40 years N
Perform carotid sinus
massage and tilt table test
Y
Cardioinhibitory carotid
Y Positive tilt-test N
sinus syndrome
N Y
Asystolic tilt-test Y
Implant a DDD PM
and counteract Implant a DDD PM
N hypotensive susceptibility (Class I)
(Class I)
Implantable loop
recorder
Y
Asystole Y Positive tilt-test N
N
Pacing not indicated
(Class III)
Figure 7 Decisionpathwayforcardiacpacinginpatientswithreflexsyncope.DDD=dual-chamber,atrioventricularpacing.Note:cardioinhibitory
carotidsinussyndromeisdefinedwhenthespontaneoussyncopeisreproducedbythecarotidsinusmassageinthepresenceofanasystolicpause>3s;
asystolictiltpositivetestisdefinedwhenthespontaneoussyncopeisreproducedinthepresenceofanasystolicpause>3s.Asymptomaticasystolic
pause(s)>3sorasymptomaticpause(s)>6sduetosinusarrest,atrioventricularblock,orthecombinationofthetwosimilarlydefineasystoledetectedby
implantablelooprecorder.FigureadaptedfromBrignoleetal.62
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 31 ---
ESCGuidelines 31
.
5.4.1 Indicationsforpacing .. vs.in21(46%) patientswho had receiveda shampacemaker pro-
.
ThisTaskForcefoundsufficientevidenceintheliteraturetorecom- .. grammedoff(P=0.0001).Inapropensityscore-matchedcompari-
.
mendpacinginhighlyselectedpatientswithreflexsyncope(i.e.those .. sonstudy,229the5-yearactuarialsyncope-freeratewas81%inthe
.
>40yearsofagewithsevererecurrentunpredictablesyncopalepi- .. pacinggroupand53%inpropensity-matchedpatients(P=0.005;HR
.
sodeswhenasystolehasbeendocumented,inducedbyeitherCSM .. = 0.25). Finally, the BioSync CLS trial was a multicentre RCT that
.
ortilttesting,orrecordedthroughamonitoringsystem)133,222(cid:2)228 .. investigatedtheusefulnessofthetilt-tabletesttoselectcandidates
.
(see SupplementaryTable7).ThereissufficientevidencethatDDD .. forcardiacpacing.228Patientsaged>_40yearswhohadatleasttwo
.
.
pacingshouldbeconsideredinordertoreducerecurrenceofsyn- . episodesofunpredictableseverereflexsyncopeduringthepastyear
.
.
copeinpatientswithdominantcardioinhibitoryCSS(asystolicpause . andatilt-inducedsyncopewithanasystolicpause>3swererandom-
.
.
>3sandspontaneoussyncopeduringCSM)andinthoseinwhom . ized to receive either an active (63 patients) or an inactive (64
.
.
there is a correlation between spontaneous symptoms and ECG . patients)dual-chamberpacemakerwithcloseloopstimulation.The
.
.
whoare>40yearsofageandhavesevererecurrentunpredictable . studyshowedthat,afteramedianfollow-upof11.2months,syncope
.
syncope.62Permanentpacemakertherapymaybeeffectiveifasystole .. occurredinsignificantlyfewerpatientsinthepacinggroupthaninthe
.
.
is a dominant feature of reflex syncope. Establishing a correlation . control group [10 (16%) vs. 34 (53%), respectively; HR 0.23; P =
.
.
betweensymptomsandbradycardiashouldbethegoaloftheclinical . 0.00005). This study supports inclusion of tilt testing as a useful
.
.
evaluationofpatientswithsyncopeandanormalbaselineECG.The .. methodtoselectpatientswithreflexsyncopeforcardiacpacing.
.
efficacy of pacing depends on the clinical setting. A comparison of .. Basedontheresultsoftheabovestudies,sufficientevidenceexists
.
results in different settings is presented in Supplementary Table 8. .. toupgradefromIIbtoItheindicationforpacinginpatientsaged>40
.
Since the publication of the 2018 ESC Guidelines on syncope,62 .. yearswithasystolictiltresponse>3s.Figure8summarizestherec-
.
sometrialshaveaddedrelevantinformationregardingthesubsetof .. ommended indicationforpacing.Althoughthere isalsoarationale
.
patientswithtilt-inducedasystolicvasovagalsyncope.TheSPAINtrial .. forpacinginpatientsaged<_40yearswhohavethesameseveritycri-
.
was a multicentre, randomized, controlled, crossover study, per- .. teria asthose >40years,thisTask Forcecannotmake anyrecom-
.
formedin46patientsaged>40yearsaffectedbyseverelyrecurrent .. mendation due to the lack of evidence from trials addressing this
.
(>5 episodes during life) syncope and cardioinhibitory tilt test .. specificpopulation.
.
response(definedasbradycardia<40b.p.m.lasting>10sorasystole .. ThereisweakevidencethatDDDmaybeusefulinreducingrecur-
.
>3s).226Duringthe24-monthfollow-up,syncoperecurredin4(9%) .. rencesofsyncopeinpatientswiththeclinicalfeaturesofadenosine-
.
patientstreatedwithaDDDpacemakerwithclosedloopstimulation .. sensitivesyncope.62Inasmallmulticentretrialperformedin80highly
.
.
Indications for pacing in patients above age 40 with reflex syncope
Y Spontaneous asystolic pause(s)
N
Test-induced asystolic pause(s) N
Y
CI-CSS
Pacing indicated
(Class I)
Extrinsic (functional)
vagally-mediated or Asystolic tilt Undocumented syncope
adenosine-sensitive
Pacing indicated Pacing not indicated
Pacing indicated (Class I) (Class III)
(Class I)
Adenosine induced
AV block > 10 sec
Pacing indicated
(Class IIb)
Figure8 Summaryofindicationsforpacinginpatients>40yearsofagewithreflexsyncope.CI-CSS=cardioinhibitorycarotidsinussyndrome.Note:
spontaneousasystolicpause=3ssymptomaticor6sasymptomatic.AdaptedfromBrignoleetal.62
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 32 ---
32 ESCGuidelines
.
.
selected elderly patients with unexplained unpredictable syncope .. 5.5.1 Recurrentundiagnosedsyncope
.
whohadinductionofthird-degreeAVBof>_10stointravenousinjec- .. Inpatientswithunexplainedsyncopeattheendofacompletework-
.
tionofabolusof20mgofadenosinetriphosphate,DDDsignificantly .. upandabsenceofanyconductiondisturbance,thelackofarationale
.
reducedthe2-yearsyncoperecurrenceratefrom69%inthecontrol .. andthenegativeresultsofsmallstudies234,235givesufficientevidence
.
groupto23%intheactivegroup.230Finally,cardiacpacingisnotindi- .. of inefficacy of cardiac pacing. Thus, cardiac pacing is not recom-
.
catedintheabsenceofadocumentedcardioinhibitoryreflex.231,232 .. mendeduntiladiagnosisismade(Figure8).
.
.
.
.
.
.
5.4.2 Pacingmodeandalgorithmselection . 5.5.2 Recurrentfalls
.
.
Even ifthe quality ofevidence is weak, DDD pacingiswidelypre- .. Between15%and20%ofunexplainedfallsmaybesyncopalinnature,
.
ferredinclinicalpracticetosingle-chamberRVpacingincounteract- .. possiblybradyarrhythmic.Retrogradeamnesia,whichisfrequentin
.
ing blood pressure fall and preventing symptom recurrences. In .. thefallingelderly,isresponsibleformisinterpretationoftheevent.62
.
patientswithtilt-inducedvasovagalsyncope,DDDwasusedmostly .. Themanagementofunexplainedfallsshouldbethesameasthatfor
.
with a rate-drop response feature that provides rapid DDD if the .. unexplained syncope (see section 5.4.1). In a randomized double-
.
devicedetectsarapiddecreaseinheartrate.Acomparisonbetween .. blindtrial,236cardiacpacingwasineffectiveinpreventingrecurrences
.
DDDclosed-loopstimulationandconventionalDDDhasbeenper- .. inpatientswithanunexplainedfallinwhomcarotidsinushypersensi-
.
formed by means of a crossover design in two small studies. Both .. tivitywasunabletoinducesyncope.
.
studiesshowedfewersyncoperecurrenceswithclosed-loopstimula- .
.
tion,bothintheacutesettingduringrepeatedtilttesting233anddur- .. Recommendationsforcardiacpacinginpatientswith
.
ing18-monthclinical follow-up.227 However, until a formalparallel .. suspected(undocumented)syncopeandunexplained
.
. falls
trial is performed, no recommendation can be given regarding the .
.
.
selectionofthepacingmode(i.e.DDDwithrate-dropresponseor .
.. Recommendations Classa Levelb
DDDwithclosed-loopstimulation)anditsprogramming. .
.
.
. Inpatientswithrecurrentunexplainedfalls,the
.
.
. sameassessmentasforunexplainedsyncope IIa C
.
.
Recommendationsforpacingforreflexsyncope .. shouldbeconsidered.62
.
.. Pacingisnotrecommendedinpatientswith
Recommendations Classa Levelb ... unexplainedfallsintheabsenceofanyother III B
.
Dual-chambercardiacpacingisindicatedto
... documentedindication.236
.
reducerecurrentsyncopeinpatientsaged>40 .. Pacingisnotrecommendedinpatientswith
.
years,withsevere,unpredictable,recurrentsyn- .. unexplainedsyncopewithoutevidenceofSND III C
copewhohave:
... orconductiondisturbance.234,235
.
• spontaneousdocumentedsymptomaticasys- ..
I A . SND=sinusnodedysfunction.
tolicpause(s)>3sorasymptomaticpause(s) .. aClassofrecommendation.
.
>6sduetosinusarrestorAVB;or .. bLevelofevidence.
.
• cardioinhibitorycarotidsinussyndrome;or ..
.
• asystolicsyncopeduringtilt .. .
testing.62,219,220,226,228,229 ..
. 6 Cardiac resynchronization
.
Dual-chambercardiacpacingmaybeconsidered .
.
. therapy toreducesyncoperecurrencesinpatientswith
IIb B
...
theclinicalfeaturesofadenosine-sensitive ..
syncope.230 ... 6.1 Epidemiology, prognosis, and
.
Cardiacpacingisnotindicatedintheabsenceof .. pathophysiologyof heart failure suitable
III B .
adocumentedcardioinhibitoryreflex.231,232 .. forcardiac resynchronization therapy by
.
.
. biventricular pacing
AVB=atrioventricularblock. ..
aClassofrecommendation. .. TheprevalenceofHFinthedevelopedworldapproximates1(cid:2)2%
bLevelofevidence. ..
. of the adult population, rising to >_10% among people aged >70
.
.. years.237TheprevalenceofHFisincreasing(by23%overthepast
.
.
. decadeaccordingtooneestimate)mainlyduetotheageingofthe
.
5.5 Pacing for suspected .. population,withtheage-specificincidenceactuallydeclining.238(cid:2)241
.
(undocumented) bradycardia .. There are threedistinct phenotypes of HFbased onthemeasure-
.
.
Inpatientswithrecurrentunexplainedsyncopeorfallsattheendof .. ment of LVEF [<40%, HF with reduced EF (HFrEF); 40(cid:2)49%, HF
.
theconventionalwork-up,ILRmonitoring shouldbe considered in .. withmildlyreducedEF(HFmrEF);and>_50%,HFwithpreservedEF
.
anattempttodocumentaspontaneousrelapseinsteadofembarking .. (HFpEF)].242 CRT is clinicallyusefulmainlyfor patientswithHFrEF
.
onempiriccardiacpacing.62 . andLVEF<_35%.PatientswithHFrEFconstitute(cid:3)50%oftheentire
1202
CSE
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 33 ---
ESCGuidelines 33
.
.
population with HF, and HFrEF is less prevalent among individuals . hadanischaemiccardiomyopathy.At7-yearfollow-up,thesubgroup
.
.
aged70yearsorolder.TheprognosisofHFvariesaccordingtothe . ofpatientswithLBBB,NYHAfunctionalclassI,andischaemiccardio-
.
.
defined population. In contemporary clinical trials ofHFrEF, 1-year . myopathyshowedanon-significanttrendtowardslowerriskofdeath
.
.
mortalityratesof(cid:3)6%areseen,whereasinlargeregistry-basedsur- . from any cause [relative risk 0.66, 95% confidence interval (CI)
.
.
veys,1-yearmortalityratesexceed20%inpatientsrecentlyhospital- . 0.30(cid:2)1.42;P=0.29].Therefore,presentCRTrecommendationsare
.
.
ized for HF, but are closer to 6% in those recruited with stable . applicable to all patients in NYHA functional class II(cid:2)IV of any
.
outpatient HF.243The concept of CRTisbasedonthefactthatin .. aetiology.
.
.
patientswithHFandLVsystolicdysfunction,high-gradeintraventric- . The MUltisite STimulation In Cardiomyopathies (MUSTIC),256,257
.
.
ularconductiondelaysarefrequentlyobserved,withaprevalenceof .. Multicenter Insync RAndomized Clinical Evaluation (MIRACLE),
.
QRS duration >120 ms in 25(cid:2)50% of patients and of LBBB in .. PAcing THerapies in Congestive Heart Failure (PATH-CHF) I and
.
15(cid:2)27% of cases. Moreover, in such patients, AV dyssynchrony is .. II,58,254,255,259 COmparison of Medical therapy, PAcing aNd
.
alsooftenpresentwithprolongedPRonthesurfaceECGinupto .. defibrillatION(COMPANION),260andCArdiacREsynchronizationin
. 52%ofcases.244(cid:2)246TheseelectricalabnormalitiesmayresultinAV, .. HeartFailure(CARE-HF)39,261trialscomparedtheeffectofCRTvs.
.
interventricular,andintra-LVmechanicaldyssynchrony.247,248 .. guideline-directedmedicaltherapyinNYHAfunctionalclassIIIorIV;in
.
RecommendationsforCRTarebasedontheresultsofthemajor .. contrast,mostrecenttrialshavecomparedCRT-DwithICDontop
.
RCTsofCRT,mostofwhichhavebeenrestrictedtothe(cid:3)60%of .. ofbestmedicaltherapyinNYHAfunctionalclassII.37,40,262(cid:2)266Few
. HFrEFpatientswhoareinSR.CRTisrecommended(inadditionto .. studies have compared CRT-pacemaker (CRT-P) with conventional
.
guideline-directedmedicaltherapy)inonlydefinedsubsetsoftheHF .. pacing.190,267,268MoststudiesofCRThavespecifiedthatLVEFshould
.
patientpopulation,themajoritybeingsymptomaticHFpatientsinSR .. be <_35%, but MADIT-CRT40 and the Resynchronization(cid:2)
.
withareducedLVEFandaQRSduration>_130ms.Othersmaller .. DefibrillationforAmbulatoryHeartFailureTrial(RAFT)37considered
.
.
groups that may be considered for CRT include New York Heart . an LVEF <_30%, and the REsynchronization reVErses Remodelling in
.
Association(NYHA)classIIIorIVHFpatientsinAFwithareduced .. SystolicleftvEntriculardysfunction(REVERSE)trial262specified<_40%.
.
.
LVEF and a QRSduration >_130 ms,provided a strategytoensure . RelativelyfewpatientswithanLVEFof35(cid:2)40%havebeenrandom-
.
.
biventricularcaptureisinplaceorthepatientisexpectedtoreturn . ized,butanindividualparticipantdatameta-analysissuggestsnodimin-
.
toSR,andoccasionallyasanupgradefromaconventionalpacemaker .. utionoftheeffectofCRTinthisgroup.33
.
.
oranICDinHFrEFpatientswhodevelopworseningHFwithahigh . NotallpatientsrespondfavourablytoCRT.Severalcharacteristics
.
.
rateofventricularpacing.ArecentsurveyintheUSA,whichderived . predict reduction in ventricular volume (reverse remodelling) and
.
.
a nationally representative estimate of theentire US population of . improvement inmorbidityand mortality.QRSwidth predictsCRT
.
.
hospitalizedpatients,foundthatovera10-yearperiod(2003(cid:2)2012), . responseandwastheinclusioncriterioninallrandomizedtrials(for
.
.
therewereanestimated378247CRT-Dimplantations,representing . ECGcriteriaforLBBBandRBBB,seeSupplementaryTable1).QRS
.
.
(cid:3)40000peryear,orroughly135permillionperyear.249InEurope, .. morphology has been related to a beneficial response to CRT.
.
previous estimates have reported that (cid:3)400 patients per million .. SeveralstudieshaveshownthatpatientswithLBBBmorphologyare
.
populationperyearmightbesuitableforCRT.Thiswasbasedonan .. more likely to respond favourably, whereas there is less certainty
.
estimatedprevalenceof35%forLVEF<_35%inarepresentativeHF .. about patients with non-LBBB morphology. Sipahi et al.269,270 per-
.
population,ofwhich41%ofpatientswereestimatedtohaveaQRS .. formedameta-analysisinwhichtheyexamined33clinicaltrialsinves-
.
duration>_120ms.ThechangetoahigherthresholdofQRSduration .. tigating the effect of QRS morphology on CRT, but only four
.
of130mswillreducetheseestimatesmodestly.250,251InSweden,a .. (COMPANION,CARE-HF,MADIT-CRT,andRAFT)includedout-
.
recentsurveyof12807HFrEFpatientsshowedthat7%hadreceived .. comes according to QRS morphology. When they evaluated the
.
CRTand69%hadnoindicationforCRT,but24%hadanindication .. effectofCRToncompositeadverseclinicaleventsin3349patients
. and had not received CRT. These data highlight the underuse of .. withLBBBatbaseline,theyobserveda36%reductioninriskwiththe
. CRT.252,253Finally,theTaskForcestressesthepointthatthedecision .. use of CRT (relative risk 0.64, 95% CI 0.52(cid:2)0.77; P < 0.00001).
. toimplantCRTrequiresashareddecision-makingwiththepatient. .. However,suchbenefitwasnotobservedinpatientswithnon-LBBB
.
.
. conductionabnormalities(relativerisk0.97,95%CI0.82(cid:2)1.15;P<
.
.
. 0.75).WhentheanalysiswaslimitedtotrialswithoutICD(CARE-HF
6.2 Indication forcardiac .
.
. andCOMPANION),thebenefit ofCRTwasstill observed onlyin
resynchronization therapy: patients in ..
. patients with LBBB (P < 0.000001). In a meta-analysis excluding
.
sinus rhythm .. COMPANIONandMADIT-CRT,LBBBwasnotfoundtobeapre-
.
CRT improves cardiac function, symptoms, and well-being, and .. dictorofmortality,incontrasttoQRSduration.266Inarecentlarge
.
.
reducesmorbidityandmortalityinanappropriatelyselectedgroup . meta-analysisoffiveRCTs(COMPANION,CARE-HF,MADIT-CRT,
.
.
ofHFpatients.CRTalsoimprovesquality-adjustedlife-yearsamong .. RAFT, and REVERSE) including 6523 participants (1766 with non-
.
patientswithmoderatetosevereHF.ThebeneficialeffectsofCRT .. LBBBQRSmorphology),CRTwasnotassociatedwithareductionin
.
havebeenextensivelyproveninpatientswithNYHAclassII,III,and .. deathand/orHFhospitalizationinpatientswithnon-LBBBQRSmor-
.
IV.37,39,40,254(cid:2)266Incontrast,thereisratherlimitedevidenceofCRT .. phology(HR0.99,95%CI0.82-1.2).271Aspatientshavebeenaggre-
.
benefitinpatientswithNYHAfunctionalclassIandischaemiccardio- .. gated in the non-LBBB category in nearly all studies and post-hoc
.
myopathy.40,265 In the Multicenter Automatic Defibrillator .. analysesonthebeneficialeffectofQRSmorphologyinCRT,itisnot
.
Implantation with Cardiac Resynchronization Therapy (MADIT- .. possibletoprovideaseparaterecommendationforCRTinpatients
.
CRT)study,265atotalof265(7.8%)of1820patientswereclassIand . presenting with diffuse intraventricular conduction disturbance and
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 34 ---
34 ESCGuidelines
.
.
RBBB.272(cid:2)277PatientswithRBBBdonotbenefitfromCRT278unless .. ECGcriteriaofintraventricularconductiondisturbance,LBBB,and
.
theyshowaso-calledmaskedLBBBonECG,277characterizedbya .. non-LBBBhavenotbeenconsistentlydefinedandreportedinanyof
.
broad, slurred, sometimes notched R wave on leads I and aVL, .. thepastCRTstudies.287,288Similarly,themodalityofQRSmeasure-
.
togetherwithaleftwardaxisdeviation.Individualizedpositioningof .. ment(automaticormanual, and ECGrecording machine) wasnot
.
theLVleadiscrucialinthesepatients. .. reported in CRT studies. However, the selection of ECG criteria
.
Animportantrecentnotionisthepossibleroleplayedbyapro- .. appearstoinfluencehardendpoints.287(cid:2)290Similarly,ECGrecording
.
longedPRinHFpatientswithnon-LBBB.Afewsingle-centrestudies .. modalityandECGmanufacturerhavebeenshowntopossiblyaffect
.
and two post-hoc analyses of large RCTs (COMPANION and .. theautomaticallymeasuredQRSduration.
.
MADIT-CRT)indicatedapotentialbenefitofimplantingCRTinthis .. Finally,CRTisconsideredinpatientsonoptimalmedicaltreatment
.
patient subgroup.244,279,280 In MADIT-CRT, the subgroup of non- .. (OMT), including beta-blockers, angiotensin-converting enzyme
.
LBBBpatientswhohadaprolongedPRdidbenefitfromCRT-D,with .. inhibitors, or angiotensin receptor blockers, and mineralocorticoid
.
.
a73%reductionintheriskofHFordeathandan81%reductionin . receptor antagonists. However, a study raises the question of the
.
theriskofall-causemortalitycomparedwithICD-onlytherapy.279In .. timingofCRT,becausetheefficacyofthemedicaltreatmentcanbe
.
non LBBB patients with normal PR, CRT-D was associated with a .. limitedinpatientswithLBBB,suggestingconsideringCRTsooner.291
.
.
trendtowardsanincreasedriskofHFordeathanda>2-foldhigher . Moreover, whereas everyday clinical practice supports the use of
.
.
mortalitycomparedwithICDtherapy,suggestingabidirectionalsig- . sacubitril/valsartan,ivabradine,andsodium(cid:2)glucoseco-transporter-
.
.
nificant interaction. However, the data are too limited to give a . 2 inhibitors, it must be emphasized that in the landmark trials
.
recommendation.279 .. documenting the efficacy of these drugs, very few patients had an .
.
TheresultsoftheMADIT-CRT,REVERSE,andRAFTtrialssuggest . indication for CRT. Thus, there are no strong data to support the
.
thatinpatientswithLBBB,thereislikelytobepotentialbenefitinall .. mandatoryuseofthesedrugsbeforeconsideringCRT.292(cid:2)295
.
.
patientswithLBBBregardlessofQRSduration,andthatnocut-off .
.
point can be identified clearly to exclude patients who will not .. Recommendationsforcardiacresynchronizationther-
.
respond according to the QRS duration.272,273,275 In contrast, any .. apyinpatientsinsinusrhythm
.
.
benefitofCRTinpatientswithnon-LBBBisevidentmostlyinthose .
.. Recommendations Classa Levelb
withaQRSduration>_150ms.Importantly,asshownintheMADIT- .
.
.
CRT long-term study and RAFT, the benefit in patients with QRS .. LBBBQRSmorphology
<150msappearedlaterduringfollow-up.265,273 ...
CRTisrecommendedforsymptomaticpatients
.
The Echocardiography Guided Cardiac Resynchronization .. withHFinSRwithLVEF<_35%,QRSduration
.
Therapy(Echo-CRT)trialsuggestedpossibleharmfromCRTwhen .. >_150ms,andLBBBQRSmorphologydespite I A
.
baselineechocardiographicmechanicaldyssynchronyinpatientswith .. OMT,inordertoimprovesymptomsandreduce
.
QRS duration <130msis used.264,281 Therefore,selectionofCRT .. morbidityandmortality.37,39,40,254(cid:2)266,283,284
.
patientsbasedsolelyontheuseofcardiacimagingdataisstronglydis- ..
CRTshouldbeconsideredforsymptomatic
.
couragedinpatientswithso-called‘narrow’QRS(i.e.<130ms). ..
patientswithHFinSRwithLVEF<_35%,QRS
.
enrIn od lli iv ni gdu pa rl edp oat mie in nt and ta lyta pap to ieo nl te sd wf ir to hm NYth Hre Ae cC lasR sT I- ID HFvs sh. oIC wD edtr thia als
t
......
d ou gyra dti eo sn pi1 te30 O(cid:2) M1 T49 ,inm os, rdan ed rtL oBB imB pQ roR vS em syo mr pp -hol-
IIa B
womenaremorelikelytorespondthanmen.282IntheUSFoodand ...
tomsandreducemorbidityand
DrugAdministrationmeta-analysisofpatient-leveldata,Zusterzeelet ... mortality.37,39,40,254(cid:2)266,283,284
al.283foundthatthemaindifferenceoccurredinpatientswithLBBB ..
. Non-LBBBQRSmorphology
andaQRSof130(cid:2)149ms.Inthisgroup,womenhada76%reduc- ..
. CRTshouldbeconsideredforsymptomatic tion in HFordeath [absoluteCRT-D to ICD difference, 23% (HR ..
. patientswithHFinSRwithLVEF<_35%,QRS 0.24,95%CI0.11(cid:2)0.53;P<0.001)]anda76%reductionindeath ..
. duration>_150ms,andnon-LBBBQRSmorphol- IIa B alone [absolute difference 9% (HR 0.24, 95% CI 0.06(cid:2)0.89; P = ..
.. ogydespiteOMT,inordertoimprovesymp-
0.03)], whereas there was no significant benefit in men for HF or .
.. tomsandreducemorbidity.37,39,40,254(cid:2)266,283,284
death [absolute difference 4% (HR 0.85, 95% CI 0.60(cid:2)1.21; P = .
.. CRTmaybeconsideredforsymptomatic
0.38)] or death alone [absolute difference 2% (HR 0.86, 95% CI .
.. patientswithHFinSRwithLVEF<_35%,QRS
0.49(cid:2)1.52;P=0.60)].Apossibleexplanationforthegreaterbenefit .
.. duration130(cid:2)149ms,andnon-LBBBQRSmor- IIb B
ofCRTinwomenhasbeenattributedtosexdifferenceinLVsize,as .
.
. phologydespiteOMT,inordertoimprove
sex-specificdifferencesinresponsedisappearwhenQRSdurationis .
normalizedtoLVend-diastolicvolume.284Recently,computermod-
... symptomsandreducemorbidity.273(cid:2)278,281
.
. QRSduration
ellingconfirmedthatsexdifferencesintheLVsizeaccountforasig- .
.
nificant proportion of the sex difference in QRS duration, and .. CRTisnotindicatedinpatientswithHFand
.
providedapossiblemechanisticexplanationforthesexdifferencein .. QRSduration<130mswithoutanindicationfor III A .
CRTresponse.285,286SimulationsaccountingforthesmallerLVsize .. RVpacing.264,282
.
.
infemaleCRTpatientspredict9-13mslowerQRSdurationthresh- ...
CRT=cardiacresynchronizationtherapy;HF=heartfailure;LBBB=leftbundle
oldsforfemales.AswithotherECGparameters(e.g.durationofQT .. branchblock;LVEF=leftventricularejectionfraction;OMT=optimalmedical
.
andcorrectedQT),itisconceivablethatQRSdurationalsohasto .. therapy;SR=sinusrhythm.
. aClassofrecommendation.
reflectsexdifference. . bLevelofevidence.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 35 ---
ESCGuidelines 35
.
.
6.3 Patients in atrial fibrillation .. In conclusion, despite the weak evidence due to lack of large,
.
. randomizedtrials,theprevailingopinionofexpertsisinfavourofthe
This sectionconsiders indications for CRT in patients with perma- ..
. usefulnessofCRTinpatientswithpermanentAFandNYHAclassIII
nentAForpersistentAFunsuitableforAFablationorafterunsuc- ..
. andIVwiththesameindicationsasforpatientsinSR,providedthat
cessfulAFablation.AFablationhasbeenreportedtoimproveLVEF ..
. AVJablationisaddedinthosepatientswithincomplete(<90-95%)
andreducetheHFhospitalizationrateinselectedpatients.Inparticu- ..
. biventricularcaptureduetoAF(Figure9).However,thereareother
lar,AFablationisrecommendedforreversingLVdysfunctioninAF ..
. causesforincompletebiventricularpacingsuchasfrequentprema-
patients when tachycardia-induced cardiomyopathy is highly prob- ..
. tureventricularbeats,whichmayneedtobetreated(withdrugsor
able,regardlessofsymptoms.296Therefore,CRTshouldbeconsid- ..
ered in those patients with persistent AF and HFrEF when AF
... ablation)beforeconsideringAVJablation.Importantly,evaluationof
ablation cannot be performed or is declined by the patient. With
... thebiventricularpacingpercentageismainlygivenbythepercentage
.. ofbiventricularpacingusingdevicememory,whichdoesnotreflect
regardtoindicationsforratecontroltherapyandinparticulartoAVJ .
ablation,refertotheESCGuidelinesforthemanagementofAF.296
... exactlytherateofeffectivebiventricularcapture.Holtermonitoring
.. mayhelptoassesstherealbiventricularcapturepercentage.309,310A
.
.. newalgorithmhasbeendevelopedthatcancontinuouslyassessthe
.
6.3.1 Patientswithatrialfibrillationandheartfailure .. effectivebiventricularpacing.311
.
whoarecandidatesforcardiacresynchronizationtherapy .. ForpatientswithpermanentAF,therearenodatasupportingthe
. AmajordeterminantofthesuccessofCRTistheeffectivedelivery .. difference in the magnitude of response to CRT according to the
.
ofbiventricularpacing.AparticularaspectofAFpatientsisthatAF .. QRSmorphologyoraQRSdurationcut-offof150ms.
.
rhythmwithfastventricularrateandirregularitymayinterferewith .. It is important to remember that limited data are available for
.
adequate biventricular pacing delivery. AF may reduce the rate of .. patientsinNYHAclassII.
.
.
effective biventricular capture by creating spontaneous, fusion, or .
.
.
pseudo-fusionbeats.Ahighrateofbiventricularpacingisnotreached .
.
intwo-thirdsofpatientswithpersistentorpermanentAF.297 .. 6.3.2 Patientswithuncontrolledheartratewhoare
.
.
DatafromlargeregistriesshowthatAFpatientsundergoingCRT . candidatesforatrioventricularjunctionablation
.
.
have an increased risk of mortality even after adjusting for several . (irrespectiveofQRSduration)
.
.
clinicalvariables.297(cid:2)299InmostAFpatientswithintactAVconduc- . AVJablationshouldbeconsideredtocontrolheartrateinpatients
.
.
tion,anadequatebiventricularpacingdeliverycanbeachievedonly .. unresponsiveorintoleranttointensiverateandrhythmcontrolther-
.
bymeansofAVJablation.300(cid:2)302AsubstudyoftheRAFTtrial300was .. apy, or who are ineligible for AF ablation, accepting that these
.
unabletoshowbenefitofCRTwithoutAVJablationwithregardto .. patients will become pacemaker dependent.296 In particular, AVJ
.
thecombinedendpointofdeathorhospitalizationforHF;notably, .. ablation combined with CRT may be preferred to AF ablation in
.
only47%ofthepatientshadabiventricularcapture>90%.Thedeci- .. severelysymptomaticpatientswithpermanentAFandatleastone
.
siontoperformAVJablationisstillamatterofdebate,butmoststud- .. hospitalizationforHF.296
.
ies have shown improvements in LV function, functional capacity, .. AVJ ablation and permanent pacing from the RV apex provides
.
exercise capacity, and survival (with the same magnitude as in .. highly efficient rate control and regularization of the ventricular
.
patientswithSR).301Gasparinietal.302comparedtotalmortalityof .. response in AF, and improves symptoms in selected patients.192 A
.
443AFpatientswhoreceivedAVJablation(n=443)andof895AF .. large study with a propensity score-matched control group194
.
patientswhoreceivedrate-slowingdrugswiththemortalityof6046 .. showeda53%reductionintotalmortalityinpatientswhounderwent
.
patientswhowereinSR.The long-termsurvivalafterCRTamong .. AVJablationcomparedwiththosetreatedwithpharmacologicalrate
.
.
patientswithAFandAVJablationwassimilartothatobservedamong . control therapy. A class IIa indication is provided in the 2020 ESC
. patients in SR (HR 0.93); the mortality was higher for AF patients .. GuidelinesonAF.296
. .
treatedwithrate-slowingdrugs(HR1.52).Themostcommonrate- . ThedownsideofRVpacing,however,isthatitinducesLVdyssyn-
. controllingdrugsusedinAFarebeta-blockers;althoughsafeevenin .. chronyin(cid:3)50%ofpatients,312andthatthismayleadtoworseningof
.
.
thecontextofAFandHFrEF,theydonotnecessarilyhavethesame . HFsymptomsinaminority.Inthemajorityofpatients,AVJablation
.
benefitasinpatientswithSR303and thebenefit(cid:2)riskratio isinflu- .. improvesLVEFevenwithRVapical(RVA)pacingduetoamelioration
.
enced by other cardiovascular comorbidities.304,305 In a systematic .. of tachycardia-induced LV dysfunction, which commonly exists in
.
review and meta-analysis,306 AVJ ablation, compared with no AVJ .. these patients. CRT may prevent RV pacing-induced LV dyssyn-
.
.
ablation, reduced mortality by 37% and reduced the rate of non- . chrony.Themulticentre,randomized,prospectiveAblateandPacein
.
response by 59% in patients with biventricular pacing <90%, but .. Atrial Fibrillation (APAF) trial313 included 186 patients in whom a
.
.
showednobenefitinthosewith>_90%biventricularpacing.Similarly, . CRTorRVpacingdevicewasimplanted,followedbyAVJablation.
.
.
Tolosana et al. observed the same rate of responders (defined as .. Duringamedianfollow-upof20months,CRTsignificantlyreduced
.
>_10%decreaseinend-systolicvolume)inAFpatientswhoreceived .. by63%theprimarycompositeendpointofdeathduetoHF,hospital-
.
AVJ ablation or rate-slowing drugs and patients in SR who had .. izationduetoHF,orworseningofHF.ThebeneficialeffectsofCRT
.
adequate biventricular pacing (97, 94, and 97%, respectively).307 .. weresimilarinpatientswithanEF<_35%,NYHAclass>_III,andQRS
.
Importantly,AVJablationdidnotimprovesurvivalforpatientsinAF .. width>_120ms,andinotherpatientswithEF>35% orNYHAclass
.
treated with CRT compared with those treated with rate-slowing .. <IIIornarrowQRS.ComparedwiththeRVpacinggroup,respond-
.
drugs when an adequate biventricular pacing was achieved either .. ers increased from63%to83% (P ¼ 0.003).314 A meta-analysis of
.
withablation(97%)orwithdrugs(94%).308 . 696 patients from five trials showed a 62% reduction in
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 36 ---
36 ESCGuidelines
Management of atrio-ventricular junction ablation in patients with:
PersistentAF unsuitable for atrial fibrillation ablation
OR
PermanentAF
Controlled heart rate
Y N
Candidate for CRT Candidate forAVJ ablation
CRT LVEF < 50%
if QRS ≥ 130 ms
(Class IIa) Y N
LVEF 40% ≤LVEF
< 40% LVEF < 50%
(HFrEF) (HFmrEF)
BiV BiV CRT CRT RV pacing
> 90 – 95%a < 90 – 95%a (Class I) (Class IIa) (Class IIa)
CRT
(Class IIb)
OR
HBP HBP
(Class IIb) (Class IIb)
NoAVJ AVJ ablation
AVJ ablation
ablation (Class IIa)
Figure9 Indicationforatrioventricularjunctionablationinpatientswithsymptomaticpermanentatrialfibrillationorpersistentatrialfibrillationunsuit-
ableforatrialfibrillationablation.AF=atrialfibrillation;AVJ=atrioventricularjunction;BiV=biventricular;CRT=cardiacresynchronizationtherapy;ESC
=EuropeanSocietyofCardiology;HBP=Hisbundlepacing;HFmrEF=heartfailurewithmildlyreducedejectionfraction;HFrEF=heartfailurewith
reducedejectionfraction;LVEF=leftventricularejectionfraction;QRS=Q,R,andSwaves;RV=rightventricular/rightventricle.aDuetoarapidventric-
ularresponse.Note:thefigureisbasedontherecommendationsintheESCGuidelinesonAF.296
.
hospitalizationforHFandamodestimprovementinLVEFcompared .. physicallimitationsofAFat1-yearfollow-up(P=0.004).Incontrastto
.
withRVpacing,butnotin6-minwalkeddistanceandqualityoflife .. the main composite endpoint, the greatest symptomatic improve-
.
assessedbymeansoftheMinnesotaLivingwithHeartFailureques- .. mentswereobservedinpatientswithLVEF>35%(P=0.0003).
.
tionnaire.315IntheAPAF-CRTRCT,102elderlypatients(meanage .. Inconclusion,thereisevidencefromrandomizedtrialsofanaddi-
.
.
72years)withpermanentAF,anarrowQRS(<_110ms),andatleast . tionalbenefitofperformingCRTpacinginpatientswithreducedEF,
.
.
onehospitalizationforHFinthepreviousyearwererandomizedto . whoarecandidatesforAVJablationforratecontroltoreducehospi-
.
AVJablationandCRTortopharmacologicalratecontroltherapy.195 .. talizationandimprovequalityoflife.ThereisevidencethatCRTis
.
.
Afteramedianfollow-upof16months,theprimarycompositeout- . superiortoRVpacinginrelievingsymptoms,butnotmortalityand
.
.
comeof HFdeath,hospitalizationdue toHF,orworseningHFhad . hospitalization in patients with mid-range reduced systolic function
.
.
occurredin10patients(20%)intheablation(AVJ)plusCRTarmand . (Figure9).
.
.
in20patients(38%)inthedrugcontrolarm(HR0.38;P=0.013).The .
.
.
results were mostly driven by a reduction in hospitalization for HF. .. 6.3.3 EmergingnovelmodalitiesforCRT:roleof
.
TheHRwas0.18(P=0.01)inpatientswithLVEF<_35%and0.62(P= .. conductionsystempacing
.
0.36)inthosewithLVEF>35%.Furthermore,patientsundergoingAVJ .. HBP, alone or in conjunction with coronary sinus pacing, is a
.
ablationandCRThada36%reductioninthespecificsymptomsand . promisingnoveltechniquefordeliveringCRT,usefulinAFpatients
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 37 ---
ESCGuidelines 37
.
undergoingAVJablation.198,199,316(cid:2)318Non-conventionalCRTusing .. hospitalizations,whichmaybereducedbyprogrammingtomaximize
.
HBP coronary sinus pacing (so-called ‘His-optimized CRT’) or left .. intrinsic conduction or prevented by CRT.148,183,190,324 Previously,
.
bundle branch area pacing, in comparison with conventional CRT, .. thebenefitofCRTupgradehadbeeninvestigatedonlybyobservatio-
.
canachieveanarrowerQRSwitha‘quasi-normal’axismorphology, .. nalcontrolledtrialsandregistries,325(cid:2)339mainlycomparingupgrade
.
.
echocardiographic improvement of mechanical resynchronization . with de novo CRT; in early, small, observational pre- vs. post-CRT
.
indexes,andabettershort-termclinicaloutcome.319(cid:2)321Ingeneral, .. studies;340(cid:2)346andincrossovertrials,347(cid:2)350providingonlylimited
.
.
the potential benefit of HBP depends on the ability to achieve a . clinicaloutcomedata.
.
.
narrow QRS complex that is similar to the native QRS complex, . Based ona recentmeta-analysis ofobservational studies, mostly
.
rather than on the LVEF. Widespread adoption of this technique .. single-centre,351 echocardiographicand functionalresponse aswell
.
.
relies upon further validation of its efficacy in large RCTs and . astheriskofmortalityorHFeventswassimilarinpatientsafterde
.
.
improvements in lead design, delivery tools, and devices (see . novovs.upgradeCRT;however,inprevioussubgroupanalysesfrom
.
section7). .. large, randomized, prospective trials such as RAFT,37 morbidity or
.
. . mortalitybenefitwasnotconfirmed.
.
Recommendationsforcardiacresynchronization .
. Clinicaloutcomesarealsoinfluencedbytheclinicalcharacteristics
therapyinpatientswithpersistentorpermanentatrial ..
fibrillation
.. of patients referred to CRT upgrade. Based on data from the
.
.. EuropeanCRTSurveyII,352ahigh-volumeregistry,andclinicalchar-
.
Recommendations Classa Levelb .. acteristics from previous studies,351 patients referred for a CRT
.
.. upgradedifferfrompatientsreferredfordenovoCRTimplantation:
1)InpatientswithHFwithpermanentAFwhoarecandidates ...
they are older (even compared with those in RCTs), mainly male
forCRT: ...
patients, and have more comorbidities suchasAF,ischaemic heart
1A)CRTshouldbeconsideredforpatientswith ...
disease,anaemia,andrenalfailure.
HFandLVEF<_35%inNYHAclassIIIorIV ...
Onaverage,the numberofupgradeproceduresreaches23%of
despiteOMTiftheyareinAFandhaveintrinsic ...
totalCRTimplantations,60% froma conventionaldevice and 40%
QRS>_130ms,providedastrategytoensure IIa C ... fromanICD352inESCcountries,showingsignificantregionaldiffer-
.
biventricularcaptureisinplace,inorderto .. ences regarding the type of implanted device, such as CRT-P or
.
improvesymptomsandreducemorbidityand .. CRT-D.352,353
mortality.302,306,307,322 ..
. Regarding procedure-related complications, several studies
.
1B)AVJablationshouldbeaddedinthecaseof .. describedahigherburdenduringupgradeprocedures,rangingfrom
.
incompletebiventricularpacing(<90(cid:2)95%)due IIa B .. 6.8%to20.9%comparedwithdenovoimplantations.339,354Thiswas
.
toconductedAF.297(cid:2)302 ..
notconfirmedinarecentanalysisofregistrydata,whereupgrades
.
2)InpatientswithsymptomaticAFandanuncontrolledheart .. hadsimilarcomplicationratestodenovoimplantations.352Notably,
.
.
ratewhoarecandidatesforAVJablation(irrespectiveofQRS . 82% of these procedures were performed in high-volume centres.
.
.
duration): . However,dataonthelong-terminfectionratesorleadrevisionsafter
.
2A)CRTisrecommendedinpatientswith .. CRTupgradearescarce.354,355
I B ..
HFrEF.196,197,306,308 . The first prospective, randomized trial, the BUDAPEST CRT
.
.
2B)CRTratherthanstandardRVpacingshould .. Upgradestudy,isstillongoing,butmayclarifythesequestions.356
IIa C .
beconsideredinpatientswithHFmrEF. ..
.
.
2C)RVpacingshouldbeconsideredinpatients .
withHFpEF.188,196,323
IIa B ....
2D)CRTmaybeconsideredinpatientswith
... Recommendationforupgradefromrightventricular
IIb C . pacingtocardiacresynchronizationtherapy
HFpEF. .. .
.
AF=atrialfibrillation;AVJ=atrioventricularjunction;CRT=cardiacresynchroniza-
... Recommendation Classa Levelb
tiontherapy;EF=ejectionfraction;HF=heartfailure;HFrEF=heartfailurewith ..
. Patientswhohavereceivedaconventionalpace-
reducedejectionfraction(<40%);HFmrEF=heartfailurewithmildlyreducedejection .
.
fraction(40-49%);HFpEF=heartfailurewithpreservedejectionfraction(>_50%) .. makeroranICDandwhosubsequentlydevelop
accordingtothe2021ESCHFGuidelines;242LVEF=leftventricularejectionfraction; ..
symptomaticHFwithLVEF<_35%despiteOMT,
NYHA=NewYorkHeartAssociation;RV=rightventricular. .. IIa B
aClassofrecommendation. .. andwhohaveasignificantcproportionofRV
.
bLevelofevidence. .. pacing,shouldbeconsideredforupgradeto
.
.. CRT.37,148,185,190,324(cid:2)352
.
.
.
. CRT=cardiacresynchronizationtherapy;HF=heartfailure;ICD=implantable
.
6.4 Patients with conventional .. cardioverter-defibrillator;LVEF=leftventricularejectionfraction;OMT=opti-
pacemakeror implantable cardioverter
.... m aCa ll asm se od fic ra el ct oh mer map eny; dR atV io= n.rightventricular.
.
defibrillator who need upgrade to . bLevelofevidence.
.
cardiac resynchronization therapy
... cAlimitof20%RVpacingforconsideringinterventionsforpacing-inducedHFis
. supportedbyobservationaldata.However,therearenodatatosupportthatany
.
Severalstudieshavedemonstratedthedeleteriouseffectofchronic .. percentageofRVpacingcanbeconsideredasdefiningatruelimitbelowwhich
RV pacing with respect to an increased risk of HF symptoms or
.. RVpacingissafeandbeyondwhichRVpacingisharmful.
1202
CSE
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 38 ---
38 ESCGuidelines
.
.
6.5 Pacing in patients with reduced left . over CRT-P by reducing arrhythmic death, it does also add ICD-
.
.
ventricular ejection fraction and a .. specificriskssuchasleadfailureandinappropriateshocks,aswellas
.
. costs.
conventional indication for .
.
. COMPANIONistheonlytrialtorandomizepatientstoCRT-Por
antibradycardia pacing ..
. CRT-D, but was designed to assess the effects of CRT compared
.
Threerandomizedtrialsprovedthesuperiorityofbiventricularpac- .. withOMT.260Crucially,itwasnotdesignedtocompareCRT-Dand
.
ingoverRVpacinginpatientswithmoderatetoseveresystolicdys- .. CRT-P. CRT-P was associated with a marginally non-significant
.
functionwhorequiredantibradycardiapacingtoimprovequalityof .. reduction in the risk of all-cause mortality (HR 0.76, 95% CI
.
life, NYHA class, and echocardiographic response.190,357,358 In the ... 0.58-1.01;P=0.06),whereasCRT-Dwasassociatedwithasignifi-
Biventricular versus RV pacing in patients with AV block (BLOCK ... cant, 36% risk reduction (HR 0.64, 95% CI 0.48(cid:2)0.86; P = 0.004).
HF)trial,691patientswithAVNdiseaseandanindicationforpace- ... Analysisofcause-specificmortalityshowedthatSCDwassignificantly
makerwithamildlyreducedEF(<50%byinclusioncriteria,average ... reducedbyCRT-D(HR0.44,95%CI0.23-0.86;P=0.02)butnot
42.9%inthepacemakergroup)wererandomizedtobiventricularor ... CRT-P(HR1.21,95%CI0.7(cid:2)2.07;P=0.50).363
.
RVpacingwithorwithoutanICD,andfollowedforanaverageof37 .. Nevertheless,theCARE-HFextensionstudyprovedthatCRT-P
months.190Theprimaryendpoint(acompositeof>_15%increasein ... alonereducedtheriskofdyingsuddenlyby5.6%.261Inlinewiththese
.
theLVend-systolicvolume,HFevents,ormortality)wassignificantly .. findings,subgroupanalysesfromRCTsinmildHFconsistentlyfound
. improved in those assigned to CRT. CRT response is high among .. areductioninventriculararrhythmiaswithCRT.364(cid:2)368Theseeffects
.
patientswithsystolicdysfunctionandexpectedfrequentRVpacing. .. were especially observed among CRT responders, suggesting that
.
Based on the MOde Selection Trial in Sinus-Node Dysfunction .. the reduction in SCD risk is related to the extent of reverse LV
(MOST),183 atleast 40% RV pacingisassociated withanincreased ... remodellingwithCRT.
.
riskofHFhospitalizationorAF. .. Meta-analyseshavedrawndifferentconclusionsonthematter.In
.
ForpatientswithnormalorpreservedEF,dataonbenefitofCRT .. thestudybyAl-Majedetal.,369thesurvivalbenefitofCRTwaslargely
.
areconflictingwithrespecttohospitalization,andnomortalitybene- .. driven by a reduction in HF-related mortality, but SCD was not
.
fitwasshown.166,268,323,359However,adverseremodellingcausedby .. reduced.Lametal.370showedthatCRT-Dsignificantlyreducedmor-
.
RV pacing was prevented by biventricular pacing, especially during .. talitycompared withmedical therapy alone [odds ratio(OR) 0.57,
.
long-term follow up.323,359,360 A single-centre study showed that .. 95%CI0.40(cid:2)0.80],butnotwhencomparedwithICDwithoutCRT
.
>20%RVpacingwasassociatedwithdeleteriousLVremodellingin .. (OR 0.82, 95% CI 0.57(cid:2)1.18) or CRT-P (OR 0.85, 95% CI
.
patients with AVB and preserved LVEF.188 Frailty should also be .. 0.60(cid:2)1.22).However,morerecently,anetworkmeta-analysisof13
.
takenintoaccountindecidingonCRTimplantation,becauseofthe .. randomized trials including >12 000 patients found that CRT-D
.
highercostsandhighcomplicationratesofthisprocedure. ... reducedtotalmortalityby19%(95%CI1(cid:2)33%,unadjusted)com-
.
.. paredwithCRT-P.275
.
Recommendationforpatientswithheartfailureand .. Some recent large observational studies highlighted the impor-
.
atrioventricularblock .. tanceofHFaetiologyintheassessmentofpotentialbenefitsofCRT-
.
.. DoverCRT-P.371(cid:2)373CRT-Dwasassociatedwithasignificantrisk
Recommendation Classa Levelb ... reduction in all-cause mortality compared with CRT-P in patients
.
CRTratherthanRVpacingisrecommendedfor
... with ischaemic cardiomyopathy. However, this difference was not
patientswithHFrEF(<40%)regardlessofNYHA
... foundinpatientswithnon-ischaemiccardiomyopathy.
classwhohaveanindicationforventricularpac-
... ThesefindingsareconsistentwiththeresultsfromtheDANISH
ingandhigh-degreeAVBinordertoreduce
I A ... study,whichassigned1116patientswithHFandnon-ischaemiccardi-
.. omyopathy to receive either a primary prophylactic ICD or usual
morbidity.Thisincludespatientswith .
AF.183,190,196,268,313,323,357(cid:2)359,361,362
... clinicalcarealone.374Inbothgroups,58%ofpatientsalsohadCRT.
.. SubgroupanalysisshowedthatCRT-DwasnotsuperiortoCRT-Pin
.
AF=atrialfibrillation;AVB=atrioventricularblock;CRT=cardiacresynchroni- .. reducingtheprimaryoutcomeofall-causemortality(HR0.91,95%
.
zationtherapy;HF=heartfailure;HFrEF=heartfailurewithreducedejection .
. CI 0.64(cid:2)1.29; P = 0.59) after a median follow-up of 67.6 months. fraction(<40%)according tothe 2021 ESCHF Guidelines;242NYHA =New .
.
YorkHeartAssociation;RV=rightventricular. .. However,inalargemulticentreregistryof>50000patients,CRT-D
aClassofrecommendation. .. was associated with a significantly lower observed mortality.375
bLevelofevidence. ..
. Similar results were found in a recent propensity-matched cohort,
.
.
. where CRT-D was associated with a significantly lower all-cause
.
.
. mortality than CRT-P in patients with ischaemic aetiology and in
.
6.6 Benefit of adding implantable
... patientswithnon-ischaemicHFunder75yearsold.376Furthermore,
.. the CeRtiTuDe Cohortstudy377 showed better survival in CRT-D
cardioverter defibrillator in patients with .
.
. vs.CRT-Pmainlyduetoareductionofnon-SCD.InanItalianmulti-
indications forcardiac resynchronization ..
. centreCRTregistry,theonlyindependentpredictorofmortalitywas
.
therapy ... the lack of an ICD.378 Whereas these studies are limited by their
.
ThemortalitybenefitofCRT-DoverCRT-Pisstillunclear,mostly .. observational design, important novel information on the issue of
.
because no head to head RCTs have been designed to compare .. CRT-Dvs.CRT-Pisexpectedtocomefromanongoingrandomized
.
thesetwo treatments. WhileCRT-D may further improve survival . trial, Re-evaluation of Optimal Re-synchronisation Therapy in
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 39 ---
ESCGuidelines 39
.
Patients withChronic HeartFailure (RESET-CRT; ClinicalTrials.gov .. oftheLVinrelationtotheLVleadposition389,390havebeenassoci-
.
IdentifierNCT03494933). .. atedwithresponsetoCRT.LVEFistheonlyparameterincludedin
.
Inconclusion,prospectiverandomizedtrialsarelacking,andavail- .. the guidelines for the selection of patients for CRT and is key to
.
abledataareinsufficienttofirmlyproveasuperiorityofCRT-Dover .. definethetypeofHF(<40%,HFrEF;40(cid:2)49%,HFmrEF;and>_50%,
.
CRT-P.However,itisimportanttoconsiderthatCRTtrialsinmild .. HFpEF).242Echocardiographyistheimagingtechniqueoffirstchoice
.
HFalmostexclusivelyincludedpatientswithanICD,37,40,262andthat .. fortheassessmentofLVEF.However,whenintravenouscontrastis
.
.
survivalbenefitofCRTwithoutanICDisuncertaininthisparticular . not available and the acoustic window does not allow accurate
.
.
group.Furthermore,observationaldatapointtowardssignificantsur- . assessment of LVEF, CMR or nuclear imaging should be consid-
.
vivalbenefitsbyCRT-DoverCRT-Pinpatientswithischaemiccardi- .. ered.242 Strain imaging (based on echocardiography or CMR) to
.
.
omyopathy, while no clear benefit has been shown in those with . quantifyLVsystolicfunctionhasshownincrementalprognosticvalue
.
.
non-ischaemiccardiomyopathy. . in HF, and allows assessment of LV mechanical dys-
.
Further predictive power concerning the risk of ventricular .. synchrony.384,391(cid:2)393 CMR with LGE techniques (which show the
.
.
arrhythmiamaybederivedbycontrast-enhancedCMR-guidedscar . presenceofmyocardialscartissue)providethebestresolutiontodif-
.
characterization.379,380WhendiscussingthechoicebetweenCRT-D .. ferentiate ischaemic cardiomyopathy and non-ischaemic cardiomy-
.
andCRT-P,itisparticularlyimportanttoconsidergeneralpredictors .. opathy.394 The location (posterolateral) and extent (transmural vs.
.
.
ofICDeffectivenesssuchasageandcomorbiditiesassociatedwitha . non-transmuralandpercentageofLVmass)ofLGEonCMRorwith
.
.
mortalityriskthatcompeteswithsuddenarrhythmicdeath.Thus,the .. nuclear techniques has been associated with the benefit from
.
additionofICDtoCRTshouldbeconsidered,especiallyinyounger .. CRT.380,387,395,396 Severe mitral regurgitation,397 lack of significant
.
patients with a good survival prognosis, ischaemic aetiology, and a .. electromechanical LV dyssynchrony,384,385,392 and RV systolic dys-
.
favourable comorbidity profile or presence of myocardial fibrosis .. function398 have been associated with less improvement in clinical
.
(Figure10).Moreover,thebenefitoftheICDisgovernedbythebal- .. symptoms and reduced survival after CRT. Several imaging techni-
.
ance between the risk of SCD and the risk of death from other .. ques have been tested to assess LV mechanical dyssynchrony, but
.
causes, as well as comorbidities. Generally, the rate of sudden .. mostmeasuresofLVdyssynchronyhavenotbeentestedinrandom-
.
arrhythmicdeathinprimarypreventionappearstobedeclining(1%/ .. izedtrialsincludingpatientswithHFrEFandwideQRS.399Thepres-
.
year). .. enceofseptalflashandapicalrocking,400timedifferencesbasedon
.
Owingtothecomplexityofthematterandthelackofclearevi- .. radialstrainandpatternsofregionallongitudinalstrain,384,392,401(cid:2)403
.
dence, it is particularly important that the choice between CRT-P .. non-invasiveandinvasiveECGmapping,385,404andvector-cardiogra-
.
and CRT-D is guided by a process of shared decision-making .. phy405havebeenproposedasnoveltechniquestopredictresponse
.
.
between patients and clinicians, taking into account both medical . to CRT. Furthermore, LV myocardial work assessed with speckle-
.
.
factsandpatientvalues. . trackingechocardiographyhasbeenassociatedwithsurvivalinCRT
.
.. recipients.406Coronarysinusvenographyiscommonlyperformedto
.
.
. detect a suitable coronary vein in which to deploy an LV lead.
Recommendationsforaddingadefibrillatorwithcar- .
.
diacresynchronizationtherapy .. Randomized trials have not systematically demonstrated that the
.
. guidanceofLVleadimplantationbasedonimaging(assessingmyocar-
.
.
Recommendations Classa Levelb .. dial scar or site of latest activation) is superior to standard prac-
.. tice.389,390,407,408 Initial experience on using artificial intelligence to
.
InpatientswhoarecandidatesforanICDand .
. combineclinical,electrical,andimagingparameterstodefinepheno-
.
whohaveCRTindication,implantationofa I A . . typesofpatientsthatwillbenefitfromCRTispromising,butmore
CRT-Disrecommended.260,369,370,381 ..
. dataareneeded.409
.
InpatientswhoarecandidatesforCRT,implan- ...
Significant (moderate to severe and severe) secondary mitral
tationofaCRT-Dshouldbeconsideredafter IIa B ... regurgitation is frequent among candidates for CRT and has been
individualriskassessmentandusingshareddeci- ...
shown to affect long-term survival as well as response to ther-
sion-making.382,383 ...
apy.406,410CRTcanimprovemitralregurgitationinasmanyas40%of
.
CRT = cardiac resynchronization therapy; CRT-D = defibrillator with cardiac .. patients.406However,in60%ofpatients,significantmitralregurgita-
.
resynchronizationtherapy;ICD=implantablecardioverter-defibrillator. .. tionisnotcorrectedand,atlong-termfollow-up,progressionofthe
a bC Lela vs es lo of fr ee vc ido em nm cee .ndation. ....
underlyingdiseasemayleadtofurtherdeteriorationofmitralvalve
.. function and poor prognosis. Transcatheter edge-to-edge mitral
.
.. valverepairhasbeendemonstratedtoimprovetheresponsetoCRT
.
.. in registries.411(cid:2)414 However, results from recent RCTs including
.
6.7 Factors influencing the efficacyof
... patients with symptomatic severe secondary mitral regurgitation
.
. despiteguideline-directedmedicaltherapy(includingCRTwhenindi-
cardiac resynchronization therapy: role .
.
. cated) have not consistently shown a benefit from transcatheter
of imaging techniques ... edge-to-edgemitralvalverepair.415,416
.
The role of cardiac imaging in selecting HF patients for CRT has .. Therefore,selectionofpatientsforCRTbasedonimagingislim-
.
been evaluated mostly in observational analyses. Cardiac dys- .. itedtothemeasurementofLVEF,whereastheassessmentofother
.
synchrony,384(cid:2)386myocardialscar,387,388andsiteoflatestactivation .. factors such as extent of myocardial scar, presence of mitral
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 40 ---
40 ESCGuidelines
+
+ CRT-P
Shared decision making Other factors in favor
of choosing
CRT-P rather than CRT-D:
Patient with
AAggee Non-ischaemic
indication for CRT
cardiomyopathy
Short life expectancy
Major comorbidities
Poor renal function
Shared decision making Patient preference
CRT-D
--
- Myocardial Fibrosis on CMR +
Figure10 Patient’sclinicalcharacteristicsandpreferencetobeconsideredforthedecision-makingbetweencardiacresynchronizationtherapypace-
makerordefibrillator.CRT-P=cardiacresynchronizationtherapy-pacemaker;CRT-D=defibrillatorwithcardiacresynchronizationtherapy;CMR=car-
diovascularmagneticresonance.
.
regurgitation, or RV systolic function is important in identifying .. 7.2 His bundle pacing
.
potentialnon-respondersthatmayneedadditionaltreatment(mitral ... HBPwasfirstreportedinhumansin2000,199andissteadilygaining
.
valveintervention,forexample). .. interestforprovidingamorephysiologicalalternativetoRVpacing.It
.
AlternativestoconventionalcoronarysinuspacingforCRT(epi- .. may also correct intraventricular conduction delay in a subset of
.
cardial,endocardial)aredescribedinsection6.1intheSupplementary .. patients,therebyprovidinganalternativetobiventricularpacingfor
.
data. .
. treatingHF.Theadventofnewtoolshasgreatlyfacilitatedimplanta-
.
.
. tion,whichhasbecomeroutineinagrowingnumberofcentres.HBP
.
.
. isusedinlieuofRVpacing,inlieuofbiventricularpacing,andasHis- 7 Alternative pacing strategies ...
optimized CRT (HOT-CRT),319 which exploits a synergistic effect
.
and sites .. between HBP and RV pacing, LVpacing, orbiventricular pacing to
.
. . improvesynchrony.Thereisgrowingevidence,mainlyfromobserva-
.
. AlternativeRVpacingsites(asopposedtoRVApacing)includepac- . tional studies, that HBP may be safe and effective in these settings
.
. ingfromtheRVoutflowtract(RVOT),themidandhighRVseptum . (SupplementaryTable10),althoughlargeRCTsandlong-termfollow-
.
(RVS),HBP,para-Hisianpacing,andleftbundlebranchareapacing, .. up are still lacking.422 With more data on safety and effectiveness,
.
.
whichincludesLVseptalpacingandleftbundlebranchpacing. . HBPislikelytoplayagrowingroleinpacingtherapyinthefuture.
.
.
.
.
.
7.1 Septal pacing ..
7.2.1 Implantationandfollow-up
.
Sincethe2013ESCGuidelines,33tworandomizedtrialsfoundnodif- .. Theuseofguidingcatheterstodeliverleadshasfacilitatedimplanta-
.
ferenceinclinicaloutcomesbetweenRVSandRVApacingintheset- .. tion,withsuccessratesexceeding80%.422Inaninternationalregistry,
.
.
tingofAVB417orCRT,418respectively.Ameta-analysisreportedan . implant success was 87% after a learning curve of 40 cases.423
.
.
echocardiographicbenefitofRVSpacinginpatientswithpre-existing .. Selective HBP is easilyrecognized byanisoelectric interval(corre-
.
reducedLVEF.419Inanobservationalstudy,RVSpacingwasassoci- .. sponding to the HV) between the pacing spike and QRS onset,
.
atedwithalowerriskofperforation.420However,trueRVSpacingis .. whereaswithnon-selectiveHBP,a‘pseudo-delta’waveisobserved
.
not easily obtained and ascertained,421 and neither beneficial nor .. duetocaptureoflocalmyocardium.424Inaddition,correctionofBBB
.
harmfuleffectsofRVSpacingcomparedwithRVApacinghavebeen .. may be observed (Figure 11). It is important to distinguish non-
.
shown on relevant clinical endpoints (Supplementary Table 9). .. selectiveHBPfrompara-Hisianpacing(wherethereisnocaptureof
.
Current evidence does not support systematically recommending .. conductiontissue)byevaluatingtransitionsinQRSmorphologyby
.
eitherRVSorRVApacingforallpatients. . reducingpacingoutputorwithpacingmanoeuvres.425
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 41 ---
ESCGuidelines 41
A B C
V V V
NS-HBP S-HBP NS-HBP Myo S-HBP corr+ S-HBP corr-
A B C
Output (V/0.5ms) 8
7
NS-HBP NS-HBP S-HBP corr+
6 Thresholds
5 His
4 Myocardium
S-HBP corr-
3
S-HBP Myo Bundle branch
2
1 LOC
LOC
LOC
0
Figure11 ThreepatientswithdifferenttypesoftransitionsinQRSmorphologywithHisbundlepacinganddecrementingpacingoutput.BBB=bundle
branchblock;Corr±=with/withoutcorrectionofbundlebranchblock;LBBB=leftbundlebranchblock;LOC=lossofcapture;Myo=myocardium;
NSHBP=non-selectiveHisbundlepacing;S-HBP=selectiveHisbundlepacing.(A)Non-selectivetoselectiveHiscapture.Notethepresenceofa
‘pseudo-delta’wavewithnon-selectivecaptureandanisoelectricintervalafterthepacingspikewithselectivecapture.(B)Non-selectiveHiscaptureto
myocardialcaptureonly.(C)SelectiveHiscapturewithcorrectionofBBBtoselectiveHiscapturewithLBBB.Note:thegraphontherightofthepanel
showsaschematicrepresentationofthedifferentthresholdsinthethreeinstances.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 42 ---
42 ESCGuidelines
.
.
. farebetterintermsofHFhospitalizationsthanpatientswithRVpac-
Table9 Advantagesanddisadvantagesofa‘backup’ ..
. ing if the percentage of ventricular pacing is >20% (HR 0.54; P =
ventricularleadwithHisbundlepacing .
.. 0.01).42Ofnote,theaveragebaselineLVEFinpatientswithHBPin
.
Advantages .. thatstudywas55%andtheaverageQRSdurationwas105ms.HBP
.
• Increasedsafety(incaseoflossofcaptureoftheHBPlead) .. maythereforeavoidclinicaldeteriorationinthesepatients,particu-
.
• Canbeusedforsensing(lowerriskofventricularundersensing,no .. larlyiftheintrinsicQRSisnarroworifBBBiscorrectedbyHBP.
.
riskofHisoratrialoversensing) .. Inaseriesof100patientswithAVBundergoingHBPbyexperi-
.
• Programmingofpacingoutputwithlowersafetymargins .. encedoperators,implantationwassuccessfulin41/54(76%)patients
.
• MayservetonarrowtheQRSwithfusionpacinginthecaseofselec- ... withinfranodalAVBandhigherinthecaseofnodalblock(93%;P<
.
tive-HBPwithuncorrectedRBBB .. 0.05).433 Over a meanfollow-up of 19 ± 12 months, lead revision
.
Disadvantages .. wasnecessaryin2/41(5%)patientswithinfranodalblockandin3/43
.
• Highercost .. (7%)withnodalblock.Notably,theaverageLVEFinthisserieswas
. • Moretransvenoushardware .. 54%,andtherearenodatareportedspecificallyonHBPinpatients
.
• Riskassociatedwiththeadditionallead(e.g.ventricularperforation) .. withAVBandreducedLVEF.HBPisanoptioninpatientswithanar-
.
• Morecomplexprogramming .. rowQRSorifHBPcorrectsBBB,butotherwisebiventricularpacing
.
• “Off-label”use(currentregulatoryapprovalandMRI-conditionality .. isindicated.
. forHBPisonlygrantedforHisleadsconnectedtotheRVport) .. Thereisa need for RCTs to compare thesafety and efficacyof
.
.. HBPwithRVpacing.Itisimportanttobalancethepotentialbenefits
.
HBP=Hisbundlepacing;MRI=magneticresonanceimaging;RBBB=rightbun- .. ofHBPwiththeaforementionedissuesofhighercapturethresholds
dlebranchblock. ...
andshorterbatterylongevity,ahigherrateofleadrevision,andmore
.
.
. frequentsensingissues,comparedwithRVpacing.Itisalsoimportant
.
.
ComparedwithRVpacing,HBPcapturethresholdsareonaverage . toconsidertheoperator’sexperienceandexpertisewithHBP,and
.
.
higher and sensing amplitudes lower. A recent observational study . whetherabackupventricularpacingleadisindicated.Thepatient’s
.
.
raisedconcernwithregardtoincreasingHBPpacingthresholdswith . safetyshouldbefirstandforemostindecision-making.
.
intermediate follow-up.426 The higher capture thresholds lead to ..
.
.
shorter battery longevity (at 5 years there were 9% generator . 7.2.2.2Paceandablate
.
changeswithHBPcomparedwith1%withRVP).427Capturethresh- .. Seven observational series, totalling >240 patients treated with a
.
.
oldsofHBPatimplantationshouldaimtobe<2.0V/1ms(or<2.5V/ . ‘pace-and-ablate’ strategy for rapidly conducted AF, found an
.
.
0.4ms)andbipolarR-wavesensingamplitude>2.0mV.Withexperi- . improvementinLVEFandNYHAclasscomparedwithbaselinewith
.
.
ence,thresholdsdecreaseasimplantersgainconfidencetoreposition . HBP.197(cid:2)199,434Long-termresultswithamedianof3yearsoffollow-
.
.
leads. Sensing issues include not only ventricular undersensing, but .. up have been reported, with favourable outcomes.434 A single-
.
alsooversensingofatrialorHispotentials(whichmaybepotentially .. blinded,randomized,crossoverstudyin16patientscomparedHBP
.
lethalinapacemaker-dependentpatient). .. withRVApacingover6monthsandfoundbetterNYHAand6-min
.
AnRVbackupleadshouldbeconsiderediftheimplanterisinex- .. walk distance with HBP, without differences in echocardiographic
.
perienced,oriftherearehighcapturethresholdsorsensingissuesin .. parameters.200 However, only four patients in this study had con-
.
pacemaker-dependentpatients,inthosescheduledforAVNablation .. firmed HBP (with para-Hisian pacing in the remaining patients).
.
(wherethereisariskofcompromisingHBP),orinpatientswithhigh- .. These studies included patients with reduced as well as preserved
.
degreeorinfranodalblock.ProsandconsarelistedinTable9. .. LVEF,197,198andQRSwidthwasonaverage<120ms.HBPisofpar-
.
Severalserieshaveshownthattherateofmid-termleadrevision .. ticularinterestinpatientswithanormalbaselineQRSmorphologyas
. isrelativelyhighat(cid:3)7%,318,423,427,428(andreportedtobeashighas .. itpreservesintrinsicventricularsynchrony,However,acaveatisthat
. 11%426), and is higher than RV pacing, which is 2(cid:2)3%.427,429 .. AVJablationmayresultinanincreaseinHBPcapturethresholdsor
. Therefore, it is advisable to follow-up these patients at least once .. inleaddislodgmentsinaminorityofpatients.197,199,318,426Owingto
.
every6monthsorplacethemonremotemonitoring(ensuringthat .. theseissuesandriskofHBPleadfailure,abackupRVleadshouldbe
.
automaticthresholdmeasurementscorrespondtothosemeasured .. considered.
.
.
manually,asthismaynotbethecaseanddependsondeviceconfigu- .
.
ration).430 Device programming should take into account specific .. 7.2.2.3Roleincardiacresynchronizationtherapy
.
requirementsforHBP,whicharecoveredindetailelsewhere.431,432 .. In 1977, Narula showed that pacingof the His bundle can correct
.
.
. LBBBinasubsetofpatients,implyingaproximalsiteofconduction
.
7.2.2 Indications .. disturbancewithlongitudinaldissociationwithintheHisbundle.435A
.
.
7.2.2.1 Pacingforbradycardia .. recentmappingstudyreportedintra-Hisianblockin46%ofpatients
OnestudyreportedthatinpatientswithAVBandnormalbaseline ... withLBBB,inwhom94%werecorrectedbytemporaryHBP.436HBP
.
LVEF, the incidence of RV pacing-induced cardiomyopathy was .. maythereforebeusedinlieuofbiventricularpacingforHBP-based
.
12.3%andtheriskwasincreasedifthepercentageofventricularpac- .. CRT, as some data have shown that results are comparable (see
.
ingwas>_20%(HR6.76;P=0.002).188However,therearenodatato .. SupplementaryTable10).437(cid:2)439Nevertheless,especiallyinCRTcan-
.
supportthatanypercentageofRVpacingcanbeconsideredasdefin- .. didates with LBBB, biventricularpacing has more solid evidence of
.
ingatruelimitbelowwhichRVpacingissafeandbeyondwhichRV .. efficacyandsafety,andthereforeremainsfirst-linetherapy.However,
.
pacingisharmful.ObservationaldataindicatethatpatientswithHBP . HBPshouldbeconsideredasabailoutsolutioninthecaseoffailed
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 43 ---
ESCGuidelines 43
LVleadimplantationalongwithotheroptionssuchassurgicalepicar- .
. HBPmaybeconsideredasanalternativetoRV
dialleads424,440(seesection6.7).Aninterestingpopulationispatients ..
. pacinginpatientswithAVBandLVEF>40%, withRBBB,whoareknowntorespondlesswelltobiventricularpac- .. IIb C
. whoareanticipatedtohave>20%ventricular
.
ing,inwhomHBPhasshownpromisingpreliminaryresultsinaseries .. pacing.42,433
of37patients.441HBPmaysometimesincompletelycorrectBBB,and ..
.
.
canbeusedinconjunctionwithRV,LV,orbiventricularpacing,asin . AVB = atrioventricular block; AVJ = atrioventricular junction; CRT = cardiac
.
theHOT-CRTstudy.319Thisisofparticularinterestinpatientswith .... r tie os nyn frc ah cr to ion niz ;a Rti Von =t rh ie ghra tp vy e; nH trB icP u= larH .isbundlepacing;LVEF=leftventricularejec-
permanentAF,inwhomaHisleadmaybeconnectedtothevacant .. aClassofrecommendation.
atrialport,thusofferingadditionaltherapeuticoptions. ... bLevelofevidence.
.
.
.
.
.
7.3 Left bundle branch area pacing .
.
.
Withleftbundlebranchareapacing,theleadisimplantedslightlydis- .. 7.4 Leadless pacing .
.
taltotheHisbundleandisscreweddeepintheLVseptum,ideallyto .. Leadlesspacemakershavebeendevelopedtoaddresslimitationstyp-
capturetheleftbundlebranch.442Advantagesofthistechniqueare ...
icallyrelatedtopulsegeneratorpocketandtransvenousleadsofcon-
.
thatelectricalparametersareusuallyexcellent,itmaybesuccessful .. ventional pacemaker systems. Currently, two leadless pacemaker
.
inblocksthataretoodistaltobetreatedwithHBP,anditalsofacili- .. systemshavebeenstudiedinclinicaltrials,ofwhichoneiscurrently
.
tates AVJ ablation, which may be challenging with HBP. However, .. availableforclinicaluse.BothareinsertedintotheRVcavitybyafem-
.
althoughthetechniqueisverypromising,dataonthismodalityare .. oralvenousapproachusingaspeciallydesignedcatheter-baseddeliv-
.
stillscarce(SupplementaryTable11),andthereisconcernregarding .. erysystem.
.
long-term lead performance and feasibility of lead extraction. .. Anumberofprospectiveregistrieshavereportedthatimplanta-
.
Recommendations for using left bundle branch area pacing cannot .. tionsuccessratesarehigh,withadequateelectricalresultsbothat
.
thereforebeformulatedatthisstage.However,conductionsystem .. implant and at follow-up (Supplementary Table 13). ‘Real-world’
.
pacing (which includes HBP and left bundle branch area pacing) is .. results of one leadless pacemaker system, including 1817 patients,
.
verylikelytoplayagrowingroleinthefuture,andthecurrentrec- .. reportedseriousadverseeventsin2.7%ofpatients.50Theprevalence
.
ommendationswillprobablyneedtoberevisedoncemoresolidevi- .. ofleadlessdeviceinfectionsislowastheprincipalsourcesofinfection
.
denceofsafetyandefficacy(fromrandomizedtrials)ispublished.A .. (i.e.thesubdermalsurgicalpocketandpacemakerleads)areabsent.
.
comparisonofRVpacing,HBP,andleftbundlebranchareapacingis .. However,duringtheinitialoperatorexperience,therewasahigher
.
providedinSupplementaryTable12. ... incidence of peri-operative major complications (6.5%), including
.
.. perforation and tamponade, vascular complications, ventricular
.
.. arrhythmias, and death.445 These data highlight the importance of
.
RecommendationsforusingHisbundlepacing .. adequatetrainingandsupervisioninthisdomainwhenstartingwith
.
.. leadless pacemaker implantation. In addition, implanting physicians
Recommendations Classa Levelb ...
should have the same competency and accreditation as those
.
InpatientstreatedwithHBP,deviceprogram- .. requiredforstandardtransvenouspacingtobeabletoofferthemost
.
mingtailoredtospecificrequirementsofHBPis I C .. suitable system for a given patient. Implantation of leadless pace-
.
recommended.430,431 .. makersshouldbeperformed inanadequatesetting (i.e.withhigh- .
InCRTcandidatesinwhomcoronarysinuslead ... resolutionmultiplanefluoroscopy)andwithcardiacsurgeryavailable
implantationisunsuccessful,HBPshouldbecon-
... onsiteduetotheriskoftamponade,whichmaybemoredifficultto
sideredasatreatmentoptionalongwithother IIa B
... managethanwithstandardpacing.446,447
. techniquessuchassurgicalepicardial .. Leadless pacemakers that only function in the VVI(R) mode
. lead.318,424,440,443 .. restrictindicationstopatientswithAForveryinfrequentpacing(e.g.
.
. paroxysmalAVB).Recently,VDDpacing(bydetectionofatrialcon-
InpatientstreatedwithHBP,implantationofan .
.
. tractionbytheaccelerometer)hasbeenintroduced,whichextends
RVleadusedas‘backup’forpacingshouldbe .
.
. indicationstopatientswithAVBwithpreservedsinusnodefunction.
consideredinspecificsituations(e.g.pacemaker .
.
. AVsynchronyismaintained70(cid:2)90%ofthetime,dependingonthe
dependency,high-gradeAVB,infranodalblock, .
IIa C .. patient’spositionandactivity,basedondatafromtwostudiesinclud-
highpacingthreshold,plannedAVJablation)or .
.. ing 73 patients in SR and high-degree AV block.448 There may in
forsensinginthecaseofissueswithdetection ..
. future be an alternative to standard DDD pacemakers in selected
(e.g.riskofventricularundersensingorover- ..
. patients if the potential benefits of leadless pacing outweigh the
sensingofatrial/Hispotentials).423,426,444 ..
HBPwithaventricularbackupleadmaybecon-
... potential benefits of 100% AV synchrony, atrial pacing, and atrial
.. arrhythmiamonitoring.
sideredinpatientsinwhoma‘pace-and-ablate’ .
strategyforrapidlyconductedsupraventricular IIb C
... Indications for leadless pacemakers include obstruction of the
.. venousrouteusedforstandardpacemakerimplantation(e.g.bilateral
arrhythmiaisindicated,particularlywhenthe .
intrinsicQRSisnarrow.197,199,200,318
... venousthoracicoutletsyndromeorchronicobstructionofthesupe-
.. riorvenacava),pocketissues(e.g.inthecaseofcachexiaordemen-
Continued .
.. tia),orparticularlyincreasedinfectionrisk[e.g.inthecaseofdialysis
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 44 ---
44 ESCGuidelines
.
.
or previous cardiovascular implantable electronic device (CIED) . recommended in patients with AVB who have not yet received
.
.
infection].Observationaldatashowedthataleadlesspacemakerwas . reperfusion therapy.469 AVB may require temporary pacing in the
.
.
asafepacingalternativeinpatientswithpreviousdeviceinfectionand .. presence of refractory symptoms or haemodynamic compromise,
.
explant,andinpatientsonchronichaemodialysis.Whereasobserva- .. butmostoftenresolvesspontaneouslywithinafewdaysandonlya
.
tionaldataindicatehighefficacyandlowcomplicationrateswithlead- .. minority of patients require permanent pacing.451,454,456,458,462 In
.
less pacemakers,50 there are currently no data from RCTs .. patients with persistent intraventricular conduction abnormalities
.
documentingthelong-termsafetyandefficacyofleadlessvs.standard .. andtransientAVBinwhompermanentpacingwasrecommendedin
.
transvenouspacemakers,andthereforetheindicationforaleadless .. the past, there is no evidence that permanent cardiac pacing
.
pacemaker should be carefully considered on a case by case basis. .. improves outcome.454,470 These patients frequently have HF and
.
Theabsenceoflong-termdataonleadlesspacemakerperformance .. poorLVfunction,andshouldbeevaluatedforICD,CRT-P,orCRT-
.
andlimiteddataonretrievabilityandend-of-lifestrategy449 require .. Dratherthanconventionalpacingifanearlydeviceimplantationis
.
careful consideration before selecting leadless pacemaker therapy, .. considered.471
.
especiallyforyoungerpatients(e.g.withalifeexpectancy>20years). .. IfAVBdoesnotresolvewithin10days,apermanentpacemaker
.
.
. shouldbeimplanted.Intheabsenceofrobustscientificdata,thewait-
.
.
. ingperiodbeforepacemakerimplantationhastobedecidedindividu-
Recommendationsforusingleadlesspacing(leadless ..
. ally. It may last up to 10 days but can be shortened to 5 days
pacemaker) ..
. dependingontheoccludedvessel,timedelay,andsuccessofrevascu-
.
.
Recommendations Classa Levelb .. larization. Conditions favouring consideration of earlier pacemaker
.
. implantation include unsuccessful or laterevascularization, anterior
.
Leadlesspacemakersshouldbeconsideredasan .. MI,bifascicularblockorAVblockbeforeMI,andprogressionofAV
.
alternativetotransvenouspacemakerswhenno .. blockwithinthefirstdaysafterMI.Sicksinussyndromeafterocclu-
.
upperextremityvenousaccessexistsorwhen IIa B ... sionoftherightcoronaryarteryresolvesinmostcases.Ifrevasculari-
riskofdevicepocketinfectionisparticularly .. zation is incomplete, pacemaker implantation can usually still be
.
high,suchaspreviousinfectionandpatientson .. postponedandimplantationonlybeperformedifsymptomsdueto
.
haemodialysis.45,47(cid:2)50,450 ...
sinusbradycardiapersist.
.
Leadlesspacemakersmaybeconsideredasan .
.
.
alternativetostandardsingle-leadventricular .
IIb C .. Recommendationsforcardiacpacingafteracutemyo-
pacing,takingintoconsiderationlifeexpectancy .. cardialinfarction
andusingshareddecision-making.45,47(cid:2)50 ..
.
.. Recommendations Classa Levelb
aClassofrecommendation. ..
bLevelofevidence. ...
Implantationofapermanentpacemakerisindi-
.
.. catedwiththesamerecommendationsasina
.
.. generalpopulation(section5.2)whenAVBdoes I C
.
8 Indications for pacing in specific .
. notresolvewithinawaitingperiodofatleast5
.
.
conditions . daysafterMI.
.
.
. InselectedpatientswithAVBinthecontextof
. .
8.1 Pacing in acute myocardial infarction ... anteriorwallMIandacuteHF,earlydevice
IIb C
In patients with acute MI, significant bradyarrhythmia may occur
.. implantation(CRT-D/CRT-P)maybe
.
due to autonomic influences or damage of the conduction system ... considered.471
byischaemiaand/orreperfusion.Therightcoronaryarterysupplies ... PacingisnotrecommendedifAVBresolvesafter III B
the sinus node in 60% and the AVN and His bundle in 90%
... revascularizationorspontaneously.454(cid:2)456,458
.
of patients.451,452 AVB is located above the His bundle in most ...
AVB=atrioventricularblock;CRT-D=defibrillatorwithcardiacresynchroniza-
patients with inferior infarction, but is usually infra-Hisian and pre- .. tiontherapy;CRT-P=cardiacresynchronizationtherapy-pacemaker;MI=myo-
.
ceded by intraventricular conduction disturbances in anterior .. cardialinfarction.
infarction.451,453(cid:2)457
.... a bC Lela vs es lo of fr ee vc ido em nm cee .ndation.
Theincidenceofhigh-degreeAVBinpatientswithST-segmentele- ..
.
vationMIhasdeclinedto3(cid:2)4%intheprimarypercutaneouscoro- ..
nary intervention era.458(cid:2)460 High-degreeAVB is most frequent in
... 8.2 Pacing aftercardiac surgery and
.
inferiororinferolateralinfarctions.455,458(cid:2)461 .. heart transplantation
.
.
Patients with high-degree AVB have higher clinical risk and . 8.2.1 Pacingaftercoronaryarterybypassgraftand
.
.
larger infarctions especially when AVB complicates an anterior . valvesurgery
.
infarction.458(cid:2)460,462,463 New-onset intraventricularconductiondis- .. AVB may occur in 1(cid:2)4% of cases after cardiac surgery and in
.
turbanceisalsoassociatedwithlargerinfarctions.464(cid:2)467 .. (cid:3)8% after repeat valvesurgery.472(cid:2)476 SND mayoccur after right
.
.
Sinus bradycardia and AVB at presentation can be vagally me- . lateral atriotomy or transseptal superior approaches to the mitral
.
diated and may respond to atropine.455,468 Revascularization is .. valve.473,474
1202
CSE
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 45 ---
ESCGuidelines 45
.
.
Pacemakerimplantationismorefrequentaftervalvularthanafter . orthird-degreeAVB.Therehavebeendoubtsaboutthelong-term
.
.
coronaryarterybypassgraft(CABG)surgery.477Inclinicalpractice, .. performanceofepicardialleads,butrecentdataindicate,atleastfor
.
anobservationperiodof3(cid:2)7daysisusuallyappliedbeforeimplant- .. epicardial LV leads, performance comparable with transvenous
.
ingapermanentpacemaker473toallowregressionoftransientbrady- .. leads.486
.
cardias. The ideal timing of pacemaker implantation after cardiac .. Ventricular pacing after mechanical tricuspid valve replacement
.
surgeryremainsatopicofcontroversy,duetothefactthat60(cid:2)70% .. usingacoronarysinusleadappearssafeandfeasible,butonlyresults
.
ofpatientsimplantedforSNDandupto25%ofthoseimplantedfor .. fromsmallpatientcohortshavebeenpublished.Proceduralsuccess
.
AVBarenotpacemakerdependentatfollow-up.473,478Inthecaseof .. ofimplantationwas100%in23patients;after5.3±2.8years,96%of
.
completeAVBoccurringwithinthefirst24haftervalvularsurgery .. leadswerefunctionalwithstablepacingandsensingparameters.487
.
and persisting for 48 h, resolution within the next 1(cid:2)2 weeks is .. HBP is emerging as a more physiological method of ventricular
.
unlikely and earlier implantation of a pacemaker may be consid- .. pacing and mayevolveintoa possiblesolutioninpatientswithAV
.
ered.479,480 The same approach appears reasonable for complete .. conductiondiseaseaftertricuspid valvesurgery.Onestudyinvesti-
.
AVBwithalowrateofescaperhythm.473ThesituationinCHDsur- .. gating30patientswithHBPaftercardiacvalveoperationsreported
.
geryandinchildrenmaybedifferent(seesection8.4). .. successful permanent HBP in 93% of these patients.488 This study
.
.
Invalvularendocarditis,predictorsofAVBaftersurgeryarepre- . included10patientswithtricuspidvalveannuloplasty.
.
.
operative conduction abnormalities, Staphylococcus aureus infection, . After replacement by a mechanical valve, transvalvular lead
. .
intracardiacabscess,tricuspidvalveinvolvement,andpreviousvalvu- . placement is contraindicated, and implanting either a coronary
.
larsurgery.481Inpatientswithendocarditisandperi-operativeAVB, .. sinusleadforventricularpacingorepicardialleads,whichmaybe .
.
earlypacemakerimplantationisreasonable,especiallywhenoneor . placedminimallyinvasively,isrecommended.Toavoiddamaginga
.
.
morepredictingfactorsarepresent.Inlightoftheinfectedstateof . repaired tricuspid valve or a tricuspid bioprosthesis, the optimal
.
.
thepatient,intra-operativeimplantationofanepicardialpacemaker . solution in patients needing ventricular pacing after such surgery
.
.
system during valvular surgery may be reasonable despite the . shouldnotincludetransvalvularleadimplantation.Implantingacor-
.
.
absenceofsoliddataoninfectionratesofepicardialvs.transvenous . onary sinus lead for ventricular pacing or minimally invasively
.
.
pacemakersystems. .. placed epicardial leads is judged to be the preferred choice.
.
.. However, asindicatedinobservationalreports, transvalvularlead
.
.. implantation wasusedwithacceptableresults,489andstillmaybe
8.2.2 Pacingafterhearttransplantation .
.. considered in selected patients after tricuspid valve annuloplasty,
SND is common and leads to permanent pacemaker implantation .
after heart transplantation in 8% of patients.473 Possible causes of
... other types of repair, and replacement of a tricuspid valve by a
.. bioprosthesis.
SNDincludesurgicaltrauma,sinusnodearterydamage,orischaemia .
andprolongedcardiacischaemictimes.482,483AVBislesscommon,
... Performingtricuspidvalvereplacementinapatientwithanexist-
.. ingRVlead,removaloftheoldRVleadandimplantationofanepi-
and is probably related to inadequate preservation of the donor .
.. cardialRVleadshouldbepreferredoversewingintheexistinglead
heart.473,483,484 Chronotropic incompetence is always present fol- .
.. betweenabioprosthesisandannulus.Thereasonsarethatsewing
lowingstandardorthotopichearttransplantation,asaresultofloss ...
intheleadmaybeassociatedwithhigherriskofleadfailureand,in
ofautonomiccontrol.AssinusnodeandAVNfunctionimprovedur- ...
the case of future need for lead extraction, such a procedure is
ingthe firstfewweeksaftertransplantation,anobservationperiod ..
. likelytorequireopenheartsurgery,whichwillbeareintervention
before pacemaker implantation may allow spontaneous improve- ..
. withhigheroperativerisk.Incasesoftricuspidvalverepairwitha
mentofbradycardia.485Thereisgeneralconsensusthatpatientsin ..
. currentannuloplastyringwithanopensegmentandwithoutcon-
whom symptomatic bradycardia persists after the third post- ..
. comitantleafletprocedures,anexistingRVleadmaybeleftinplace
operative week may require permanent pacemaker implantation. ..
. withoutsewingitinbetweentheringandtheannulus.However,even
DDD(R)modewithminimizedventricularpacinginthecaseofintact ..
. in isolated annuloplasty procedures, an existing RV lead should
AVNconductionisrecommended.483 ..
. ideally be removed to avoid future lead-related complications to
.
.
. the repaired tricuspid valve and an epicardial RV lead should be
.
.
8.2.3 Pacingaftertricuspidvalvesurgery .. implanted. Particularly in patients not in need of a dual-chamber
.
An underestimated aspect of the surgical management of tricuspid .. device,theuseofaleadlesspacemakerforventricularpacingmay
.
valvediseaseistoaddresstrans-tricuspidpacemakerorICDleads. .. serveasafeasiblefuturealternativeaftertricuspidvalverepairor
.
Suchleadscaninterferewiththefunctionofarepairedtricuspidvalve .. replacementbyabioprosthesis.However,experienceisverylim-
.
ortricuspidvalveprosthesis. .. ited,andnolong-termdataareavailableinthiscohort.Crossinga
.
PlacinganepicardialRVleadatthetimeoftricuspidvalvesurgery .. mechanical tricuspid valve with the delivery sheath and a leadless
.
isthemoststraightforwardalternativeincaseswithtypeIIsecond- . pacemakeriscontraindicated.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 46 ---
46 ESCGuidelines
.
.
Recommendationsforcardiacpacingaftercardiacsur- . 7)Patientsrequiringpacingaftermechan-
.
geryandhearttransplantation .. icaltricuspidvalvereplacement .. III C
. ImplantationofatransvalvularRVleadshould
Recommendations Classa Levelb ..
. beavoided.
.
.
1)High-degreeorcompleteAVBafter ..
. AVB = atrioventricular block; RV = right ventricular; SND = sinus node
cardiacsurgery .. dysfunction.
.
Aperiodofclinicalobservationofatleast5 .. aClassofrecommendation.
daysisindicatedtoassesswhethertherhythm
... bLevelofevidence.
.
disturbanceistransientandresolves. I C . ..
.
However,inthecaseofcompleteAVBwith ..
.
.
lowornoescaperhythmwhenresolutionis .
.
.
unlikely,thisobservationperiodcanbe .. 8.3 Pacing after transcatheter aortic
shortened.473,478 ..
. valve implantation
.
2)Surgeryforvalvularendocarditisand .
.. Forextendedliteratureonpatientswithpre-proceduralRBBBand
intraoperativecompleteAVB ...
post-procedural LBBB see sections 8.3.1 and 8.3.2 in the
Immediateepicardialpacemakerimplantation ..
. Supplementarydata.
shouldbeconsideredinpatientswithsurgery ..
. Rates of permanent pacemaker implantation after TAVI range
forvalvularendocarditisandcompleteAVBif ..
IIa C . between 3.4% and 25.9% in randomized trials and large regis-
oneofthefollowingpredictorsofpersistenceis ...
tries.490(cid:2)502WhereastheassociationbetweenpacingafterTAVIand
present:pre-operativeconductionabnormality, ...
outcomeiscontroversial,503(cid:2)509RVpacingmayleadtodeterioration
Staphylococcusaureusinfection,intracardiac ...
inLVfunction.183,510,511Thus,effortstominimizeunnecessaryper-
abscess,tricuspidvalveinvolvement,orprevious ..
. manentpacingarewarranted.
valvularsurgery.481 ..
. Predictorsforpermanentpacing(Table10andsupplementarytable
.
3)SNDaftercardiacsurgeryandheart .
. 14),especiallyRBBB,whichhasbeenidentifiedasthemostconsistent
.
transplantation .
. and powerful predictor for permanent pacemaker implantation,
.
Beforepermanentpacemakerimplantation,a IIa C .
.. shouldbeincorporatedintoproceduralplanningincludingtranscath-
periodofobservationofupto6weeksshould .
.. eterheartvalveselection,implantationheight,andballooninflations.
beconsidered.473 .
.. Patients with pre-existing advanced conduction system disease
4)Chronotropicincompetenceafter ...
whomayhaveanindicationforpermanentpacingirrespectiveofthe
hearttransplantation ...
TAVI procedure need consultation with an electrophysiologist
Cardiacpacingshouldbeconsideredforchro-
IIa C
...
beforetheprocedure.Thereiscurrentlynoevidencetosupportper-
notropicincompetencepersistingfor>6weeks ...
manentpacemakerimplantationasa ‘prophylactic’measurebefore
afterhearttransplantationtoimprovequalityof ...
TAVIinasymptomaticpatientsorinpatientswhodonotmeetthe
life.485 ...
standardindicationsforpacemakerimplantation.
.
5)Patientsrequiringpacingatthetimeof .. A recommended approach for the management of conduction
.
tricuspidvalvesurgery .. abnormalitiesafterTAVIisdetailedinFigure12.Patientswithoutnew
.
Transvalvularleadsshouldbeavoidedandepi- .. conductiondisturbancespost-TAVIareatverylowriskofdeveloping
.
cardialventricularleadsused.Duringtricuspid .. high-degree AVB.533(cid:2)535 Conversely, management of patients with
. valvesurgery,removalofpre-existingtransvalv- .. persistent complete or high-degree AVB should follow standard
. ularleadsshouldbeconsideredandpreferred
IIa C
... guidelines.Permanentpacemakerimplantationappearswarrantedin
oversewingintheleadbetweentheannulus .. patients with intraprocedural AVB that persists for 24-48 h after
.
andabioprosthesisorannuloplastyring.Inthe .. TAVI or appears later. Data to guide the management of patients
.
caseofanisolatedtricuspidannuloplastybased .. withotherconductionabnormalitiesatbaselineorpost-procedure
.
onanindividualrisk(cid:2)benefitanalysis,apre- .. aremorelimited.
.
existingRVleadmaybeleftinplacewithoutjail- .. Giventhecloseanatomicalproximityoftheaorticvalveandthe
.
ingitbetweenringandannulus. .. leftbundlebranch,themostfrequentconductionabnormalityafter
.
6)Patientsrequiringpacingafterbiologi- .. TAVIisnew-onset LBBB.504,536(cid:2)538 Onlya small minorityofthese
.
.
caltricuspidvalvereplacement/tricuspid . patientsrequirepacemakerimplantation.536,537Thus,EPS539(cid:2)541or
.
.
valveringrepair .. long-term monitoring536 in lieu of pacemaker implantation may be
.
Whenventricularpacingisindicated,transve- .. considered542,543 (see section 8 in the Supplementary data). Several
.
nousimplantationofacoronarysinusleador IIa C .. high-risksubgroupsofpatientswithnewLBBBhavebeenidentified
.
minimallyinvasiveplacementofanepicardial .. (see Figure 12, and section 8 in the Supplementary data). In such
.
ventricularleadshouldbeconsideredandpre- .. patientswithdynamicprogressionofconductionabnormalitiesafter
.
ferredoveratransvenoustransvalvular .. TAVI(new BBBwithdynamicprolongationofQRSand/orPR),an
.
approach.487 .. extended monitoring period in hospital of up to 5 days should be
.
Continued . considered. Conversely, patients with new-onset LBBB but QRS
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 47 ---
ESCGuidelines 47
Table10 Predictorsforpermanentpacingaftertranscatheteraorticvalveimplantation
Characteristics References
ECG
RightBBB 512(cid:2)528
PR-intervalprolongation 517,521,525,527
Leftanteriorhemiblock 517,525
Patient
Olderage(per1-yearincrease) 529
Malesex 518,519,525,529
Largerbodymassindex(per1-unitincrease) 529
Anatomical
Severemitralannularcalcification 512,515
LVoutflowtractcalcifications 522
Membranousseptumlength 528,530
Porcelainaorta 531
Highermeanaorticvalvegradient 519
Procedural
Self-expandablevalve 512,513,525,529,531
Deepervalveimplantation 517,518,520,522,528,532
LargerratiobetweenprosthesisdiameterversusannulusorLVoutflowtractdiameter 524,529,532
Balloonpost-dilatation 519,521,529
TAVI in native valve vs. valve-in-valve procedure 531
AVB=atrioventricularblock;BBB=bundlebranchblock;ECG=electrocardiogram;LV=leftventricular;TAVI=transcatheteraorticvalveimplantation.
Formoredetaileddata,seeSupplementaryTables14and15.
Management of conduction abnormalities in patients afterTAVI
Persistent new
Pre-existing
LBBB with
Pre-existing RBBB conduction
QRS > 150 ms
with new abnormality with
Persistenta New onset or PR > 240 ms
post-procedure prolongation of
high degreeAVB alternating BBB with no further
conduction QRS (> 20 ms) or
prolongation disturbanceb PR (> 20 ms)f
during > 48h
after procedurec
Ambulatory ECG Ambulatory ECG
monitoringd monitoringd
(Class IIa) (Class IIb)
OR OR
Permanent PM Permanent PM EPSe EPSe
(Class I) (Class IIa) (Class IIa) (Class IIb)
Figure12 Managementofconductionabnormalitiesaftertranscatheteraorticvalveimplantation.AF=atrialfibrillation;AV=atrioventricular;AVB=
atrioventricularblock;BBB=bundlebranchblock;ECG=electrocardiogram;EPS=electrophysiologystudy;HV=His(cid:2)ventricularinterval;LBBB=left
bundlebranchblock;LVEF=leftventricularejectionfraction;PM=pacemaker;QRS=Q,R,andSwaves;RBBB=rightbundlebranchblock;TAVI=
transcatheteraorticvalveimplantation.a24-48hpost-procedure.bTransienthigh-degreeAVB,PRprolongation,oraxischange.cHigh-riskparametersfor
high-degreeAVblockinpatientswithnew-onsetLBBBinclude:AF,prolongedPRinterval,andLVEF<40%.dAmbulatorycontinuousECGmonitoringfor
7-30days.eEPSwithHV>_70msmaybeconsideredpositiveforpermanentpacing.fWithnofurtherprolongationofQRSorPRduring48-hobservation.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 48 ---
48 ESCGuidelines
.
.
<150 msmay notrequirefurther evaluationduring hospitalization. . forpacemakertherapyinpatientswithCHDisbasedonexpertcon-
.
.
When EPS is contemplated, it shouldbe performed >_3 days post- . sensusandindividualevaluationduetolackofevidencefromRCTs.
.
.
procedureandaftertheconductionabnormalitieshavestabilized. . Inthe presenceof anintracardiacshuntbetweenthe systemicand
.
.
Thetypeofpermanentpacemakerimplantedshouldfollowstand- . pulmonarycirculation,endovascularleadplacementisrelativelycon-
.
ardguidance(seesections5,6,and7).Giventhelowratesoflong- .. traindicatedduetotheriskofarterialembolism.551
.
termdependencyonpacing,544,545algorithmspromotingspontane- .. Theclinicalpresentationmayvaryconsiderably;evenseverebra-
.
.
ousAVconductionshouldbeused. . dycardiaincongenitalAVBmayremainoligosymptomaticorasymp-
.
.
. tomatic. Periodic Holter recordings may be useful for patients at
.
.
Recommendationsforcardiacpacingaftertranscath-
... specificriskofbradyarrhythmia.
.
eteraorticvalveimplantation .
.
.
.
. 8.4.1 Sinusnodedysfunctionand
Recommendations Classa Levelb ..
. bradycardia(cid:2)tachycardiasyndrome .
.
Permanentpacingisrecommendedinpatients . ThereisnoevidencethatSNDdirectlyleadstoincreasedmortality
.
.
withcompleteorhigh-degreeAVBthatpersists I B .. inCHD.However,itmaybeassociatedwithahigherrateofpost-
.
for24-48hafterTAVI.546 .. operativeatrialflutter,with1:1AVconductioninCHD,andthuslead
Permanentpacingisrecommendedinpatients ... tomorbidityandpotentiallymortality.552,553
.
withnew-onsetalternatingBBBafter I C ..
.
TAVI.533,547 .. 8.4.1.1Indicationsforpacemakerimplantation
.
Earlycpermanentpacingshouldbeconsideredin .. In patients with symptomatic chronotropic incompetence, pace-
.
patientswithpre-existingRBBBwhodevelop .. makerimplantationisjustifiedwhenothercauses(seesection4)have
anyfurtherconductiondisturbanceduringor IIa B ... been ruled out.554,555 Increasing theheartrate throughpermanent
.
afterTAVI.d .. pacing to prevent atrial arrhythmias may be considered.556 The
.
AmbulatoryECGmonitoringeorEPSfshouldbe ... underlying evidence is weak, as the benefit of atrial-based pacing
consideredforpatientswithnewLBBBwith
... observed in patients without structural heart disease could not be
QRS>150msorPR>240mswithnofurther IIa C
... validatedinCHD.21,557,558Thegeneralconsensusisthatifpermanent
prolongationduringthe>48hafter
... pacing is necessary, single-lead atrial-based pacing should be pre-
TAVI.536,537,548 ... ferredtolimitthenumberofleads,especiallyinyoungpatientswith
AmbulatoryECGmonitoringeorEPSfmaybe
... adequateAVconduction.559Inpatientswithcongenitallycorrected
.
. transposition of the great arteries requiring ventricular pacing
consideredforpatientswithapre-existingcon- .
IIb C .. because of high-degree AVB, CRT should be considered. Current
ductionabnormalitywhodevelopprolongation .
.
. evidence to use devices with atrial antitachycardia pacing to treat
ofQRSorPR>20ms.g .
.. intra-atrialre-entranttachycardiasinpatientswithCHD560,561istoo
Prophylacticpermanentpacemakerimplantation ..
. limitedtomakegeneralrecommendations.
isnotindicatedbeforeTAVIinpatientswith III C ..
.
RBBBandnoindicationforpermanentpacing. ..
.
.. 8.4.2 Congenitalatrioventricularblock
A CF RT= =at cri aa rl dfi iab cri rll ea st yio nn c; hA roV nB iz= atia ot nrio thv ee rn at pri yc ;u Ela Cr Gbl =oc ek l; eB ctB rB oc= arb du ion gd rl ae mb ;r Ean Pc Sh =b elo lec ck -; ....
A number of maternal or fetal factors can cause congenital heart
trophysiologystudy;HV=His(cid:2)ventricularinterval;LBBB=leftbundlebranch .. block,particularlyautoimmunediseasessuchassystemiclupuseryth-
.
block;RBBB=rightbundlebranchblock;SR=sinusrhythm;TAVI=transcath- .. ematosusandSjo¨grensyndrome(SupplementaryTable16).
eteraorticvalveimplantation.ForthedefinitionofalternatingBBB,seesection ..
. PatientspresentingwithcongenitalAVBmaybeasymptomaticor
5.3.1. . .
aClassofrecommendation. . maypresentwithreducedexercisecapacity,syncopalattacks,con-
. bLevelofevidence. ..
gestive HF, ventricular dysfunction, and dilatation. Rarely, in SCD,
c dI Tm rm ane sd ieia nt te hly iga hf -t de er gp rr eo ec Aed Vu Br ,e Po Rr pw roith loin ng2 a4 tioh.
n,orQRSaxischange.
....
congenital AVB is diagnosed as the cause.562,563 SCD may occur
.
eAmbulatory continuous ECG monitoring (implantable or external) for 7(cid:2)30 .. throughincreasedpropensitytodevelopbradycardia-relatedventric-
days.536,549 ..
ulararrhythmiassuchastorsades-de-pointes.
fEPSshouldbeperformed>_3daysafterTAVI.ConductiondelaywithHV>_70 ..
.
msmaybeconsideredpositiveforpermanentpacing.540,541,550 .
.
gWithnofurtherprolongationofQRSorPRduring48-hobservation. .. 8.4.2.1Indicationsforpacemakerimplantation
Note:CRTinpatientsrequiringpacingafterTAVIhasthesameindicationasfor .. There is general consensus that prophylactic pacing is indicated in
.
generalpatients(seesection6). .
. asymptomatic patients with any of the following risk factors: mean
.
.
.. daytime heart rate <50 b.p.m., pauses greater than three times
.
8.4. Cardiac pacing and cardiac .. the cycle length of the ventricular escape rhythm, a broad QRS
.
resynchronization therapy in congenital
... escape rhythm, prolonged QT interval, or complex ventricular
.. ectopy.564(cid:2)566Clinicalsymptoms,suchassyncope,pre-syncope,HF,
heart disease .
.. or chronotropic incompetence, are indications for pacemaker
.
Permanent pacing in patients with moderate or complex CHD .. implantation.564,567,568Ifventriculardysfunctionisattributedtohae-
.
should be performed in centres with a multidisciplinary team and .. modynamic compromise caused by bradycardia, permanent pacing
.
expertiseinCHD-relateddevicetherapy.Generally,decision-making . maybeindicated.518,567Despiteamodestqualityofevidence,there
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 49 ---
ESCGuidelines 49
isstrongconsensusthatpatientswiththird-orsecond-degreeAVB .
. Inpatientswithpersistentpost-operativebifas-
.
(Mobitz type II) must receive permanent cardiac pacing therapy if ...
cicularblockassociatedwithtransientcomplete IIb C
symptomaticorwithriskfactors.Inasymptomaticpatientswithout ... AVB,permanentpacingmaybeconsidered.572
risk factors, opinion on the benefit of cardiac pacing diverges, and ...
InpatientswithcomplexCHDandasympto-
permanentpacingmaybeconsidered.567,569 ...
maticbradycardia(awakerestingheartrate<40 . IIb C
.
. b.p.m.orpauses>3s),permanentpacingmaybe
.
8.4.3 Post-operativeatrioventricularblock .
. consideredonanindividualbasis.
.
Post-operativehigh-degree AVB is estimated to occur in 1(cid:2)3% of .
.
patientsundergoingsurgeryforCHD.518,569,570Inchildren,transient .. AVB=atrioventricularblock;BBB=bundlebranchblock;b.p.m.=beatsper
.
early post-operative AVB usually resolves within 7(cid:2)10 days.571 In .. minute;CHD=congenitalheartdisease;ECG=electrocardiogram.
. aClassofrecommendation.
.
adults with CHD, there are no data to support a different waiting .. bLevelofevidence.
.
periodbeforedecidingforpermanentpacing post-operativelythan .
.
.
afterothercardiacsurgery.AfterrecoveryfromcompleteAVB,bifas- .
.
.
cicular block occasionally persists, which is associated with an .. 8.4.4 Cardiacresynchronization
.
increasedriskoflaterecurrentAVBandsuddendeath.572Theprog- ..
StandardindicationsforCRTmaybeconsideredinCHD,takinginto
.
nosis is poor for patients with untreated post-operative complete .. accountthattheanatomy,morphologyofthesystemicventricle,and
.
AVB.573 ..
cause ofdyssynchrony, aswell asQRS morphology, maybe atypi-
.
.. cal.574 Multidisciplinary teams in experienced centres should be
.
8.4.3.1 Indicationsforpacemakerimplantation .. involvedinthedecision-makingprocess.
.
Thereisastrongrecommendationforpermanentpacinginpatients ..
.
withpersistentsecond-orthird-degreeAVB.Inpatientswithpersis- .. 8.5 Pacing in hypertrophic
.
tentbifascicularblockassociatedwithtransientAVBorpermanent .. cardiomyopathy
.
prolongedPRinterval,consensusforpacemakerimplantationismod- ..
. 8.5.1 Bradyarrhythmia
.
est.Post-operativeHVintervaldeterminationmayhelptoestimate .
. AVB in hypertrophic cardiomyopathy (HCM) should generally be
the risk in patients with prolonged PR or bifascicular block.573 In ..
. treatedaccordingtotherecommendationsinthisguideline(seesec-
.
patientswithbifascicularblockandlongPRaftersurgeryforCHD, .
. tion 5.2). Certain genetically inherited subtypes of HCM are more
the risk of extensive damage to the conduction system is high,572 ..
. pronetodevelopAVB,asisthecasewithtransthyretinamyloidosis,
.
therefore pacemaker implantation may be indicated even without .
.. Anderson(cid:2)FabryandDanondiseases,PRKAG2syndrome,andmito-
HVmeasurement.Implantationofepicardialleadsshouldbeconsid- .
.. chondrialcytopathies.575,576AnICD/CRT-Dratherthanapacemaker
eredduringsurgeryinpatientswithcomplexCHDandahighlifetime .
.. shouldbeconsideredinpatientswithsymptomaticbradycardiawho
risk of pacemaker implantation, in order to reduce the rate of .
.. haveLVEF<_35%orotherwisefulfilthecriteriaforprimarypreven-
reoperation. .
.. tionofSCDbycurrentguidelines.576(Forextendedliteratureoncon-
.
.. ductiondisordersinHCMseetheSupplementarydata,section8.5.)
.
.
.
.
Recommendationsforcardiacpacinginpatientswith .
. 8.5.2 Pacingforthemanagementofleftventricular
congenitalheartdisease ..
. outflowtractobstruction
.
.
Recommendations Classa Levelb .. InpatientswithsymptomscausedbyLVoutflowtractobstruction,
.
. treatmentoptionsincludedrugs,surgery,septalalcoholablation,and
.
Inpatientswithcongenitalcompleteorhigh- .. AVsequentialpacingwithashortAVdelay.Threesmall,randomized,
.
.
degreeAVB,pacingisrecommendedifoneof . placebo-controlledstudiesandseverallong-termobservationalstud-
.
.
thefollowingriskfactorsispresent: . ies reported reductions in LV outflow tract gradients, and variable
.
.
a.Symptoms . improvement in symptoms and quality of life with AV sequential
.
b.Pauses>3(cid:4)thecyclelengthoftheventricu- .. pacing.577(cid:2)582 Myectomy achieved superior haemodynamic results
I C ..
larescaperhythm . comparedwithDDDpacing,583butisamoreinvasiveandhigherrisk
.
.
c.BroadQRSescaperhythm .. intervention. In one trial, a subgroup analysis suggested that older
.
d.ProlongedQTinterval .. patients (>65 years) are more likely to benefit from DDD AV
.
e.Complexventricularectopy .. sequentialpacing.579Arecentmeta-analysis—comprising34studies
.
f.Meandaytimeheartrate<50b.p.m. .. and1135patients—foundthatpacingreducedtheLVoutflowgra-
.
Inpatientswithcongenitalcompleteorhigh- .. dient by 35%, with a non-significant trend towards reduction in
.
degreeAVB,permanentpacingmaybeconsid- IIb C .. NYHAclass.584
.
eredevenifnoriskfactorsarepresent.566 .. Shareddecision-makingshouldbeemployedwhenconsideringthe
.
Continued . treatmentofchoiceforpatientswithobstructiveHCM.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 50 ---
50 ESCGuidelines
.
Recommendationsforpacinginhypertrophicobstruc-
... AscurrentICDsprovideallpacemakerfunctions,astandalone
tivecardiomyopathy .. pacemakerisrarelyindicatedinLQTStoday.However,inindivid-
.
.. ual patients with LQTS and catecholamine-induced torsades-de-
.
Recommendations Classa Levelb .. pointes, shock therapy may be disadvantageous or even fatal; in
.
.. these cases, pacing and beta-blocker therapy alone without an
AVsequentialpacingwithshortAVdelaymay .
.. ICDmaybeused.PacemakerinsteadofICDimplantationrepre-
beconsideredinpatientsinSRwhohaveother .
.. sents a treatment option in neonates and small infants with
pacingorICDindicationsifdrug-refractory .
IIb B .. LQTS,594 and an alternative in LQTS patients with symptomatic
symptomsorbaselineorprovocableLVoutflow .
.. bradycardia(spontaneousordue tobeta-blockers)ifventricular
tractgradients>_50mmHgare .
.
. tachyarrhythmiasareunlikelyorifICDimplantationisnotdesired
present.576(cid:2)581,584 .
.
. (e.g.patientpreference).
AVsequentialpacingwithshortAVdelaymaybe ..
. An indication for a pacemaker in LQTS exists in neonates and
consideredinselectedadultswithdrug-refractory ..
. infantswitha2:1AVBduetoexcessivecorrectedQTprolongation
symptoms,>_50mmHgbaselineorprovocableLV
IIb B
...
withlongmyocardialrefractoryperiods.595
outflowtractgradient,inSR,whoareunsuitable ..
. Temporarypacingatanincreasedrate(usually90-120b.p.m.)isan
.
fororunwillingtoconsiderotherinvasiveseptal .
. importanttreatmentinLQTSpatientswithelectricalstorm,because
reductiontherapies.576(cid:2)581,584 ..
. anincreaseinthebasicheartrateshortensthewindowofvulnerability
.
AVsequentialpacingwithshortAVdelaymay .
. forreinductionoftorsadedepointesventriculartachycardia. .
beconsideredinselectedpatientswithdrug- .
.
.
refractorysymptoms,>_50mmHgbaselineor
IIb C
...
8.6.2 Neuromusculardiseases
provocableLVoutflowtractgradients,inSR,at ..
. Neuromusculardiseasesareagroupofheterogeneousinheriteddis-
highriskofdevelopingAVBduringseptal ..
. ordersaffectingthe skeletal muscle and frequentlyalso involvethe
ablation.585,586 ..
. heart(forextendedliteratureonconductiondisordersinneuromus-
.
.
AV=atrioventricular;AVB=atrioventricularblock;ICD=implantablecardi- . culardisease,seethesupplementaryliteratureonpacinginraredis-
.
overter-defibrillator;LV=leftventricular;SR=sinusrhythm. .. ease and Supplementary Table 17). The cardiac phenotype variably
aClassofrecommendation. ..
bLevelofevidence. .. includes all types of cardiomyopathies, conduction defects with or
.
Pacingparametersshouldbeoptimizedtoachievemaximumpre-excitationof .. without cardiomyopathies, and supraventricular and ventricular
theRVapexwithminimalcompromiseofLVfilling(typicallyachievedwitharest- .. tachyarrhythmias.596(cid:2)598 Duchenne, Becker, and limb-girdle types
ingsensedAVintervalof100±30ms).587 ..
. 2C,2F,and2Iaremusculardystrophiesinwhichthedevelopmentof
.
.
. dilatedcardiomyopathyiscommonandusuallythepredominantfea-
.
.
. ture.Arrhythmiasandconductiondiseasecanbeassociatedwiththe
8.5.3 Pacemakerimplantationfollowingseptal .
.
myectomyandalcoholseptalablation
... development of cardiomyopathy.596(cid:2)598 Such patients are consid-
Inastudyinvolving2482patientswithobstructiveHCM,2.3%devel-
... ered for pacemakers or ICDs on the basis of guidelines used for
opedAVBafterseptalmyectomy588(only0.6%inthosewithnormal
... othernon-ischaemiccardiomyopathies.242Myotonicdystrophytypes
baseline conduction vs. 34.8% in patients with pre-existing RBBB).
... 1and2,Emery(cid:2)Dreifuss,andlimb-girdletype1Boftenpresentwith
AlcoholseptalablationcausesAVBin7(cid:2)20%ofpatients;576those ... conductiondiseaseandassociatedarrhythmias,andvariablywithcar-
with pre-existing conduction defects, mainly LBBB, are at highest
... diomyopathy.596,597 Therecommendations present guidance in the
risk.585 ... instanceswheretherecommendationsforcardiacpacingdifferfrom
. thoseusedforotherpatientswithbradycardia.
. .
.
. 8.5.4 Cardiacresynchronizationtherapyinend-stage .
.
. Recommendationsforcardiacpacinginrarediseases hypertrophiccardiomyopathy .
.
Basedonthefindingsofasmallcohortstudy,589CRTwasgivenboth ..
.. Recommendations Classa Levelb
aclassIIaandaclassIIbrecommendationinpreviousguidelinesfor .
.
.
patientswithHCM,HF,LBBB,andLVEF<50%.576,590Morerecent .. Inpatientswithneuromusculardiseasessuchas
.
studiesdidnotdemonstratesustainedefficacyofthistherapy.591(cid:2)593 ... myotonicdystrophytype1andanysecond-or
I C
Untilfurtherevidencebecomesavailable,standardcriteriaforCRT .. third-degreeAVBorHV>_70ms,withorwithout
.
arerecommendedinpatientswithHCM(section6). .. symptoms,permanentpacingisindicated.c599(cid:2)602
.
.. Inpatientswithneuromusculardiseasesuchas
.
8.6 Pacing in rare diseases .. myotonicdystrophytype1withPR>_240msor
. IIb C
8.6.1 LongQTsyndrome ... QRSduration>_120ms,permanentpacemaker
Therearemultipleinter-relationshipsbetweenthedifferentformsof
... implantationmaybeconsidered.c600,603,604
.
longQTsyndrome(LQTS)andbradycardia:LQTScanbeassociated ...
AVB=atrioventricularblock;CRT=cardiacresynchronizationtherapy;HV=
with sinus bradycardia; very long ventricular myocardial refractory .. His(cid:2)ventricularinterval;ICD=implantablecardioverter-defibrillator.
periodscancause2:1AVB;suddenratechangescantriggertorsades-
... aClassofrecommendation.
de-pointestachycardia;andtreatmentwithbeta-blockerstosuppress
.... b cWLev he el no ef vee rvid pe acn ic ne g.
isindicatedinneuromusculardisease,CRToranICDshould
sympathetictriggersoftorsades-de-pointesmaycausebradycardia. . beconsideredaccordingtorelevantguidelines.
1202
CSE
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 51 ---
ESCGuidelines 51
.
8.6.3 DilatedcardiomyopathywithlaminA/Cmutation .. presentations.621,622InKearns(cid:2)Sayresyndrome,themostcommon
.
MutationsintheLMNAgene,whichencodeslaminAandCinter- .. cardiacmanifestationisconductiondisease,whichmayprogressto
.
mediatefilamentsofthenuclearenvelope,causeavarietyofinherited .. completeAVBandcauseSCD.623(cid:2)625
.
diseasesdefinedas‘laminopathies’.605(cid:2)607Accordingtothetypeof ..
.
mutation, they can lead to isolated cardiac disorders or additional .. RecommendationsforpacinginKearns(cid:2)Sayre
.
systemicormusculoskeletaldisorderssuchastheEmery(cid:2)Dreifuss .. syndrome
.
autosomal dominant variant or limb-girdle dystrophy. Around ..
5(cid:2)10% of dilated cardiomyopathies are induced by LMNA gene
... Recommendations Classa Levelb
.
mutations, manifested as cardiac conduction disease, tachyarrhyth- ... InpatientswithKearns(cid:2)Sayresyndromewho
mias,orimpairedmyocardialcontractility.596,606(cid:2)620SNDandcon- ...
havePRprolongation,anydegreeofAVB,BBB,
ductiondiseasearefrequentlythefirstmanifestation,inmanycases ... orfascicularblock,permanentpacingshouldbe IIa C
withpreservedLVsizeandfunction.613,614LMNA-relatedcardiomy- ... considered.c621(cid:2)625
.
opathyismoremalignantthanmostothercardiomyopathies,carry- .
. InpatientswithKearns(cid:2)Sayresyndromewith-
.
ing a higher risk of SCD in asymptomatic mutation carriers with .
. outcardiacconductiondisorder,permanent preserved or only mildly decreased LV contractility.610(cid:2)615 .. IIb C
. pacingmaybeconsidered
.
Pacemaker implantation does not reduce the riskof SCD in these .. prophylactically.c621(cid:2)625
.
patients.Ameta-analysisofmodeofdeathinLMNAmutationsdem- .
.
onstratedthat46%ofpatientswhodiedsuddenlyhadanimplanted .. AVB = atrioventricular block; BBB = bundle branch block; CRT = cardiac
.
. resynchronizationtherapy;ICD=implantablecardioverter-defibrillator;PR=PR
pacemaker. Sudden death rates weresimilar in those withisolated .
.. interval.
cardiomyopathyandthosewithanadditionalneuromuscularpheno- .. aClassofrecommendation.
type.611 Complex ventricular arrhythmias are common in patients .. bLevelofevidence.
.
withconductiondisturbances.612,613,615Intwostudies,patientswith .... tc oW th he en re ev lee vr ap na tc gin ug idi es linin ed si .cated,CRToranICDshouldbeconsideredaccording
LMNAmutationsandanindicationforpermanentpacingunderwent ..
.
ICD implantation, and appropriate ICD therapies occurred in 42% ..
.
and52%ofpatientswithin3and5years,respectively.612,613These ..
.
findingsledtotheclinicalpracticetoconsiderICDratherthanpace- ...
8.6.5 Infiltrativeandmetabolicdiseases
makerimplantationinLMNA-relatedconductiondisease.614,620For ...
Infiltrativecardiomyopathyissecondarytoabnormaldepositionand
additional clinical risk factors for ventricular tachyarrhythmias and ..
. accumulationofpathologicalproductsinthemyocardialinterstitium,
suddendeathfoundinpatientswithdilatedcardiomyopathydueto ..
. while storage diseases lead to their intracellularaccumulation. The
LMNAgenemutations,seeSupplementaryTable18.CRT(D)should ..
. maincauseofinfiltrativecardiomyopathyisamyloidosis,whilestor-
beconsideredifthepatienthasAVBandLVEF<50%,andahighfre- ..
. agediseasesincludehaemochromatosis,Fabry’sdisease,andglycogen
quencyofventricularpacingisexpected(section6andSupplementary ..
. storagediseases.Inpatientswithcardiacamyloid,conductiondefects,
Table18).Theriskscoreoflife-threateningventriculararrhythmiain ..
. tachyarrhythmias,andSCDarecommon.Baseduponcurrentknowl-
.
laminopathiescanbepredictedbyarecentlydevelopedandvalidated .
. edge,conventionalindicationsshouldbeusedforpacinginthisgroup
module(https://lmna-risk-vta.fr/).616 ..
. ofpatients.
.
.
. RecommendationforpatientswithLMNAgenemuta- ..
tions(forreferences,seeSupplementaryTable18) .. 8.6.6 Inflammatorydiseases
.
.
. Infections(viral,bacterialincludingBorreliosis,protozoa,fungal,para-
. Recommendation Classa Levelb .. sites),autoimmune(e.g.giantcellmyocarditis,sarcoidosis,rheumatic
. .
. heart disease, connective tissue disease, eosinophilic myocarditis),
InpatientswithLMNAgenemutations,including . .
. toxic(alcohol,cocaine,cancertherapies,especiallymonoclonalanti-
Emery(cid:2)Dreifussandlimb-girdlemusculardys- .
.
. bodies),andphysicalreactions(radiationtherapy)cancauseinflam-
trophieswhofulfilconventionalcriteriaforpace- .
.
. matoryheartdisease.InvolvementoftheAVNandtheconduction
makerimplantationorwhohaveprolongedPR IIa C ..
. systemismorefrequentthanthatofthesinusnode.AVBmayindi-
intervalwithLBBB,ICDimplantationwithpacing ..
. cateinvolvementoftheseptumintheinflammatoryprocessandisa
capabilitiesshouldbeconsideredifatleast1- ..
. predictor of adverse outcome. Ventricular arrhythmias may also
yearsurvivalisexpected.616 ..
. occurbecauseofmyocardialpathology.
.
.
ICD=implantablecardioverter-defibrillator;LBBB,leftbundlebranchblock. . Wheninflammatoryheartdiseaseiscomplicatedbybradycardia,
.
a bC Lela vs es lo of fr ee vc ido em nm cee .ndation. ....
especiallyAVB,specifictherapyshouldbeappliedifavailable,eventu-
.. allybacked-upbytemporarypacingorintravenousadministrationof
.
.. isoprenaline. Otherwise, immunosuppressive therapy or awaiting
.
.. spontaneous resolution may be sufficient. If bradycardia does not
.
8.6.4 Mitochondrialcytopathies .. resolvewithinaclinicallyreasonableperiodorcannotbeexpected
.
Mitochondrialcytopathiesareaheterogeneousgroupofhereditary .. to resolve (e.g. after radiation therapy), permanent pacing is indi-
.
disorders,inwhichcardiomyopathies,conductiondefects,andven- .. cated.Beforechoosingadevicetype,theindicationforanICDand/
.
tricular arrhythmias are the most common cardiac . orCRTratherthanasingle-chamberorDDDpacemakershouldbe
1202
CSE
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 52 ---
52 ESCGuidelines
.
.
consideredbecausemostcausesofinflammatorydiseasecausingbra- .. pauses>3(cid:4)thecyclelengthoftheventricularescaperhythm,wide
.
dycardiamayalsoresultinreducedmyocardialcontractilityandven- .. QRS escape rhythm, prolonged QT interval, complex ventricular
.
tricularfibrosis. .. ectopy, meandaytimeheart rate<50 b.p.m.) is present. However,
.
.. women with complete heart block who exhibit a slow, wide QRS
.
8.6.6.1 Sarcoidosis .. complex escape rhythm should undergo pacemaker implantation
.
PersistentorintermittentAVBcanoccurinsarcoidosis,whichshows .. duringpregnancy.Therisksofpacemakerimplantationaregenerally
.
apropensitytoinvolvethebasalintraventricularseptum.InaFinnish .. lowandcanbeperformedsafely,especiallyifthefoetusisbeyond8
.
registry,143of325patients(44%)diagnosedwithcardiacsarcoidosis .. weeksgestation.Apacemakerforthealleviationofsymptomaticbra-
.
hadMobitzIIsecond-orthird-degreeAVBintheabsenceofother .. dycardiacanbeimplantedatanystageofpregnancyusingechoguid-
.
explanatorycardiacdisease.626Ahistoryofsyncope,pre-syncope,or .. anceorelectroanatomicnavigationminimizingfluoroscopy.636,637
.
palpitationspointstowardsbradycardia,butalsotopotentialventric- ..
.
.
ulartachyarrhythmia.AVBisthemostcommonclinicalpresentation .
.
inpatientswithclinicallyevidentcardiacsarcoidosis.627,628Diagnostic .. 9 Special considerations on device
.
.
stepsinclude ECGmonitoring, echocardiography, cardiacMRI,and . implantations and peri-operative
.
.
myocardial or other involved tissue biopsy. Fluorodeoxyglucose- .
positron emission tomography may be useful.629 The chances and
... management
.
.
timecourseofresolutionofAVBwithimmunosuppressivetherapy .
are not clear,630 but may be low.88 Long-term data are available
... 9.1 General considerations
.
mainlyfromaCanadianprospectivestudy(32patients),627aJapanese .. Patientswithclinicalsignsofactiveinfectionand/orfevershouldnot
.
retrospective study (22 patients),628 and a Finnish registry (325 .. undergo a permanent pacemaker (including leadless pacemaker)
.
patients).626 Reversibility of conduction disorder is unpredictable .. implantation until they have been afebrile for at least 24 h. Febrile
.
and,eveninpatientswithtransientAVB,permanentpacingshouldbe ... patientswhohavebeenstartedonantibioticsshouldideallyreceivea
considered.631 Immunosuppressive treatment may increase risk of ... complete course ofantibiotic treatment and shouldbe afebrilefor
deviceinfection.However,therearenofirmdatatosupportdevice ... 24hafterterminationofantibiotictreatmentbeforedefinitepace-
.
implantation before initiation of immunosuppressive medication. .. maker implantation is performed if acute pacing is not required. If
.
PatientswithcardiacsarcoidosisandAVBareathighriskofSCDdur- .. possible,theuseoftemporarytransvenouspacingshouldbeavoided.
.
inglong-termfollow-up,evenifLVEFis>35%.626Patientswithevena .. In patients in need of acute pacing, temporary transvenous pacing
.
mildormoderatedecreaseinLVEF(35(cid:2)49%)areatincreasedrisk .. shouldbeestablished,preferablywithjugularoraxillar/lateralsubcla-
of SCD.632,633 Therefore, in patients with cardiac sarcoidosis who ... vian vein access.638 In a multicentre, prospective study with 6319
.
have an indication for cardiac pacing and LVEF <50%, a CRT-D .. patients, fever within 24 h of implantation (OR 5.83, 95% CI
.
shouldbeconsideredratherthanapacemaker634(section6). .. 2.00(cid:2)16.98) and temporary pacing before implantation (OR 2.46,
.
. 95%CI1.09(cid:2)5.13)werepositivelycorrelatedwiththeoccurrence
.
Recommendationsforpacingincardiacsarcoidosis .. ofdeviceinfection.639Inthecaseofpatientswithchronicrecurrent
.
.
. infection,minimallyinvasiveimplantationofanepicardialpacemaker
.
Recommendations Classa Levelb .. maybeconsidered.
.
.
.
Inpatientswithcardiacsarcoidosiswhohave ..
. 9.2 Antibiotic prophylaxis
permanentortransientAVB,implantationofa ..
IIa C . devicecapableofcardiacpacingshouldbecon- .. The use of pre-operative systemic antibiotic prophylaxis is re-
.
sidered.c88,629,630 .. commended as the standard of care in pacemaker implantation
.
. procedures.Theriskofinfectionissignificantlyreducedwithasingle
Inpatientswithsarcoidosisandanindicationfor . .
. doseofprophylacticantibiotic(cefazolin1(cid:2)2gi.v.orflucloxacillin
permanentpacingwhohaveLVEF<50%,implan- IIa C . .
tationofaCRT-Dshouldbeconsidered.631,634 .. 1(cid:2)2 g i.v.) given within 30(cid:2)60 min [90(cid:2)120 min for vancomycin
.. (15mg/kg)]beforetheprocedure.640(cid:2)643Theantibioticprophylaxis
.
AVB=atrioventricularblock;CRT-D=defibrillatorwithcardiacresynchroniza- .. should cover S. aureusspecies, but routine coverageofmethicillin- .
tiontherapy;ICD=implantablecardioverter-defibrillator;LVEF=leftventricular .
. resistant S. aureus is not recommended. The use of vancomycin
ejectionfraction. ..
aClassofrecommendation. .. shouldbeguidedbypatientriskformethicillin-resistantS.aureuscol-
bLevelofevidence. .. onizationandtheprevalenceofthebacteriuminthecorresponding
.
acW ccoh re dn ie nv ge tr op tha ecin reg lei vs anin td gic ua idte ed linein s.sarcoidosis, an ICD should be considered .... institution.638
.. Incontrast,post-operativeantibioticprophylaxisdoesnotreduce
.
.. theincidenceofinfection.644,645
.
8.7 Cardiac pacing in pregnancy .
.
.
. 9.3 Operative environment and skin
Vaginal delivery carries no extra risks in a mother with congenital .
.
complete heart block, unless contraindicated for obstetric rea- .. antisepsis
.
sons.635Forwomenwhohaveastable,narrowcomplexjunctional ...
Thepacemakerimplantationprocedureshouldbeperformedinan
.
escaperhythm,pacemakerimplantationmaynotbenecessaryorcan .. operating environment that meets the standards of sterility as
.
bedeferreduntilafterdeliveryifnoneoftheriskfactors(syncope, . requiredforothersurgicalimplantprocedures.638,646
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 53 ---
ESCGuidelines 53
.
.
Basedondatafromsurgicalandintravascularcatheterprocedures, .. dependingontheclinicalscenarioandconcomitantantiplateletther-
.
skin antisepsis should be performed using chlorhexidine(cid:2)alcohol .. apy,eitherstoppingorcontinuingnon-vitaminKantagonistoralanti-
.
insteadofpovidone-iodine(cid:2)alcohol.647,648InalargeRCTcomprising .. coagulantsmightbereasonableatthetimeofdeviceimplantation.652
.
2546 patients, chlorhexidine(cid:2)alcohol was associated with a lower .. Patientsondualantiplatelettherapyhaveasignificantlyincreased
.
incidenceofshort-termintravascularcatheter-relatedinfections(HR .. risk of post-operative pocket haematoma compared with patients
.
0.15,95%CI0.05-0.41;P=0.0002).647 .. treated with aspirin alone or without antiplatelet therapy. In such
.
... cases, P2Y
12
receptor inhibitors should be discontinued for 3(cid:2)7
.. days (according to the specific drug) before the procedure where
.
9.4 Management of anticoagulation .. possibleandbasedonanindividualizedriskassessment.638,653,654For
.
Itiswellknownthatthedevelopmentofapockethaematomaafter .. moredetailsonthemanagementofanticoagulationinthepacemaker
.
the implantation of a pacemaker system significantly increases the .. procedure,refertoTable11.
.
risk for subsequent pocket infection.641,643,649 The Bridge or ..
.
.
Continue Coumadin for Device Surgery Randomized Controlled .
.
.
Trial(BRUISECONTROL)provedthataclinicallysignificantpocket .
.
. 9.5 Venous access
haematomaisanindependentriskfactorforsubsequentdeviceinfec- .
.
tion (HR 7.7, 95% CI 2.9(cid:2)20.5; P < 0.0001).649 Therefore, it is of .. Transvenous leadimplantationforpacemaker implantation iscom-
.
.
utmostimportancetotakeallstepstoavoidpost-operativepocket . monly performed by venous access via the cephalic, subclavian, or
.
.
haematoma. . axillaryvein.Inthe case ofclinicalsignsofvenousocclusionofthe .
.
Heparinbridgingforpacemakerimplantationinpatientsanticoagu- . subclavianveinortheinnominatevein,pre-operativeimaging(venog-
.
.
latedwithavitaminKantagonistleadstoasignificant4.6-foldincrease . raphyorchestCTscan)maybeusefulinplanningvenousaccessor
.
.
in post-operative pocket haematoma compared with a continued . analternativeaccessaheadoftheprocedure.Inthecaseofimpossi-
.
.
warfarinstrategy.650Internationalnormalizedratiotaperingandtem- . blesuperiorvenousaccess,appropriate,alternativeapproachesmay
.
.
poraryshiftingofdualantiplatelettosingleantiplateletadministration .. be transfemoral lead implantation, or implantation of a leadless
.
may significantly reduce the haematoma and infection rate by 75% .. deviceorepicardialleads.
.
and74%,respectively,comparedwithheparinbridging.651 .. WhenusingtheSeldingertechnique,thereisariskofapneumo-
.
Regarding non-vitamin K antagonist oral anticoagulants, the .. thorax,haemothorax,inadvertentarterialpuncture,andinjurytothe
.
Randomized Controlled Trial of Continued Versus Interrupted .. brachial plexus during venous puncture of the subclavian vein and
.
DirectOralAnti-CoagulantattheTimeofDeviceSurgery(BRUISE .. (lessso)theaxillaryvein.Theserisksareavoidablebyusingtheceph-
.
CONTROL-2)wasstoppedprematurelyduetofutilitybecausethe .. alic vein approach, which allows venous insertion of leads under
.
eventratewasfarlowerthananticipated;however,itsuggestedthat, . direct vision. Subclavian vein access is associated with a 7.8-fold
Table11 Managementofanticoagulationinpacemakerprocedures
Dualantiplatelettherapy655,656 NOAC652 VKA650 OAC1antiplatelet657
ThromboticriskafterPCI
Intermediateorlow High
>1monthPCI <1monthPCI
>6monthsacutecoronary <6monthsacutecoronary
syndromeatindexPCI syndromeatindexPCI
Lowprocedural ContinueaspirinAND Electivesurgery:Consider Continueorinterruptas Continuea ContinueOAC(VKAaor
bleedingriskFirst DiscontinueP2Y inhibi- postponementOtherwise: peroperatorpreference.If NOAC).Discontinueanti- 12
implant tors:Ticagreloratleast • Continueaspirin interruption,thenbasedon plateletperpatient-specific
3daysbeforesurgery • ContinueP2Y CrClandspecificNOAC risk/benefitanalysis
12
Clopidogrelatleast5days inhibitor
Highprocedural beforesurgeryPrasugrelat ContinueaspirinAND
bleedingriskDevice least7daysbeforesurgery DiscontinueP2Y inhibi-
12
exchange,upgrade/ tors:Ticagreloratleast3
revisionprocedure daysbeforesurgery,
Clopidogrelatleast5days
beforesurgery,Prasugrelat
least7daysbeforesurgery.
BridgingwithGPIIb/IIIa
inhibitors
CrCl=creatinineclearance;GP=glycoprotein;NOAC=non-vitaminKantagonistoralanticoagulant;OAC=oralanticoagulant;PCI=percutaneouscoronaryintervention;
VKA=vitaminKantagonist.
aTargetinternationalnormalizedratiowithintherapeuticrange.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 54 ---
54 ESCGuidelines
.
increasedriskofpneumothorax.658Prospectivedataonaxillaryvein .. developedtoallowforfullextractabilityinthelongterm.However,
.
.
puncturesuggestalowerriskofaccess-relatedcomplicationscom- . the ease of extractability at long term has not yet been
.
paredwithsubclavianpuncture.659Ultrasoundguidanceforaxillary .. proven.667(cid:2)669
.
.
veinpuncturehasbeendescribedasahelpfultechniqueforachieving .
.
asafeanduncomplicatedpuncture.660 .. 9.7 Lead position
.
.
Withregardstoleadfailureafterimplantation,thereisevidence . Ventricular pacing has traditionally been performed from the RV
.
.
thattheaxillaryveinrouteisassociatedwithalowerrateofleadfail- .. apex.Sincetheintroductionofactivefixationleads,alternativepacing
.
uresinlong-termfollow-up.Inaretrospectivestudycomprising409 .. sitessuchastheRVOTseptumorthemid-septumhavebeeneval-
.
patients and mean follow-up of 73.6 ± 33.1 months, lead failure .. uated in order to provide more physiological pacing. However,
.
occurredin1.2%ofpatientswithcontrast-guidedaxillaryveinpunc- .. despitetwodecadesofresearch,theclinicalbenefitofRVnon-apical
.
ture, 2.3% of patients with cephalic vein cutdown, and 5.6% of .. pacingremainsuncertain.670Thismaybepartlyexplainedbyvariabil-
.
patients with subclavian vein puncture. In multivariable regression .. ityinthepositionofthelead,whichisoftenunintentionallyplacedon
. analysis,theonlypredictorofleadfailurewassubclavianveinpunc- .. theanteriorfreewall,whereitmaybeassociatedwithadverseout-
.
tureinsteadofaxillaryveinaccess(HR0.26,95%CI0.071(cid:2)0.954;P .. come.671(cid:2)673 The main advantage of septal pacing probably lies in
.
=0.042).Whenanalysingthesuccessratesofthedifferentvenous .. the avoidance of perforation of the free wall. In a study of 2200
.
access approaches, the cephalic vein approach showed the lowest .. patientsimplantedwithapacemakerorICDlead,anapicalposition
. successrate(78.2%vs.axillaryvein97.6%andsubclavianvein96.8%; .. wasindependentlyassociatedwithcardiacperforation(OR3.37;P=
.
P<0.001).661 .. 0.024).420Aseptalpositionmaythereforebepreferableinpatientsat
.
.
. increasedriskofperforation,suchaselderlypatientsespeciallywitha
.
9.6 Lead considerations .. bodymassindex<20kg/m2,aswellaswomen.670,674
.
.
Inchoosingbetweenactiveorpassivefixationpacemakerleadsinthe . Placingtheleadonthemid-septummaybechallenging(evenmore
.
.
RAorRV,oneshouldconsiderthepotentialforperforationandperi- . sointheRVOTseptum,whichisasmallertargetarea).Theuseof
.
.
carditis,aswellasextractability.Activefixationleadshaveahigher . multiplefluoroscopicviewsandspeciallyshapedstyletsisusefulfor
.
tendencytocreatepericardialeffusionsaswellasovertperforations. .. thispurposeandisoutlinedinarecentEHRAconsensuspaper.34In
.
.
Passivefixationleads,duetothenon-isodiametricdesignofthelead . thiscontext,itisimportanttomentionthattheaccuracyandrepro-
.
.
tip,maybeafactorinlowerproceduralsuccessratesandhigherrisk . ducibility of fluoroscopic assessment of RV lead positions is often
.
forcomplicationswithleadextraction,althoughthispointisfarfrom ... inaccurate.421
.
beingclearandisstillunderevaluation.662AnRCTisrequiredtoclar- .. Multiple fluoroscopic views are also recommended for placing
.
ifythisissue. .. RVAleads,toensurethereisnoinadvertentplacementoftheleadin
.
Regarding perforations, an uncontrolled, non-randomized study .. acoronarysinustributaryorintheLVviaanintracardiacshuntor
.
comprising3815patientswithimplantofanRVleadshowednosig- .. arterialaccess.
.
nificantdifferencewithregardstomyocardialperforationsbetween .. ThecoronarysinusmaybeusedforLVpacingwithouttheneedto
.
activeandpassivefixationleads(0.5%vs.0.3%;P=0.3).663Activefix- .. crossthetricuspidvalve.Itmayalsobeusedinthecaseofotherdiffi-
.
ationleadsalsoallowselectivesitepacinginregionsoftheRVthat .. cultiesindeployinganRVlead(e.g.inthe caseofatricuspidvalve
.
aresmoothwalled(e.g.themid-septum).TheRAis,however,thin .. prosthesis). In selected patients, the outcome is similar to RV
.
walled,andperforationoftheRAfreewallbyactivefixationleadshas .. pacing.675,676
.
been demonstrated. Some implanting physicians prefer to implant .. The RA appendage is usually the preferred site for atrial pacing.
.
passiveleads in patients atelevated risk ofperforation(e.g. elderly .. The lateralatriummaycarrya riskofphrenicnervecapture.677,678
.
patients).However,basedonexpertopinionandontheresultsofa .. Alternativepacing sitestoavoid AFsuch as Bachman’sbundleand
. single-centre, retrospective study on ICD leads (637 patients), in .. theregionofthecoronarysinusostiumhavenotshownbenefitand
. youngpatients,theuseofactivefixationleadsintheRAandRVis .. arenottoberecommendedinroutinepractice.679,680
. recommendedintermsoffutureextractability.664 ..
.
. 9.8 Device pocket
Leadstabilityandphrenicnervestimulationareimportantaspects .
.
.
ofcoronarysinusleadimplantation.Withregardstoboth,quadripo- . In recent years, therehasbeen increasing awareness ofthedevice
.
.
larleadsseemtohaverelevantadvantages.Therateofphrenicnerve . pocketasasourceofcomplications.Avoidanceofpocketinfections
.
.
stimulation requiring lead revision is significantly lower compared . hasbecomeaspecialfocusindevicetherapy.Theroleofpockethae-
.
with that in bipolar coronary sinus leads.665,666 Furthermore, lead .. matomasinthedevelopmentofinfectionshasbeendiscussedearlier.
.
.
stability is increased because quadripolar leads can usually be . Itisevidentthatbesidesadequatemanagementofanticoagulation,a
.
.
implantedinthewedgedposition.Ifimplantedinanapicalposition . propersurgicaltechniquewithmeticuloushaemostasisisofutmost
.
.
duetowedging,theuseoftheproximalpolesavoidsapicalstimula- .. importance.
.
tion. Therefore, quadripolar leads are recommended for coronary .. Mostpacemakersareimplantedwiththecreationofasubcutane-
.
sinusleadimplantation.ActivefixationLVleadsviaasidehelixhave .. ouspocket.681Inpatientswithalowbodymassindexandtherefore
.
beendeveloped,andresultshaveprovedreliablestability,easyaccess .. littlesubcutaneoustissue,inthecaseofTwiddler’ssyndrome,orfor
.
tothetargetpacingsite,andstableLVpacingthresholdinthelong .. aestheticreasons,creationofasubmuscularpocketmaybeprefera-
.
term.Incomparisonwithpassivefixationquadripolarleads,activefix- .. ble.However,thismayrequiredeepersedationforimplantationand
.
ationbipolarandquadripolarleadsachievedsimilarresults.Thelead .. generatorreplacementsduetopain.Todate,therearenodatafrom
.
design with an active fixation mechanism via a side helix was . RCTs comparing the two approaches for creating device pockets.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 55 ---
ESCGuidelines 55
Historicaldatafrom1000patientswithICDimplantsshowedsignifi- ...
Inpacemakerimplantationsinpatientswithpos-
cantly shorter procedural times for patients with subcutaneous ...
siblepocketissuessuchasincreasedriskofero-
devicepockets.Nosignificantdifferenceswithregardtopockethae- ...
sionduetolowbodymassindex,Twiddler’s IIb C
matomas were found. There were no significant differences in the ..
. syndrome,orforaestheticreasons,asubmuscu-
.
cumulativepercentagesofpatientsfreefromcomplicationduringfol- .
. lardevicepocketmaybeconsidered.
low-up.682 ..
. Heparinbridgingofanticoagulatedpatientsis
Pocketirrigationattheendoftheprocedurewithnormalsaline .. III A
. notrecommended.650,689
.
leadstodilutionofpossiblecontaminantsandeliminatesdebrisfrom .
thewoundbeforeclosure.683,684Additionofantibioticstotherinsing
... Permanentpacemakerimplantationisnotrec-
solutiondoesnotreducetheriskofdeviceinfections.683 ... ommendedinpatientswithfever.Pacemaker III B
.. implantationshouldbedelayeduntilthepatient
The World-wide Randomized Antibiotic Envelope Infection .
.. hasbeenafebrileforatleast24h.638,639
Prevention Trial (WRAP-IT study) investigated the effect of an .
.
. absorbableantibiotic-elutingenvelopeonthedevelopmentofpost- .. CIED=cardiovascularimplantableelectronicdevice.
operative CIED infections. A total of 6983 patients undergoing a
.. aClassofrecommendation.
.. bLevelofevidence.
CIEDpocketrevision,generatorreplacement,orsystemupgrade,or ..
.
initialimplantationofaCRT-Dwererandomlyassigned,ina1:1ratio, ..
.
toreceivetheantibioticenvelopeornot.TherateofCIEDinfection ..
.
inpatientswhohadtheantibacterialenvelopewas0.7%vs.1.2%in ..
thecontrolgroup(HR0.6,95%CI0.36(cid:2)0.98;P=0.04).685Noeffect ... 10 Complications of cardiac
.
oninfectionratewasobservedinthesubgroupwithpacemakers.685 .. pacing and cardiac
.
.
Consideringcost-effectivenessaspects,theuseofanantibioticenve- .
.. resynchronization therapy
lopemaybeconsideredinpacemakerpatientsathighriskforCIED .
.
.
infections.Riskfactorstobeconsideredinthiscontextareend-stage .
.. 10.1 General complications
renaldisease,chronicobstructivepulmonarydisease,diabetesmelli- .
.
tus,anddevicereplacement,revision,orupgradeprocedures.638 .. CardiacpacingandCRTareassociatedwithasubstantialriskofcom-
.
.. plications (Table 12), most of which occur in the perioperative
.
.. phase,429,690butasizableriskremainsduringlong-termfollow-up.691
.
Recommendationsregardingdeviceimplantationsand .. Complication rates after dual-chamber pacemaker implantation in
.
peri-operativemanagement .. theMOSTtrialwere4.8%at30days,5.5%at90days,and7.5%at3
.
.. years.692 However, ‘real-life’ data indicate a higher risk.690,693 In a
Recommendations Classa Levelb ...
recentstudyof >81000patientsreceiving denovoCIED implanta-
.
Administrationofpre-operativeantibioticpro- ... tions,majorcomplicationsoccurredin8.2%within90daysofhospi-
phylaxiswithin1hofskinincisionisrecom-
... taldischarge.694Mortalityinhospital(0.5%)andwithin30days(0.8%)
I A .
mendedtoreduceriskofCIED .. waslow.
.
infection.641,643.686 .. Complicationrisksgenerallyincreasewiththecomplexityofthe
.
. deviceandaremorecommoninthecontextofadeviceupgradeor
Chlorhexidine(cid:2)alcoholinsteadofpovidone- .
.
. lead revisions compared with de novo implantation. In a Danish iodine(cid:2)alcoholshouldbeconsideredforskin IIa B .
.
antisepsis.647,648 .. population-based cohort study, complications were observed in
.
. 9.9% of patients at first device implantation and in 14.8% upon
Forvenousaccess,thecephalicoraxillaryvein
IIa B
...
upgrade or lead revision.354 Procedures limited to replacement of
shouldbeconsideredasfirstchoice.658,659 ..
. thegeneratorhadalowercomplicationrisk(5.9%).Intheprospec-
Toconfirmtargetventricularleadposition,use .. . tive REPLACE registry, a similar proportion (4%) of complication
ofmultiplefluoroscopicviewsshouldbe IIa C ..
.. risksinthesettingofgeneratorreplacementwasreported,butmuch
considered. .
.. higher risks were found inthose with oneormore additionallead
Forimplantationofcoronarysinusleads,quadri- .
.. insertions(upto15.3%).695Accordingly,majorcomplicationswere
polarleadsshouldbeconsideredasfirst IIa C .
.. particularlymorecommonwithCRTupgradeprocedures,afinding
choice.665,666,687 .
.. thatwascorroboratedinalargeUSinpatientcohort339andapro-
Rinsingthedevicepocketwithnormalsalinesol- ... spectiveItalianobservationalstudy.696Therateofproceduralcom-
utionbeforewoundclosureshouldbe IIa C ... plicationsalsoincreaseswithcomorbidityburden.697
considered.683,684 ...
Thus,carefulshareddecision-makingiswarrantedwhenconsider-
.
InpatientsundergoingareinterventionCIED .. ingupgradestomorecomplexsystems.Thisalsoappliestoprophy-
.
procedure,theuseofanantibiotic-elutingenve- IIb B .. lacticreplacementofrecalledCIEDgeneratorsandleads,ascenario
lopemaybeconsidered.685,688 ...
inwhichproceduralrisksshouldbecarefullyweighedagainsttherisks
.
Pacingofthemid-ventricularseptummaybe .. associatedwithdeviceorleadfailure.698
.
consideredinpatientsathighriskofperforation .. Overall, complication rates are closely linked to individual and
IIb C .
(e.g.elderly,previousperforation,lowbody .. centreimplantationvolumes.429,658,693Complicationswereincreased
.
massindex,women).420,674 .. by60%ininexperiencedoperatorswhohadperformedfewerthan
Continued
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 56 ---
56 ESCGuidelines
.
25implantations.429Datafromalargenationalqualityassurancepro- .. passive fixation RA lead (OR 2.2) were the most important risk
.
.
grammeforpacemakersandCRT-Pshowedthattheannualhospital . predictors.
.
.
implantation volume was inversely related to complication rates, . Ameta-analysisof25CRTtrialsnotedmechanicalcomplications
.
.
with the greatest difference observed between the lowest (1-50 . in3.2%(includingcoronarysinusdissectionorperforation,pericar-
.
.
implantations/year)andthesecondlowestquintile(51(cid:2)90implanta- . dialeffusionortamponade,pneumothorax,andhaemothorax),other
.
tions/year).699 Furthermore, emergency and out-of-hours proce- .. lead problems in 6.2%, and infections in 1.4%. Peri-implantation
.
dures are associated with increased complication rates.354 These .. deathsoccurredin0.3%.369
.
.
dataclearlysuggestthatCIEDproceduresshouldbeperformedby .
.
.
operatorsandcentreswithasufficientproceduralvolume. ...
10.2.2 Haematoma
.
.. Pockethaematomaisafrequentcomplication(2.1(cid:2)9.5%),whichcan
.
.. usuallybemanagedconservatively.Evacuation,requiredin0.3(cid:2)2%
.
10.2 Specific complications .. ofcases,isassociatedwithan(cid:3)15timesincreasedriskofinfection.639
.
10.2.1 Leadcomplications
... Moreover, patients developing pocket haematoma stay in hospital
Pacemakerleadsareafrequentsourceofcomplicationsduetodis-
... longerandhaveahigherin-hospitalmortalityrate(2.0%vs.0.7%).724
lodgement,insulationdefects,leadfractures,andsensingorthreshold
... Hence,appropriateprecautionsarecritical,andreoperationshould
problems.InaDanishcohort,lead-relatedinterventions(2.4%)were ... belimitedtopatientswithseverepain,persistentbleeding,distension
themostcommonmajorcomplication.354LVleadshaveaparticular ... ofthesutureline,andimminentskinnecrosis.Manyhaematomascan
propensityforcomplicationssuchasdislodgementandcoronaryvein
... beavoidedbycarefulhaemostasisandoptimalmanagementofanti-
.
dissectionorperforation.700Inanationwideregistry,LVleads(4.3%) .. plateletandanticoagulantdrugs.
.
weremorecommonlyassociatedwithcomplicationscomparedwith ..
.
RAleads(2.3%)andRVleads(2.2%).429ACRTdevice(OR3.3)and .. 10.2.3 Infection
.
.
. Infection is one of the most worrying CIED complications, causing
.
.. significantmorbidity,mortality,andhealthcarecosts.725,726Infection
.
Table12 Complicationsofpacemakerandcardiac .. ratesarehigherwithdevicereplacementorupgradeprocedures,695
.
resynchronizationtherapyimplantation .. as well asCRTorICDimplants compared with simplepacemaker
.
IncidenceofcomplicationsafterCIEDtherapy % ... implantation.727 Olsen etal.702 reported thelifetime riskofsystem
.
Lead-relatedreintervention354,639,690,692,695,700,701 1.0(cid:2)5.9 .. infectioninpatientswith:apacemaker(1.19%),ICD(1.91%),CRT-P
.
(includingdislodgement,malposition,subclaviancrush .. (2.18%),andCRT-D(3.35%).Specifically,patientsundergoingreop-
.
syndrome,etc.) .. erations, those with a previous device-related infection, men, and
.
CIED-relatedinfections,<12 0.7(cid:2)1.7
... youngerpatientshadasignificantlyhigherriskofinfection.
months354,639,641,645,685,695,702 ... Similar findings have been reported in a large cohortofpatients
Superficialinfection354 1.2
... receivinganICD,withinfectionratesof1.4%forsingle,1.5%fordual,
Pocketinfections354 0.4
... and2.0%forbiventricularICDs.728Inaddition,earlyreintervention
.. (OR2.70),previousvalvularsurgery(OR1.53),reimplantation(OR
Systemicinfections354 0.5 ...
1.35), renal failure on dialysis (OR 1.34),chronic lung disease (OR
CIED-relatedinfections,>12months702(cid:2)709 1.1(cid:2)4.6 ...
1.22),cerebrovasculardisease(OR1.17),andwarfarinuse(OR1.16)
Pocketinfections702 1.3 ... wereassociatedwithanincreasedriskofinfection.702Infectionsalso
.
Systemicinfections702,705 0.5(cid:2)1.2 .. occurmorefrequentlywithuseoftemporarypacingorotherproce-
.
Pneumothorax354,658,690,692,700,701,707 0.5(cid:2)2.2 .. duresbeforeimplantation(OR2.5and5.8,respectively),earlyrein-
.
. Haemothorax695 0.1 . terventions (OR 15), and lack of antibiotic prophylaxis (OR
.
Brachialplexusinjury695 <0.1 ... 2.5).639,729
.
Cardiacperforation354,663,690,692,695 0.3(cid:2)0.7 .. Furthercomprehensiveinformationonhowtoprevent,diagnose,
.
. andtreatCIEDinfectionshasbeenprovidedinarecentEHRAcon-
Coronarysinusdissection/perforation710,288 0.7(cid:2)2.1 .
.. sensusdocument.642
Revisionduetopain/discomfort354,690 0.1(cid:2)0.4 ..
.
.
Diaphragmaticstimulationrequiring 0.5(cid:2)5 .
.
reintervention711,712,665,713 .. 10.2.4 Tricuspidvalveinterference
.
Haematoma354,639,650,652,654,690,700,714,715 2.1(cid:2)5.3 ... CIED leads may interfere with tricuspid valve function intra-
. operativelybycausingdamagetothetricuspidvalve leafletsorthe
Tricuspidregurgitation716(cid:2)718 5(cid:2)15 ..
Pacemakersyndrome146,701,719 1(cid:2)20
... subvalvularapparatus,orchronicallyafteroperationorleadextrac-
.. tion. This damage has been linked to haemodynamic deterioration
Generator/leadproblem354,639,690 0.1(cid:2)1.5 ... andanadverseclinicaloutcome.730Infact,moderatetoseveretricus-
Deepvenousthrombosis(acuteor 0.1(cid:2)2.6 ... pidregurgitationisgenerallyassociatedwithexcessmortality731,732
chronic)354,720,721 ... andoccursatasignificantlyhigherrateinCIEDpatients.733Theprev-
Anycomplication354,639,690,692,695,707,722,723 5(cid:2)15 ... alence of significant tricuspid regurgitation (defined as grade 2 or
.
Mortality(<30days)354,694 0.8(cid:2)1.4 .. above) following CIED implantation varies between 10% and 39%.
.
CIED=cardiovascularimplantableelectronicdevice. . Most studies attribute a greater harm with ICD leads and in the
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 57 ---
ESCGuidelines 57
.
presenceofmultipleRVleads.45,46,49,445,642,685,697,709,728,730(cid:2)732The .. decision-making.Theintegrated-careapproachhasitsoriginsinthe
.
issueofleadinterferencewithbioprosthetictricuspidvalvesorafter .. chronic care model developed by Wagner et al.,740 and has the
.
.
annuloplastyorrepairisdebated.Furthermore,thereisnofirmevi- . potential to improve clinical and patient outcomes in arrhythmia
.
dencesupportingthatpacing-inducedRVdyssynchronysignificantly .. management741(cid:2)743 (see section 12). Relevant specialists to be
.
.
contributestotricuspidregurgitation.Arecentstudyrandomizing63 . includedintheinterdisciplinaryteamareincludedaccordingtothe
.
.
patientstopacingleadpositionsintheRVapex,RVS,orLVpacingvia . patient’sneedsandlocalserviceavailability(Figure13).
.
.
thecoronarysinusdidnotaffectthedevelopmentoftricuspidregur- .
.
.
gitation.734 The diagnostic work-up of CIED lead-related tricuspid .
.
.
regurgitationbasedonclinical,haemodynamic,andinparticularecho- ..
. 11.1 Magnetic resonance imaging in
cardiographic (2D, 3D, and Doppler) evaluation is often challeng- ..
ing.735 While clear guidance for the management of tricuspid ... patients with implanted cardiac devices
.
regurgitationinthepresenceofCIEDleadsisstilllacking,ahighlevel .. MRIisafrequentrequirementinpatientswithimplantedpacemakers.
. of clinical suspicion is required, not discounting the possibility that .. It may cause adverse effects such as inappropriate device function
.
worseningHFmaybeaconsequenceofthemechanicaleffectontri- .. duetodeviceresetorsensingproblems,interactionwiththemag-
.
cuspid leaflet mobilityorcoaptation.730 General treatmentoptions .. neticreedswitch,inductionofcurrentsresultinginmyocardialcap-
.
includemedicaltherapyaimingtorelievecongestionandleadextrac- .. ture, heating at the lead tip with changes in sensing or capture
. tionwithcarefulreplacement,oruseofalternativepacingstrategies, .. thresholds,orleadperforation.Riskfactorsforadverseeventswith
.
such as LV pacing via the coronary sinus or epicardial leads. .. MRIsarelistedinSupplementaryTable19.
.
However,transvenousleadextractionitselfcarriesariskofdamage .. Currently,mostmanufacturersproposedevicesthatareMRIcon-
.
tothetricuspidvalveand,hence,worseningtricuspidregurgitation. .. ditional.ItistheentireCIEDsystem(i.e.combinationofgenerator
.
.
Whileleadless pacing eliminatesthe need for transvalvularleads, it . andleads,whichneedtobefromthesamemanufacturer)thatdeter-
.
.
maystillnegativelyaffecttricuspidvalvefunction,potentiallydueto . minesMRIconditionality,andnottheindividualelements.MRIscans
.
.
mechanicalinterferenceandabnormalelectricalandmechanicalven- . maybe limited to1.5Tand awhole-bodyspecificabsorptionrate
.
tricularactivation.736Indicationsforsurgicalvalverepairorreplace- .. (SAR)<2W/kg(headSAR<3.2W/kg),butsomemodelsallow3T
.
.
mentinthecontextofCIED-inducedtricuspidregurgitationfollow . andupto4W/kgwhole-bodySAR.Themanufacturermayspecifyan
.
.
current recommendations based on the presence of symptoms, . exemptionperiod(usually6weeks)afterimplantation,butitmaybe
.
.
severityoftricuspidregurgitation,andRVfunction.Whenconsider- .. reasonabletoperformanMRIscanearlierifclinicallywarranted.
.
ingtricuspidvalvesurgery,managementoftheRVleadshouldfollow .. ThereisampleevidencethatMRIscanbeperformedsafelyinnon-
therecommendationsoutlinedinsection8.2.3.737Methodsforpercu- ... conditionalpacemakers,aslongasanumberofprecautionsaretak-
.
taneoustricuspidrepairhaverecentlygainedmajorattention,butevi- .. en.744(cid:2)746 In 2017, the Heart Rhythm Society published an expert
.
denceinfavourofsuchinterventionsinthecontextoflead-related .. consensus statement on MRIs in patients with CIEDs, which was
.
tricuspidregurgitationisstilllimited.738 .. developedwithandendorsedbyanumberofassociationsincluding
.
.. theEHRAandseveralradiologicalassociations.745Fordetailedrec-
.
10.2.5 Other .. ommendations on appropriate workflow and programming, see
.
Increasedcomplicationriskshavebeenobservedinwomen(mainly ... SupplementaryTables20,21,and22andSupplementaryFigure2.
pneumothoraxandcardiacperforation)andinthosewithalowbody ... Whenleadsareconnectedtoagenerator,thelattercomponent
mass index.354,739 Patients older than 80 years were also found to ... absorbspartoftheenergyanddissipatesheatviathelargesurface
have a lower risk of lead-related reinterventions compared with ... area.Abandonedtransvenousleadsarepronetoheatingofthelead
patientsaged60(cid:2)79years(1.0%vs.3.1%).354 ... tipby(cid:3)10(cid:5)Casshownbyaninvitrostudy.747Itis,however,difficult
.
Finally, suboptimal atrioventricular synchrony may lead to the .. toextrapolateresultsfromexperimentalmodelstotheinvivosetting.
.
pacemakersyndrome,givingrisetocannonwavescausedbysimulta- .. No adverse events were reported from four series totalling 125
neous atrial and ventricular contractions and symptoms of fatigue,
... patientswithabandonedtransvenousleads.748(cid:2)751Thelargeststudy
dizziness,andhypotension(seesection5).Long-termRVpacingindu- ... reported 80 patients749 who underwent 97 scans (including the
.
ces a dyssynchronous ventricular activation pattern that may pro- .. thoracicregion),limitedtoanSAR<1.5W/kg.Halfofthecohorthad
.
moteprogressiveLVdysfunctionandclinicalHF.Strategiestoavoid .. measurementoftroponinlevelsbeforeandafterthescan,without
.
and resolve the adverse effect of RV pacing have been discussed .. anysignificantchanges.Therefore,1.5TMRIscans(limitedtoSAR
.
above(section6). .. <1.5 W/kg) may be considered in selected patients, taking into
.
. account the risk(cid:2)benefit ratio, particularly if the scans are extra-
.
.
. thoracicandpatientsarenotpacemakerdependent.
.
.
11 Management considerations .. Epicardialleadsconnectedtoageneratorresultina10(cid:5)Cincrease
.
.. intemperatureduringinvitrotesting,andbyasmuchas77(cid:5)Cwith
.
IntegratedmanagementofpacemakerandCRTpatients,deliveredby .. abandonedepicardialleads.747Datafrom23patientswithepicardial
.
aninterdisciplinaryteaminpartnershipwiththepatientand family, .. leads have been reported,749(cid:2)752 including 14 patients with aban-
.
should be adopted in order to deliver comprehensive treatment .. doned epicardial leads,749(cid:2)751 without any adverse effect of MRI
.
acrossthecontinuumofhealthcare(seesection12).Theintegrated- .. scans.Giventhepaucityofdatarelatedtosafetyinpatientswithepi-
.
careapproachisindicatedinpacemakerandCRTpatientstoensure .. cardialleads,leadadaptors/extenders,ordamagedleads,recommen-
.
a patient-centred approach and patient involvement in shared . dationscannotbemadeatthisstageregardingMRIsinthesepatients.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 58 ---
58 ESCGuidelines
Integrated management of patients with pacemaker and CRT
Emphasising patient-centred care and shared decision making
Ensure optimal device Pre-implant assessment and adherence to
selection and implantation low-risk implantation surgery
Provide physiological pacing Structured follow-up with tailored device programming
and symptom control (remote monitoring and in-office)
Management of underlying Including stroke prevention in atrial fibrillation and
cardiac disease heart failure optimization
Patient education/
Including personal goals and/or action plan
self-management
Healthcare professional Including certifications for optimal quality
education in relevant specialities
Smoking cessation, alcohol, dietary
Lifestyle modification
and exercise interventions
Psychosocial management
Psychological assessment and/or treatment
and support
Strategies to promote Educate patients about what to expect from the device and
medical adherence medical treatment using available technologies
Including different disciplines when relevant;
Multidisciplinary
electrophysiologists, cardiologists,nurses, allied professionals,
team approach
psychologist, dietician and pharmacist
Clear communication
between primary and Including timely end-of-life discussions
secondary care
Figure13Integratedmanagementofpatientswithpacemakerandcardiacresynchronizationtherapy.CRT=cardiacresynchronizationtherapy.
.
.
Evaluation must be made on a case by case basis by balancing the . A flowchartsummarizingthe managementof patientswith a pace-
.
.
advantagesofMRIwiththepotentialrisksandavailabilityofalterna- . makerundergoingMRIisshowninFigure14.
.
.
tiveimagingmethodsandusingshareddecision-making. . Thereisevidenceindicatingthat1.5TMRIsmaybeperformedin
.
.
Ingeneral,MRIsshouldalwaysbeperformedinthecontextofa . patientswithtemporaryepicardialwires756aswellaswithtransve-
.
.
rigorouslyappliedstandardizedinstitutionalworkflow,followingthe .. nouspacemakeractivefixationleadsimplantedtoexternalizedpace-
.
appropriateconditionsofuse(includingprogramming).744,746,753(cid:2)755 .. makersusedfortemporarypacing.751
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 59 ---
ESCGuidelines 59
Evaluating magnetic resonance imaging in pacemaker patients
Y MRI-conditional system
N
Past exemption period Alternative imaging
after implementation mode available
N
Strongly Presence of epicardial leads,
reconsider Y or connected fractured leads,
MRIa or lead adaptors/extenders
Y N Y N
Presence of
abandoned leads
N
Y
MRI following MRI following MRI only if benefits
conditions of use MRI Alternative appropriate outweigh risk
and standardized imaging standardized (max. 1.5T,
workflow (Class IIa) technique workflow SAR < 1.5W/Kg)
(Class I) (Class IIa) (Class IIb)
Figure14 Flowchartforevaluatingmagneticresonanceimaginginpacemakerpatients.MRI=magneticresonanceimaging;SAR=specificabsorption
rate.aConsideronlyifthereisnoimagingalternativeandtheresultofthetestiscrucialforapplyinglife-savingtherapiesforthepatient.
.
.
Recommendationsforperformingmagneticresonance ...
11.2 Radiation therapy in pacemaker
imaginginpacemakerpatients .
. . patients
.
. Recommendations Classa Levelb .. AnincreasingnumberofpatientswithCIEDsarereferredforradio-
. .. therapy,757withareportedannualrateof4.33treatmentsper100
InpatientswithMRI-conditionalpacemakersys- .
.
tems,cMRIscanbeperformedsafelyfollowing I A .. 000 person-years. Radiotherapy uses high-energy ionizing radiation
.
. including X-rays, gamma rays, and charged particles, which might themanufacturer’sinstructions.745,753(cid:2)755 .
.
. causesoftwareandhardwareerrorsinCIEDs,especiallywhenpho-
Inpatientswithnon-MRI-conditionalpacemaker ..
. tonradiationbeamenergyexceeds6(cid:2)10MV,andtheradiationdose
systems,MRIshouldbeconsideredifnoalterna- ...
tothedeviceishigh(>2(cid:2)10Gy).758,759Harderrorsarerare,andare
tiveimagingmodeisavailableandifnoepicardial IIa B ..
. mostoftenduetodirectirradiationtothedevice.Thiscancauseirre-
leads,abandonedordamagedleads,orlead ..
. versiblehardwaredamage,requiringdevicereplacement.Softerrors
adaptors/extendersarepresent.744,746 ..
.. aremorecommon,andareassociatedwithsecondaryneutronpro-
MRImaybeconsideredinpacemakerpatients .
.. ductionbyirradiation.760Sucherrorstypicallyincluderesetsofthe
withabandonedtransvenousleadsifnoalterna- IIb C .
.. devicewithoutcausingstructuraldamage,andcanbesolvedwithout
tiveimagingmodalityisavailable.748(cid:2)751 .
.. replacement.757,759
.
MRI=magneticresonanceimaging. .. Electromagnetic interference during radiotherapy can cause
.
aClassofrecommendation. .. oversensing,althoughthisveryrarelyoccursinclinicalpractice.760
b cCLe ov mel bo inf ae tv ioid nen oce f.
MRI-conditional generator and lead(s) from the same
....
Device relocation before radiotherapy is very rarely recom-
manufacturer. . mended, and only if the current location of the device interferes
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 60 ---
60 ESCGuidelines
.
.
with adequate tumour treatment or in very selected high-risk . prophylacticallywhentheneedforpacingisanticipated(e.g.aftercar-
.
cases.757,761 .. diac surgery).764,765 Modalities for emergency temporary pacing
.
.
According to published recommendations for CIED . includetransvenous,epicardial,andtranscutaneousapproaches.The
.
patients,745,759,762theriskofmalfunction(oradverseevents)ishigher .. transvenousapproachoftenrequiresfluoroscopicguidance,although
.
inthefollowingsituationsforpacemakerpatients: .. echo-guided placement is also feasible.766 Balloon-tipped floating
.
.
. cathetersareeasiertoinsert,morestable,andsaferthansemi-rigid
• Withphotonradiationapplyingenergy>6(cid:2)10MV:theriskofmal- ..
.. catheters.767,768 Patientswho undergotransvenous temporary car-
functions(usuallysofterrors)isduetosecondaryneutronpro- .
.. diacpacinghaveahighriskforprocedure-relatedcomplications(e.g.
duction, isnot associated withthe target zone, and cannotbe .
.. cardiacperforation,bleeding,malfunction,arrhythmias,andacciden-
shielded. .
• Withacumulativedosereachingthedevice>2Gy(moderaterisk)or
... talelectrodedisplacement)andcomplicationsrelatedtoimmobiliza-
>10Gy(high-risk):thedosereachingthepacemakercanbeesti-
... tion(e.g.infection,delirium,andthromboticevents).764,765,769(cid:2)775In
.. addition,previoustemporarypacingisassociatedwithanincreased
matedbeforeandmeasuredduringtreatment,iscorrelatedwith . .. riskofpermanentpacemakerinfection.639,641Apercutaneoustrans-
thetargetzone,andcanbeshielded. .
• Ifthepatientispacemakerdependent.
... venousactivefixationleadconnectedtoanexternaldeviceissafer
.. and more comfortable for patients requiring prolonged temporary
.
.. pacing.776(cid:2)779Therearenogooddatathatsupporteitherajugular
Appropriatedecision-makingissuggestedinFigure15. . .. oraxillar/subclavianaccess;however,intrathoracicsubclavianpunc-
ExperiencewithprotonradiationtherapyinCIEDpatientsislim- .
.. tureshouldbeavoidedtoreducetheriskofpneumothorax.Ajugular
ited. However, compared with photon irradiation, this radiation .
.
. accessshouldbepreferredifimplantationofapermanentipsilateral
modalityproducesmoresecondaryneutrons,whichmayaffectthe .
.
riskofdeviceerrorsorfailure.763Currently,nospecificguidancecan .. deviceisplanned.Inselectedcaseswherefastandefficientpacingis
.
. needed,afemoralaccessmaybeused.Owingtoinstabilityofpassive
begivenregardingprotonradiationtherapyinCIEDpatients. .
.
. leads placed through the femoral vein and immobilization of the
The specific recommendations of CIED manufacturers are .
.
. patient,thedurationofthisapproachshouldbeasshortaspossible
reportedinSupplementaryTable23. .
.
. until bradycardia has resolved or a more permanent solution has
.
.
. been established. The epicardial approach is mostly used following
.
11.3 Temporary pacing .. cardiacsurgery.Removaloftheseleadsisassociatedwithcomplica-
.
Temporary pacing can provide electronic cardiac stimulation in
... tionssuchasbleedingandtamponade.780(cid:2)782Transcutaneoustem-
.
patients with acute life-threatening bradycardia or can be placed . porarypacingisafastandeffectivenon-invasivemethod,butisnotas
Pacemaker management in patients undergoing radiation therapy
Device-specific treatment planning considerations:a
Avoid direct radiation
Limit cumulative dose
Reduce beam energy to minimize direct neutron radiation
Comprehensive PM evaluation before radiation therapy
Neutron-producing
treatment ( > 10 MV)
Y N
Weekly comprehensive Comprehensive PM evaluation
PM evaluation after end of radiation therapy
Figure15 PacemakermanagementduringradiationtherapyECG=electrocardiographic;PM=pacemaker.aRelocationofthedevice,continuousECG
monitoring,reprogramming,ormagnetapplicationareveryrarelyindicated.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 61 ---
ESCGuidelines 61
.
stable asthe transvenous approach, and is limited by the need for .. 11.4 Peri-operative management in
.
continuoussedation.783Thismodalityshouldonlybeusedinemer- ..
patients with cardiovascular implantable
.
gencysettingsorwhennootheroptionisavailable,andunderclose ...
electronic devices
haemodynamic monitoring.784 Before starting temporary pacing, ..
.. AdvisorydocumentstohelpmanagepatientswithCIEDsintheperi-
chronotropicmedicationshouldbeconsidered,takingintoaccount .
.. operative period have been issued by several professional societ-
side effects, contraindications, and interactions with other .
.. ies.786(cid:2)789 Supplementary Table 24 summarizes general
medication. .
.. recommendationsonthemanagementofthesepatients.
This Task Force concludes that temporary transvenous pacing .
.
.
should be avoided if possible; when it is required, the lead should .. • Electromagnetic interference (EMI) may induce oversensing
.
remaininsituforasshortatimeaspossible.Theuseoftemporary .. (more likely with unipolar leads), activation of rate-responsive
.
pacingshouldbelimitedtotheemergencytreatmentofpatientswith .. sensors,deviceresetting,orotherdamage.Themostcommon
.
severebradyarrhythmiacausingsyncopeand/orhaemodynamiccom- .. sourceofEMIiselectrocautery,althoughitisrareduringbipolar
. promise, and to cases in whom those bradyarrhythmias are antici- .. electrocautery>5 cm fromtheCIED and monopolarelectro-
.
pated.Temporarytransvenouspacingisrecommendedwhenpacing .. cautery below the umbilicus.790 To reduce the risk of EMI,
.
indications are reversible, such as in the context of antiarrhythmic .. monopolar electrocautery should be applied in short (<5 s)
.
druguse,myocardialischaemia,myocarditis,electrolytedisturbances, .. pulses,withtheskinpatchesawayfromtheareaofthedevice.
.
toxic exposure, after cardiac surgery, or as a bridge to permanent .. OthersourcesofEMIincluderadiofrequencyprocedures,nerve
.
pacemaker implantation when this procedure is not immediately .. stimulators,andotherelectronicdevices.
.
availableorpossibleduetoconcomitantinfection.Lastly,ifapatient .. • Theperi-operativestrategyshouldbetailoredbasedontheindi-
.
meets the permanent pacemaker implantation criteria, this proce- .. vidual needs and values of patients, procedure, and
.
dureshouldbeperformedpromptly. .. device.786(cid:2)789 Most procedures will not require any interven-
.
.. tion.791 In pacemaker-dependent patients, a magnet should be
.
.
. appliedduringdeliveryofdiathermypulses,or,ifEMIislikelyto
Recommendationsregardingtemporarycardiacpacing ..
. occur or magnet stability cannot be guaranteed, the device
.
.
Recommendations Classa Levelb .. should be reprogrammed to an asynchronous mode (VOO/
.
. DOO).Theresponsetomagnetapplicationmaydifferbetween
.
Temporarytransvenouspacingisrecommended .. device manufactures. CIEDs with a rate-responsive function
.
incasesofhaemodynamic-compromisingbra- .. using an active sensor may also require magnet application or
I C .
dyarrhythmiarefractorytointravenouschrono- .. disablingofthisfunctiontopreventinappropriaterapidpacing.
.
tropicdrugs.764,765 ..
Post-operativeCIEDinterrogationisrecommendedifmalfunc-
.
.
Transcutaneouspacingshouldbeconsideredin . tion is suspected or if the device has been exposed to strong
.
.
casesofhaemodynamic-compromisingbradyar-
IIa C
... EMI.
rhythmiawhentemporarytransvenouspacingis .
.
notpossibleoravailable.783(cid:2)785 ...
11.5 Cardiovascular implantable
.
Temporarytransvenouspacingshouldbecon- .. electronic devices and sports activity
.
sideredwhenimmediatepacingisindicatedand ..
. Regularexerciseisstronglyrecommendedforpreventionofcardio-
pacingindicationsareexpectedtobereversible,
IIa C
...
vascular disease.792(cid:2)795 Restrictions to patients with a pacemaker,
suchasinthecontextofmyocardialischaemia, ..
. whereappropriate,aremotivatedbyunderlyingcardiovasculardis-
myocarditis,electrolytedisturbances,toxic ..
. ease. Therefore, it is important to address issues of exercise and exposure,oraftercardiacsurgery.771(cid:2)773 ..
. sportsparticipationwithallpacemakerpatientsaspartofashared
.
Temporarytransvenouspacingshouldbecon- .
. decision-making process. Comprehensive recommendations for
.
sideredasabridgetopermanentpacemaker .
. physical activity in patients with cardiovascular disease have been
.
implantationwhenthisprocedureisnotimmedi- IIa C .. published.792,796
.
atelyavailableorpossibleduetoconcomitant .
infection.771(cid:2)773
... Thereisconsensusthatcontactsports(e.g.rugbyormartialarts)
.. shouldbeavoidedsoasnottoriskdamageofdevicecomponentsor
Forlong-termtemporarytransvenouspacing,an ...
haematomaattheimplantationsite.Forparticipationinsportssuch
activefixationleadinsertedthroughtheskinand IIa C ... asfootball,basketball,orbaseball,specialprotectiveshieldsarerec-
connectedtoanexternalpacemakershouldbe ...
ommendedtoreducetheriskoftraumatothedevice.Sportinter-
considered.641,776,777,779 ...
ests and right or left arm dominance should be considered when
.
aClassofrecommendation. ... selecting the implantation site, and submuscular placement can be
bLevelofevidence. . consideredtoreducetheriskofimpact.Alateralvascularaccessis
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 62 ---
62 ESCGuidelines
.
.
preferabletopreventtheriskofsubclaviancrushoftheleadassoci- . thedeviceshouldbetreatedasasingleentity,withprogrammingtail-
.
.
atedwitharmexercisesaboveshoulderlevel.Itisrecommendedto . oredtomeetthepatient’sneeds.Thegoalsareto(i)ensurepatient
.
.
abstainfromvigorousexerciseandipsilateralarmexercisefor4(cid:2)6 . safety;(ii)providephysiologicalpacing;(iii)improvepatientqualityof
.
.
weekspost-deviceimplantation. . life;(iv)improvepatientclinicalmanagement;and(v)maximizedevice
.
.
Of note, recommendations regarding sports activity in patients . longevity.Requirementforfollow-upoftheunderlyingcardiacdisease
.
withanICDdifferfromthoseinpacemakerpatients.797,798 .. shouldnotbeoverlooked.Inadditiontothetechnicalcheckandopti-
.
.
. mizationofprogramming,propercounsellingofthepatientandhis/her
.
.
. familyarenecessarytomeetthesegoals.Thefrequencyoffollow-up
.
11.6 When pacing is no longer indicated .
. depends on the type of device (CRT and HBP are associated with
.
.
Different management options are available in patients with . more clinical or technical issues and need closer surveillance) and
.
.
implantedpacemakersystemsinwhompacingisnolongerindicated: .. whethertheyareonremotedevicemanagement(Table13).
.
.
.
Leavepacemakergeneratorandpacemakerleadsinsitu. . • Remote devicemanagementincludes remotefollow-upwith full .
.
Explantpacemakergeneratorandabandonleads. . remote device interrogation at scheduled intervals (to replace
.
.
Explantpacemakergeneratorandleads. . in-officevisits),remotemonitoringwithunscheduledtransmission
.
.
Thefeasibilityofoption1dependsontheend-of-lifebehaviourof . of pre-defined alert events, and patient-initiated follow-up with
.
.
theimplantedgenerator,whichismanufacturerdependent,andmay . unscheduledinterrogationsasaresultofapatientexperiencinga .
beerraticandleadtocomplicationsinrarecases.799Option1isthe .. real or perceived clinical event. Most studies have focused on
.
.
preferredapproachtoselectedfrailandelderlypatients. .. patients with ICDs and CRT-Ds, and have shown a significant
.
Option2comeswithalowproceduralriskbutmaybeassociated .. reductionindelaybetweeneventdetection/clinicaldecision,and
.
with the disadvantages of lead abandonment, including future MRI. .. fewerinappropriateshocks.804Tworandomizednon-inferiority
.
Especiallyinyoungpatients,thepotentialnecessaryfuturerequire- .. trials with single-chamber805 or DDD805,806 pacemakers (no
.
mentforleadextractionofabandonedleadsduetoinfectionandthe .. CRT-P) showed that in-office visits can be safely spaced to
.
associatedelevatedproceduralriskduetolongerdurationofimplan- .. 18(cid:2)24 month intervals if patients are on remote monitoring
.
tationprocedureneedtobetakenintoaccount.Severalstudieshave .. with deviceshaving automatic thresholdalgorithms.Spacing of
.
shown increased complexity,lowerproceduralsuccess,and higher .. scheduled in-office visits is particularly convenient for elderly
.
complication rates of lead extraction procedures of abandoned .. patientswithlimitedmobility,butalsoforyoungormidlle-aged
.
leads.800(cid:2)803 .. patientswithfull-timejobs,familycommitments,etc.,andinspe-
.
Option3comeswiththehighestinitialproceduralrisk,butelimi- .. cificsituations(e.g.toavoidexposureduringapandemic).
.
nates all possibilities of future device-related complications. When .. • Itisimportanttoconductremotedevicemanagementwithan
.
performed in specialized high-volume centres with current extrac- .. appropriate set-up that delivers a structured approach to
.
tiontools,leadextractionprocedurescanbecarriedoutwithhigh .. remote follow-up and a timely response to alerts. Third-party
.
complete procedural success rates and low complication rates.802 .. providers can be useful to triage alerts and assist with this
.
This approachmaybe appropriate forthecombinationofayoung .. task.807 Importantly, compliance with the General Data
.
patient,lowriskforextraction,andanexperiencedextractor. .. Protection Regulation should be respected, as outlined in a
.
Aspartofapatient-centredapproach,thedecisioninsuchsitua- .. recentESCregulatoryaffairs/EHRAdocument.808
..
..
tionshastobebasedonanindividualrisk(cid:2)benefitanalysisinashared ..
. .
decision-makingprocesstogetherwiththepatientandhis/hercarers. .
.
.
Thisincludesprovidingsufficientinformationtoachieveaninformed .
.. Table13 Frequencyoffollow-upforroutinepacemaker
decision-making. Important factors to take into consideration are .. andcardiacresynchronizationtherapy,eitherinperson
.
patientage,patientcondition,comorbidities,pacemakersystem,lead .. aloneorcombinedwithremotedevicemanagement
.
implantduration,andthepatient’slifeexpectancy. ..
. In-officeonly In-office1remote
.
.
Recommendationwhenpacingisnolongerindicated .. Alldevices Within72hand In-officewithin72hand
.
. 2(cid:2)12weeksafter 2(cid:2)12weeksafter
.
.
Recommendation Classa Levelb .. implantation implantation
.
.. CRT-Por Every6months Remoteevery6monthsand
Whenpacingisnolongerindicated,thedecision .
.. HBP in-officeevery12monthsa
onmanagementstrategyshouldbebasedonan .
I C .. Single/dual- Every12monthsthenevery Remoteevery6monthsand
individualrisk(cid:2)benefitanalysisinashareddeci- . .
. chamber 3-6monthsatsignsofbat- in-officeevery18-24
sion-makingprocesstogetherwiththepatient. . .. terydepletion monthsa
.
aClassofrecommendation. ...
CRT-P = cardiac resynchronization therapy-pacemaker; HBP = His bundle
bLevelofevidence. .
. pacing.
.
.. aRemotefollow-upcanonlyreplacein-officevisitsifautomaticcapturethreshold
.. algorithmsperformaccurately(andarepreviouslyverifiedin-office).
.
11.7 Device follow-up . Note:additionalin-officefollow-upmayberequired(e.g.toverifytheclinical
.
. effectofmodificationofprogramming,orforfollow-upatechnicalissue).
Generalprinciplesoffollow-uparecoveredhere,asin-depthrecom- ...
Remote monitoring (i.e. of pre-defined alerts) should be implemented in all
mendationsarebeyondthescopeofthisdocument.Thepatientand .. instancesalongwithremotefollow-ups.
1202
CSE 1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 63 ---
ESCGuidelines 63
.
Recommendationsforpacemakerandcardiacresynch-
... patienttomakeabalanceddecision.824(cid:2)826Choosingtheappropri-
ronizationtherapy-pacemakerfollow-up .. ate educational material is an important component of promoting
.
.. thelearningprocessofpatients.827(cid:2)830Basedonthepatient’sneeds
.
Recommendations Classa Levelb .. andpreferences,theeducationshouldbeperformedbeforeimplan-
.
.
. tation, at discharge, and during follow-up using a person-centred
Remotedevicemanagementisrecommendedto .
.
. approach(Table14).Allpatientsshouldreceiveabrochureprovided
reducethenumberofin-officefollow-upsin ..
. by the manufacturer as well as a device identification card before
patientswithpacemakerswhohavedifficulties
I A
...
discharge.
toattendin-officevisits(e.g.duetoreduced ..
. This Task Force emphasizes the importance of patient-centred
mobilityorothercommitments,oraccordingto ..
. careandshareddecision-makingbetweenpatientsandclinicians.The
patientpreference).805,806,809 ..
. decisiontoimplantapacemaker/CRTshouldbebasedonthebest
.
Remotemonitoringisrecommendedinthecase .
. availableevidencewithconsiderationoftheindividualrisk(cid:2)benefits
.
ofadevicecomponentthathasbeenrecalledor . . ofeachoption,thepatient’spreferences,andgoalsofcare.Thecon-
.
isonadvisory,toenableearlydetectionof .
I C .. sultationshouldincludewhetherthepatientisagoodcandidatefor
actionableeventsinpatients,particularlythose .
. pacemaker/CRT treatment, and possible alternative treatment
.
whoareatincreasedrisk(e.g.inthecaseof .
.. options should be discussed in a way that can be understood by
pacemakerdependency). .
.. everyone involved in the discussion. Using theprinciples of shared
In-officeroutinefollow-upofsingle-anddual- ...
decision-making and informed consent/refusal, patients with
chamberpacemakersmaybespacedbyupto24
IIa A
...
decision-makingcapacityhavetherighttorefusepacemakertherapy,
monthsinpatientsonremotedevice ...
eveniftheyarepacemakerdependent.
management.805,806 ..
.
Remotedevicemanagementofpacemakers
..
.
shouldbeconsideredinordertoprovideearlier
.. Recommendationregardingpatient-centredcareand
.
. shareddecision-makingincardiacpacingandcardiac
detectionofclinicalproblems(e.g.arrhythmias) IIa B .
.. resynchronizationtherapy
ortechnicalissues(e.g.leadfailureorbattery ..
.
depletion).806,810 .. Recommendation Classa Levelb
.
.
aClassofrecommendation. ...
InpatientsconsideredforpacemakerorCRT,
bLevelofevidence. ...
thedecisionshouldbebasedonthebestavail-
.
.. ableevidencewithconsiderationofindividual
.
.
. risk(cid:2)benefitsofeachoption,thepatient’spref-
12 Patient-centred care and ...
erences,andgoalsofcare,anditisrecom- I C
.
.
shared decision-making in cardiac . mendedtofollowanintegratedcareapproach
.
. . andusetheprinciplesofpatient-centredcare
pacing and cardiac ..
. andshareddecision-makinginthe
.
resynchronization therapy .. consultation.831(cid:2)836
.
.
.
.. CRT=cardiacresynchronizationtherapy.
Providingpatient-centredcareisaholisticprocessthatemphasizes .. aClassofrecommendation.
.
partnershipsinhealthbetweenpatientandclinician,acknowledging .. bLevelofevidence.
.
the patient’s needs, beliefs, expectations, healthcare preferences, . .
goals, and values.811(cid:2)813 In patient-centred care, the focus is on .. .
.
shared decision-making, accepting that patients generally prefer to . .
.
take an active role in decisions about their health.814,815 This .
.
.
approachhasbeenshowntoimprovehealthoutcomesandhealth- .. 13 Quality indicators
.
careexperiences.814,816Clinicianshaveadutytodefineandexplain ..
.
thehealthcareproblemandmakerecommendationsaboutthebest .. Qualityindicatorsaretoolsthatmaybeusedtoevaluatecarequality,
.
availableevidenceacrossallavailableoptionsatthetime,includingno .. including that of processes of care and clinical outcomes.837 They
.
treatment,while ensuringthat thepatient’s values and preferences .. mayalsoserveasamechanismforenhancingadherencetoguideline
.
areconsidered(Figure16).817(cid:2)820 ..
recommendationsthroughqualityassuranceendeavoursandbench-
.
Decisionaids,suchaswritteninformationand/ortheuseofinter- .. markingofcareproviders.838Assuch,theroleofqualityindicatorsin
.
activewebsitesorweb-basedapplications,cancomplementtheclini- .. driving quality improvement is increasingly recognized and attracts
.
cians’counsellingandthusfacilitateshareddecision-making.822When ..
interest from healthcare authorities, professional organizations,
.
decisionaidsareused,patientsfeelmoreknowledgeable,havemore .. payers,andthepublic.839
.
accurate risk perceptions, and take a more activepart in the deci- .. TheESCrecognizestheneedformeasuringandreportingquality
.
sion.823Inpatientswithpoorlanguageorliteracyskills,aswellasin ..
andoutcomesofcardiovascularcare.Oneaspectofthisisthedevel-
.
.
thosewithcognitiveimpairment,communicationstrategies,including . opmentandimplementationofqualityindicatorsforcardiovascular
.
.
thehelpofaqualifiedinterpreter,isrecommended,asthishelpsthe .. disease. The methodology by which the ESC quality indicators are
1202
CSE
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 64 ---
64 ESCGuidelines
Seek the patient’s participation
Define and explain the healthcare problem and communicate that a choice exists. Discuss possible
alternative treatment options, including that patients with decision-making capacity have the right
to refuse PM/CRT therapy,even if the patient is pacemaker dependent.
The consultation should be discussed in a way that can be understood by everyone involved
in the discussion.
Encourage the patient to become involved in the consultation and invite family to participate.
Help the patient explore and compare treatment options
Provide an overview of the implantation process, and address all aspects of how the device works
and the conditions it treats.
Discuss the benefits and risks with each option, including potential complications and
treatment refusal.
Access the patient’s values and preferences
Supplement the counselling with different decision aids to facilitate SDM. In patients with poor
language skills, cognitive impairment, or low health literacy, a variety of communication strategies
should be used in order for the patient to make a deliberate decision.
Take into account the patient´s preferences and goals of care, and what matters most to the patient.
Reach a decision with the patient
Make evidence based recommendations with consideration of individual risk-benefits of each option,
while ensuring that the patient's beliefs, expectations, values,goals, and preferences are considered.
Decide together on the best available option.
Evaluate the patient’s decision
Evaluate if the decision is reasonable and understood.
Based on the patient´s needs and preferences, the education should be repeated prior discharge,
and at the follow-up appointments using a person centred approach.
Figure 16 Exampleofshareddecision-makinginpatientsconsideredforpacemaker/CRTimplantation.ModifiedfromtheprinciplesoftheSHARE
Approach.821CRT=Cardiacresynchronizationtherapy;PM=pacemaker;SDM=SharedDecisionMaking.
Table14 Topicsandcontentthatmaybeincludedinpatienteducation
Topics Contentthatmaybeincludedinpatienteducation
Biophysiological Disease/condition,pacemakerindication,implantationprocess,possibleperiproceduralorlatecomplicationsandmalfunction,
pacemaker/CRTfunctionandtechnicalaspects,patientnotifier(ifapplicable),batteryreplacement
Demonstrationofpacemakerdummies
Functional Dailyactivities:mobility,physicalactivitiesandsports,possiblephysicalrestrictions(armmovements),sexualactivities,driving
restrictions,travelling,woundcare,medicationuse
Normalpostoperativesignsandsymptomsandself-care;pain,stiffnessintheshoulder,swellingortendernessaroundthe
pacemakerpocket
Financial Costsoftreatmentandrightsinthesocialsecuritysystem,insuranceissues,sickleave
Emotional Possibleemotionsandreactionstopacemakertreatment:anxiety,worries,bodyimage
Social Availablesupport:telephone-basedsupport,face-to-facegroupsessions,patientforums,andpeer-supportgroups
Possibleemploymentrestrictionsandelectromagneticinterference
Ethical Rightsanddutiesofpatientsandhealthcareproviders:consent/refusalofpacemakerorCRTtherapy,orwithdrawal
oftherapy
Informationaboutregistrationinthenationalpacemakerregistry
Practical Pacemakeridentificationcardcontactinformationtothepacemakerclinic
Follow-uproutines:remotelyor/andhospitalbased
Wheretogetmoreinformation:reliableweb-basedinformation/sources,whichorganizationsprovidereliablehealth
information
CRT=cardiacresynchronizationtherapy.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 65 ---
ESCGuidelines 65
Table15 Aselectionofthedevelopedqualityindicatorsforpatientsundergoingcardiovascularimplantableelectronic
deviceimplantation
Qualityindicator Domain
CentresprovidingCIEDservicesshouldparticipateinatleastoneCIEDregistry Structuralqualityindicatora
Numerator:NumberofcentresparticipatinginatleastoneregistryforCIED
CentresprovidingCIEDservicesshouldmonitorandreportthevolumeofproceduresperformedbyindivid- Structuralqualityindicator
ualoperatorsonanannualbasis
Numerator:Numberofcentresmonitoringandreportingthevolumeofproceduresperformedbyindividualoperators
CentresprovidingCIEDservicesshouldhaveavailableresources(ambulatoryECGmonitoring,echocardio- Structuralqualityindicator
gram)tostratifypatientsaccordingtotheirriskforventriculararrhythmias
Numerator:NumberofcentreswithanavailableambulatoryECGandechocardiogramservice
CentresprovidingCIEDservicesshouldhaveapreproceduralchecklisttoensurediscussionwiththepatient Structuralqualityindicator
regardingrisks,benefits,andalternativetreatmentoptions
Numerator:Numberofcentresthathaveachecklisttoensurediscussionwithpatientregardingrisks,benefits,andalternativetreatmentoptionsbefore
CIEDimplantation
CentresprovidingCIEDservicesshouldhaveestablishedprotocolstofollow-uppatientswithin2-12weeks Structuralqualityindicator
followingimplantation
Numerator:Numberofcentresthathaveanestablishedprotocoltofollowuppatientswithin2-12weeksfollowingCIEDimplantation
ProportionofpatientsconsideredforCIEDimplantationwhoreceiveprophylacticantibiotics1hbeforetheir Patientassessment
procedure
Numerator:Numberofpatientswhoreceiveantibiotics1hbeforetheirCIEDimplantationprocedure
Denominator:NumberofpatientsundergoingCIEDimplantationprocedure
Annualrateofproceduralcomplicationsb30daysfollowingCIEDimplantation Outcomes
Numerator:Numberofpatientswhodeveloponeormoreproceduralcomplicationsbwithin30daysofCIEDimplantation
Denominator:NumberofpatientsundergoingCIEDimplantationprocedure
CIED=cardiovascularimplantableelectronicdevice;ECG=electrocardiogram.
aStructuralqualityindicatorsarebinarymeasurements(yes/no),andthusonlythenumeratorisdefined.
bCIED-relatedbleeding,pneumothorax,cardiacperforation,tamponade,pockethaematoma,leaddisplacement(allrequiringintervention),orinfection.
.
developedhasbeenpublished.839Todate,asuiteofqualityindicators .. 14 Key messages
.
.
for an initial tranche of cardiovascular conditions has been pro- .
.
duced.839,840Tofacilitatequalityimprovementinitiatives,thedisease- ..
.. • Intheevaluationofcandidatesforpermanentpacemakerimplan-
specific ESC quality indicators are included in corresponding ESC .
ClinicalPracticeGuidelines.296,841Thisisfurtherenhancedbywayof
... tation,athoroughanddetailedpre-operativeevaluationisrec-
.. ommended.Thisshouldalwaysincludecarefulhistorytakingand
theirintegrationintheESCregistries,suchastheEurObservational .
.. physical examination, laboratory testing, documentation of the
Research Programme (EORP) and the European Unified Registries ...
typeofbradyarrhythmiarequiringtreatment,andcardiacimag-
On Heart Care Evaluation and Randomized Trials (EuroHeart) ...
ing.Inselectedcases,additionaltests,EPS,and/orgenetictesting
project.842 ...
areindicated.
AnumberofregistriesexistforpatientsundergoingCIEDimplan- ...
• Ambulatory ECG monitoring is useful in the evaluation of
tation,843providing‘real-world’dataaboutthequalityandoutcomes ...
patientswithsuspectedbradycardiaorcardiacconductiondisor-
ofCIEDcare.702However,thereisalackofawidelyagreedsetof ...
der,tocorrelaterhythmdisturbanceswithsymptoms.Choiceof
qualityindicatorsthatencompassesthemultifacetednatureofCIED ...
typeofmonitoringshouldbebasedonfrequencyandnatureof
care, and that serves as a bridge between clinical registries and ...
symptomsandpatientpreferences.
guidelinerecommendations.Thus,andinparallelwiththewritingof ...
• In patients with SND including those with bradycar-
theseguidelines,asuiteofqualityindicatorsforpatientsundergoing ...
dia(cid:2)tachycardia type of SND, when symptoms can clearly be
CIEDimplantationwasdeveloped.Thefulllistofthesequalityindica- ...
attributedtobradyarrhythmia,cardiacpacingisindicated.
tors, as well as their specifications and development methodology, ... • In patients with SR and permanent or paroxysmal third- or
has been published elsewhere,844 with a selection presented in ... second-degreetype2orhigh-degreeAVB,cardiacpacingisindi-
.
Table15. .. catedirrespectiveofsymptoms.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 66 ---
66 ESCGuidelines
.
• In patients with permanent AF and permanent or paroxysmal .. chlorhexidine(cid:2)alcohol should be preferred for skin antisepsis,
.
AVB,single-leadventricularpacingisindicated. .. andcephalicoraxillaryveinaccessshouldbeattemptedasfirst
.
• In patients with syncope and unexplained falls, the diagnosis .. choice.
.
should be ascertained using the available diagnostic methods .. • HeparinbridgingshouldbeavoidedinCIEDprocedurestomini-
.
beforepacemakertreatmentisconsidered. .. mizetheriskofhaematomaandpocketinfection.
.
• InpatientswithsymptomaticHFandLVEF<_35%despiteOMT .. • Inpatients undergoinga CIED reinterventionprocedure, using
.
whoareinSRandhaveLBBBQRSmorphology,CRTisrecom- .. anantibiotic-elutingenvelopemaybeconsideredtoreducethe
.
mendedwhenQRSdurationis>_150ms,andshouldbeconsid- .. riskofinfection.
.
eredwhenQRSdurationis130(cid:2)149ms.Forpatientswithnon- .. • In the majority of patients with a pacemaker or CRT, a well-
.
LBBBQRSmorphology,evidenceforbenefitofCRTislesscon- .. indicated MRI can be performed if no epicardial leads, aban-
.
vincing,especiallywithnormalPRandQRSduration<150ms. .. doned or damaged leads, or lead adaptors/extenders are
.
CRTshouldnotbeusedinpatientswithHFandQRSduration .. present,andcertainprecautionsaretaken.
.
<130ms,unlessthereisneedforventricularpacing. .. • Radiationtherapycanbeofferedtopatientswithapacemaker
.
• SelectionofpatientsforCRTbasedonimagingislimitedtothe .. orCRTifanindividualizedtreatmentplanningandriskstratifica-
.
measurementofLVEF,whereastheassessmentofotherfactors, .. tionisdonebeforehandandthedeviceisinterrogatedasrecom-
.
suchasextentofmyocardialscar,presenceofmitralregurgita- .. mendedaroundtheperiodofradiationtherapy.
.
tion,orRVsystolicfunction,isimportanttoanticipatepotential .. • Remotedevicemanagementisvaluableforearlierdetectionof
.
non-responderswhomayneedadditionaltreatments(e.g.mitral .. clinicalproblemsandtechnicalissues,andmayallowlongerspac-
.
valveintervention). .. ingbetweenin-officefollow-ups.
.
• In patients with permanent AF, symptomatic HF, LVEF <_35%, .. • The principles of patient-centred care and shared decision-
.
andQRS>_130mswhoremaininNYHAclassIIIorambulatory .. makingshouldbeusedintheconsultationbothpre-operatively
.
IVdespiteOMT,CRTshouldbeconsidered. .. andduringfollow-upforpatientsconsideredfororlivingwitha
.
• ForpatientswithAFandCRT,AVJablationshouldbeconsid- .. pacemakerorCRT.
.
eredwhenatleast90(cid:2)95%effectivebiventricularpacingcannot ..
.
.
beachieved. .
.
• Forpatientswithhigh-degreeAVBandanindicationforcardiac ..
. 15 Gaps in evidence
pacingwhohaveHFrEF(LVEF<40%),CRTratherthanRVpac- ..
.
ingisrecommended. ..
• HBPmayresultinnormalornear-normalventricularactivation,
... CliniciansresponsibleformanagingpacemakerandCRTcandidates,
and is an attractive alternative to RV pacing. To date, no data
... and patients, must frequently make treatment decisions without
fromrandomizedtrialssupportthatHBPisnon-inferiortoRV
... adequateevidenceorconsensusofexpertopinion.Thefollowingisa
pacingwithrespecttosafetyandefficacy.Therefore,HBPmay
... shortlistofselected,commonissuesthatdeservetobeaddressedin
beconsideredforselectedpatientswithAVBandLVEF>40%,
... futureclinicalresearch.
.
.
whoareanticipatedtohave>20%ventricularpacing. . • Bestpre-implantevaluationprogramme,includingwhentoapply
.
• In patients offered HBP, implantation of an RV lead used as .. advancedimagingmethodstoensureoptimalchoiceofCIEDfor
.
‘backup’forpacingshouldbeconsideredindividually. .. eachpatient.
.
• HBPmaycorrectventricularconductioninasubsetofpatients .. • Benefit of implementing genetic testing of CIED patients and
. withLBBBandmaythereforebeusedinlieuofbiventricularpac- .. theirrelativeswhenconductiontissuediseaseisdiagnosed.
.
ingforHBP-basedCRTinselectedpatients. .. • Whether use of rate-adaptive pacing in general is beneficial in
.
• In patients treated with HBP, device programming tailored to .. patientswithSND. .
specificrequirementsofHBPmustbeensured. .. • WhethercatheterablationofAFwithoutpacemakerimplanta- .
• Implantingaleadlesspacemakershouldbeconsideredwhenno .. tionisnon-inferiortopacemakerimplantationwithrespectto
.
upper extremity venous access exists, when risk of device .. freedom from bradycardia-related symptoms in patients with
.
pocket infection is particularly increased, and in patients on .. symptomaticconversionpausesafterAF.
.
haemodialysis. .. • Inpatientswithreflexsyncope,studiesofwhichpacingmodeis
.
• Patients undergoing TAVI are at increased risk of developing .. superiorareneeded.
.
AVB. Decisions regarding cardiac pacing after TAVI should be .. • InpatientswithanindicationforVVIpacing,thelong-termeffi-
.
takenbaseduponpre-existingandnewconductiondisturbances. .. cacy and safety of choosing leadless pacing need to be docu-
.
AmbulatoryECGmonitoringfor7(cid:2)30daysorEPSmaybecon- .. mentedinRCTs.
.
sideredinpatientspost-TAVIwithnewLBBBorprogressionof .. • InpatientswithHF,itremainstobeshownthatCRTimproves
.
pre-existingconductionanomaly,butnotyetanyindicationfora .. outcomeinpatientswithoutLBBB.
.
pacemaker. .. • Inpatientswithpermanent/persistentAF,HF,andBBB,anyben-
.
• Inpatientsundergoingsurgeryforendocarditisortricuspidvalve .. eficialeffectsofCRTremaintobeproveninRCTs.
.
surgerywhohaveordevelopAVBundersurgery,placementof .. • There is a lack of RCTs documenting the effect of CRT in
.
epicardialpacingleadsduringsurgeryshouldbeconsidered. .. patientswithHFtreatedwithnovelHFdrugsincludingsacubitril/
.
• To reduce the risk of complications, pre-operative anti- .. valsartan, ivabradine, and sodium(cid:2)glucose co-transporter-2
.
biotics must be administered before CIED procedures, . inhibitors.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 67 ---
ESCGuidelines 67
.
.
• ThebeneficialeffectsofupgradingtoCRTfromastandardpace- . • Insymptomaticpatientswithend-stageHCMandLBBB,thereis
.
.
makerorICDinpatientswithHFandahighfrequencyofRV . a need to better define the criteria for CRT implantation and
.
.
pacingneedtobedocumented. . documenttheclinicalfeaturesassociatedwithsustainedbenefit
.
.
• WhenimplantingtheLVelectrode,itisunknownwhethertar- . fromtheprocedure.
.
.
geting the latest local activation mechanically or electrically . • Optimal treatment including cardiac pacing for patients with
.
.
causesanimprovedeffectofCRTandabetterpatientoutcome. . congenitalAVBshouldbeinvestigated.
.
.
• Itisunknownwhetheremployinganytypeofpre-implantimag- . • In pacemaker candidates with cardiomyopathies with >1 year
.
.
ingtodecideaboutLVandRVleadplacementinCRTmaycause . expected survival who do not fulfil standard criteria for ICD
.
.
betterapatientoutcome. . implantation,criteriaforICDinsteadofpacemakerimplantation
.
.
• Inpatientswithanindicationforpermanentpacingandneedfor . shouldbebetterdefined.
.
.
ahighfrequencyofRVpacingbecauseofAVB,itisnotknown . • The optimal pre-operative handling in CIED implantations and
.
.
whichpatientandtreatmentcharacteristicspredictdevelopment . potential use of pre-operative skin disinfection and/or pre-
.
. ofpacing-inducedcardiomyopathyorHF. . hospitalizationdecolonizationinS.aureuscarriersremainstobe
.
.
• In patients with AVB and an indication for cardiac pacing, the . determined.
.
.
long-termefficacyandsafetyofHBPasanalternativetoRVpac- . • The optimal approach for the different operational procedure
.
.
ing need to be proven in RCTs. In addition, the selection of . elementsinCIEDimplantations,especiallyforchoiceofvenous
.
. patientsmostlikelytobenefitfromHBPisnotyetdefined. . access,active orpassive fixation leads in right-sided chambers,
.
• InpatientswithHFandanindicationforCRT,thelong-termeffi- .. specific pacing sites, use of haemostatic agents in the pocket,
.
.
cacyandsafetyofimplementingHBPasanalternativetoorele- . choice of suture types, and application ofpressure dressing at
.
.
ment of CRT with biventricular pacing need to be proven in . theendoftheprocedureremainstobedetermined.
.
.
RCTs. In addition, the selection of CRT candidates who are . • Patients with a need forimmediate cardiacpacing occasionally
.
.
mostlikelytobenefitfromHBPisnotyetdefined. . present with fever and infection; typically, treatment includes
.
.
• FurtherstudiesareneededtodeterminewhetherHBPcouldbe . temporary transvenous pacing and antibiotics, followed by
.
.
usedtoimproveresponseinCRTnon-responders. . implantationofapermanentpacemakeraftertheinfectionhas
.
• Theefficacyandsafetyofleftbundlebranchareapacingremain .. resolved. It is unknown whether immediate implantation of a
.
.
tobedocumented. . permanent pacemaker after initiation of antibiotics would be
.
• SuperiorityofaspecificlocationfortheRVlead(i.e.septal,out- .. inferior.
.
flowtract,orapical)hasnotbeendocumentedforstandardpac- .. • Theroleofpatienteducation,patient-centredcare,andshared
.
ingindicatedforbradycardiaorforCRT. .. decision-makingshouldbestudiedinCIEDpopulations.
.
• BetterpredictionofwhowilldevelopAVBafterTAVIisneeded. .
16 ‘What to do’ and ‘what not to do’ messages from the Guidelines
Recommendations Classa Levelb
............ ............
Evaluationofthepatientwithsuspectedordocumentedbradycardiaorconductionsystemdisease
Monitoring
AmbulatoryECGmonitoringisrecommendedintheevaluationofpatientswithsuspectedbradycardiatocorrelaterhythm I C
disturbanceswithsymptoms.
Carotidmassage
Oncecarotidstenosisisruledout,cCSMisrecommendedinpatientswithsyncopeofunknownorigincompatiblewitha
I B
reflexmechanismorwithsymptomsrelatedtopressure/manipulationofthecarotidsinusarea.
Exercisetest
Exercisetestingisrecommendedinpatientswhoexperiencesymptomssuspiciousofbradycardiaduringorimmediatelyafter
I C
exertion.
Imaging
Cardiacimagingisrecommendedinpatientswithsuspectedordocumentedsymptomaticbradycardiatoevaluatethepres-
enceofstructuralheartdisease,todetermineLVsystolicfunction,andtodiagnosepotentialcausesofconduction I C
disturbances.
Laboratorytests
Inadditiontopre-implantlaboratorytests,dspecificlaboratorytestsarerecommendedinpatientswithclinicalsuspicionfor
potentialcausesofbradycardia(e.g.thyroidfunctiontests,Lymetitre,digitalislevel,potassium,calcium,andpH)todiagnose I C
andtreattheseconditions.
Continued
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 68 ---
68 ESCGuidelines
Sleepevaluation
ScreeningforSASisrecommendedinpatientswithsymptomsofSASandinthepresenceofseverebradycardiaoradvanced
I C
AVBduringsleep.
Recommendationforimplantablelooprecorder
Inpatientswithinfrequent(lessthanonceamonth)unexplainedsyncopeorothersymptomssuspectedtobecausedbybra-
dycardiainwhomacomprehensiveevaluationdidnotdemonstrateacause,long-termambulatorymonitoringwithanILRis I A
recommended.
Cardiacpacingforbradycardiaandconductionsystemdisease
InpatientswithSNDandaDDDpacemaker,minimizationofunnecessaryventricularpacingthroughprogrammingis
I A
recommended.
PacingisindicatedinSNDwhensymptomscanclearlybeattributedtobradyarrhythmias. I B
Pacingisindicatedinsymptomaticpatientswiththebradycardia(cid:2)tachycardiaformofSNDtocorrectbradyarrhythmiasand
I B
enablepharmacologicaltreatment,unlessablationofthetachyarrhythmiaispreferred.
PacingisnotrecommendedinpatientswithbradyarrhythmiasrelatedtoSNDwhichareasymptomaticorduetotransient
III C
causesthatcanbecorrectedandprevented.
PacingisindicatedinpatientsinSRwithpermanentorparoxysmalthird-orsecond-degreetype2,infranodal2:1,orhigh-
I C
degreeAVB,irrespectiveofsymptoms.e
Pacingisindicatedinpatientswithatrialarrhythmia(mainlyAF)andpermanentorparoxysmalthird-orhigh-degreeAVB,
I C
irrespectiveofsymptoms.
InpatientswithpermanentAFinneedofapacemaker,ventricularpacingwithrateresponsefunctionisrecommended. I C
PacingisnotrecommendedinpatientswithAVBduetotransientcausesthatcanbecorrectedandprevented. III C
Inpatientswithunexplainedsyncopeandbifascicularblock,apacemakerisindicatedinthepresenceofeitherabaselineHV
intervalof>_70ms,second-orthird-degreeintra-orinfra-Hisianblockduringincrementalatrialpacing,orabnormalresponse I B
topharmacologicalchallenge.
PacingisindicatedinpatientswithalternatingBBBwithorwithoutsymptoms. I C
PacingisnotrecommendedforasymptomaticBBBorbifascicularblock. III B
Recommendationsforpacingforreflexsyncope
Dual-chambercardiacpacingisindicatedtoreducerecurrentsyncopeinpatientsaged>40years,withsevere,unpredictable,
recurrentsyncopewhohave:
• spontaneousdocumentedsymptomaticasystolicpause(s)>3sorasymptomaticpause(s)>6sduetosinusarrestorAVB;
I A
or
• cardioinhibitorycarotidsinussyndrome;or
• asystolicsyncopeduringtilttesting.
Cardiacpacingisnotindicatedintheabsenceofadocumentedcardioinhibitoryreflex. III B
Pacingisnotrecommendedinpatientswithunexplainedfallsintheabsenceofanyotherdocumentedindication. III B
PacingisnotrecommendedinpatientswithunexplainedsyncopewithoutevidenceofSNDorconductiondisturbance. III C
CRT
CRTisrecommendedforsymptomaticpatientswithHFinSRwithLVEF<_35%,QRSduration>_150ms,andLBBBQRSmor-
I A
phologydespiteOMT,toimprovesymptomsandreducemorbidityandmortality.
CRTisnotindicatedinpatientswithHFandaQRSduration<130mswithoutindicationforRVpacing. III A
InpatientswithsymptomaticAFandanuncontrolledheartratewhoarecandidatesforAVJablation(irrespectiveofQRS
I B
duration),CRTisrecommendedinpatientswithHFrEF.
CRTratherthanRVpacingisrecommendedforpatientswithHFrEF(<40%)regardlessofNYHAclasswhohaveanindica-
I A
tionforventricularpacingandhigh-degreeAVBinordertoreducemorbidity.ThisincludespatientswithAF.
InpatientswhoarecandidatesforanICD,andwhohaveCRTindication,implantationofaCRT-Disrecommended. I A
RecommendationsforusingHisbundlepacing
InpatientstreatedwithHisbundlepacing,deviceprogrammingtailoredtospecificrequirementsofHisbundlepacingis
I C
recommended.
Pacinginacutemyocardialinfarction
Implantationofapermanentpacemakerisindicatedwiththesamerecommendationsasinageneralpopulation(section5.2)
I C
whenAVBdoesnotresolvewithinawaitingperiodofatleast5daysafterMI.
PacingisnotrecommendedifAVBresolvesafterrevascularizationorspontaneously. III B
Continued
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 69 ---
ESCGuidelines 69
Recommendationsforcardiacpacingaftercardiacsurgeryandhearttransplantation
High-degreeorcompleteAVBaftercardiacsurgery:aperiodofclinicalobservationofatleast5daysisindicatedtoassess
whethertherhythmdisturbanceistransientandresolves.However,thisobservationperiodcanbeshortenedinthecaseof I C
completeAVBwithlowornoescaperhythmwhenresolutionisunlikely.
Patientsrequiringpacingaftermechanicaltricuspidvalvereplacement:implantationofatransvalvularRVleadshouldbeavoided. III C
RecommendationsforcardiacpacingafterTAVI
Permanentpacingisrecommendedinpatientswithcompleteorhigh-degreeAVBthatpersistsfor24-48hafterTAVI. I B
Permanentpacingisrecommendedinpatientswithnew-onsetalternatingBBBafterTAVI. I C
ProphylacticpermanentpacemakerimplantationisnotindicatedbeforeTAVIinpatientswithRBBBandnoindicationforper-
III C
manentpacing.
Recommendationsforcardiacpacinginpatientswithcongenitalheartdisease
Inpatientswithcongenitalcompleteorhigh-degreeAVB,pacingisrecommendedifoneofthefollowingriskfactorsispresent:
i. Symptoms
ii. Pauses>3(cid:4)thecyclelengthoftheventricularescaperhythm
iii.BroadQRSescaperhythm I C
iv.ProlongedQTinterval
v. Complexventricularectopy
vi.Meandaytimeheartrate<50b.p.m.
Recommendationsforcardiacpacinginrarediseases
Inpatientswithneuromusculardiseasessuchasmyotonicdystrophytype1andanysecond-orthird-degreeAVBorHV>_70
I C
ms,withorwithoutsymptoms,permanentpacingisindicated.f
Recommendationsregardingdeviceimplantationsandperi-operativemanagement
Administrationofpre-operativeantibioticprophylaxiswithin1hofskinincisionisrecommendedtoreducetheriskofCIEDinfection. I A
Heparinbridgingofanticoagulatedpatientsisnotrecommended. III A
Permanentpacemakerimplantationisnotrecommendedinpatientswithfever.Pacemakerimplantationshouldbedelayed
III B
untilthepatienthasbeenafebrileforatleast24h.
Recommendationsforperformingmagneticresonanceimaginginpacemakerpatients
InpatientswithMRI-conditionalpacemakersystems,gMRIcanbeperformedsafelyfollowingthemanufacturer’sinstructions. I A
Recommendationsregardingtemporarycardiacpacing
Temporarytransvenouspacingisrecommendedincasesofhaemodynamic-compromisingbradyarrhythmiarefractoryto
I C
intravenouschronotropicdrugs.
Recommendationwhenpacingisnolongerindicated
Whenpacingisnolongerindicated,thedecisiononmanagementstrategyshouldbebasedonanindividualrisk(cid:2)benefitanal-
I C
ysisinashareddecision-makingprocesstogetherwiththepatient.
Recommendationsforpacemakerandcardiacresynchronizationtherapy-pacemakerfollow-up
Remotedevicemanagementisrecommendedtoreducethenumberofin-officefollow-upvisitsinpatientswithpacemakerswho
I A
havedifficultiesinattendingin-officevisits(e.g.duetoreducedmobilityorothercommitments,oraccordingtopatientpreference).
Remotemonitoringisrecommendedinthecaseofadevicecomponentthathasbeenrecalledorisonadvisory,toenableearly
I C
detectionofactionableeventsinpatients,particularlythosewhoareatincreasedrisk(e.g.incaseofpacemakerdependency).
Recommendationregardingpatient-centredcareincardiacpacingandcardiacresynchronizationtherapy
InpatientsconsideredforapacemakerorCRT,thedecisionshouldbebasedonthebestavailableevidencewithconsidera-
tionofindividualrisk(cid:2)benefitsofeachoption,thepatient’spreferences,andgoalsofcare,anditisrecommendedtofollow I C
anintegratedcareapproachandusetheprinciplesofpatient-centredcareandshareddecision-makingintheconsultation.
AF=atrialfibrillation;AVB=atrioventricularblock;AVJ=atrioventricularjunction;BBB=bundlebranchblock;b.p.m.=beatsperminute;CIED=cardiovascularimplantable
electronicdevice;CRT=cardiacresynchronizationtherapy;CRT-D=defibrillatorwithcardiacresynchronizationtherapy;CSM=carotidsinusmassage;DDD=dual-chamber,
atrioventricular pacing; ECG = electrocardiogram; EPS = electrophysiology study; HF = heart failure; HFrEF = heart failure with reduced ejection fraction; HV =
His(cid:2)ventricularinterval;ICD=implantablecardioverter-defibrillator;ILR=implantablelooprecorder;LBBB=leftbundlebranchblock;LV=leftventricular;LVEF=leftven-
tricularejectionfraction;MI=myocardialinfarction;MRI=magneticresonanceimaging;NYHA=NewYorkHeartAssociation;OMT=optimalmedicaltherapy;RBBB=right
bundlebranchblock;RV=rightventricular;SAS=sleepapnoeasyndrome;SND=sinusnodedysfunction;SR=sinusrhythm;TAVI=transcatheteraorticvalveimplantation.
aClassofrecommendation.
bLevelofevidence.
cCSMshouldnotbeundertakeninpatientswithprevioustransientischaemicattack,stroke,orknowncarotidstenosis.CarotidauscultationshouldbeperformedbeforeCSM.
Ifacarotidbruitispresent,carotidultrasoundshouldbeperformedtoexcludecarotiddisease.
dCompletebloodcounts,prothrombintime,partialthromboplastintime,serumcreatinine,andelectrolytes.
eInasymptomaticnarrowQRScomplexand2:1AVB,pacingmaybeavoidedifsupra-Hisianblockisclinicallysuspected(concomitantWenckebachisobservedandblockdisap-
pearswithexercise)ordemonstratedatEPS.
fWheneverpacingisindicatedinneuromusculardisease,CRToranimplantablecardioverter-defibrillatorshouldbeconsideredaccordingtorelevantguidelines.
gCombinationofMRIconditionalgeneratorandlead(s)fromthesamemanufacturer.
1202
CSE
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 70 ---
70 ESCGuidelines
.
17 Supplementary data .. Coordinator)(Sweden),MagdyAbdelhamid(Egypt),VictorAboyans
.
.
. (France),ElenaArbelo(Spain),RiccardoAsteggiano(Italy),Gonzalo
.
Supplementary data with additional Supplementary Figures, Tables, and .. Baro(cid:2)n-Esquivias (Spain), Johann Bauersachs (Germany), Mauro Biffi
.
text complementing the full text are available on the European Heart .. (Italy),UlrikaBirgersdotter-Green(UnitedStatesofAmerica),Maria
.
Journal website and via the ESC website at https://www.escardio.org/ .
. Grazia Bongiorni (Italy), Michael A. Borger (Germany), Jelena
.
guidelines. .. C(cid:3)elutkiene_ (Lithuania), Maja Cikes (Croatia), Jean-Claude Daubert
.
.
. (France), Inga Drossart (Belgium), Kenneth Ellenbogen (United
.
.
. StatesofAmerica),PerryM.Elliott(UnitedKingdom),LarissaFabritz
18 Author Information ..
.. (United Kingdom), Volkmar Falk (Germany), Laurent Fauchier
.
Author/Task Force Member Affiliations: Mads Brix
... (France), Francisco Fern(cid:2)andez-Avile´s (Spain), Dan Foldager
Kronborg,DepartmentofCardiology,AarhusUniversityHospital,
... (Denmark), Fredrik Gadler (Sweden), Pastora Gallego Garcia De
AarhusN,Denmark;YoavMichowitz,JesselsonIntegratedHeart
... Vinuesa (Spain), Bulent Gorenek (Turkey), Jose M. Guerra (Spain),
.. KristinaHermannHaugaa(Norway),JeroenHendriks(Netherlands),
Center, Faculty of Medicine, Hebrew University, Shaare Zedek .
.. Thomas Kahan (Sweden), Hugo A. Katus (Germany), Aleksandra
MedicalCenter,Jerusalem,Israel;AngeloAuricchio,Department .
.. Konradi (Russia), Konstantinos C. Koskinas (Switzerland), Hannah
of Cardiology, Istituto Cardiocentro Ticino, Lugano, Switzerland; .
.. Law(United Kingdom),BasilS.Lewis(Israel),NicholasJohnLinker
Israel Moshe Barbash, Leviev Heart Center, Sheba Medical . .. (United Kingdom), Maja-Lisa Løchen (Norway), Joost Lumens
Center,SacklerFacultyofMedicine,TelAvivUniversity,RamatGan, .
.. (Netherlands), Julia Mascherbauer (Austria), Wilfried Mullens
Israel;Jose´ A.Barrabe´s,DepartmentofCardiology,Valld’Hebron .
.. (Belgium), KlaudiaVivien Nagy (Hungary), Eva Prescott (Denmark),
HospitalUniversitari,UniversitatAutonomadeBarcelona,CIBERCV, .
.. Pekka Raatikainen (Finland), Amina Rakisheva (Kazakhstan), Tobias
Barcelona, Spain; Giuseppe Boriani, Cardiology Division, .
.
. Reichlin(Switzerland),RenatoPietroRicci(Italy),EvgenyShlyakhto
Department of Biomedical, Metabolic and Neural Sciences, .
.
. (Russia),MartaSitges(Spain),MiguelSousa-Uva(Portugal),Richard
University of Modena and Reggio Emilia, Modena, Italy; Frieder .
.
. Sutton(Monaco),PiotrSuwalski(Poland),JesperHastrupSvendsen
Braunschweig, Department of Cardiology, Karolinska University .
.
. (Denmark), Rhian M. Touyz (United Kingdom), Isabelle C. Van
Hospital, Stockholm, Sweden; Michele Brignole, Cardiology, ..
. Gelder (Netherlands), Kevin Vernooy (Netherlands), Johannes
IRCCS Istituto Auxologico Italiano, Milan, Italy; Haran Burri, ..
. Waltenberger (Germany), Zachary Whinnett (United Kingdom),
Cardiology, University Hospital of Geneva, Geneva, Switzerland; ..
. KlausK.Witte(UnitedKingdom).
Andrew J.S.Coats,FacultyofMedicine,UniversityofWarwick, ..
.
Coventry, United Kingdom; Jean-Claude Deharo, Cardiology La ..
. ESCNationalCardiacSocietiesactivelyinvolvedinthereview
Timone, Aix Marseille Universite´, Marseille, France; Victoria ..
. process ofthe 2021 ESC Guidelines on cardiacpacingand cardiac
Delgado, Cardiology, Leiden University Medical Center, Leiden, ..
Netherlands;Gerhard-PaulDiller,DepartmentofCardiologyIII,
... resynchronizationtherapy:Algeria:AlgerianSocietyofCardiology,
Adult Congenital and Valvular Heart Disease, University Hospital
... Brahim Kichou; Armenia: Armenian Cardiologists Association,
Muenster,Muenster,Germany;CarstenW.Israel,Departmentof
... Armen Khachatryan; Austria: Austrian Society of Cardiology,
Medicine-Cardiology, Diabetology and Nephrology, Bethel-Clinic,
... Daniel Scherr; Belarus: Belorussian Scientific Society of
Bielefeld, Germany; Andre Keren, Cardiology, Hadassah-Hebrew
... Cardiologists, Alexandr Chasnoits; Belgium: Belgian Society of
.. Cardiology, Georges H. Mairesse; Bosnia and Herzegovina:
University Hospital, Jerusalem, Israel; Reinoud E. Knops, .
.. Association of Cardiologists of Bosnia and Herzegovina, Mugdim
Cardiology and Electrophysiology, Amsterdam University Medical .
.. Bajric; Bulgaria: Bulgarian Society of Cardiology, Vasil Velchev;
Center, Amsterdam, Netherlands; Dipak Kotecha, Institute of .
.. Croatia: Croatian Cardiac Society, Vedran Velagic; Cyprus:
Cardiovascular Sciences, University of Birmingham, Birmingham, . .. Cyprus Society of Cardiology, Elias Papasavvas; Czech Republic:
UnitedKingdom;ChristopheLeclercq,DepartmentofCadiology, . .. Czech Society of Cardiology, Milos Taborsky; Denmark: Danish
Rennes UniversityHospital, Rennes,France; Be´laMerkely, Heart . .. Society of Cardiology, Michael Vinther;Egypt: EgyptianSociety of
and Vascular Center, Semmelweis University, Budapest, Hungary; .
.
. Cardiology,JohnKamelZarifTawadros;Estonia:EstonianSociety
Christoph Starck, Department of Cardiothoracic & Vascular .
.
. of Cardiology, Ju¨ri Voitk; Finland: Finnish Cardiac Society, Jarkko
Surgery, German Heart Center Berlin, Berlin, Germany; Ingela .
.
. Karvonen; France: French Society of Cardiology, Paul Milliez;
Thyle´n, Department of Health, Medicine and Caring Sciences, .
.
. Georgia: Georgian Society of Cardiology, Kakhaber Etsadashvili;
Linko¨ping University, Linko¨ping, Sweden; Jose´ Maria Tolosana, ..
. Germany:GermanCardiacSociety,ChristianVeltmann;Greece:
Arrhythmia Section, Cardiovascular Institute, Hospital Clinic, ..
. Hellenic Society of Cardiology, Nikolaos Fragakis; Hungary:
UniversityofBarcelona,Barcelona,Catalonia,Spain. ..
. HungarianSocietyofCardiology,LaszloAlajosGelle´r;Ireland:Irish
.
.
. Cardiac Society, Richard Sheahan; Israel: Israel Heart Society,
.
.
19 Appendix .. Avishag Laish-Farkash; Italy: Italian Federation of Cardiology,
.
. Massimo Zecchin; Kazakhstan: Association of Cardiologists of
.
.
. Kazakhstan,AyanAbdrakhmanov;Kosovo(Republicof):Kosovo
ESCScientificDocumentGroup .
.
IncludesDocumentReviewersandESCNationalCardiacSocieties.
.. Society ofCardiology, Ibadete Bytyc¸i;Kyrgyzstan: Kyrgyz Society
.
.. of Cardiology, Kurbanbek Kalysov; Latvia: Latvian Society of
.
Document Reviewers: Francisco Leyva (CPG Review .. Cardiology, Oskars Kalejs; Lebanon: Lebanese Society
.
Coordinator) (United Kingdom), Cecilia Linde (CPG Review . ofCardiology,BernardAbi-Saleh;Lithuania:LithuanianSocietyof
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 71 ---
ESCGuidelines 71
.
.
Cardiology, Germanas Marinskis; Luxembourg: Luxembourg . 6. Ector H, Rickards AF, Kappenberger L, Linde C, Vardas P, Oto A, Santini M,
.
Society of Cardiology, Laurent Groben; Malta: Maltese Cardiac .. Sutton R, Working Group on Cardiac Pacing. The World Survey of Cardiac
.. PacingandImplantableCardioverterDefibrillators:calendaryear1997—Europe.
Society,MarkAdrianSammut;Moldova(Republicof):Moldavian .. PacingClinElectrophysiol2001;24:863(cid:2)868.
.
Society of Cardiology, Mihail Rizov; Montenegro: Montenegro . 7. MondHG,IrwinM,EctorH,ProclemerA.Theworldsurveyofcardiacpacing
.
Society of Cardiology, Mihailo Vukmirovic; Morocco: Moroccan .. andcardioverter-defibrillators:calendaryear2005anInternationalCardiacPacing
.. and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol
Society of Cardiology, Rachida Bouhouch; Netherlands: .. 2008;31:1202(cid:2)1212.
.
Netherlands Society of Cardiology, Mathias Meine; North . 8. BradshawPJ,StobieP,KnuimanMW,BriffaTG,HobbsMS.Trendsintheinci-
.
Macedonia: North Macedonian Society of Cardiology, Lidija
.. dence and prevalence of cardiac pacemaker insertions in an ageing population.
.. OpenHeart2014;1:e000177.
Poposka;Norway:NorwegianSocietyofCardiology,OleChristian .. 9. JohanssonBW.Completeheartblock.Aclinical,hemodynamicandpharmacologi-
.
Mjølstad; Poland: Polish Cardiac Society, Maciej Sterlinski; .. cal study in patients with and without an artificial pacemaker. Acta Med Scand
Portugal: Portuguese Society of Cardiology, Nat(cid:2)alia Anto(cid:2)nio; ... Suppl1966;451:1(cid:2)127.
. 10. Edhag O. Long-term cardiac pacing. Experience of fixed-rate pacing with an
Romania: Romanian Society of Cardiology, Calin Siliste; Russian .. endocardialelectrodein260patients.ActaMedScandSuppl1969;502:9(cid:2)110.
. Federation: Russian Society of Cardiology, Sergey Valentinovich .. 11. EdhagO,SwahnA.Prognosisofpatientswithcompleteheartblockorarrhyth-
Popov; San Marino: San Marino Society of Cardiology, Roberto
... micsyncopewhowerenottreatedwithartificialpacemakers.Along-termfol-
. low-upstudyof101patients.ActaMedScand1976;200:457(cid:2)463.
Bini; Serbia: Cardiology Society of Serbia, Goran Milasinovic; .. 12. FriedbergCK,DonosoE,SteinWG.Nonsurgicalacquiredheartblock.AnnNY
.
Slovakia:SlovakSocietyofCardiology,PeterMargitfalvi;Slovenia: .. AcadSci1964;111:835(cid:2)847.
SlovenianSocietyofCardiology,IgorZupan;Spain:SpanishSociety
... 13. ShawDB,HolmanRR,GowersJI.Survivalinsinoatrialdisorder(sick-sinussyn-
. drome).BrMedJ1980;280:139(cid:2)141.
of Cardiology, O(cid:2)scar Cano; Sweden: Swedish Society of ... 14. AlboniP,MenozziC,BrignoleM,PaparellaN,GaggioliG,LolliG,CappatoR.
Cardiology, Rasmus Borgquist; Switzerland: Swiss Society of .. Effectsofpermanentpacemakerandoraltheophyllineinsicksinussyndromethe
.
Cardiology, Tobias Reichlin; Syrian Arab Republic: Syrian .. THEOPACEstudy:arandomizedcontrolledtrial.Circulation1997;96:260(cid:2)266.
. 15. Sutton R, Kenny RA. The natural history of sick sinus syndrome. Pacing Clin
.
Cardiovascular Association, Ahmad Rasheed Al Saadi; Tunisia: .. Electrophysiol1986;9:1110(cid:2)1114.
Tunisian Society of Cardiology and Cardio-Vascular Surgery, .. 16. Hofer S, Anelli-Monti M, Berger T, Hintringer F, Oldridge N, Benzer W.
.
. Psychometricpropertiesofanestablishedheartdiseasespecifichealth-relatedqual-
Abdeddayem Haggui; Turkey: Turkish Society of Cardiology, Ilyas .
. ityoflifequestionnaireforpacemakerpatients.QualLifeRes2005;14:1937(cid:2)1942.
.
Atar; United Kingdom of Great Britain and Northern .. 17. FleischmannKE,OravEJ,LamasGA,MangioneCM,SchronE,LeeKL,Goldman
.
Ireland:BritishCardiovascularSociety,AnthonyW.C.Chow. . L. Pacemaker implantation and quality of life in the Mode Selection Trial
.
. (MOST).HeartRhythm2006;3:653(cid:2)659.
.
ESCClinicalPracticeGuidelinesCommittee(CPG):Colin
.... 18. WLo ip lke oz- ffJim BLe ,ne Mz anF, giG ono eld Cm Man ,YL, oO onra Cv ,E VJ, itE al ll een Kb ,o Lg ae mn aK s, GSt Aam .Hbl ee ar ltB h, vM ala ur ein sc bh ea fk orR e,
Baigent (Chairperson) (United Kingdom), Magdy Abdelhamid .. andafterpacemakerimplantation.AmHeartJ2002;144:687(cid:2)692.
.
(Egypt), Victor Aboyans (France), Sotiris Antoniou (United .. 19. NewmanD,LauC,TangAS,IrvineJ,PaquetteM,WoodendK,DorianP,Gent
Kingdom),ElenaArbelo(Spain),RiccardoAsteggiano(Italy),Andreas
.... M re, laK tee drr qC u, alC ityon on fol ll iy feS iJ n,C tT heOP CP anIn adve ias ntig Tat ro iar ls. oE fff Pe hc yt so iof lop ga ic cin Pg acm ino gd .e Ao mn Hhe ea al rt th-
J
Baumbach(United Kingdom),Michael A.Borger (Germany),Jelena .. 2003;145:430(cid:2)437.
.
C(cid:3)elutkiene_ (Lithuania), Maja Cikes (Croatia), Jean-Philippe Collet .. 20. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK,
(France),VolkmarFalk(Germany),LaurentFauchier(France),Chris
... Marinchak RA, Estes NA 3rd, Mitchell GF, Lieberman EH, Mangione CM,
. GoldmanL.Qualityoflifeandclinicaloutcomesinelderlypatientstreatedwith
P.Gale(UnitedKingdom),SigrunHalvorsen(Norway),BernardIung .. ventricularpacingascomparedwithdual-chamberpacing.PacemakerSelection
.
(France), Tiny Jaarsma (Sweden), Aleksandra Konradi (Russia), .. intheElderlyInvestigators.NEnglJMed1998;338:1097(cid:2)1104.
Konstantinos C. Koskinas (Switzerland), Dipak Kotecha (United
... 21. LamasGA,LeeKL,SweeneyMO,SilvermanR,LeonA,YeeR,MarinchakRA,
. FlakerG,SchronE,OravEJ,HellkampAS,GreerS,McAnultyJ,EllenbogenK,
Kingdom), Ulf Landmesser (Germany), Basil S. Lewis (Israel), Ales .. Ehlert F, Freedman RA, Estes NA 3rd, Greenspon A, Goldman L, Mode .
Linhart(CzechRepublic),Maja-LisaLøchen(Norway),LisNeubeck .. SelectionTrialinSinus-NodeDysfunction.Ventricularpacingordual-chamber
.. pacingforsinus-nodedysfunction.NEnglJMed2002;346:1854(cid:2)1862.
(United Kingdom), Jens Cosedis Nielsen (Denmark); Steffen E. .
. 22.TjongFVY,BeurskensNEG,deGrootJR,WaweruC,LiuS,RitterP,ReynoldsD,
. Petersen (United Kingdom), Eva Prescott (Denmark), Amina .. WildeAAM,KnopsRE,MICRAInvestigators.Health-relatedqualityoflifeimpact
Rakisheva(Kazakhstan),MartaSitges(Spain),RhianM.Touyz(United .. ofatranscatheterpacingsystem.JCardiovascElectrophysiol2018;29:1697(cid:2)1704.
.
. 23. GoetteA,KalmanJM,AguinagaL,AkarJ,CabreraJA,ChenSA,ChughSS,Corradi Kingdom). .
. D,D’AvilaA,DobrevD,FenelonG,GonzalezM,HatemSN,HelmR,HindricksG,
.
.. HoSY,HoitB,JalifeJ,KimYH,LipGY,MaCS,MarcusGM,MurrayK,NogamiA,
.. SandersP,UribeW,VanWagonerDR,NattelS,DocumentReviewers.EHRA/
.
. HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition,
.
19 References .. characterization,andclinicalimplication.Europace2016;18:1455(cid:2)1490.
.. 24. KottkampH.Fibroticatrialcardiomyopathy:aspecificdisease/syndromesupply-
.
. ing substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV
.
1. TimmisA,TownsendN,GaleC,GrobbeeR,ManiadakisN,FlatherM,WilkinsE, . node disease, and thromboembolic complications. J Cardiovasc Electrophysiol
.
Wright L, Vos R, Bax J, Blum M, Pinto F, Vardas P, ESC Scientific Document .. 2012;23:797(cid:2)799.
Group.EuropeanSocietyofCardiology:cardiovasculardiseasestatistics2017.Eur .. 25. SodeckGH,DomanovitsH,MeronG,RauschaF,LosertH,ThalmannM,Vlcek
.
HeartJ2018;39:508(cid:2)579. . M, Laggner AN. Compromising bradycardia: management in the emergency
.
2. MondHG,ProclemerA.The11thworldsurveyofcardiacpacingandimplantable . department.Resuscitation2007;73:96(cid:2)102.
.
cardioverter-defibrillators:calendaryear2009—aWorldSocietyofArrhythmia’s .. 26. El-SherifN,JalifeJ.Paroxysmalatrioventricularblock:arephase3andphase4
project.PacingClinElectrophysiol2011;34:1013(cid:2)1027. .. blockmechanismsormisnomers?HeartRhythm2009;6:1514(cid:2)1521.
.
3. Gregoratos G. Permanent pacemakers in older persons. J Am Geriatr Soc . 27. Lee S, Wellens HJ, Josephson ME. Paroxysmal atrioventricular block. Heart
.
1999;47:1125(cid:2)1135. .. Rhythm2009;6:1229(cid:2)1234.
4. MondHG.TheWorldSurveyofCardiacPacingandCardioverterDefibrillators: .. 28. Narula OS, Samet P, Javier RP. Significance of the sinus-node recovery time.
.
calendaryear1997.PacingClinElectrophysiol2001;24:869(cid:2)870. . Circulation1972;45:140(cid:2)158.
.
5. MondHG.TheWorldSurveyofCardiacPacingandCardioverterDefibrillators: . 29. AlboniP,MenozziC,BrignoleM,PaparellaN,LolliG,OddoneD,DinelliM.An
.
calendar year 1997—Asian Pacific, Middle East, South America, and Canada. .. abnormalneuralreflexplaysaroleincausingsyncopeinsinusbradycardia.JAm
PacingClinElectrophysiol2001;24:856(cid:2)862. . CollCardiol1993;22:1130(cid:2)1134.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 72 ---
72 ESCGuidelines
.
.
30. BrignoleM,MenozziC,GianfranchiL,OddoneD,LolliG,BertullaA.Neurally . performanceofaleadlesscardiacpacemaker:1-yearfollow-upoftheLEADLESS
.
mediatedsyncopedetectedbycarotidsinusmassageandhead-uptilttestinsick . trial.JAmCollCardiol2015;65:1497(cid:2)1504.
.
sinussyndrome.AmJCardiol1991;68:1032(cid:2)1036. .. 48. SperzelJ,DefayeP,DelnoyPP,GarciaGuerreroJJ,KnopsRE,TondoC,Deharo
31. BrignoleM, DeharoJC, De Roy L, Menozzi C, Blommaert D, Dabiri L, Ruf J, .. JC,WongT,NeuzilP.PrimarysafetyresultsfromtheLEADLESSObservational
.
GuieuR.Syncopeduetoidiopathicparoxysmalatrioventricularblock:long-term . Study.Europace2018;20:1491(cid:2)1497.
.
follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol .. 49. RobertsPR,ClementyN,AlSamadiF,GarwegC,Martinez-SandeJL,IacopinoS,
2011;58:167(cid:2)173. .. JohansenJB,VinolasPratX,KowalRC,KlugD,MontL,SteffelJ,LiS,VanOsch
.
32. DeharoJC,BrignoleM,GuieuR.Adenosinehypersensitivityandatrioventricular . D, El-Chami MF. A leadless pacemaker in the real-world setting: The Micra
.
block.HerzschrittmachertherElektrophysiol2018;29:166(cid:2)170. . Transcatheter Pacing System Post-Approval Registry. Heart Rhythm
.
33. BrignoleM,AuricchioA,Baron-EsquiviasG,BordacharP,BorianiG,Breithardt .. 2017;14:1375(cid:2)1379.
OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, .. 50. El-ChamiMF,Al-SamadiF,ClementyN,GarwegC,Martinez-SandeJL,PicciniJP,
.
LeclercqC,LindeC,MontL,PadelettiL,SuttonR,VardasPE,ESCCommittee . IacopinoS,LloydM,VinolasPratX,JacobsenMD,RitterP,JohansenJB,TondoC,
.
for Practice Guidelines. 2013 ESC Guidelines on cardiac pacing and cardiac . LiuF,FaganDH,EakleyAK,RobertsPR.UpdatedperformanceoftheMicratrans-
.
resynchronizationtherapy:theTaskForceoncardiacpacingandresynchroniza- .. catheterpacemakerinthereal-worldsetting:acomparisontotheinvestigational
.
tiontherapyoftheEuropeanSocietyofCardiology(ESC).Developedincollabo- . studyandatransvenoushistoricalcontrol.HeartRhythm2018;15:1800(cid:2)1807.
.
ration with the European Heart Rhythm Association (EHRA). Eur Heart J . 51. OvsyshcherI,GuettaV,BondyC,PorathA.Firstderivativeofrightventricular
. 2013;34:2281(cid:2)2329. .. pressure,dP/dt,asasensorforarateadaptiveVVIpacemaker:initialexperience.
34. BurriH,StarckC,AuricchioA,BiffiM,BurriM,D’AvilaALR,DeharoJC,Glikson .. PacingClinElectrophysiol1992;15:211(cid:2)218.
.
M,IsraelC,LauCAR,LeclercqC,LoveC,NielsenJC,VernooyK,Reviewers, . 52. LauCP,ButrousGS,WardDE,CammAJ.Comparisonofexerciseperformanceof
.
DagresNRC,BovedaSRC,ButterC,MarijonE,BraunschweigF,MairesseGH, . sixrate-adaptiverightventricularcardiacpacemakers.AmJCardiol1989;63:833(cid:2)838.
.
Gleva M, Defaye P, Zanon F, Lopez-Cabanillas N, Guerra JM, Vassilikos VP, .. 53. Lau CP, Antoniou A, Ward DE, Camm AJ. Initial clinical experience with a
Martins Oliveira M. EHRA expert consensus statement and practical guideon .. minuteventilationsensingratemodulatedpacemaker:improvementsinexercise
.
optimal implantation technique for conventional pacemakers and implantable . capacityandsymptomatology.PacingClinElectrophysiol1988;11:1815(cid:2)1822.
.
cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the .. 54. BendittDG,MianulliM,FetterJ,BensonDWJr,DunniganA,MolinaE,Gornick
Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart .. CC, Almquist A. Single-chamber cardiac pacing with activity-initiated chrono-
.
RhythmSociety(LAHRS).Europace2021;doi:10.1093/europace/euaa367. . tropic response: evaluation by cardiopulmonary exercise testing. Circulation
.
35. Belott P, Reynolds D. Permanent pacemaker and implantable cardioverter- . 1987;75:184(cid:2)191.
.
defibrillatorimplantationinadults.In:EllenbogenKA,WilcoffBL,KayNG,Lau .. 55. LandzbergJS,FranklinJO,MahawarSK,HimelmanRB,BotvinickEH,SchillerNB,
CP, Auricchio A, eds. Clinical Cardiac Pacing, Defibrillation and Resynchronization .. Springer MJ, Griffin JC. Benefits of physiologic atrioventricular synchronization
.
Therapy.5thed.Elsevier;2017.p631(cid:2)691. . forpacingwithanexerciserateresponse.AmJCardiol1990;66:193(cid:2)197.
.
36. AuricchioA,StellbrinkC,BlockM,SackS,VogtJ,BakkerP,KleinH,KramerA, . 56. IwaseM,HatanoK,SaitoF,KatoK,MaedaM,MiyaguchiK,AokiT,YokotaM,
.
Ding J, Salo R, Tockman B, Pochet T, Spinelli J. Effect of pacing chamber and .. HayashiH,SaitoH,MuraseM.EvaluationbyexerciseDopplerechocardiography
.
atrioventriculardelayonacutesystolicfunctionofpacedpatientswithcongestive . ofmaintenanceofcardiacoutputduringventricularpacingwithorwithoutchro-
.
heartfailure.ThePacingTherapiesforCongestiveHeartFailureStudyGroup. . notropicresponse.AmJCardiol1989;63:934(cid:2)938.
.
The Guidant Congestive Heart Failure Research Group. Circulation .. 57. BuckinghamTA,WoodruffRC,PenningtonDG,ReddRM,JanosikDL,Labovitz
1999;99:2993(cid:2)3001. .. AJ,GravesR,KennedyHL.Effectofventricularfunctionontheexercisehemo-
.
37. TangAS,WellsGA,TalajicM,ArnoldMO,SheldonR,ConnollyS,Hohnloser . dynamicsofvariableratepacing.JAmCollCardiol1988;11:1269(cid:2)1277.
.
SH,NicholG,BirnieDH,SappJL,YeeR,HealeyJS,RouleauJL.Cardiac-resynch- . 58. PadelettiL,PieragnoliP,DiBiaseL,ColellaA,LandolinaM,MoroE,OraziS,
.
ronization therapy for mild-to-moderate heart failure. N Engl J Med .. VicentiniA,MagliaG,PensabeneO,RacitiG,BaroldSS.Isadual-sensorpace-
2010;363:2385(cid:2)2395. .. maker appropriate in patients with sino-atrial disease? Results from the
.
38. SaxonLA,BristowMR,BoehmerJ,KruegerS,KassDA,DeMarcoT,CarsonP, . DUSISLOGstudy.PacingClinElectrophysiol2006;29:34(cid:2)40.
.
DiCarloL,FeldmanAM,GalleE,EcklundF.Predictorsofsuddencardiacdeath .. 59. Nowak B, Misselwitz B, Expert committee ‘Pacemaker Institute of Quality
and appropriate shock in the Comparison of Medical Therapy, Pacing, and .. Assurance Hessen’, Erdogan A, Funck R, Irnich W, Israel CW, Olbrich HG,
.
Defibrillation in Heart Failure (COMPANION) Trial. Circulation . Schmidt H, Sperzel J, Zegelman M. Do gender differences exist in pacemaker
.
2006;114:2766(cid:2)2772. . implantation?—results of an obligatory external quality control program.
.
39. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, .. Europace2010;12:210(cid:2)215.
TavazziL.Theeffectofcardiacresynchronizationonmorbidityandmortalityin .. 60. Mohamed MO, Volgman AS, Contractor T, Sharma PS, Kwok CS, Rashid M,
.
heartfailure.NEnglJMed2005;352:1539(cid:2)1549. . MartinGP,BarkerD,PatwalaA,MamasMA.Trendsofsexdifferencesinout-
.
40. MossAJ,HallWJ,CannomDS,KleinH,BrownMW,DaubertJP,EstesNA3rd, . comes of cardiac electronic device implantations in the United States. Can J .
FosterE,GreenbergH,HigginsSL,PfefferMA,SolomonSD,WilberD,Zareba .. Cardiol2020;36:69(cid:2)78.
W, MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the .. 61. Moore K, Ganesan A, Labrosciano C, Heddle W, McGavigan A, Hossain S,
.
preventionofheart-failureevents.NEnglJMed2009;361:1329(cid:2)1338. . HortonD,HariharaputhiranS,RanasingheI.Sexdifferencesinacutecomplica-
. 41. Verma N, Knight BP. Update in cardiac pacing. Arrhythm Electrophysiol Rev .. tionsofcardiacimplantableelectronicdevices:implicationsforpatientsafety.J
2019;8:228(cid:2)233. .. AmHeartAssoc2019;8:e010869.
.
42. AbdelrahmanM,SubzposhFA,BeerD,DurrB,NaperkowskiA,SunH,Oren . 62. BrignoleM,MoyaA,deLangeFJ,DeharoJC,ElliottPM,FanciulliA,Fedorowski .
JW,DandamudiG,VijayaramanP.ClinicaloutcomesofHisbundlepacingcom- . A,FurlanR,KennyRA,MartinA,ProbstV,ReedMJ,RiceCP,SuttonR,Ungar
.
paredtorightventricularpacing.JAmCollCardiol2018;71:2319(cid:2)2330. .. A,vanDijkJG.2018ESCGuidelinesforthediagnosisandmanagementofsyn-
43. Bhatt AG, Musat DL, Milstein N, Pimienta J, Flynn L, Sichrovsky T, Preminger .. cope.EurHeartJ2018;39:1883(cid:2)1948.
.
MW,MittalS.Theefficacyofhisbundlepacing:lessonslearnedfromimplemen- . 63. PrioriSG,Blomstrom-LundqvistC,MazzantiA,BlomN,BorggrefeM,CammJ,
.
tation for the first time at an experienced electrophysiology center. JACC Clin . ElliottPM,FitzsimonsD,HatalaR,HindricksG,KirchhofP,KjeldsenK,KuckKH,
.
Electrophysiol2018;4:1397(cid:2)1406. .. Hernandez-MadridA,NikolaouN,NorekvalTM,SpauldingC,VanVeldhuisen
.
44. AliN,KeeneD,ArnoldA,Shun-ShinM,WhinnettZI,AfzalSohaibSM.Hisbun- . DJ. 2015 ESC Guidelines for the management of patients with ventricular
.
dlepacing:anewfrontierinthetreatmentofheartfailure.ArrhythmElectrophysiol . arrhythmiasandthepreventionofsuddencardiacdeath:TheTaskForceforthe
.
Rev2018;7:103(cid:2)110. .. Management of Patients with Ventricular Arrhythmias and the Prevention of
45. ReynoldsD,DurayGZ,OmarR,SoejimaK,NeuzilP,ZhangS,NarasimhanC, .. SuddenCardiacDeathoftheEuropeanSocietyofCardiology(ESC).Endorsed
.
Steinwender C, Brugada J, Lloyd M, Roberts PR, Sagi V, Hummel J, Bongiorni . by:AssociationforEuropeanPaediatricandCongenitalCardiology(AEPC).Eur
.
MG, Knops RE, Ellis CR, Gornick CC, Bernabei MA, Laager V, Stromberg K, . HeartJ2015;36:2793(cid:2)2867.
.
WilliamsER,HudnallJH,RitterP,MicraTranscatheterPacingStudyGroup.A .. 64. Kaess BM, Andersson C, Duncan MS, Larson MG, Aasbjerg K, Gislason GH,
leadless intracardiac transcatheter pacing system. N Engl J Med .. Torp-PedersenC,VasanRS.Familialclusteringofcardiacconductiondefectsand
.
2016;374:533(cid:2)541. . pacemakerinsertion.CircArrhythmElectrophysiol2019;12:e007150.
.
46. ReddyVY,ExnerDV,CantillonDJ,DoshiR,BunchTJ,TomassoniGF,Friedman .. 65. AckermanMJ,PrioriSG,WillemsS,BerulC,BrugadaR,CalkinsH,CammAJ,
PA,EstesNA3rd,IpJ,NiaziI,PlunkittK,BankerR,PorterfieldJ,IpJE,Dukkipati .. Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H,
.
SR,LeadlessIIStudyInvestigators.Percutaneousimplantationofanentirelyintra- . McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A,
.
cardiacleadlesspacemaker.NEnglJMed2015;373:1125(cid:2)1135. . WolpertC,ZipesDP.HRS/EHRAexpertconsensusstatementonthestateof
.
47. KnopsRE,TjongFV,NeuzilP,SperzelJ,MillerMA,PetruJ,SimonJ,SedivaL,de .. genetic testing for the channelopathies and cardiomyopathies. Heart Rhythm
GrootJR,DukkipatiSR,KoruthJS,WildeAA,KautznerJ,ReddyVY.Chronic . 2011;8:1308(cid:2)1339.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 73 ---
ESCGuidelines 73
.
.
66. KerrSR,PearceMS,BrayneC,DavisRJ,KennyRA.Carotidsinushypersensitivity . 88. KandolinR,LehtonenJ,KupariM.Cardiacsarcoidosisandgiantcellmyocarditis
.
inasymptomaticolderpersons:implicationsfordiagnosisofsyncopeandfalls. . ascausesofatrioventricularblockinyoungandmiddle-agedadults.CircArrhythm
.
ArchInternMed2006;166:515(cid:2)520. .. Electrophysiol2011;4:303(cid:2)309.
67. PuggioniE,GuiducciV,BrignoleM,MenozziC,OddoneD,DonateoP,CrociF, .. 89. Turner JJO. Hypercalcaemia—presentation and management. Clin Med (Lond)
.
SolanoA,LolliG,TomasiC,BottoniN.Resultsandcomplicationsofthecarotid . 2017;17:270(cid:2)273.
.
sinusmassageperformedaccordingtothe‘methodofsymptoms’.AmJCardiol .. 90. ChonSB,KwakYH, Hwang SS, OhWS, BaeJH. Severehyperkalemiacanbe
2002;89:599(cid:2)601. .. detectedimmediatelybyquantitativeelectrocardiographyandclinicalhistoryin
.
68.BrignoleM,UngarA,CasagrandaI,GuliziaM,LunatiM,AmmiratiF,DelRossoA, . patients with symptomatic or extreme bradycardia: a retrospective cross-
.
SasdelliM,SantiniM,MaggiR,VitaleE,MorrioneA,FranceseGM,VecchiMR,Giada . sectionalstudy.JCritCare2013;28:1112.e7(cid:2)1112.e13.
.
F. Prospective multicentre systematic guideline-based management of patients .. 91. MandellBF.Cardiovascularinvolvementinsystemiclupuserythematosus.Semin
referredtotheSyncopeUnitsofgeneralhospitals.Europace2010;12:109(cid:2)118. .. ArthritisRheum1987;17:126(cid:2)141.
.
69. SolariD,MaggiR,OddoneD,SolanoA,CrociF,DonateoP,BrignoleM.Clinical . 92.WanD,BlakelyC,BranscombeP,Suarez-FusterL,GloverB,BaranchukA.Lymecar-
.
context and outcome of carotid sinus syndrome diagnosed by means of the .. ditisandhigh-degreeatrioventricularblock.AmJCardiol2018;121:1102(cid:2)1104.
‘methodofsymptoms’.Europace2014;16:928(cid:2)934. .. 93. NakayamaY,OhnoM,YonemuraS,UozumiH,KobayakawaN,FukushimaK,
.
70. Solari D, Maggi R, Oddone D, Solano A, Croci F, Donateo P, Wieling W, . TakeuchiH,AoyagiT.Acaseoftransient2:1atrioventricularblock,resolvedby
.
BrignoleM.Assessmentofthevasodepressorreflexincarotidsinussyndrome. . thyroxine supplementation for subclinical hypothyroidism. Pacing Clin
. CircArrhythmElectrophysiol2014;7:505(cid:2)510. .. Electrophysiol2006;29:106(cid:2)108.
71. Mangrum JM, DiMarco JP. The evaluation and management of bradycardia. N .. 94. NobleK,IslesC.Hyperkalaemiacausingprofoundbradycardia.Heart2006;92:1063.
.
EnglJMed2000;342:703(cid:2)709. . 95. IshikawaT,TsujiY,MakitaN.Inheritedbradyarrhythmia:adiversegeneticback-
.
72. SuttonR.Reflexatrioventricularblock.FrontCardiovascMed2020;7:48. . ground.JArrhythm2016;32:352(cid:2)358.
.
72a.DaCostaD,BradyWJ,EdhouseJ.Bradycardiasandatrioventricularconduction .. 96. SmitsJP,VeldkampMW,WildeAA.Mechanismsofinheritedcardiacconduction
block.BMJ2002;324:535(cid:2)538. .. disease.Europace2005;7:122(cid:2)137.
.
73. SteinbergJS,VarmaN,CygankiewiczI,AzizP,BalsamP,BaranchukA,Cantillon . 97. PrioriSG,WildeAA,HorieM,ChoY,BehrER,BerulC,BlomN,BrugadaJ,
.
DJ, Dilaveris P, Dubner SJ, El-Sherif N, Krol J, Kurpesa M, La Rovere MT, .. ChiangCE,HuikuriH,KannankerilP,KrahnA,LeenhardtA,MossA,Schwartz
LobodzinskiSS,LocatiET,MittalS,OlshanskyB,PiotrowiczE,SaxonL,Stone .. PJ, Shimizu W, Tomaselli G, Tracy C. HRS/EHRA/APHRS expert consensus
.
PH,TereshchenkoL,TurittoG,WimmerNJ,VerrierRL,ZarebaW,Piotrowicz . statementonthediagnosisandmanagementofpatientswithinheritedprimary
.
R.2017ISHNE-HRSexpertconsensusstatementonambulatoryECGandexter- . arrhythmiasyndromes:documentendorsedbyHRS,EHRA,andAPHRSinMay
.
nalcardiacmonitoring/telemetry.HeartRhythm2017;14:e55-e96. .. 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm
74. BrubakerPH,KitzmanDW.Chronotropicincompetence:causes,consequences, .. 2013;10:1932(cid:2)1963.
.
andmanagement.Circulation2011;123:1010(cid:2)1020. . 98. BrodskyM,WuD,DenesP,KanakisC,RosenKM.Arrhythmiasdocumentedby
.
75.Savonen KP, Kiviniemi V, Laukkanen JA, Lakka TA, Rauramaa TH, Salonen JT, . 24hourcontinuouselectrocardiographicmonitoringin50malemedicalstudents
.
Rauramaa R. Chronotropic incompetence and mortality in middle-aged men with .. withoutapparentheartdisease.AmJCardiol1977;39:390(cid:2)395.
.
knownorsuspectedcoronaryheartdisease.EurHeartJ2008;29:1896(cid:2)1902. . 99. ClarkeJM,HamerJ,SheltonJR,TaylorS,VenningGR.Therhythmofthenormal
.
76. Byrne JM, Marais HJ, Cheek GA. Exercise-induced complete heart block in a . humanheart.Lancet1976;1:508(cid:2)512.
.
patientwithchronicbifascicularblock.JElectrocardiol1994;27:339(cid:2)342. .. 100.FlegJL,KennedyHL.Cardiacarrhythmiasinahealthyelderlypopulation:detec-
77. WissocqL,EnnezatPV,MouquetF.Exercise-inducedhigh-degreeatrioventricu- .. tionby24-hourambulatoryelectrocardiography.Chest1982;81:302(cid:2)307.
.
larblock.ArchCardiovascDis2009;102:733(cid:2)735. . 101.Grimm W, Hoffmann J, Menz V, Kohler U, Heitmann J, Peter JH, Maisch B.
.
78. WoelfelAK,SimpsonRJJr,GettesLS,FosterJR.Exercise-induceddistalatrio- . Electrophysiologicevaluationofsinusnodefunctionandatrioventricularcon-
.
ventricularblock.JAmCollCardiol1983;2:578(cid:2)581. .. ductioninpatientswithprolongedventricularasystoleduringobstructivesleep
79. SumiyoshiM,NakataY,YasudaM,TokanoT,OguraS,NakazatoY,Yamaguchi .. apnea.AmJCardiol1996;77:1310(cid:2)1314.
.
H. Clinical and electrophysiologic features of exercise-induced atrioventricular . 102.Zwillich C, Devlin T, White D, Douglas N, Weil J, Martin R. Bradycardia
.
block.AmHeartJ1996;132:1277(cid:2)1281. .. during sleep apnea. Characteristics and mechanism. J Clin Invest
80. Oliveros RA, Seaworth J, Weiland FL, Boucher CA. Intermittent left anterior .. 1982;69:1286(cid:2)1292.
.
hemiblockduringtreadmillexercisetest.Correlationwithcoronaryarteriogram. . 103.GuilleminaultC,PoolP,MottaJ,GillisAM.SinusarrestduringREMsleepin
.
Chest1977;72:492(cid:2)494. . youngadults.NEnglJMed1984;311:1006(cid:2)1010.
.
81. Bharati S, Dhingra RC, Lev M, Towne WD, Rhimtoola SH, Rosen KM. .. 104.GrimmW,KoehlerU,FusE,HoffmannJ,MenzV,FunckR,PeterJH,MaischB.
ConductionsysteminapatientwithPrinzmetal’sanginaandtransientatrioven- .. Outcome of patients with sleep apnea-associated severe bradyarrhythmias
.
tricularblock.AmJCardiol1977;39:120(cid:2)125. . after continuous positive airway pressure therapy. Am J Cardiol
.
82.KnuutiJ,WijnsW,SarasteA,CapodannoD,BarbatoE,Funck-BrentanoC,Prescott . 2000;86:688(cid:2)692. .
E,StoreyRF,DeatonC,CuissetT,AgewallS,DicksteinK,EdvardsenT,EscanedJ, .. 105.KoehlerU,FusE,GrimmW,PankowW,SchaferH,StammnitzA,PeterJH.
GershBJ,SvitilP,GilardM,HasdaiD,HatalaR,MahfoudF,MasipJ,MunerettoC, .. Heartblockinpatientswithobstructivesleepapnoea:pathogeneticfactorsand
.
ValgimigliM,AchenbachS,BaxJJ.2019ESCGuidelinesforthediagnosisandmanage- . effectsoftreatment.EurRespirJ1998;11:434(cid:2)439.
. mentofchroniccoronarysyndromes.EurHeartJ2019;41:407(cid:2)477. .. 106.SimantirakisEN,SchizaSI,MarketouME,ChrysostomakisSI,ChlouverakisGI,
83. HallidayBP,GulatiA,AliA,GuhaK,NewsomeS,ArzanauskaiteM,VassiliouVS, .. KlapsinosNC,SiafakasNS,VardasPE.Severebradyarrhythmiasinpatientswith
.
Lota A, Izgi C, Tayal U, Khalique Z, Stirrat C, Auger D, Pareek N, Ismail TF, . sleep apnoea: the effect of continuous positive airway pressure treatment: a .
Rosen SD, Vazir A, Alpendurada F, Gregson J, Frenneaux MP, Cowie MR, . long-term evaluation using an insertable loop recorder. Eur Heart J
.
ClelandJGF,CookSA,PennellDJ,PrasadSK.Associationbetweenmidwalllate .. 2004;25:1070(cid:2)1076.
gadoliniumenhancementandsuddencardiacdeathinpatientswithdilatedcardi- .. 107.SuttonR,FedorowskiA,OlshanskyB,GertvanDijkJ,AbeH,BrignoleM,de
.
omyopathy and mild and moderate left ventricular systolic dysfunction. . LangeF,KennyRA,LimPB,MoyaA,RosenSD,RussoV,StewartJM,ThijsRD,
.
Circulation2017;135:2106(cid:2)2115. .. Benditt DG. Tilt testing remains a valuable asset. Eur Heart J
84. KazmirczakF,ChenKA,AdabagS,vonWaldL,RoukozH,BendittDG,Okasha .. 2021;42:1654(cid:2)1660.
.
O,Farzaneh-FarA,MarkowitzJ,NijjarPS,VelangiPS,BhargavaM,PerlmanD, . 108.DaCostaA,DefayeP,Romeyer-BouchardC,RocheF,DauphinotV,Deharo
.
Duval S, Akcakaya M, Shenoy C. Assessment of the 2017 AHA/ACC/HRS . JC,JaconP,LamaisonD,BathelemyJC,IsaazK,LaurentG.Clinicalimpactof
.
Guideline Recommendations for Implantable Cardioverter-Defibrillator .. theimplantablelooprecorderinpatientswithisolatedsyncope,bundlebranch
ImplantationinCardiacSarcoidosis.CircArrhythmElectrophysiol2019;12:e007488. .. blockandnegativeworkup:arandomizedmulticentreprospectivestudy.Arch
.
85. AquaroGD,PerfettiM,CamastraG,MontiL,DellegrottaglieS,MoroC,Pepe . CardiovascDis2013;106:146(cid:2)154.
.
A,TodiereG,LanzilloC,ScatteiaA,DiRomaM,PontoneG,PerazzoloMarra . 109.Farwell DJ, Freemantle N, Sulke N. The clinical impact of implantable loop
.
M,BarisonA,DiBellaG.CardiacMRwithlategadoliniumenhancementinacute .. recordersinpatientswithsyncope.EurHeartJ2006;27:351(cid:2)356.
myocarditis with preserved systolic function: ITAMY Study. J Am Coll Cardiol .. 110.Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope
.
2017;70:1977(cid:2)1987. . trial: conventional diagnostic testing versus a prolonged monitoring strategy.
.
86. FerreiraVM,Schulz-MengerJ,HolmvangG,KramerCM,CarboneI,SechtemU, .. Circulation2001;104:46(cid:2)51.
Kindermann I, Gutberlet M, Cooper LT, Liu P, Friedrich MG. Cardiovascular .. 111.PodoleanuC,DaCostaA,DefayeP,TaiebJ,GalleyD,BruP,MauryP,MaboP,
.
magneticresonanceinnonischemicmyocardialinflammation:expertrecommen- . BovedaS,CellarierG,AnselmeF,KouakamC,DelarcheN,DeharoJC.Early
.
dations.JAmCollCardiol2018;72:3158(cid:2)3176. . useofanimplantablelooprecorderinsyncopeevaluation:arandomizedstudy
.
87. ZhouY,LowerEE,LiHP,CosteaA,AttariM,BaughmanRP.Cardiacsarcoidosis: .. inthecontextoftheFrenchhealthcaresystem(FRESHstudy).ArchCardiovasc
theimpactofageandimplanteddevicesonsurvival.Chest2017;151:139(cid:2)148. . Dis2014;107:546(cid:2)552.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 74 ---
74 ESCGuidelines
.
.
112. SulkeN,SugiharaC,HongP,PatelN,FreemantleN.Thebenefitofaremotely . neurallymediatedsyncopeanddocumentedasystole:ThirdInternationalStudy
.
monitoredimplantablelooprecorderasafirstlineinvestigationinunexplained . on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation
.
syncope:theEaSyASIItrial.Europace2016;18:912(cid:2)918. .. 2012;125:2566(cid:2)2571.
113. GannD,TolentinoA,SametP.Electrophysiologicevaluationofelderlypatients .. 134.Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W,
.
with sinus bradycardia: a long-term follow-up study. Ann Intern Med . Andresen D, Benditt DG, Vardas P, International Study on Syncope of
.
1979;90:24(cid:2)29. .. Uncertain Etiology Group. Early application of an implantable loop recorder
114. MenozziC,BrignoleM,AlboniP,BoniL,PaparellaN,GaggioliG,LolliG.The .. allowseffectivespecifictherapyinpatientswithrecurrentsuspectedneurally
.
naturalcourseofuntreatedsicksinussyndromeandidentificationofthevaria- . mediatedsyncope.EurHeartJ2006;27:1085(cid:2)1092.
.
blespredictiveofunfavorableoutcome.AmJCardiol1998;82:1205(cid:2)1209. . 135.AssemanP,BerzinB,DesryD,VilaremD,DurandP,DelmotteC,SarkisEH,
.
115. McAnultyJH,RahimtoolaSH,MurphyE,DeMotsH,RitzmannL,KanarekPE, .. LekieffreJ,TheryC.Persistentsinusnodalelectrogramsduringabnormallypro-
KauffmanS.Naturalhistoryof‘high-risk’bundle-branchblock:finalreportofa .. longed postpacing atrial pauses in sick sinus syndrome in humans: sinoatrial
.
prospectivestudy.NEnglJMed1982;307:137(cid:2)143. . blockvsoverdrivesuppression.Circulation1983;68:33(cid:2)41.
.
116. GrondaM,MagnaniA,OcchettaE,SauroG,D’AulerioM,CarforaA,RossiP. . 136.Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG,
.
Electrophysiologicalstudyofatrio-ventricularblockandventricularconduction .. BadhwarV,BrugadaJ,CammJ,ChenPS,ChenSA,ChungMK,CosedisNielsen
.
defects. Prognostic and therapeutical implications. G Ital Cardiol . J,CurtisAB,DaviesDW,DayJD,d’AvilaA,NatasjadeGrootNMS,DiBiaseL,
.
1984;14:768(cid:2)773. . DuytschaeverM,EdgertonJR,EllenbogenKA,EllinorPT,ErnstS,FenelonG,
. 117. BergfeldtL,EdvardssonN,RosenqvistM,VallinH,EdhagO.Atrioventricular .. GerstenfeldEP,HainesDE,HaissaguerreM,HelmRH,HylekE,JackmanWM,
blockprogressioninpatientswithbifascicularblockassessedbyrepeatedelec- .. Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R,
.
trocardiography and a bradycardia-detecting pacemaker. Am J Cardiol . Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF,
.
1994;74:1129(cid:2)1132. . Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E,
.
118. Kaul U, Dev V, Narula J, Malhotra AK, Talwar KK, Bhatia ML. Evaluation of .. ReynoldsMR,SandersP,ScanavaccaM,SchillingR,TondoC,TsaoHM,Verma
patientswithbundlebranchblockand‘unexplained’syncope:astudybasedon .. A, Wilber DJ, Yamane T, Document Reviewers. 2017 HRS/EHRA/ECAS/
.
comprehensive electrophysiologic testing and ajmaline stress. Pacing Clin . APHRS/SOLAECEexpertconsensusstatementoncatheterandsurgicalabla-
.
Electrophysiol1988;11:289(cid:2)297. .. tionofatrialfibrillation.Europace2018;20:e1(cid:2)e160.
119. Moya A, Garcia-Civera R, Croci F, Menozzi C, Brugada J, Ammirati F, Del .. 137.ChenYW,BaiR,LinT,SalimM,SangCH,LongDY,YuRH,TangRB,GuoXY,
.
RossoA,Bellver-NavarroA,Garcia-SacristanJ,BortnikM,MontL,Ruiz-Granell . YanXL,NieJG,DuX,DongJZ,MaCS.Pacingorablation:whichisbetterfor
.
R,NavarroX.Diagnosis,management,andoutcomesofpatientswithsyncope . paroxysmalatrialfibrillation-relatedtachycardia(cid:2)bradycardiasyndrome?Pacing
.
andbundlebranchblock.EurHeartJ2011;32:1535(cid:2)1541. .. ClinElectrophysiol2014;37:403(cid:2)411.
120. TwidaleN,HeddleWF,TonkinAM.Procainamideadministrationduringelec- .. 138.InadaK,YamaneT,TokutakeK,YokoyamaK,MishimaT,HiokiM,NaruiR,Ito
.
trophysiologystudy—utilityasaprovocativetestforintermittentatrioventricu- . K, Tanigawa S, Yamashita S, Tokuda M, Matsuo S, Shibayama K, Miyanaga S,
.
larblock.PacingClinElectrophysiol1988;11:1388(cid:2)1397. . DateT,SugimotoK,YoshimuraM.Theroleofsuccessfulcatheterablationin
.
121. Scheinman MM,PetersRW, SuaveMJ,DesaiJ,AbbottJA,CoganJ,WohlB, .. patientswithparoxysmalatrialfibrillationandprolongedsinuspauses:outcome
.
WilliamsK.ValueoftheH(cid:2)Qintervalinpatientswithbundlebranchblock . duringa5-yearfollow-up.Europace2014;16:208(cid:2)213.
.
and the role of prophylactic permanent pacing. Am J Cardiol . 139.JacksonLR,2nd,RathakrishnanB,CampbellK,ThomasKL,PicciniJP,Bahnson
.
1982;50:1316(cid:2)1322. .. T,StiberJA,DaubertJP.Sinusnodedysfunctionandatrialfibrillation:areversi-
122. Roca-Luque I, Oristrell G, Francisco-Pasqual J, Rodriguez-Garcia J, Santos- .. blephenomenon?PacingClinElectrophysiol2017;40:442(cid:2)450.
.
Ortega A, Martin-Sanchez G, Rivas-Gandara N, Perez-Rodon J, Ferreira- . 140.ConnollySJ,KerrCR,GentM,RobertsRS,YusufS,GillisAM,SamiMH,Talajic
.
Gonzalez I, Garcia-Dorado D, Moya-Mitjans A. Predictors of positive . M,TangAS,KleinGJ,LauC,NewmanDM.Effectsofphysiologicpacingversus
.
electrophysiological study inpatients with syncope and bundle branch block: .. ventricularpacingontheriskofstrokeanddeathduetocardiovascularcauses.
PR interval and type of conduction disturbance. Clin Cardiol 2018;41:1537(cid:2) .. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med
.
1542. . 2000;342:1385(cid:2)1391.
.
123. BrignoleM,MenozziC,MoyaA,Garcia-CiveraR,MontL,AlvarezM,Errazquin .. 141.HealeyJS,ToffWD,LamasGA,AndersenHR,ThorpeKE,EllenbogenKA,Lee
F,BeirasJ,BottoniN,DonateoP.Mechanismofsyncopeinpatientswithbun- .. KL,SkeneAM,SchronEB,SkehanJD,GoldmanL,RobertsRS,CammAJ,Yusuf
.
dle branch block and negative electrophysiological test. Circulation . S, Connolly SJ. Cardiovascular outcomes with atrial-based pacing compared
.
2001;104:2045(cid:2)2050. . with ventricular pacing: meta-analysis of randomized trials, using individual
.
124. RubensteinJJ,SchulmanCL,YurchakPM,DeSanctisRW.Clinicalspectrumof .. patientdata.Circulation2006;114:11(cid:2)17.
thesicksinussyndrome.Circulation1972;46:5(cid:2)13. .. 142.Ross RA, Kenny RA. Pacemaker syndrome in older people. Age Ageing
.
125. ShortDS.Thesyndromeofalternatingbradycardiaandtachycardia.BrHeartJ . 2000;29:13(cid:2)15.
.
1954;16:208(cid:2)214. . 143.MitsuokaT,KennyRA,YeungTA,ChanSL,PerrinsJE,SuttonR.Benefitsof .
126. GoldbergerJJ,JohnsonNP,GideaC.Significanceofasymptomaticbradycardia .. dualchamberpacinginsicksinussyndrome.BrHeartJ1988;60:338(cid:2)347.
forsubsequentpacemakerimplantationandmortalityinpatients>60yearsof .. 144.SweeneyMO,BankAJ,NsahE,KoullickM,ZengQC,HettrickD,SheldonT,
.
age.AmJCardiol2011;108:857(cid:2)861. . LamasGA,SearchAVExtensionandManagedVentricularPacingforPromoting
. 127. Nielsen JC, Thomsen PE, Hojberg S, Moller M, Vesterlund T, Dalsgaard D, .. AtrioventricularConductionTrial.Minimizingventricularpacingtoreduceatrial
MortensenLS,NielsenT,AsklundM,FriisEV,ChristensenPD,SimonsenEH, .. fibrillationinsinus-nodedisease.NEnglJMed2007;357:1000(cid:2)1008.
.
Eriksen UH, Jensen GV, Svendsen JH, Toff WD, Healey JS, Andersen HR, . 145.AndersenHR,NielsenJC,ThomsenPE,ThuesenL,MortensenPT,Vesterlund .
DANPACEInvestigators.Acomparisonofsingle-leadatrialpacingwith dual- . T, Pedersen AK. Long-termfollow-up of patients from arandomised trial of
.
chamberpacinginsicksinussyndrome.EurHeartJ2011;32:686(cid:2)696. .. atrial versus ventricular pacing for sick-sinus syndrome. Lancet
128. Breivik K, Ohm OJ, Segadal L. Sick sinus syndrome treated with permanent .. 1997;350:1210(cid:2)1216.
.
pacemaker in 109 patients. A follow-up study. Acta Med Scand . 146.AndersenHR,ThuesenL,BaggerJP,VesterlundT,ThomsenPE.Prospective
.
1979;206:153(cid:2)159. .. randomised trial of atrial versus ventricular pacing in sick-sinus syndrome.
129. HartelG,TalvensaariT.Treatmentofsinoatrialsyndromewithpermanentcar- .. Lancet1994;344:1523(cid:2)1528.
.
diacpacingin90patients.ActaMedScand1975;198:341(cid:2)347. . 147.KristensenL,NielsenJC,MortensenPT,PedersenOL,PedersenAK,Andersen
.
130. RasmussenK. Chronicsinus nodedisease: natural course andindications for . HR.Incidenceofatrialfibrillationandthromboembolisminarandomisedtrial
.
pacing.EurHeartJ1981;2:455(cid:2)459. .. ofatrialversusdualchamberpacingin177patientswithsicksinussyndrome.
131. SasakiY,ShimotoriM,AkahaneK,YonekuraH,HiranoK,EndohR,KoikeS, .. Heart2004;90:661(cid:2)666.
.
KawaS,FurutaS,HommaT.Long-termfollow-upofpatientswithsicksinus . 148.WilkoffBL,CookJR,EpsteinAE,GreeneHL,HallstromAP,HsiaH,KutalekSP,
.
syndrome:acomparisonofclinicalaspectsamongunpaced,ventricularinhibited . Sharma A, Dual Chamber VVI Implantable Defibrillator Trial Investigators.
.
paced, and physiologically paced groups. Pacing Clin Electrophysiol .. Dual-chamberpacingorventricularbackuppacinginpatientswithanimplant-
1988;11:1575(cid:2)1583. .. abledefibrillator:theDualChamberandVVIImplantableDefibrillator(DAVID)
.
132. Senturk T, Xu H, Puppala K, Krishnan B, Sakaguchi S, Chen LY, Karim R, . Trial.JAMA2002;288:3115(cid:2)3123.
.
DickinsonO,BendittDG.Cardiacpausesincompetitiveathletes:asystematic .. 149.Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D,
review examining the basis of current practice recommendations. Europace .. BenjaminEJ,VasanRS,WangTJ.Long-termoutcomesinindividualswithpro-
.
2016;18:1873(cid:2)1879. . longed PR interval or first-degree atrioventricular block. JAMA
.
133. BrignoleM,MenozziC,MoyaA,AndresenD,BlancJJ,KrahnAD,WielingW, . 2009;301:2571(cid:2)2577.
.
BeirasX,DeharoJC,RussoV,TomainoM,Sutton R,International Studyon .. 150.NielsenJC,ThomsenPE,HojbergS,MollerM,RiahiS,DalsgaardD,Mortensen
SyncopeofUncertainEtiologyInvestigators.Pacemakertherapyinpatientswith . LS,NielsenT,AsklundM,FriisEV,ChristensenPD,SimonsenEH,EriksenUH,
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 75 ---
ESCGuidelines 75
.
.
Jensen GV, Svendsen JH, Toff WD, Healey JS, Andersen HR, DANPACE . AtrioVEntricular Conduction pReservation (CAN-SAVE R) Trial. J Am Heart
.
Investigators.Atrialfibrillationinpatientswithsicksinussyndrome:theassocia- . Assoc2015;4:e001983
.
tion with PQ-interval and percentage of ventricular pacing. Europace .. 170.BellocciF,SpampinatoA,RicciR,PuglisiA,CapucciA,DiniP,BorianiG,Botto
2012;14:682(cid:2)689. .. G,CurnisA,MoracchiniPV,NicotraG,LisiF,NigroP.Antiarrhythmicbenefits
.
151. AuricchioA,EllenbogenKA.Reducingventricularpacingfrequencyinpatients . of dual chamber stimulation with rate-response in patients with paroxysmal
.
withatrioventricularblock:isittimetochangethecurrentpacingparadigm? .. atrial fibrillation and chronotropic incompetence: a prospective, multicentre
CircArrhythmElectrophysiol2016;9:e004404. .. study.Europace1999;1:220(cid:2)225.
.
152. ShurrabM,HealeyJS,Haj-YahiaS,KaoutskaiaA,BorianiG,CarrizoA,BottoG, . 171.SantiniM,RicciR,PuglisiA,MangiameliS,ProclemerA,MenozziC,DeFabrizio
.
NewmanD,PadelettiL,ConnollySJ,CrystalE.Reductioninunnecessaryven- . G, Leoni G, Lisi F, De Seta F. Long-term haemodynamic and antiarrhythmic
.
tricularpacingfailstoaffecthardclinicaloutcomesinpatientswithpreserved .. benefitsofDDIRversusDDIpacingmodeinsicksinussyndromeandchrono-
leftventricularfunction:ameta-analysis.Europace2017;19:282(cid:2)288. .. tropicincompetence.GItalCardiol1997;27:892(cid:2)900.
.
153. JankelsonL,BordacharP,StrikM,PlouxS,ChinitzL.Reducingrightventricular . 172.Capucci A, Boriani G, Specchia S, Marinelli M, Santarelli A, Magnani B.
.
pacingburden:algorithms,benefits,andrisks.Europace2019;21:539(cid:2)547. .. Evaluation by cardiopulmonary exercise test of DDDR versus DDD pacing.
154. PascaleP,PruvotE,GrafD.Pacemakersyndromeduringmanagedventricular .. PacingClinElectrophysiol1992;15:1908(cid:2)1913.
.
pacing mode: what is the mechanism? J Cardiovasc Electrophysiol . 173.LamasGA,KnightJD,SweeneyMO,MianulliM,JorapurV,KhalighiK,CookJR,
.
2009;20:574(cid:2)576. . SilvermanR,RosenthalL,Clapp-ChanningN,LeeKL,MarkDB.Impactofrate-
. 155. MansourF,KhairyP.Electricalstormduetomanagedventricularpacing.Heart .. modulatedpacingonqualityoflifeandexercisecapacity—evidencefromthe
Rhythm2012;9:842(cid:2)843. .. Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). Heart
.
156. SekitaG,HayashiH,NakazatoY,DaidaH.Ventricularfibrillationinducedby . Rhythm2007;4:1125(cid:2)1132.
.
short(cid:2)long(cid:2)short sequence during managed ventricular pacing. J Cardiovasc . 174.HociniM,SandersP,DeisenhoferI,JaisP,HsuLF,ScaveeC,WeerasoriyaR,
.
Electrophysiol2011;22:1181. .. Raybaud F, Macle L, Shah DC, Garrigue S, Le Metayer P, Clementy J,
157. VavasisC,SlotwinerDJ,GoldnerBG,CheungJW.Frequentrecurrentpolymor- .. HaissaguerreM.Reverseremodelingofsinusnodefunctionaftercatheterabla-
.
phic ventricular tachycardia during sleep due to managed ventricular pacing. . tion of atrial fibrillation in patients with prolonged sinus pauses. Circulation
.
PacingClinElectrophysiol2010;33:641(cid:2)644. .. 2003;108:1172(cid:2)1175.
158. vanMechelenR,SchoonderwoerdR.Riskofmanagedventricularpacingina .. 175.MyminD,MathewsonFA,TateRB,ManfredaJ.Thenaturalhistoryofprimary
.
patientwithheartblock.HeartRhythm2006;3:1384(cid:2)1385. . first-degreeatrioventricularheartblock.NEnglJMed1986;315:1183(cid:2)1187.
.
159. StockburgerM,BovedaS,MorenoJ,DaCostaA,HatalaR,BrachmannJ,Butter . 176.BaroldSS,IlercilA,LeonelliF,Herweg B.First-degreeatrioventricularblock.
.
C,GarciaSearaJ,RolandoM,DefayeP.Long-termclinicaleffectsofventricular .. Clinicalmanifestations,indicationsforpacing,pacemakermanagement&conse-
pacingreductionwithachangeovermodetominimizeventricularpacingina .. quences during cardiac resynchronization. J Interv Card Electrophysiol
.
generalpacemakerpopulation.EurHeartJ2015;36:151(cid:2)157. . 2006;17:139(cid:2)152.
.
160. HealeyJS,ConnollySJ,GoldMR,IsraelCW,VanGelderIC,CapucciA,Lau . 177.ShawDB,GowersJI,KekwickCA,NewKH,WhistanceAW.IsMobitztypeI
.
CP,FainE,YangS,BailleulC,MorilloCA,CarlsonM,ThemelesE,KaufmanES, .. atrioventricularblockbenigninadults?Heart2004;90:169(cid:2)174.
.
HohnloserSH,ASSERTInvestigators.Subclinicalatrialfibrillationandtheriskof . 178.CoumbeAG,NaksukN,NewellMC,SomasundaramPE,BendittDG,Adabag
.
stroke.NEnglJMed2012;366:120(cid:2)129. . S. Long-term follow-up of older patients with Mobitz type I second degree
.
161. MunawarDA,MahajanR,AgbaedengTA,ThiyagarajahA,TwomeyDJ,Khokhar .. atrioventricularblock.Heart2013;99:334(cid:2)338.
K,O’SheaC,YoungGD,Roberts-ThomsonKC,MunawarM,LauDH,Sanders .. 179.Strasberg B, Amat YLF, Dhingra RC, Palileo E, Swiryn S, Bauernfeind R,
.
P.Implicationofventricularpacingburden andatrialpacing therapiesonthe . WyndhamC,RosenKM.Naturalhistoryofchronicsecond-degreeatrioventric-
.
progression of atrial fibrillation: a systematic review and meta-analysis of . ularnodalblock.Circulation1981;63:1043(cid:2)1049.
.
randomizedcontrolledtrials.HeartRhythm2019;16:1204(cid:2)1214. .. 180.DhingraRC,DenesP,WuD,ChuquimiaR,RosenKM.Thesignificanceofsec-
162. PadelettiL, Purerfellner H, Mont L, TukkieR, Manolis AS, Ricci R, Inama G, .. ond degree atrioventricular block and bundle branch block. Observations
.
Serra P, Scheffer MG, Martins V, Warman EN, Vimercati M, Grammatico A, . regardingsiteandtypeofblock.Circulation1974;49:638(cid:2)646.
.
BorianiG,MINERVAInvestigators.New-generationatrialantitachycardiapacing .. 181.ToffWD,CammAJ,SkehanJD,UnitedKingdomPacingCardiovascularEvents
(ReactiveATP)isassociatedwithreducedriskofpersistentorpermanentatrial .. Trial Investigators. Single-chamber versus dual-chamber pacing for high-grade
.
fibrillationinpatientswithbradycardia:resultsfromtheMINERVArandomized . atrioventricularblock.NEnglJMed2005;353:145(cid:2)155.
.
multicenterinternationaltrial.HeartRhythm2015;12:1717(cid:2)1725. . 182.CastelnuovoE,SteinK,PittM,GarsideR,PayneE.Theeffectivenessandcost-
.
163. Pujol-LopezM,SanAntonioR,TolosanaJM,MontL.Programmingpacemakers .. effectivenessofdual-chamberpacemakerscomparedwithsingle-chamberpace-
toreduceandterminateatrialfibrillation.CurrCardiolRep2019;21:127. .. makersforbradycardiaduetoatrioventricularblockorsicksinussyndrome:
.
164. BorianiG,TukkieR,ManolisAS,MontL,PurerfellnerH,SantiniM,InamaG, . systematic review and economic evaluation. Health Technol Assess 2005;9:iii,
.
Serra P, de Sousa J, Botto GL, Mangoni L, Grammatico A, Padeletti L, . xi(cid:2)xiii,1(cid:2)246. .
MINERVAInvestigators.Atrialantitachycardiapacingandmanagedventricular .. 183.SweeneyMO,HellkampAS,EllenbogenKA,GreensponAJ,FreedmanRA,Lee
pacinginbradycardiapatientswithparoxysmalorpersistentatrialtachyarrhyth- .. KL,LamasGA.Adverseeffectofventricularpacingonheartfailureandatrial
.
mias: the MINERVA randomized multicentre international trial. Eur Heart J . fibrillationamongpatientswithnormalbaselineQRSdurationinaclinicaltrial
. 2014;35:2352(cid:2)2362. .. of pacemaker therapy for sinus node dysfunction. Circulation
165. CrossleyGH,PadelettiL,ZweibelS,HudnallJH,ZhangY,BorianiG.Reactive .. 2003;107:2932(cid:2)2937.
.
atrial-based antitachycardia pacing therapy reduces atrial tachyarrhythmias. . 184.NahlawiM,WaligoraM,SpiesSM,BonowRO,KadishAH,GoldbergerJJ.Left .
PacingClinElectrophysiol2019;42:970(cid:2)979. . ventricularfunctionduringandafterrightventricularpacing.JAmCollCardiol
.
166. Stockburger M, Gomez-Doblas JJ, Lamas G, Alzueta J, Fernandez-Lozano I, .. 2004;44:1883(cid:2)1888.
Cobo E, Wiegand U, ConchaJF, Navarro X, Navarro-LopezF, de Teresa E. .. 185.SweeneyMO,PrinzenFW.Anewparadigmforphysiologicventricularpacing.J
.
Preventing ventricular dysfunction in pacemaker patients without advanced . AmCollCardiol2006;47:282(cid:2)288.
.
heart failure: results from a multicentre international randomized trial . 186.TayalB,FruelundP,SogaardP,RiahiS,PolcwiartekC,AtwaterBD,GislasonG,
.
(PREVENT-HF).EurJHeartFail2011;13:633(cid:2)641. .. RisumN,Torp-PedersenC,KoberL,KragholmKH.Incidenceofheartfailure
.
167. Stockburger M,DefayeP, Boveda S,Stancak B,Lazarus A,Sipotz J,Nardi S, . after pacemaker implantation: a nationwide Danish Registry-based follow-up
.
Rolando M, Moreno J. Safety and efficiency of ventricular pacing prevention . study.EurHeartJ2019;40:3641(cid:2)3648.
.
with an AAI-DDD changeover mode in patients with sinus node disease or .. 187.KhurshidS,EpsteinAE,VerdinoRJ,LinD,GoldbergLR,MarchlinskiFE,Frankel
atrioventricular block: impact on battery longevity—a sub-study of the .. DS.Incidenceandpredictorsofrightventricularpacing-inducedcardiomyop-
.
ANSWERtrial.Europace2016;18:739(cid:2)746. . athy.HeartRhythm2014;11:1619(cid:2)1625.
.
168. ThibaultB,SimpsonC,GagneCE,BlierL,SenaratneM,McNicollS,StuglinC, . 188.KiehlEL,MakkiT,KumarR,GumberD,KwonDH,RickardJW,KanjM,Wazni
.
WilliamsR,PinterA,KhaykinY,NitzscheR.ImpactofAVconductiondisorders .. OM,SalibaWI,VarmaN,WilkoffBL,CantillonDJ.Incidenceandpredictorsof
on SafeR mode performance. Pacing Clin Electrophysiol 2009;32 Suppl .. right ventricular pacing-induced cardiomyopathy in patients with complete
.
1:S231(cid:2)235. . atrioventricular block and preserved left ventricular systolic function. Heart
.
169. ThibaultB,DucharmeA,BaranchukA,DubucM,DyrdaK,GuerraPG,Macle .. Rhythm2016;13:2272(cid:2)2278.
L,MondesertB,RivardL,RoyD,TalajicM,AndradeJ,NitzscheR,KhairyP, .. 189.KhurshidS,Obeng-GyimahE,SuppleGE,SchallerR,LinD,OwensAT,Epstein
.
CAN-SAVE R Study Investigators. Very low ventricular pacing rates can be . AE,DixitS,MarchlinskiFE,FrankelDS.Reversalofpacing-inducedcardiomyop-
.
achievedsafelyinaheterogeneouspacemakerpopulationandprovideclinical . athy following cardiac resynchronization therapy. JACC Clin Electrophysiol
.
benefits: the CANadian Multi-Centre Randomised Study-Spontaneous .. 2018;4:168(cid:2)177.
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 76 ---
76 ESCGuidelines
.
.
190. CurtisAB,WorleySJ,AdamsonPB,ChungES,NiaziI,SherfeseeL,ShinnT, . 211.OlshanskyB,HahnEA,HartzVL,PraterSP,MasonJW.Clinicalsignificanceof
.
Sutton MS, Biventricular versus Right Ventricular Pacing in Heart Failure . syncopeintheelectrophysiologicstudyversuselectrocardiographicmonitoring
.
PatientswithAtrioventricularBlockTrialInvestigators.Biventricularpacingfor .. (ESVEM)trial.TheESVEMInvestigators.AmHeartJ1999;137:878(cid:2)886.
atrioventricular block and systolic dysfunction. N Engl J Med .. 212.Roca-Luque I, Francisco-Pasqual J, Oristrell G, Rodriguez-Garcia J, Santos-
.
2013;368:1585(cid:2)1593. . Ortega A, Martin-Sanchez G, Rivas-Gandara N, Perez-Rodon J, Ferreira-
.
191. PitcherD,PapouchadoM,JamesMA,ReesJR.Twentyfourhourambulatory .. GonzalezI,Garcia-DoradoD,Moya-MitjansA.Flecainideversusprocainamide
electrocardiographyinpatientswithchronicatrialfibrillation.BrMedJ(ClinRes .. inelectrophysiologicalstudyinpatientswithsyncopeandwideQRSduration.
.
Ed)1986;292:594. . JACCClinElectrophysiol2019;5:212(cid:2)219.
.
192. Chatterjee NA, Upadhyay GA, Ellenbogen KA, McAlister FA, Choudhry NK, . 213.SantiniM,CastroA,GiadaF,Ricci R,InamaG,Gaggioli G,Calo L,OraziS,
.
SinghJP.Atrioventricularnodalablationinatrialfibrillation:ameta-analysisand .. ViscusiM,ChiodiL,BartolettiA,Foglia-ManzilloG,AmmiratiF,LoricchioML,
systematicreview.CircArrhythmElectrophysiol2012;5:68(cid:2)76. .. PedrinazziC,TurreniF,GaspariniG,AccardiF,RacitiG,RavieleA.Prevention
.
193. OzcanC,JahangirA,FriedmanPA,PatelPJ,MungerTM,ReaRF,LloydMA, . ofsyncopethroughpermanentcardiacpacinginpatientswithbifascicularblock
.
PackerDL,HodgeDO,GershBJ,HammillSC,ShenWK.Long-termsurvival . andsyncopeofunexplainedorigin:thePRESSstudy.CircArrhythmElectrophysiol
.
after ablation of the atrioventricular node and implantation of a permanent .. 2013;6:101(cid:2)107.
.
pacemaker in patients with atrial fibrillation. N Engl J Med . 214.CammAJ,Lu¨scherTF,MaurerG,SerruysPW(eds).ESCCardioMed.3rded.
.
2001;344:1043(cid:2)1051. . Oxford,UK:OxfordUniversityPress;2018.
. 194. GarciaB,ClementyN,BenhendaN,PierreB,BabutyD,OlshanskyB,Fauchier .. 215.Peters RW, Scheinman MM, Modin C, O’Young J, Somelofski CA, Mies C.
L.Mortalityafteratrioventricularnodalradiofrequencycatheterablationwith .. Prophylactic permanent pacemakers for patients with chronic bundle branch
.
permanentventricularpacinginatrialfibrillation:outcomesfromacontrolled . block.AmJMed1979;66:978(cid:2)985.
.
nonrandomizedstudy.CircArrhythmElectrophysiol2016;9. . 216.ArmaganijanLV,ToffWD,NielsenJC,AndersenHR,ConnollySJ,Ellenbogen
.
195. Brignole M, Pokushalov E, Pentimalli F, Palmisano P, Chieffo E, Occhetta E, .. KA,HealeyJS.Areelderlypatientsatincreasedriskofcomplicationsfollowing
QuartieriF,Calo(cid:4)L,UngarA,MontL.Arandomizedcontrolledtrialofatrio- .. pacemaker implantation? A meta-analysis of randomized trials. Pacing Clin
.
ventricularjunctionablationandcardiacresynchronizationtherapyinpatients . Electrophysiol2012;35:131(cid:2)134.
.
with permanent atrial fibrillation and narrow QRS. Eur Heart J .. 217.GadlerF,ValzaniaC,LindeC.Currentuseofimplantableelectricaldevicesin
2018;39:3999(cid:2)4008. .. Sweden: data from the Swedish pacemaker and implantable cardioverter-
.
196. Doshi RN, DaoudEG, Fellows C, Turk K, Duran A,Hamdan MH, Pires LA, . defibrillatorregistry.Europace2015;17:69(cid:2)77.
.
PAVE StudyGroup. Leftventricular-based cardiac stimulation postAV nodal . 218.ShurrabM,ElitzurY,HealeyJS,GulaL,KaoutskaiaA,IsraelC,LauC,CrystalE.
.
ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol .. VDDvsDDDpacemakers:ameta-analysis.CanJCardiol2014;30:1385(cid:2)1391.
2005;16:1160(cid:2)1165. .. 219.BrignoleM,AmmiratiF,ArabiaF,QuartieriF,TomainoM,UngarA,LunatiM,
.
197. HuangW,SuL,WuS,XuL,XiaoF,ZhouX,EllenbogenKA.Benefitsofper- . Russo V, Del Rosso A, Gaggioli G, Syncope Unit Project Two Investigators.
.
manentHisbundlepacingcombinedwithatrioventricularnodeablationinatrial . Assessment of a standardized algorithm for cardiac pacing in older patients
.
fibrillationpatientswithheartfailurewithbothpreservedandreducedleftven- .. affected by severe unpredictable reflex syncopes. Eur Heart J
.
tricularejectionfraction.JAmHeartAssoc2017;6:e005309. . 2015;36:1529(cid:2)1535.
.
198. Vijayaraman P, Subzposh FA, Naperkowski A. Atrioventricular node ablation . 220.Brignole M, Arabia F, Ammirati F, Tomaino M, Quartieri F, Rafanelli M, Del
.
andHisbundlepacing.Europace2017;19:iv10-iv16. .. RossoA,RitaVecchiM,RussoV,GaggioliG,SyncopeUnitProjectinvestiga-
199. Deshmukh P, Casavant DA, Romanyshyn M, Anderson K. Permanent, direct .. tors. Standardized algorithm for cardiac pacing in older patients affected by
.
His-bundlepacing:anovelapproachtocardiacpacinginpatientswithnormal . severe unpredictable reflex syncope: 3-year insights from the Syncope Unit
.
His(cid:2)Purkinjeactivation.Circulation2000;101:869(cid:2)877. . Project2(SUP2)study.Europace2016;18:1427(cid:2)1433.
.
200. OcchettaE,BortnikM,MagnaniA,FrancalacciG,PiccininoC,PlebaniL,Marino .. 221.SuttonR,BrignoleM.Twenty-eightyearsofresearchpermitreinterpretationof
P.Preventionofventriculardesynchronizationbypermanentpara-Hisianpacing .. tilt-testing: hypotensive susceptibility rather than diagnosis. Eur Heart J
.
after atrioventricular node ablation in chronic atrial fibrillation: a crossover, . 2014;35:2211(cid:2)2212.
.
blinded, randomized study versus apical right ventricular pacing. J Am Coll .. 222.Claesson JE, Kristensson BE, Edvardsson N, Wahrborg P. Less syncope and
Cardiol2006;47:1938(cid:2)1945. .. mildersymptomsinpatients treated withpacingforinducedcardioinhibitory
.
201. Lau CP,Rushby J,Leigh-JonesM, Tam CY,PolonieckiJ, Ingram A, Sutton R, . carotidsinussyndrome:arandomizedstudy.Europace2007;9:932(cid:2)936.
.
CammAJ.Symptomatologyandqualityoflifeinpatientswithrate-responsive . 223.BrignoleM,MenozziC,LolliG,BottoniN,GaggioliG.Long-termoutcomeof
.
pacemakers: a double-blind, randomized, crossover study. Clin Cardiol .. pacedandnonpacedpatientswithseverecarotidsinussyndrome.AmJCardiol
1989;12:505(cid:2)512. .. 1992;69:1039(cid:2)1043.
.
202. Leung SK, Lau CP. Developments in sensor-driven pacing. Cardiol Clin . 224.SuttonR,BrignoleM,MenozziC,RavieleA,AlboniP,GianiP,MoyaA.Dual-
.
2000;18:113(cid:2)155,ix. . chamberpacinginthetreatmentofneurallymediatedtilt-positivecardioinhibi- .
203. OtoMA,MuderrisogluH,OzinMB,KorkmazME,KaramehmetogluA,Oram .. torysyncope:pacemakerversusnotherapy:amulticenterrandomizedstudy.
A, Oram E, Ugurlu S. Quality of life in patients with rate responsive pace- .. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation
.
makers: a randomized, cross-over study. Pacing Clin Electrophysiol . 2000;102:294(cid:2)299.
. 1991;14:800(cid:2)806. .. 225.AmmiratiF,ColivicchiF,SantiniM,SyncopeD,TreatmentStudyInvestigators.
204. Proietti R, Manzoni G, Di Biase L, Castelnuovo G, Lombardi L, Fundaro C, .. Permanentcardiacpacingversusmedicaltreatmentforthepreventionofrecur-
.
VeglianteN,PietrabissaG,SantangeliP,CanbyRA,SagoneA,VieccaM,Natale . rentvasovagalsyncope:amulticenter,randomized,controlledtrial.Circulation .
A.Closedloopstimulationiseffectiveinimprovingheartrateandbloodpres- . 2001;104:52(cid:2)57.
.
sureresponsetomentalstress:reportofasingle-chamberpacemakerstudyin .. 226.Baron-EsquiviasG,MorilloCA,Moya-MitjansA,Martinez-AldayJ,Ruiz-Granell
patients with chronotropic incompetent atrial fibrillation. Pacing Clin .. R,Lacunza-RuizJ,Garcia-CiveraR,Gutierrez-CarreteroE,Romero-GarridoR.
.
Electrophysiol2012;35:990(cid:2)998. . Dual-chamberpacingwithclosedloopstimulationinrecurrentreflexvasovagal
.
205. Barold SS. Indications forpermanent cardiac pacing infirst-degree AVblock: .. syncope:theSPAINstudy.JAmCollCardiol2017;70:1720(cid:2)1728.
classI,II,orIII?PacingClinElectrophysiol1996;19:747(cid:2)751. .. 227.Russo V, Rago A, Papa AA, Golino P, Calabro R, Russo MG, Nigro G. The
.
206. Brecker SJ, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing . effect of dual-chamber closed-loop stimulation on syncope recurrence in
.
with short atrioventricular delay in dilated cardiomyopathy. Lancet . healthypatientswithtilt-inducedvasovagalcardioinhibitorysyncope:aprospec-
.
1992;340:1308(cid:2)1312. .. tive,randomised,single-blind,crossoverstudy.Heart2013;99:1609(cid:2)1613.
207. CarrozP,DelayD,GirodG.Pseudo-pacemakersyndromeinayoungwoman .. 228.BrignoleM,RussoV,ArabiaF,OliveiraM,PedroteA,AertsA,RapacciuoloA,
.
withfirst-degreeatrio-ventricularblock.Europace2010;12:594(cid:2)596. . BovedaS,DeharoJC,MagliaG,NigroG,GiacopelliD,GargaroA,TomainoM,
.
208. EnglundA,BergfeldtL,RehnqvistN,AstromH,RosenqvistM.Diagnosticvalue . BioSyncCSLtrialInvestigators.Cardiacpacinginsevererecurrentreflexsyn-
.
ofprogrammedventricularstimulationinpatientswithbifascicularblock:apro- .. copeandtilt-inducedasystole.EurHeartJ2020;42:508(cid:2)516.
spective study of patients with and without syncope. J Am Coll Cardiol .. 229.RussoV,RagoA,DeRosaM,PapaAA,SimovaI,PetrovI,BonevN,Gargaro
.
1995;26:1508(cid:2)1515. . A,GolinoP,NigroG.Doescardiacpacingreducesyncopalrecurrencesincar-
.
209. MoradyF,HigginsJ,PetersRW,SchwartzAB,ShenEN,BhandariA,Scheinman .. dioinhibitory vasovagal syncope patients selected with head-up tilt test?
MM, Sauve MJ. Electrophysiologic testing in bundle branch block and unex- .. Analysisofa5-yearfollow-updatabase.IntJCardiol2018;270:149(cid:2)153.
.
plainedsyncope.AmJCardiol1984;54:587(cid:2)591. . 230.FlammangD,ChurchTR,DeRoyL,BlancJJ,LeroyJ,MairesseGH,OtmaniA,
.
210. TabriziF,RosenqvistM,BergfeldtL,EnglundA.Long-termprognosisinpatients . Graux PJ, Frank R, Purnode P, ATP Multicenter Study. Treatment of unex-
.
withbifascicularblock—thepredictivevalueofnoninvasiveandinvasiveassess- .. plained syncope: a multicenter, randomized trial of cardiac pacing guided by
ment.JInternMed2006;260:31(cid:2)38. . adenosine5’-triphosphatetesting.Circulation2012;125:31(cid:2)36.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 77 ---
ESCGuidelines 77
.
.
231. Connolly SJ,Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, . utilizationassociatedwithcardiacresynchronizationtherapydefibrillatorimplanta-
.
Morillo C, Gent M, VPS II Investigators. Pacemaker therapy for prevention .. tionintheUnitedStates.JCardiovascElectrophysiol2018;29:1425(cid:2)1435.
of syncope in patients with recurrent severe vasovagal syncope: Second .. 250.KhanNK,GoodeKM,ClelandJG,RigbyAS,FreemantleN,EastaughJ,Clark
Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA .. AL, de Silva R, Calvert MJ, Swedberg K, Komajda M, Mareev V, Follath F.
.
2003;289:2224(cid:2)2229. . PrevalenceofECGabnormalitiesinaninternationalsurveyofpatientswithsus-
.
232. Raviele A, Giada F, Menozzi C, Speca G, Orazi S, Gasparini G, Sutton R, .. pected or confirmed heart failure at death or discharge. Eur J Heart Fail
Brignole M, Vasovagal Syncope Pacing Trial Investigators. A randomized, .. 2007;9:491(cid:2)501.
.
double-blind, placebo-controlled study of permanent cardiac pacing for the . 251.ClelandJG,McDonaghT,RigbyAS,YassinA,WhittakerT,DargieHJ.Thenational
.
treatmentofrecurrenttilt-inducedvasovagalsyncope.Thevasovagalsyncope . heartfailureauditforEnglandandWales2008(cid:2)2009.Heart2011;97:876(cid:2)886.
.
andpacingtrial(SYNPACE).EurHeartJ2004;25:1741(cid:2)1748. .. 252.Lund LH, Braunschweig F, Benson L, Stahlberg M, Dahlstrom U, Linde C.
233. PalmisanoP,Dell’EraG,RussoV,ZaccariaM,MangiaR,BortnikM,DeVecchi .. Associationbetweendemographic,organizational,clinical,andsocio-economic
.
F,GiubertoniA,PattiF,MagnaniA,NigroG,RagoA,OcchettaE,AccogliM. . characteristicsandunderutilizationofcardiacresynchronizationtherapy:results
.
Effectsofclosed-loopstimulationvs.DDDpacingonhaemodynamicvariations .. fromtheSwedishHeartFailureRegistry.EurJHeartFail2017;19:1270(cid:2)1279.
andoccurrenceofsyncopeinducedbyhead-uptilttestinolderpatientswith .. 253.DicksteinK,NormandC,AuricchioA,BogaleN,ClelandJG,GittAK,Stellbrink
.
refractorycardioinhibitoryvasovagalsyncope:theTilttest-InducedREsponsein . C,AnkerSD,FilippatosG,GaspariniM,HindricksG,BlomstromLundqvistC,
.
Closed-loop Stimulation multicentre, prospective, single blind, randomized . PonikowskiP,RuschitzkaF,BottoGL,BulavaA,DurayG,IsraelC,LeclercqC,
. study.Europace2018;20:859(cid:2)866. .. Margitfalvi P, Cano O, Plummer C, Sarigul NU, Sterlinski M, Linde C. CRT
234. ProclemerA,FacchinD,FeruglioGA.[Syncopeofunknownoriginafterelec- .. SurveyII:aEuropeanSocietyofCardiologysurveyofcardiacresynchronisation
.
trophysiologic study: is the treatment with pacemaker useful?]. G Ital Cardiol . therapyin11088patients—whoisdoingwhattowhomandhow?EurJHeart
.
1990;20:195(cid:2)201. . Fail2018;20:1039(cid:2)1051.
.
235. RavieleA,ProclemerA,GaspariniG,DiPedeF,DeliseP,PiccoloE,Feruglio .. 254.Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C,
GA. Long-term follow-up of patients with unexplained syncope and negative .. SchondubeF,WolfhardU,BockerD,KrahnefeldO,KirkelsH.Long-termclini-
.
electrophysiologicstudy.EurHeartJ1989;10:127(cid:2)132. . cal effect of hemodynamicallyoptimizedcardiac resynchronization therapy in
.
236. ParrySW,SteenN,BextonRS,TynanM,KennyRA.Pacinginelderlyrecurrent .. patients with heartfailure andventricular conduction delay. J AmCollCardiol
fallerswithcarotidsinushypersensitivity:arandomised,double-blind,placebo .. 2002;39:2026(cid:2)2033.
.
controlledcrossovertrial.Heart2009;95:405(cid:2)409. . 255.AuricchioA,StellbrinkC,ButterC,SackS,VogtJ,MisierAR,BockerD,Block
.
237. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart . M,KirkelsJH,KramerA,HuvelleE.Clinicalefficacyofcardiacresynchronization
.
2007;93:1137(cid:2)1146. .. therapyusingleftventricularpacinginheartfailurepatientsstratifiedbyseverity
238. DunlaySM,WestonSA,JacobsenSJ,RogerVL.Riskfactorsforheartfailure:a .. ofventricularconductiondelay.JAmCollCardiol2003;42:2109(cid:2)2116.
.
population-basedcase(cid:2)controlstudy.AmJMed2009;122:1023(cid:2)1028. . 256.CazeauS,LeclercqC,LavergneT,WalkerS,VarmaC,LindeC,GarrigueS,
.
239. KenchaiahS,EvansJC,LevyD,WilsonPW,BenjaminEJ,LarsonMG,Kannel . Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC. Effects of
.
WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med .. multisitebiventricularpacinginpatientswithheartfailureandintraventricular
.
2002;347:305(cid:2)313. . conductiondelay.NEnglJMed2001;344:873(cid:2)880.
.
240. Rawshani A, Rawshani A, Franzen S, Sattar N, Eliasson B, Svensson AM, . 257.LindeC,LeclercqC,RexS,GarrigueS,LavergneT,CazeauS,McKennaW,
.
ZetheliusB,MiftarajM,McGuireDK,RosengrenA,GudbjornsdottirS.Riskfac- .. Fitzgerald M, Deharo JC, Alonso C, Walker S, Braunschweig F, Bailleul C,
tors,mortality,andcardiovascularoutcomesinpatientswithtype2diabetes.N .. DaubertJC.Long-termbenefitsofbiventricularpacingincongestiveheartfail-
.
EnglJMed2018;379:633(cid:2)644. . ure:resultsfromtheMUltisiteSTimulationincardiomyopathy(MUSTIC)study.
.
241. ConradN,JudgeA,TranJ,MohseniH,HedgecottD,CrespilloAP,AllisonM, . JAmCollCardiol2002;40:111(cid:2)118.
.
HemingwayH,ClelandJG,McMurrayJJV,RahimiK.Temporaltrendsandpat- .. 258.AbrahamWT,FisherWG,SmithAL,DelurgioDB,LeonAR,LohE,Kocovic
ternsinheartfailureincidence:apopulation-basedstudyof4millionindividuals. .. DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J,
.
Lancet2018;391:572(cid:2)580. . Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in
.
242. McDonaghTA,MetraM,AdamoM,GardnerRS,BaumbachA,Bo¨hmM,Burri .. chronicheartfailure.NEnglJMed2002;346:1845(cid:2)1853.
H, Butler J, C(cid:3)elutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro .. 259.Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, Lieberman R,
.
MG,FarmakisD,GilardM,HeymansS,HoesAW,JaarsmaT,JankowskaEA, . LiemLB,O’ConnellJB,SchroederJS,WheelanKR.Effectsofcardiacresynchro-
.
Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, . nizationondiseaseprogressioninpatientswithleftventricularsystolicdysfunc-
.
MunerettoC,PiepoliMF,PriceS,RosanoGMC,RuschitzkaF,SkibelundAK; .. tion, an indication for an implantable cardioverter-defibrillator, and mildly
ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and .. symptomaticchronicheartfailure.Circulation2004;110:2864(cid:2)2868.
.
treatment of acute and chronic heart failure. Eur Heart J 2021;doi:10.1093/ . 260.BristowMR,SaxonLA,BoehmerJ,KruegerS,KassDA,DeMarcoT,CarsonP,
.
eurheartj/ehab368. . DiCarloL,DeMetsD,WhiteBG,DeVriesDW,FeldmanAM.Cardiac-resynch- .
243. Crespo-LeiroMG,AnkerSD,MaggioniAP,CoatsAJ,FilippatosG,RuschitzkaF, .. ronization therapy with or without an implantable defibrillator in advanced
FerrariR,PiepoliMF,DelgadoJimenezJF,MetraM,FonsecaC,HradecJ,Amir .. chronicheartfailure.NEnglJMed2004;350:2140(cid:2)2150.
.
O,LogeartD,DahlstromU,MerkelyB,DrozdzJ,GoncalvesovaE,Hassanein . 261.ClelandJG,DaubertJC,ErdmannE,FreemantleN,GrasD,KappenbergerL,
. M, Chioncel O, Lainscak M, Seferovic PM, Tousoulis D, Kavoliuniene A, .. TavazziL.Longer-termeffectsofcardiacresynchronizationtherapyonmortal-
Fruhwald F, Fazlibegovic E, Temizhan A, Gatzov P, Erglis A, Laroche C, .. ity in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF)
.
MebazaaA.EuropeanSocietyofCardiologyHeartFailureLong-TermRegistry . trialextensionphase].EurHeartJ2006;27:1928(cid:2)1932. .
(ESC-HF-LT):1-yearfollow-upoutcomesanddifferencesacrossregions.EurJ . 262.Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C.
.
HeartFail2016;18:613(cid:2)625. .. Randomizedtrialofcardiacresynchronizationinmildlysymptomaticheartfail-
244. OlshanskyB,DayJD,SullivanRM,YongP,GalleE,SteinbergJS.Doescardiac .. urepatientsandinasymptomaticpatientswithleftventriculardysfunctionand
.
resynchronizationtherapyprovideunrecognizedbenefitinpatients withpro- . previousheartfailuresymptoms.JAmCollCardiol2008;52:1834(cid:2)1843.
.
longedPRintervals?Theimpactofrestoringatrioventricularsynchrony:ananal- . 263.DaubertC,GoldMR,AbrahamWT,GhioS,HassagerC,GoodeG,Szili-Torok
.
ysisfromtheCOMPANIONTrial.HeartRhythm2012;9:34(cid:2)39. .. T, Linde C. Prevention of disease progression by cardiac resynchronization
.
245. Gervais R, Leclercq C, Shankar A, Jacobs S, Eiskjaer H, Johannessen A, . therapy in patients with asymptomatic or mildly symptomatic left ventricular
.
Freemantle N, Cleland JG, Tavazzi L, Daubert C, CARE-HF investigators. . dysfunction: insights from the European cohort of the REVERSE
.
Surface electrocardiogram to predict outcome in candidates for cardiac .. (Resynchronization Reverses Remodeling in Systolic Left Ventricular
resynchronizationtherapy:asub-analysisoftheCARE-HFtrial.EurJHeartFail .. Dysfunction)trial.JAmCollCardiol2009;54:1837(cid:2)1846.
.
2009;11:699(cid:2)705. . 264.RuschitzkaF,AbrahamWT,SinghJP,BaxJJ,BorerJS,BrugadaJ,DicksteinK,
.
246. FriedmanDJ,BaoH,SpatzES,CurtisJP,DaubertJP,Al-KhatibSM.Association . Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J. Cardiac-
.
BetweenaProlonged PRintervalandoutcomesofcardiacresynchronization .. resynchronizationtherapyinheartfailurewithanarrowQRScomplex.NEnglJ
therapy: a report from the National Cardiovascular Data Registry. Circulation .. Med2013;369:1395(cid:2)1405.
.
2016;134:1617(cid:2)1628. . 265.GoldenbergI,KutyifaV,MossAJ.Survivalwithcardiac-resynchronizationther-
.
247. LeclercqC,KassDA.Retimingthefailingheart:principlesandcurrentclinical .. apy.NEnglJMed2014;371:477(cid:2)478.
statusofcardiacresynchronization.JAmCollCardiol2002;39:194(cid:2)201. .. 266.Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Claude Daubert J,
.
248. Leclercq C, Hare JM. Ventricular resynchronization: current state of the art. . Sherfesee L, Wells GA, Tang AS. An individual patient meta-analysis of five
.
Circulation2004;109:296(cid:2)299. . randomizedtrialsassessingtheeffectsofcardiacresynchronizationtherapyon
.
249. Patel N, Viles-Gonzalez J, Agnihotri K, Arora S, Patel NJ, Aneja E, Shah M, .. morbidityandmortalityinpatientswithsymptomaticheartfailure.EurHeartJ
BadhekaAO,PothineniNV.Frequencyofin-hospitaladverseoutcomesandcost . 2013;34:3547(cid:2)3556.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 78 ---
78 ESCGuidelines
.
.
267. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, Djiane P, . improvespredictionoflong-termcardiacresynchronizationtherapyoutcome.
.
MaboP,LevyT,GadlerF,BailleulC,DaubertJC.Comparativeeffectsofper- . CircArrhythmElectrophysiol2018;11:e006767.
.
manent biventricular and right-univentricular pacing in heart failure patients .. 285.StraussDG,SelvesterRH,WagnerGS.Definingleftbundlebranchblockinthe
withchronicatrialfibrillation.EurHeartJ2002;23:1780(cid:2)1787. .. eraofcardiacresynchronizationtherapy.AmJCardiol2011;107:927(cid:2)934.
.
268. FunckRC,MuellerHH,LunatiM,PiorkowskiC,DeRoyL,PaulV,Wittenberg . 286.LeeAWC,O’ReganDP,GouldJ,SidhuB,SieniewiczB,PlankG,WarrinerDR,
.
M,WuenschD,BlancJJ.Characteristicsofalargesampleofcandidatesforper- .. LamataP,RinaldiCA,NiedererSA.Sex-dependentQRSguidelinesforcardiac
manent ventricular pacing included in the Biventricular Pacing for Atrio- .. resynchronizationtherapyusingcomputermodelpredictions.BiophysicalJournal
.
ventricular Block to Prevent Cardiac Desynchronization Study (BioPace). . 2019;117:2375(cid:2)2381.
.
Europace2014;16:354(cid:2)362. . 287.Caputo ML, van Stipdonk A, Illner A, D’Ambrosio G, Regoli F, Conte G,
.
269. SipahiI,CarriganTP,RowlandDY,StamblerBS,FangJC.ImpactofQRSdura- .. MoccettiT,KlersyC,PrinzenFW,VernooyK,AuricchioA.Thedefinitionof
tiononclinicaleventreductionwithcardiacresynchronizationtherapy:meta- .. leftbundlebranchblockinfluencestheresponsetocardiacresynchronization
.
analysisofrandomizedcontrolledtrials.ArchInternMed2011;171:1454(cid:2)1462. . therapy.IntJCardiol2018;269:165(cid:2)169.
.
270. SipahiI,ChouJC,HydenM,RowlandDY,SimonDI,FangJC.EffectofQRS . 288.vanStipdonkAMW,VanbelleS,TerHorstIAH,LuermansJG,MeineM,Maass
.
morphologyonclinicaleventreductionwithcardiacresynchronizationtherapy: .. AH,AuricchioA,PrinzenFW,VernooyK.Largevariabilityinclinicaljudgement
.
meta-analysis of randomized controlled trials. Am Heart J . and definitions of left bundle branch block to identify candidates for cardiac
.
2012;163:260(cid:2)267.e263. . resynchronisationtherapy.IntJCardiol2019;286:61(cid:2)65.
. 271. Cunnington C, Kwok CS, Satchithananda DK, Patwala A, Khan MA, Zaidi A, .. 289.TomlinsonDR,BashirY,BettsTR,RajappanK.AccuracyofmanualQRSdura-
Ahmed FZ, Mamas MA. Cardiac resynchronisation therapy is not associated .. tionassessment:itsimportanceinpatientselectionforcardiacresynchroniza-
.
with a reduction in mortality or heart failure hospitalisation in patients with . tion and implantable cardioverter defibrillator therapy. Europace
.
non-left bundle branch block QRS morphology: meta-analysis of randomised . 2009;11:638(cid:2)642.
.
controlledtrials.Heart2015;101:1456(cid:2)1462. .. 290.VancuraV,WichterleD,UlcI,SmidJ,BrabecM,ZarybnickaM,RokytaR.The
272. ZarebaW,KleinH,CygankiewiczI,HallWJ,McNittS,BrownM,CannomD, .. variability of automated QRS duration measurement. Europace
.
Daubert JP, Eldar M, Gold MR, Goldberger JJ, Goldenberg I, Lichstein E, . 2017;19:636(cid:2)643.
.
PitschnerH,RashtianM,SolomonS,ViskinS,WangP,MossAJ.Effectivenessof .. 291.SzeE,SamadZ,DunningA,CampbellKB,LoringZ,AtwaterBD,ChiswellK,
cardiac resynchronization therapy by QRS morphology in the Multicenter .. KissloJA,VelazquezEJ,DaubertJP.Impairedrecoveryofleftventricularfunc-
.
AutomaticDefibrillatorImplantation Trial-CardiacResynchronizationTherapy . tioninpatientswith cardiomyopathyandleftbundlebranchblock.JAmColl
.
(MADIT-CRT).Circulation2011;123:1061(cid:2)1072. . Cardiol2018;71:306(cid:2)317.
.
273. BirnieDH,HaA,HigginsonL,SidhuK,GreenM,PhilipponF,ThibaultB,Wells .. 292.Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A,
G,TangA.ImpactofQRSmorphologyanddurationonoutcomesaftercardiac .. Lerebours G, Tavazzi L, SHIFT Investigators. Ivabradine and outcomes in
.
resynchronizationtherapy:resultsfromtheResynchronization-Defibrillationfor . chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet
.
AmbulatoryHeartFailureTrial(RAFT).CircHeartFail2013;6:1190(cid:2)1198. . 2010;376:875(cid:2)885.
.
274. BilchickKC,KamathS,DiMarcoJP,StukenborgGJ.Bundle-branchblockmor- .. 293.McMurrayJJ,PackerM,DesaiAS,GongJ,LefkowitzMP,RizkalaAR,RouleauJL,
.
phologyandotherpredictorsofoutcomeaftercardiacresynchronizationther- . Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators
.
apyinMedicarepatients.Circulation2010;122:2022(cid:2)2030. . Committees.Angiotensin(cid:2)neprilysininhibitionversusenalaprilinheartfailure.
.
275. WoodsB,HawkinsN,MealingS,SuttonA,AbrahamWT,BeshaiJF,KleinH, .. NEnglJMed2014;371:993(cid:2)1004.
Sculpher M, Plummer CJ, Cowie MR. Individual patient data network meta- .. 294.NijstP,MartensP,DauwJ,TangWHW,BertrandPB,PendersJ,BruckersL,
.
analysis of mortality effects of implantable cardiac devices. Heart . VorosG,WillemsR,VandervoortPM,DupontM,MullensW.Withdrawalof
.
2015;101:1800(cid:2)1806. . neurohumoral blockade after cardiac resynchronization therapy. J Am Coll
.
276. Gold MR, Thebault C, Linde C, Abraham WT, Gerritse B, Ghio S, St John .. Cardiol2020;75:1426(cid:2)1438.
Sutton M, Daubert JC. Effect of QRS duration and morphology on cardiac .. 295.MullensW,AuricchioA,MartensP,WitteK,CowieMR,DelgadoV,Dickstein
.
resynchronization therapy outcomes in mild heart failure: results from the . K,LindeC,VernooyK,LeyvaF,BauersachsJ,IsraelCW,LundLH,DonalE,
.
Resynchronization Reverses Remodeling in Systolic Left Ventricular .. Boriani G, Jaarsma T, Berruezo A, Traykov V, Yousef Z, Kalarus Z, Cosedis
Dysfunction(REVERSE)study.Circulation2012;126:822(cid:2)829. .. NielsenJ,SteffelJ,VardasP,CoatsA,SeferovicP,EdvardsenT,HeidbuchelH,
.
277. FantoniC,KawabataM,MassaroR,RegoliF,RaffaS,AroraV,Salerno-Uriarte . RuschitzkaF,LeclercqC.Optimizedimplementationofcardiacresynchroniza-
.
JA, Klein HU, Auricchio A. Right and left ventricular activation sequence in . tiontherapy:acallforactionforreferralandoptimizationofcare:ajointposi-
.
patients with heart failure and right bundle branch block: a detailed analysis .. tion statement from the Heart Failure Association (HFA), European Heart
using three-dimensional non-fluoroscopic electroanatomic mapping system. J .. Rhythm Association (EHRA), and European Association of Cardiovascular
.
CardiovascElectrophysiol2005;16:112(cid:2)119;discussion120(cid:2)121. . Imaging (EACVI) of the European Society of Cardiology. Eur J Heart Fail
.
278. Nery PB, Ha AC, Keren A, Birnie DH. Cardiac resynchronization therapy in . 2020;22:2349(cid:2)2369. .
patientswithleftventricularsystolicdysfunctionandrightbundlebranchblock: .. 296.HindricksG,PotparaT,DagresN,ArbeloE,BaxJJ,Blomstrom-LundqvistC,
asystematicreview.HeartRhythm2011;8:1083(cid:2)1087. .. BorianiG,CastellaM,DanGA,DilaverisPE,FauchierL,FilippatosG,Kalman
.
279. Kutyifa V, StockburgerM, Daubert JP,HolmqvistF, Olshansky B, SchugerC, . JM,LaMeirM,LaneDA,LebeauJP,LettinoM,LipGYH,PintoFJ,ThomasGN,
. KleinH,GoldenbergI,BrenyoA,McNittS,MerkelyB,ZarebaW,MossAJ.PR .. Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL, ESC Scientific
intervalidentifiesclinicalresponseinpatientswithnon-leftbundlebranchblock: .. DocumentGroup.2020ESCGuidelinesforthediagnosisandmanagementof
.
a Multicenter Automatic Defibrillator Implantation Trial-Cardiac . atrialfibrillationdevelopedincollaborationwiththeEuropeanAssociationof .
Resynchronization Therapy substudy. Circ Arrhythm Electrophysiol . Cardio-ThoracicSurgery(EACTS).EurHeartJ2020;42:373(cid:2)498.
.
2014;7:645(cid:2)651. .. 297.OusdigianKT,BorekPP,KoehlerJL,HeywoodJT,ZieglerPD,WilkoffBL.The
280. KewcharoenJ,KanitsoraphanC.ProlongedPRintervalandoutcomeincardiac .. epidemicofinadequatebiventricularpacinginpatientswithpersistentorper-
.
resynchronizationtherapy.ArqBrasCardiol2019;113:109(cid:2)110. . manent atrial fibrillation and its association with mortality. Circ Arrhythm
.
281. Steffel J, Robertson M,Singh JP,Abraham WT, Bax JJ, Borer JS, DicksteinK, .. Electrophysiol2014;7:370(cid:2)376.
FordI,GorcsanJ3rd,GrasD,KrumH,SogaardP,HolzmeisterJ,BrugadaJ, .. 298.KoplanBA,KaplanAJ,WeinerS,JonesPW,SethM,ChristmanSA.Heartfail-
.
RuschitzkaF.TheeffectofQRSdurationoncardiacresynchronizationtherapy . uredecompensationandall-causemortalityinrelationtopercentbiventricular
.
inpatientswithanarrowQRScomplex:asubgroupanalysisoftheEchoCRT . pacinginpatientswithheartfailure:isagoalof100%biventricularpacingneces-
.
trial.EurHeartJ2015;36:1983(cid:2)1989. .. sary?JAmCollCardiol2009;53:355(cid:2)360.
282. Arshad A, Moss AJ, Foster E, Padeletti L, Barsheshet A, Goldenberg I, .. 299.HayesDL,BoehmerJP,DayJD,GilliamFR3rd,HeidenreichPA,SethM,Jones
.
GreenbergH,HallWJ,McNittS,ZarebaW,SolomonS,SteinbergJS.Cardiac . PW,SaxonLA.Cardiacresynchronizationtherapyandtherelationshipofper-
.
resynchronization therapy is more effective in women than in men: the . cent biventricular pacing to symptoms and survival. Heart Rhythm
.
MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with .. 2011;8:1469(cid:2)1475.
CardiacResynchronizationTherapy)trial.JAmCollCardiol2011;57:813(cid:2)820. .. 300.HealeyJS,HohnloserSH,ExnerDV,BirnieDH,ParkashR,ConnollySJ,Krahn
.
283. Zusterzeel R, Selzman KA, Sanders WE, Canos DA, O’Callaghan KM, . AD, Simpson CS, Thibault B, Basta M, Philippon F, Dorian P, Nair GM,
.
CarpenterJL,PinaIL,StraussDG.Cardiacresynchronizationtherapyinwomen: .. SivakumaranS,YetisirE,WellsGA,TangAS.Cardiacresynchronizationther-
US Food and Drug Administration meta-analysis of patient-level data. JAMA .. apy in patients with permanent atrial fibrillation: results from the
.
InternMed2014;174:1340(cid:2)1348. . Resynchronization for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail
.
284. Zweerink A, Friedman DJ, Klem I, van de Ven PM, Vink C, Biesbroek PS, . 2012;5:566(cid:2)570.
.
HansenSM,EmerekK,KimRJ,vanRossumAC,AtwaterBD,NijveldtR,Allaart .. 301.GanesanAN,BrooksAG,Roberts-ThomsonKC,LauDH,KalmanJM,Sanders
CP.SizeMatters:NormalizationofQRSdurationtoleftventriculardimension . P. Role of AV nodal ablation in cardiac resynchronization in patients with
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 79 ---
ESCGuidelines 79
.
.
coexistent atrial fibrillation and heart failure a systematic review. J Am Coll . 321.ColucciaG,VitaleE,CoralloS,AsteM,OdagliaF,DonateoP,OddoneD,Brignole
.
Cardiol2012;59:719(cid:2)726. . M.Additionalbenefitsofnonconventionalmodalitiesofcardiacresynchronization
.
302. GaspariniM,LeclercqC,LunatiM,LandolinaM,AuricchioA,SantiniM,Boriani .. therapyusingHisbundlepacing.JCardiovascElectrophysiol2020;31:647(cid:2)657.
G,LampB,ProclemerA,CurnisA,KlersyC,LeyvaF.Cardiacresynchroniza- .. 322.KirchhofP,BenussiS,KotechaD,AhlssonA,AtarD,CasadeiB,CastellaM,
.
tion therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac . Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J,
.
ResynchronizationTherapyinAtrialFibrillationPatientsMultinationalRegistry). .. PopescuBA,SchottenU,VanPutteB,VardasP.2016ESCGuidelinesforthe
JACCHeartFail2013;1:500(cid:2)507. .. management of atrial fibrillation developed in collaboration with EACTS. Eur
.
303. KotechaD,HolmesJ,KrumH,AltmanDG,ManzanoL,ClelandJG,LipGY, . HeartJ2016;37:2893(cid:2)2962.
.
Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, . 323.YuCM,ChanJY,ZhangQ,OmarR,YipGW,HussinA,FangF,LamKH,Chan
.
ShibataMC,RigbyA,FlatherMD,Beta-BlockersinHeartFailureCollaborative .. HC,FungJW.Biventricularpacinginpatientswithbradycardiaandnormalejec-
Group.Efficacyofbetablockersinpatientswithheartfailureplusatrialfibrilla- .. tionfraction.NEnglJMed2009;361:2123(cid:2)2134.
.
tion:anindividual-patientdatameta-analysis.Lancet2014;384:2235(cid:2)2243. . 324.Tanaka H, Hara H, Adelstein EC, Schwartzman D, Saba S, Gorcsan J 3rd.
.
304. ZiffOJ,SamraM,HowardJP,BromageDI,RuschitzkaF,FrancisDP,KotechaD. . ComparativemechanicalactivationmappingofRVpacingtoLBBBby2Dand
.
Beta-blocker efficacy across different cardiovascular indications: an umbrella .. 3Dspeckletrackingandassociationwithresponsetoresynchronizationther-
.
reviewandmeta-analyticassessment.BMCMed2020;18:103. . apy.JACCCardiovascImaging2010;3:461(cid:2)471.
.
305. DochertyKF,ShenL,CastagnoD,PetrieMC,AbrahamWT,BohmM,Desai . 325.MaraiI,GurevitzO,CarassoS,NofE,Bar-LevD,LuriaD,ArbelY,FreimarkD,
. AS,DicksteinK,KoberLV,PackerM,RouleauJL,SolomonSD,SwedbergK, .. FeinbergMS,EldarM,GliksonM.Improvementofcongestiveheartfailureby
VazirA,ZileMR,JhundPS,McMurrayJJV.Relationshipbetweenheartrateand .. upgrading of conventional to resynchronization pacemakers. Pacing Clin
.
outcomesinpatientsinsinusrhythmoratrialfibrillationwithheartfailureand . Electrophysiol2006;29:880(cid:2)884.
.
reducedejectionfraction.EurJHeartFail2020;22:528(cid:2)538. . 326.Witte KK, Pipes RR, Nanthakumar K, Parker JD. Biventricular pacemaker
.
306. YinJ,HuH,WangY,XueM,LiX,ChengW,LiX,YanS.Effectsofatrioven- .. upgradeinpreviouslypacedheartfailurepatients—improvementsinventricular
tricular nodal ablation on permanent atrial fibrillation patients with cardiac .. dyssynchrony.JCardFail2006;12:199(cid:2)204.
.
resynchronization therapy: a systematic review and meta-analysis. Clin Cardiol . 327.Duray GZ, Israel CW, Pajitnev D, Hohnloser SH. Upgrading to biventricular
.
2014;37:707(cid:2)715. .. pacing/defibrillationsystemsinrightventricularpacedcongestiveheartfailure
307. TolosanaJM,ArnauAM,MadridAH,MaciasA,LozanoIF,OscaJ,QuesadaA, .. patients:prospectiveassessmentofproceduralparametersandresponserate.
.
ToqueroJ,France´sRM,BolaoIG,BerruezoA,SitgesM,Alcal(cid:2)aMG,BrugadaJ, . Europace2008;10:48(cid:2)52.
.
Mont L. Cardiac resynchronization therapy in patients with permanent atrial . 328.NageleH,DodeckJ,BehrensS,AziziM,HashagenS,EisermannC,CastelMA.
.
fibrillation.Isit mandatoryto ablate the atrioventricular junction to obtain a .. Hemodynamicsandprognosisafterprimarycardiacresynchronizationsystem
goodresponse?EurJHeartFail2012;14:635(cid:2)641. .. implantation compared to ‘upgrade’ procedures. Pacing Clin Electrophysiol
.
308. TolosanaJM,TruccoE,KhatibM,DoltraA,BorrasR,CastelM,BerruezoA, . 2008;31:1265(cid:2)1271.
.
ArbeloE,SitgesM,MatasM,GuaschE,BrugadaJ,MontL.Completeatrioven- . 329.Foley PW, Muhyaldeen SA, Chalil S, Smith RE, Sanderson JE, Leyva F. Long-
.
tricularblockdoesnotreducelong-termmortalityinpatientswithpermanent .. termeffectsofupgradingfromrightventricularpacingtocardiacresynchroniza-
.
atrialfibrillationtreatedwithcardiacresynchronizationtherapy.EurJHeartFail . tiontherapyinpatientswithheartfailure.Europace2009;11:495(cid:2)501.
.
2013;15:1412(cid:2)1418. . 330.WokhluA,ReaRF,AsirvathamSJ,WebsterT,BrookeK,HodgeDO,WisteHJ,
.
309. KamathGS,CotigaD,KoneruJN,ArshadA,PierceW,AzizEF,MandavaA, .. DongY,HayesDL,ChaYM.Upgradeanddenovocardiacresynchronization
MittalS,SteinbergJS.Theutilityof12-leadHoltermonitoringinpatientswith .. therapy:impactofpacedorintrinsicQRSmorphologyonoutcomesandsur-
.
permanentatrialfibrillationfortheidentificationofnonrespondersaftercardiac . vival.HeartRhythm2009;6:1439(cid:2)1447.
.
resynchronizationtherapy.JAmCollCardiol2009;53:1050(cid:2)1055. . 331.Frohlich G, Steffel J, Hurlimann D, Enseleit F, Luscher TF, Ruschitzka F,
.
310. Hernandez-Madrid A, Facchin D, Klepfer RN, Ghosh S, Matia R, Moreno J, .. Abraham WT, Holzmeister J. Upgrading to resynchronization therapy after
LocatelliA.Devicepacingdiagnosticsoverestimateeffectivecardiacresynchro- .. chronicrightventricularpacingimprovesleftventricularremodelling.EurHeart
.
nizationtherapypacingresultsofthehOLterforEfficacyanalysisofCRT(OLE . J2010;31:1477(cid:2)1485.
.
CRT)study.HeartRhythm2017;14:541(cid:2)547. .. 332.PaparellaG,SciarraL,CapulziniL,FrancesconiA,DeAsmundisC,SarkozyA,
311. PlummerCJ,FrankCM,B(cid:2)ariZ,AlHebaishiYS,KlepferRN,StadlerRW,Ghosh .. CazzinR,BrugadaP.Long-termeffectsofupgradingtobiventricularpacing:dif-
.
S,LiuS,MittalS.Anovelalgorithmincreasesthedeliveryofeffectivecardiac . ferences with cardiac resynchronization therapy as primary indication. Pacing
.
resynchronization therapy during atrial fibrillation: the CRTee randomized . ClinElectrophysiol2010;33:841(cid:2)849.
.
crossovertrial.HeartRhythm2018;15:369(cid:2)375. .. 333.BogaleN,WitteK,PrioriS,ClelandJ,AuricchioA,GadlerF,GittA,Limbourg
312. TopsLF,SchalijMJ,HolmanER,vanErvenL,vanderWallEE,BaxJJ.Rightven- .. T, Linde C, Dickstein K. The European Cardiac Resynchronization Therapy
.
tricularpacingcaninduceventriculardyssynchronyinpatientswithatrialfibrilla- . Survey: comparison of outcomes between de novo cardiac resynchronization
.
tionafteratrioventricularnodeablation.JAmCollCardiol2006;48:1642(cid:2)1648. . therapyimplantationsandupgrades.EurJHeartFail2011;13:974(cid:2)983. .
313. BrignoleM,Botto G,MontL,IacopinoS,DeMarchi G,OddoneD,LuziM, .. 334.GageRM,BurnsKV,BankAJ.Echocardiographicandclinicalresponsetocar-
Tolosana JM, Navazio A, Menozzi C. Cardiac resynchronization therapy in .. diacresynchronizationtherapyinheartfailurepatientswithandwithoutpre-
.
patientsundergoingatrioventricularjunctionablationforpermanentatrialfibril- . viousrightventricularpacing.EurJHeartFail2014;16:1199(cid:2)1205.
. lation:arandomizedtrial.EurHeartJ2011;32:2420(cid:2)2429. .. 335.TayalB,GorcsanJ3rd,Delgado-MonteroA,GodaA,RyoK,SabaS,RisumN,
314. BrignoleM,BottoGL,MontL,OddoneD,IacopinoS,DeMarchiG,Campoli .. Sogaard P. Comparative long-term outcomes after cardiac resynchronization
.
M,SebastianiV,VincentiA,GarciaMedinaD,OscaAsensiJ,MociniA,Grovale . therapyinrightventricularpacedpatientsversusnativewideleftbundlebranch .
N,DeSantoT,MenozziC.Predictorsofclinicalefficacyof‘AblateandPace’ . blockpatients.HeartRhythm2016;13:511(cid:2)518.
.
therapyinpatientswithpermanentatrialfibrillation.Heart2012;98:297(cid:2)302. .. 336.TerHorstIA,KuijpersY,van‘tSantJ,TuinenburgAE,CramerMJ,MeineM.
315. StavrakisS,GarabelliP,ReynoldsDW.Cardiacresynchronizationtherapyafter .. ‘AreCRTupgradeproceduresmorecomplexandassociatedwithmorecom-
.
atrioventricularjunctionablationforsymptomaticatrialfibrillation:ameta-anal- . plicationsthandenovoCRTimplantations?’Asinglecentreexperience.Neth
.
ysis.Europace2012;14:1490(cid:2)1497. .. HeartJ2016;24:75(cid:2)81.
316. SharmaPS,VijayaramanP,EllenbogenKA.PermanentHisbundlepacing:shaping .. 337.LiparL,SrivathsanK,ScottLR.Short-termoutcomeofcardiacresynchroniza-
.
thefutureofphysiologicalventricularpacing.NatRevCardiol2020;17:22(cid:2)36. . tion therapy—a comparison between newly implanted and chronically right
.
317. HuangW,SuL,WuS,XuL,XiaoF,ZhouX,EllenbogenKA.ANovelpacing . ventricle-pacedpatients.IntJCardiol2016;219:195(cid:2)199.
.
strategywithlowandstableoutput:pacingtheleftbundlebranchimmediately .. 338.VamosM,ErathJW,BariZ,VaganyD,LinzbachSP,BurmistravaT,IsraelCW,
beyondtheconductionblock.CanJCardiol2017;33:1736.e1(cid:2)1736.e73. .. DurayGZ,HohnloserSH.Effectsofupgradeversusdenovocardiacresynchro-
.
318. Sharma PS, Dandamudi G, Herweg B, Wilson D, Singh R, Naperkowski A, . nizationtherapyonclinicalresponseandlong-termsurvival:resultsfromamul-
.
KoneruJN,EllenbogenKA,VijayaramanP.PermanentHis-bundlepacingasan . ticenterstudy.CircArrhythmElectrophysiol2017;10:e004471.
.
alternativetobiventricularpacingforcardiacresynchronizationtherapy:amul- .. 339.CheungJW,IpJE,MarkowitzSM,LiuCF,ThomasG,FeldmanDN,Swaminathan
ticenterexperience.HeartRhythm2018;15:413(cid:2)420. .. RV,LermanBB,KimLK.Trendsandoutcomesofcardiacresynchronizationther-
.
319. Vijayaraman P, Herweg B, Ellenbogen KA, Gajek J. His-optimized cardiac . apyupgradeprocedures:acomparativeanalysisusingaUnitedStatesNational
.
resynchronizationtherapytomaximizeelectricalresynchronization:afeasibility .. Database2003(cid:2)2013.HeartRhythm2017;14:1043(cid:2)1050.
study.CircArrhythmElectrophysiol2019;12:e006934. .. 340.LeonAR,GreenbergJM,KanuruN,BakerCM,MeraFV,SmithAL,LangbergJJ,
320. BoczarK,SławutaA,Za˛bekA,DRebskiM,VijayaramanP,GajekJ,LelakowskiJ, .. DeLurgioDB.Cardiacresynchronizationinpatientswithcongestiveheartfail-
.
Małecka B. Cardiac resynchronization therapy with His bundle pacing. Pacing . ureandchronicatrialfibrillation:effectofupgradingtobiventricularpacingafter
.
ClinElectrophysiol.2019;42:374(cid:2)380. .. chronicrightventricularpacing.JAmCollCardiol2002;39:1258(cid:2)1263.
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 80 ---
80 ESCGuidelines
.
.
341. Baker CM, Christopher TJ, Smith PF, Langberg JJ, Delurgio DB, Leon AR. . 361.ChungES,StJohnSuttonMG,MealingS,SidhuMK,PadhiarA,TsintzosSI,Lu
.
Addition of a left ventricular lead to conventional pacing systems inpatients . X, Verhees KJP, Lautenbach AA, Curtis AB. Economic value and cost-
.
withcongestiveheartfailure:feasibility,safety,andearlyresultsin60consecu- .. effectiveness of biventricular versus right ventricular pacing: results from the
tivepatients.PacingClinElectrophysiol2002;25:1166(cid:2)1171. .. BLOCK-HFstudy.JMedEcon2019;22:1088(cid:2)1095.
.
342. Valls-BertaultV,FatemiM,GilardM,PennecPY,EtienneY,BlancJJ.Assessment . 362.Orlov MV, Gardin JM, Slawsky M, Bess RL, Cohen G, Bailey W, Plumb V,
.
ofupgradingtobiventricularpacinginpatientswithrightventricularpacingand .. Flathmann H, de Metz K. Biventricular pacing improves cardiac function
congestive heart failure after atrioventricular junctional ablation for chronic .. and prevents further left atrial remodeling in patients with symptomatic
.
atrialfibrillation.Europace2004;6:438(cid:2)443. . atrial fibrillation after atrioventricular node ablation. Am Heart J
.
343. EldadahZA,RosenB,HayI,EdvardsenT,JayamV,DickfeldT,MeiningerGR, . 2010;159:264(cid:2)270.
.
Judge DP, Hare J, Lima JB, Calkins H, Berger RD. The benefit of upgrading .. 363.CarsonP,AnandI,O’ConnorC,JaskiB,SteinbergJ,LwinA,LindenfeldJ,Ghali
chronically right ventricle-paced heart failure patients to resynchronization .. J,BarnetJH,FeldmanAM,BristowMR.Modeofdeathinadvancedheartfailure:
.
therapydemonstratedbystrainrateimaging.HeartRhythm2006;3:435(cid:2)442. . the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart
.
344. ShimanoM,TsujiY,YoshidaY,IndenY,TsuboiN,ItohT,SuzukiH,Muramatsu .. Failure(COMPANION)trial.JAmCollCardiol2005;46:2329(cid:2)2334.
T,OkadaT,HarataS,YamadaT,HirayamaH,NattelS,MuroharaT.Acuteand .. 364.BarsheshetA,WangPJ,MossAJ,SolomonSD,Al-AhmadA,McNittS,Foster
.
chroniceffectsofcardiacresynchronizationinpatientsdevelopingheartfailure . E,HuangDT,KleinHU,ZarebaW,EldarM,GoldenbergI.Reverseremodeling
.
with long-term pacemaker therapy for acquired complete atrioventricular . and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter
. block.Europace2007;9:869(cid:2)874. .. AutomaticDefibrillatorImplantationTrial-CardiacResynchronizationTherapy).
345. Laurenzi F, Achilli A, Avella A, Peraldo C, Orazi S, Perego GB, Cesario A, .. JAmCollCardiol2011;57:2416(cid:2)2423.
.
ValsecchiS,DeSantoT,PuglisiA,TondoC.Biventricularupgradinginpatients . 365.GoldMR,LindeC,AbrahamWT,GardiwalA,DaubertJC.Theimpactofcar-
.
with conventional pacing system and congestive heart failure: results and . diacresynchronizationtherapyontheincidenceofventriculararrhythmiasin
.
responsepredictors.PacingClinElectrophysiol2007;30:1096(cid:2)1104. .. mildheartfailure.HeartRhythm2011;8:679(cid:2)684.
346. Vatankulu MA, Goktekin O, Kaya MG, Ayhan S, Kucukdurmaz Z, Sutton R, .. 366.Sapp JL, Parkash R, Wells GA, Yetisir E, Gardner MJ, Healey JS, Thibault B,
.
Henein M. Effect of long-term resynchronization therapy on left ventricular . SternsLD,BirnieD,NeryPB,SivakumaranS,EssebagV,DorianP,TangAS.
.
remodeling in pacemaker patients upgraded to biventricular devices. Am J .. Cardiacresynchronizationtherapyreducesventriculararrhythmiasinprimary
Cardiol2009;103:1280(cid:2)1284. .. butnotsecondaryprophylacticimplantablecardioverterdefibrillatorpatients:
.
347. HoijerCJ,MeurlingC,BrandtJ.Upgradetobiventricularpacinginpatientswith . insight from the Resynchronization in Ambulatory Heart Failure trial. Circ
.
conventionalpacemakersandheartfailure:adouble-blind,randomizedcross- . ArrhythmElectrophysiol2017;10:e004875.
.
overstudy.Europace2006;8:51(cid:2)55. .. 367.KutyifaV,MossAJ,SolomonSD,McNittS,AktasMK,BarsheshetA,MerkelyB,
348. Delnoy PP, Ottervanger JP, Vos DH, Elvan A, Misier AR, Beukema WP, .. ZarebaW,GoldenbergI.Reducedriskoflife-threateningventriculartachyar-
.
SteendijkP,vanHemelNM.Upgradingtobiventricularpacingguidedbypres- . rhythmiaswithcardiacresynchronizationtherapy:relationshiptoleftventricu-
.
sure(cid:2)volume loop analysis during implantation. J Cardiovasc Electrophysiol . larejectionfraction.EurJHeartFail2015;17:971(cid:2)978.
.
2011;22:677(cid:2)683. .. 368.Gold MR, Daubert JC, Abraham WT, Hassager C, Dinerman JL, Hudnall JH,
.
349. van Geldorp IE, Vernooy K, Delhaas T, Prins MH, Crijns HJ, Prinzen FW, . CerkvenikJ,LindeC.Implantabledefibrillatorsimprovesurvivalinpatientswith
.
DijkmanB.Beneficialeffectsofbiventricularpacinginchronicallyrightventricu- . mildly symptomatic heart failure receiving cardiac resynchronization therapy:
.
larpacedpatientswithmildcardiomyopathy.Europace2010;12:223(cid:2)229. .. analysisofthelong-termfollow-upofremodelinginsystolicleftventriculardys-
350. LeclercqC,CazeauS,LelloucheD,FossatiF,AnselmeF,DavyJM,SadoulN, .. function(REVERSE).CircArrhythmElectrophysiol2013;6:1163(cid:2)1168.
.
KlugD,MolloL,DaubertJC.Upgradingfromsinglechamberrightventricular . 369.Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-analysis: cardiac
.
tobiventricularpacinginpermanentlypacedpatientswithworseningheartfail- . resynchronizationtherapyforpatientswithlesssymptomaticheartfailure.Ann
.
ure:theRD-CHFStudy.PacingClinElectrophysiol2007;30Suppl1:S23(cid:2)S30. .. InternMed2011;154:401(cid:2)412.
351. KosztinA,VamosM,AradiD,SchwertnerWR,KovacsA,NagyKV,ZimaE, .. 370.Lam SK, Owen A. Combined resynchronisation and implantable defibrillator
.
GellerL,DurayGZ,KutyifaV,MerkelyB.Denovoimplantationvs.upgrade . therapyinleftventriculardysfunction:Bayesiannetworkmeta-analysisofrando-
.
cardiacresynchronizationtherapy:asystematicreviewandmeta-analysis.Heart .. misedcontrolledtrials.BMJ2007;335:925.
FailRev2018;23:15(cid:2)26. .. 371.KutyifaV,GellerL,BogyiP,ZimaE,AktasMK,OzcanEE,BeckerD,NagyVK,
.
352. Linde CM, Normand C, Bogale N, Auricchio A, Sterlinski M, Marinskis G, . Kosztin A, Szilagyi S, Merkely B. Effect of cardiac resynchronization therapy
.
SticherlingC,BulavaA,PerezOC,MaassAH,WitteKK,RekvavaR,AbdelaliS, . with implantable cardioverter defibrillator versus cardiac resynchronization
.
Dickstein K. Upgrades from a previous device compared to de novo cardiac .. therapywithpacemakeronmortalityinheartfailurepatients:resultsofahigh-
resynchronizationtherapyintheEuropeanSocietyofCardiologyCRTSurvey .. volume,single-centreexperience.EurJHeartFail2014;16:1323(cid:2)1330.
.
II.EurJHeartFail2018;20:1457(cid:2)1468. . 372.BarraS,BovedaS,ProvidenciaR,SadoulN,DuehmkeR,ReitanC,BorgquistR,
.
353. RaatikainenMJP,ArnarDO,MerkelyB,NielsenJC,HindricksG,HeidbuchelH, . NarayananK,Hidden-LucetF,KlugD,DefayeP,GrasD,AnselmeF,Leclercq .
CammJ.Adecadeofinformationontheuseofcardiacimplantableelectronic .. C,HermidaJS,DeharoJC,LooiKL,ChowAW,VirdeeM,FynnS,LeHeuzey
devices and interventional electrophysiological procedures in the European .. JY,MarijonE,AgarwalS.Addingdefibrillationtherapytocardiacresynchroniza-
.
Society of Cardiology Countries: 2017 report from the European Heart . tion on the basis of the myocardial substrate. J Am Coll Cardiol
. RhythmAssociation.Europace2017;19:ii1(cid:2)ii90. .. 2017;69:1669(cid:2)1678.
354. KirkfeldtRE,JohansenJB,NohrEA,JorgensenOD,NielsenJC.Complications .. 373.LeyvaF,ZegardA,UmarF,TaylorRJ,AcquayeE,GubranC,ChalilS,PatelK,
.
aftercardiacimplantableelectronicdeviceimplantations:ananalysisofacom- . PantingJ,MarshallH,QiuT.Long-termclinicaloutcomesofcardiacresynchro- .
plete,nationwidecohortinDenmark.EurHeartJ2014;35:1186(cid:2)1194. . nizationtherapywithorwithoutdefibrillation:impactoftheaetiologyofcardi-
.
355. BorianiG,DiembergerI.Cardiacresynchronizationtherapyintherealworld: .. omyopathy.Europace2018;20:1804(cid:2)1812.
needtoupgradeoutcomeresearch.EurJHeartFail2018;20:1469(cid:2)1471. .. 374.Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E, Jensen G,
.
356. MerkelyB,KosztinA,RokaA,GellerL,ZimaE,KovacsA,BorosAM,KleinH, . HildebrandtP,SteffensenFH,BruunNE,EiskjaerH,BrandesA,ThogersenAM,
.
WraniczJK,HindricksG,ClemensM,DurayGZ,MossAJ,GoldenbergI,Kutyifa . Gustafsson F, Egstrup K, Videbaek R, HassagerC, Svendsen JH, Hofsten DE,
.
V.RationaleanddesignoftheBUDAPEST-CRTUpgradeStudy:aprospective, .. Torp-PedersenC,PehrsonS,DANISHInvestigators.Defibrillatorimplantation
.
randomized,multicentreclinicaltrial.Europace2017;19:1549(cid:2)1555. . in patients with nonischemic systolic heart failure. N Engl J Med
.
357. KindermannM,HennenB,JungJ,GeiselJ,BohmM,FrohligG.Biventricularver- . 2016;375:1221(cid:2)1230.
.
susconventionalrightventricularstimulationforpatientswithstandardpacing .. 375.LeyvaF,ZegardA,OkaforO,deBonoJ,McNultyD,AhmedA,MarshallH,
indication and left ventricular dysfunction: the Homburg Biventricular Pacing .. RayD,QiuT.Survivalaftercardiacresynchronizationtherapy:resultsfrom50
.
Evaluation(HOBIPACE).JAmCollCardiol2006;47:1927(cid:2)1937. . 084implantations.Europace2019;21:754(cid:2)762.
.
358. MartinelliFilhoM,deSiqueiraSF,CostaR,GrecoOT,MoreiraLF,D’AvilaA, . 376.Gras M, Bisson A, Bodin A, Herbert J, Babuty D, Pierre B, Clementy N,
.
HeistEK.Conventionalversusbiventricularpacinginheartfailureandbradyar- .. Fauchier L. Mortality and cardiac resynchronization therapy with or without
rhythmia:theCOMBATstudy.JCardFail2010;16:293(cid:2)300. .. defibrillationinprimaryprevention.Europace2020;22:1224(cid:2)1233.
.
359. Yu CM, Fang F, Luo XX, Zhang Q, Azlan H, Razali O. Long-term follow-up . 377.Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze-Gadonneix J,
.
resultsofthepacingtoavoidcardiacenlargement(PACE)trial.EurJHeartFail .. DefayeP,JacobS,PiotO,DeharoJC,PerierMC,MulakG,HermidaJS,Milliez
2014;16:1016(cid:2)1025. .. P,GrasD,CesariO,Hidden-LucetF,AnselmeF,ChevalierP,MauryP,Sadoul
.
360. AlbertsenAE,MortensenPT,JensenHK,PoulsenSH,EgebladH,NielsenJC. . N,BordacharP,CazeauS,ChauvinM,EmpanaJP,JouvenX,DaubertJC,Le
.
Adverseeffectofrightventricularpacingpreventedbybiventricularpacingdur- . HeuzeyJY.Causes-of-deathanalysisofpatientswithcardiacresynchronization
.
ing long-term follow-up: a randomized comparison. Eur J Echocardiogr .. therapy: an analysis of the CeRtiTuDe cohort study. Eur Heart J
2011;12:767(cid:2)772. . 2015;36:2767(cid:2)2776.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 81 ---
ESCGuidelines 81
.
.
378. Morani G, Gasparini M, Zanon F, Casali E, Spotti A, Reggiani A, Bertaglia E, . LancellottiP,HabibG,ElliottP,EdvardsenT,CosynsB,PopescuBA,EACVI
.
SolimeneF,MolonG,AccogliM,TommasiC,PaolettiPeriniA,CiardielloC, . Scientific Documents Committee. Multimodality imaging in the diagnosis, risk
.
PadelettiL.Cardiacresynchronizationtherapy-defibrillatorimproveslong-term .. stratification, and management of patients with dilated cardiomyopathies: an
survival compared with cardiac resynchronization therapy-pacemaker in .. expertconsensusdocumentfromtheEuropeanAssociationofCardiovascular
.
patientswithaclassIAindicationforcardiacresynchronizationtherapy:data . Imaging.EurHeartJCardiovascImaging2019;20:1075(cid:2)1093.
.
fromtheContakItalianRegistry.Europace2013;15:1273(cid:2)1279. .. 395.BleekerGB,KaandorpTA,LambHJ,BoersmaE,SteendijkP,deRoosA,van
379. Acosta J, Fernandez-Armenta J, Borras R, Anguera I, Bisbal F, Marti-Almor J, .. derWallEE,SchalijMJ,BaxJJ.Effectofposterolateralscartissueonclinicaland
.
TolosanaJM,PenelaD,AndreuD,Soto-IglesiasD,EvertzR,MatielloM,Alonso . echocardiographic improvement after cardiac resynchronization therapy.
.
C,VilluendasR,deCaraltTM,PereaRJ,OrtizJT,BoschX,SerraL,PlanesX, . Circulation2006;113:969(cid:2)976.
.
GreiserA,EkinciO,LasalviaL,MontL,BerruezoA.Scarcharacterizationto .. 396.YpenburgC,RoesSD,BleekerGB,KaandorpTA,deRoosA,SchalijMJ,van
predictlife-threateningarrhythmiceventsandsuddencardiacdeathinpatients .. derWallEE,BaxJJ.Effectoftotalscarburdenoncontrast-enhancedmagnetic
.
withcardiacresynchronizationtherapy:theGAUDI-CRTstudy.JACCCardiovasc . resonance imaging on response to cardiac resynchronization therapy. Am J
.
Imaging2018;11:561(cid:2)572. .. Cardiol2007;99:657(cid:2)660.
380. LeyvaF,ZegardA,AcquayeE,GubranC,TaylorR,FoleyPWX,UmarF,Patel .. 397.vanderBijlP,KhidirM,AjmoneMarsanN,DelgadoV,LeonMB,StoneGW,
.
K,PantingJ,MarshallH,QiuT.Outcomesofcardiacresynchronizationtherapy . BaxJJ.Effectoffunctionalmitralregurgitationonoutcomeinpatientsreceiving
.
with or without defibrillation in patients with nonischemic cardiomyopathy. J . cardiac resynchronization therapy for heart failure. Am J Cardiol
. AmCollCardiol2017;70:1216(cid:2)1227. .. 2019;123:75(cid:2)83.
381. Cleland JG, Freemantle N, Erdmann E, Gras D, Kappenberger L, Tavazzi L, .. 398.LeongDP,HokeU,DelgadoV,AugerD,WitkowskiT,ThijssenJ,vanErvenL,
.
DaubertJC.Long-termmortalitywithcardiacresynchronizationtherapyinthe . BaxJJ,SchalijMJ,MarsanNA.Rightventricularfunctionandsurvivalfollowing
.
Cardiac Resynchronization-Heart Failure (CARE-HF) trial. Eur J Heart Fail . cardiacresynchronisationtherapy.Heart2013;99:722(cid:2)728.
.
2012;14:628(cid:2)634. .. 399.ChungES,LeonAR,TavazziL,SunJP,NihoyannopoulosP,MerlinoJ,Abraham
382. Barra S, Looi KL, Gajendragadkar PR, Khan FZ, Virdee M, Agarwal S. .. WT,GhioS,LeclercqC,BaxJJ,YuCM,GorcsanJ3rd,StJohnSuttonM,De
.
Applicability of a risk score for prediction of the long-term benefit of the . SutterJ,MurilloJ.ResultsofthePredictorsofResponsetoCRT(PROSPECT)
.
implantablecardioverterdefibrillatorinpatientsreceivingcardiacresynchroni- .. trial.Circulation2008;117:2608(cid:2)2616.
zationtherapy.Europace2016;18:1187(cid:2)1193. .. 400.BeelaAS,UnluS,DuchenneJ,CiarkaA,DarabanAM,KotrcM,AaronesM,
.
383. GoldenbergI,VyasAK,HallWJ,MossAJ,WangH,HeH,ZarebaW,McNittS, . SzulikM,WinterS,PenickaM,NeskovicAN,KukulskiT,AakhusS,WillemsR,
.
AndrewsML,MADIT-IIInvestigators.Riskstratificationforprimaryimplantation . Fehske W, Faber L, Stankovic I, Voigt JU. Assessment of mechanical dyssyn-
.
ofacardioverter-defibrillatorinpatientswithischemicleftventriculardysfunc- .. chronycanimprovetheprognosticvalueofguideline-basedpatientselection
tion.JAmCollCardiol2008;51:288(cid:2)296. .. for cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging
.
384. LumensJ,TayalB,WalmsleyJ,Delgado-MonteroA,HuntjensPR,Schwartzman . 2019;20:66(cid:2)74.
.
D,AlthouseAD,DelhaasT,PrinzenFW,GorcsanJ3rd.Differentiatingelectro- . 401.DelgadoV,YpenburgC,vanBommelRJ,TopsLF,MollemaSA,MarsanNA,
.
mechanical from non-electrical substrates of mechanical discoordination to .. BleekerGB,SchalijMJ,BaxJJ.Assessmentofleftventriculardyssynchronyby
.
identifyresponderstocardiacresynchronizationtherapy.CircCardiovascImaging . speckletrackingstrainimagingcomparisonbetweenlongitudinal,circumferen-
.
2015;8:e003744. . tial, and radial strain in cardiac resynchronization therapy. J Am Coll Cardiol
.
385. PlouxS,LumensJ,WhinnettZ,MontaudonM,StromM,RamanathanC,Derval .. 2008;51:1944(cid:2)1952.
N,ZemmouraA,DenisA,DeGuillebonM,ShahA,HociniM,JaisP,RitterP, .. 402.Risum N, Tayal B, Hansen TF, Bruun NE, Jensen MT, Lauridsen TK, Saba S,
.
Haissaguerre M, Wilkoff BL, Bordachar P. Noninvasive electrocardiographic . KissloJ,GorcsanJ3rd,SogaardP.Identificationoftypicalleftbundlebranch
.
mapping to improve patient selection for cardiac resynchronization therapy: . blockcontractionbystrainechocardiographyisadditivetoelectrocardiography
.
beyond QRS duration and left bundle branch block morphology. J Am Coll .. inpredictionoflong-termoutcomeaftercardiacresynchronizationtherapy.J
Cardiol2013;61:2435(cid:2)2443. .. AmCollCardiol2015;66:631(cid:2)641.
.
386. ParsaiC,BijnensB,SutherlandGR,BaltabaevaA,ClausP,MarciniakM,PaulV, . 403.LeendersGE,LumensJ,CramerMJ,DeBoeckBW,DoevendansPA,Delhaas
.
Scheffer M, Donal E, Derumeaux G, Anderson L. Toward understanding .. T,PrinzenFW.Septaldeformationpatternsdelineatemechanicaldyssynchrony
responsetocardiacresynchronizationtherapy:leftventriculardyssynchronyis .. and regional differences incontractility: analysis of patient data using a com-
.
onlyoneofmultiplemechanisms.EurHeartJ2009;30:940(cid:2)949. . putermodel.CircHeartFail2012;5:87(cid:2)96.
.
387. AdelsteinEC,TanakaH,SomanP,MiskeG,HabermanSC,SabaSF,GorcsanJ . 404.Mafi-Rad M, Van’t Sant J, Blaauw Y, Doevendans PA, Cramer MJ, Crijns HJ,
.
3rd.Impactofscarburdenbysingle-photonemissioncomputedtomography .. PrinzenFW,MeineM,VernooyK.Regionalleftventricularelectricalactivation
myocardialperfusionimagingonpatientoutcomesfollowingcardiacresynchro- .. andpeakcontractionarecloselyrelatedincandidatesforcardiacresynchroni-
.
nizationtherapy.EurHeartJ2011;32:93(cid:2)103. . zationtherapy.JACCClinElectrophysiol2017;3:854(cid:2)862.
.
388. TaylorRJ,UmarF,PantingJR,StegemannB,LeyvaF.Leftventricularleadposi- . 405.MaassAH,VernooyK,WijersSC,van‘tSantJ,CramerMJ,MeineM,Allaart .
tion, mechanical activation, and myocardial scarin relation to left ventricular .. CP, De Lange FJ, Prinzen FW, Gerritse B, Erdtsieck E, Scheerder COS, Hill
reverseremodelingandclinicaloutcomesaftercardiacresynchronizationther- .. MRS,ScholtenM,KloostermanM,TerHorstIAH,VoorsAA,VosMA,Rienstra
.
apy: a feature-tracking and contrast-enhanced cardiovascular magnetic reso- . M,VanGelderIC.Refiningsuccessofcardiacresynchronizationtherapyusinga
. nancestudy.HeartRhythm2016;13:481(cid:2)489. .. simplescorepredictingtheamountofreverseventricularremodelling:results
389. SabaS,MarekJ,SchwartzmanD,JainS,AdelsteinE,WhiteP,OyenugaOA, .. from the Markers and Response to CRT (MARC) study. Europace
.
Onishi T, Soman P, Gorcsan J 3rd. Echocardiography-guided left ventricular . 2018;20:e1-e10. .
lead placement for cardiac resynchronization therapy: results of the Speckle . 406.van der Bijl P, Vo NM, Kostyukevich MV, Mertens B, Ajmone Marsan N,
.
Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circ .. DelgadoV,BaxJJ.Prognosticimplicationsofglobal,leftventricularmyocardial
HeartFail2013;6:427(cid:2)434. .. workefficiencybeforecardiacresynchronizationtherapy.EurHeartJCardiovasc
.
390. StephansenC,SommerA,KronborgMB,JensenJM,NorgaardBL,GerdesC, . Imaging2019;20:1388(cid:2)1394.
.
KristensenJ,JensenHK,FyenboDB,BoucheloucheK,NielsenJC.Electrically . 407.Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O’Halloran D, Elsik M, Read PA,
.
vs.imaging-guidedleftventricularleadplacementincardiacresynchronization .. BegleyD,FynnSP,DutkaDP.Targetedleftventricularleadplacementtoguide
.
therapy:arandomizedcontrolledtrial.Europace2019;21:1369(cid:2)1377. . cardiac resynchronization therapy: the TARGET study: a randomized, con-
.
391. Delgado-Montero A, Tayal B, Goda A, Ryo K, Marek JJ, Sugahara M, Qi Z, . trolledtrial.JAmCollCardiol2012;59:1509(cid:2)1518.
.
AlthouseAD,SabaS,SchwartzmanD,GorcsanJ3rd.Additiveprognosticvalue .. 408.Sommer A, Kronborg MB, Norgaard BL, Poulsen SH, Bouchelouche K,
of echocardiographic global longitudinal and global circumferential strain to .. Bottcher M, Jensen HK, Jensen JM, Kristensen J, Gerdes C, Mortensen PT,
.
electrocardiographic criteria in patients with heart failure undergoing cardiac . NielsenJC.Multimodalityimaging-guidedleftventricularleadplacementincar-
.
resynchronizationtherapy.CircCardiovascImaging2016;9. . diacresynchronizationtherapy:arandomizedcontrolledtrial.EurJHeartFail
.
392. Gorcsan J 3rd, Anderson CP, Tayal B, Sugahara M, Walmsley J, Starling RC, .. 2016;18:1365(cid:2)1374.
Lumens J. Systolic stretch characterizes the electromechanical substrate .. 409.CikesM,Sanchez-Martinez S,Claggett B,DuchateauN,PiellaG,ButakoffC,
.
responsive to cardiac resynchronization therapy. JACC Cardiovasc Imaging . Pouleur AC, Knappe D, Biering-Sorensen T, Kutyifa V, Moss A, Stein K,
.
2019;12:1741(cid:2)1752. .. SolomonSD,BijnensB.Machinelearning-basedphenogroupinginheartfailure
393. Khidir MJH, Abou R, Yilmaz D, Ajmone Marsan N, Delgado V, Bax JJ. .. to identify responders to cardiac resynchronization therapy. Eur J Heart Fail
.
Prognostic value of global longitudinal strain in heart failure patients treated . 2019;21:74(cid:2)85.
.
withcardiacresynchronizationtherapy.HeartRhythm2018;15:1533(cid:2)1539. . 410.DiBiaseL,AuricchioA,MohantyP,BaiR,KautznerJ,PieragnoliP,RegoliF,
.
394. DonalE,DelgadoV,Bucciarelli-DucciC,GalliE,HaugaaKH,CharronP,Voigt .. Sorgente A, Spinucci G, Ricciardi G, Michelucci A, Perrotta L, Faletra F,
JU, Cardim N, Masci PG, Galderisi M, Gaemperli O, Gimelli A, Pinto YM, . Mlcochova H, Sedlacek K, Canby R, Sanchez JE, Horton R, Burkhardt JD,
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 82 ---
82 ESCGuidelines
.
.
MoccettiT,PadelettiL,NataleA.Impactofcardiacresynchronizationtherapy . 428.ZanonF,AbdelrahmanM,MarcantoniL,NaperkowskiA,SubzposhFA,Pastore
.
ontheseverityofmitralregurgitation.Europace2011;13:829(cid:2)838. . G,BaraccaE,BoarettoG,RaffagnatoP,TiribelloA,DandamudiG,Vijayaraman
.
411. Auricchio A, Schillinger W, Meyer S, Maisano F, Hoffmann R, Ussia GP, .. P.LongtermperformanceandsafetyofHisbundlepacing:amulticenterexpe-
PedrazziniGB,vanderHeydenJ,FratiniS,KlersyC,KomtebeddeJ,FranzenO. .. rience.JCardiovascElectrophysiol2019;30:1594(cid:2)1601.
.
Correctionofmitralregurgitationinnonresponderstocardiacresynchroniza- . 429.KirkfeldtRE,JohansenJB,NohrEA,MollerM,ArnsboP,NielsenJC.Riskfac-
.
tiontherapybyMitraClipimprovessymptomsandpromotesreverseremodel- .. torsforleadcomplicationsincardiacpacing:apopulation-basedcohortstudy
ing.JAmCollCardiol2011;58:2183(cid:2)2189. .. of28,860Danishpatients.HeartRhythm2011;8:1622(cid:2)1628.
.
412. D’Ancona G, Ince H, Schillinger W, SengesJ,OuarrakT, Butter C, Seifert M, . 430.Starr N, Dayal N, Domenichini G, Stettler C, Burri H. Electrical parameters
.
SchauT,LubosE,BoekstegersP,vonBardelebenRS,SafakE.Percutaneoustreat- . with His-bundle pacing: considerations for automated programming. Heart
.
mentofmitralregurgitationinpatientswithimpairedventricularfunction:impact .. Rhythm2019;16:1817(cid:2)1824.
ofintracardiacelectronicdevices(fromtheGermanTranscatheterMitralValve .. 431.BurriH,KeeneD,WhinnettZ,ZanonF,VijayaramanP.Deviceprogramming
.
InterventionsRegistry).CatheterCardiovascInterv2019;94:755(cid:2)763. . forHisbundlepacing.CircArrhythmElectrophysiol2019;12:e006816.
.
413. GiaimoVL,ZappullaP,CirasaA,TempioD,SanfilippoM,RapisardaG,Trovato . 432.LustgartenDL,SharmaPS, Vijayaraman P.Troubleshooting andprogramming
.
D,GraziaAD,LiottaC,GrassoC,CapodannoD,TamburinoC,CalviV.Long- .. considerationsforHisbundlepacing.HeartRhythm2019;16:654(cid:2)662.
.
termclinicalandechocardiographicoutcomesofMitracliptherapyinpatients . 433.Vijayaraman P, Naperkowski A, Ellenbogen KA, Dandamudi G.
.
nonresponders to cardiac resynchronization. Pacing Clin Electrophysiol . Electrophysiologic insights into site of atrioventricular block. JACC Clin
. 2018;41:65(cid:2)72. .. Electrophysiol2015;1:571(cid:2)581.
414. SeifertM,SchauT,SchoeppM,AryaA,NeussM,ButterC.MitraClipinCRT .. 434.SuL,CaiM,WuS,WangS,XuT,VijayaramanP,HuangW.Long-termper-
.
non-responderswithseveremitralregurgitation.IntJCardiol2014;177:79(cid:2)85. . formanceandriskfactorsanalysisafterpermanentHis-bundlepacingandatrio-
.
415. ObadiaJF,Messika-ZeitounD,LeurentG,IungB,BonnetG,PiriouN,Lefevre . ventricular node ablation in patients with atrial fibrillation and heart failure.
.
T,PiotC,RouleauF,CarrieD,NejjariM,OhlmannP,LeclercqF,SaintEtienne .. Europace2020;22:ii19(cid:2)ii26.
C, Teiger E, Leroux L, Karam N, Michel N, Gilard M, Donal E, Trochu JN, .. 435.Narula OS. Longitudinal dissociation in the His bundle. Bundle branch block
.
Cormier B, Armoiry X, Boutitie F, Maucort-Boulch D, Barnel C, Samson G, . due to asynchronous conduction within the His bundle in man. Circulation
.
GuerinP,VahanianA,MewtonN,MITRA-FRInvestigators.Percutaneousrepair .. 1977;56:996(cid:2)1006.
or medical treatment for secondary mitral regurgitation. N Engl J Med .. 436.UpadhyayGA,CherianT,ShatzDY,BeaserAD,AzizZ,OzcanC,BromanMT,
.
2018;379:2297(cid:2)2306. . NayakHM,TungR.Intracardiacdelineationofseptalconductioninleftbundle-
.
416. StoneGW,LindenfeldJ,AbrahamWT,KarS,LimDS,MishellJM,WhisenantB, . branchblockpatterns.Circulation2019;139:1876(cid:2)1888.
.
GrayburnPA,RinaldiM,KapadiaSR,RajagopalV,SarembockIJ,BriekeA,Marx .. 437.UpadhyayGA,VijayaramanP,NayakHM,VermaN,DandamudiG,SharmaPS,
SO, Cohen DJ, Weissman NJ, Mack MJ, COAPT Investigators. Transcatheter .. SaleemM,MandrolaJ,GenoveseD,TungR.Hiscorrectivepacingorbiventric-
.
mitral-valve repair in patients with heart failure. N Engl J Med . ular pacing for cardiac resynchronization in heart failure. J Am Coll Cardiol
.
2018;379:2307(cid:2)2318. . 2019;74:157(cid:2)159.
.
417. KayeGC,LinkerNJ,MarwickTH,PollockL,GrahamL,PouliotE,PolonieckiJ, .. 438.UpadhyayGA,VijayaramanP,NayakHM,VermaN,DandamudiG,SharmaPS,
.
Gammage M, Protect-Pace trial investigators. Effect of right ventricular . SaleemM,MandrolaJ,GenoveseD,OrenJW,SubzposhFA,AzizZ,BeaserA,
.
pacing lead site on left ventricular function in patients with high-grade . Shatz D, Besser S, Lang RM, Trohman RG, Knight BP, Tung R, His-Sync
.
atrioventricularblock:resultsoftheProtect-Pacestudy.EurHeartJ2015;36: .. Investigators.On-treatmentcomparisonbetweencorrectiveHisbundlepacing
856(cid:2)862. .. andbiventricularpacingforcardiacresynchronization:asecondaryanalysisof
.
418. LeclercqC,SadoulN,MontL,DefayeP,OscaJ,MoutonE,IsnardR,HabibG, . theHis-SYNCPilotTrial.HeartRhythm2019;16:1797(cid:2)1807.
.
Zamorano J, Derumeaux G, Fernandez-Lozano I, SEPTAL CRT Study . 439.LustgartenDL,CrespoEM,Arkhipova-JenkinsI,LobelR,WingetJ,KoehlerJ,
.
Investigators.Comparisonofrightventricularseptalpacingandrightventricular .. LibermanE,SheldonT.His-bundlepacingversusbiventricularpacingincardiac
apicalpacinginpatientsreceivingcardiacresynchronizationtherapydefibrilla- .. resynchronization therapy patients: a crossover design comparison. Heart
.
tors:theSEPTALCRTStudy.EurHeartJ2016;37:473(cid:2)483. . Rhythm2015;12:1548(cid:2)1557.
.
419. HussainMA,Furuya-KanamoriL,KayeG,ClarkJ,DoiSA.TheEffectofright .. 440.Giraldi F, Cattadori G, Roberto M, Carbucicchio C, Pepi M, Ballerini G,
ventricularapicalandnonapicalpacingontheshort-andlong-termchangesin .. Alamanni F, Della Bella P, Pontone G, Andreini D, Tondo C, Agostoni PG.
.
left ventricular ejection fraction: a systematic review and meta-analysis of . Long-term effectiveness of cardiac resynchronization therapy in heart failure
.
randomized-controlledtrials.PacingClinElectrophysiol2015;38:1121(cid:2)1136. . patientswithunfavorablecardiacveinsanatomycomparisonofsurgicalversus
.
420. CanoO,AndresA,AlonsoP,OscaJ,Sancho-TelloMJ,OlagueJ,Martinez-DolzL. .. hemodynamicprocedure.JAmCollCardiol2011;58:483(cid:2)490.
Incidenceandpredictorsofclinicallyrelevantcardiacperforationassociatedwith .. 441.Sharma PS, Naperkowski A, Bauch TD, Chan JYS, Arnold AD, Whinnett ZI,
.
systematicimplantationofactive-fixationpacinganddefibrillationleads:asingle- . Ellenbogen KA, Vijayaraman P. Permanent His bundle pacing for cardiac
.
centreexperiencewithover3800implantedleads.Europace2017;19:96(cid:2)102. . resynchronizationtherapyinpatientswithheartfailureandrightbundlebranch .
421. SommerA,KronborgMB,NorgaardBL,GerdesC,MortensenPT,NielsenJC. .. block.CircArrhythmElectrophysiol2018;11:e006613.
Leftandrightventricularleadpositionsareimpreciselydeterminedbyfluoro- .. 442.HuangW,ChenX,SuL,WuS,XiaX,VijayaramanP.Abeginner’sguideto
.
scopy in cardiac resynchronization therapy: a comparison with cardiac com- . permanentleftbundlebranchpacing.HeartRhythm2019;16:1791(cid:2)1796.
. putedtomography.Europace2014;16:1334(cid:2)1341. .. 443.Barba-PichardoR,ManovelSanchezA,Fernandez-GomezJM,Morina-Vazquez
422. ZanonF,EllenbogenKA,DandamudiG,SharmaPS,HuangW,LustgartenDL, .. P,Venegas-GameroJ,Herrera-CarranzaM.Ventricularresynchronizationther-
.
TungR,TadaH,KoneruJN,BergemannT,FaganDH,HudnallJH,Vijayaraman . apy by direct His-bundle pacing using an internal cardioverter defibrillator. .
P.PermanentHis-bundlepacing:asystematicliteraturereviewandmeta-analy- . Europace2013;15:83(cid:2)88.
.
sis.Europace2018;20:1819(cid:2)1826. .. 444.ZweerinkA,BakelantsE,StettlerC,BurriH.Cryoablationvs.radiofrequency
423. Keene D, Arnold AD, Jastrzebski M, Burri H, Zweibel S, Crespo E, .. ablation of the atrioventricular node in patients with His-bundle pacing.
.
ChandrasekaranB,BassiS,JoghetaeiN,SwiftM,MoskalP,FrancisDP,FoleyP, . Europace2020;23:421(cid:2)430.
.
Shun-ShinMJ,WhinnettZI.Hisbundlepacing,learningcurve,procedurechar- . 445.ValitonV,GrafD,PruvotE,CarrozP,FromerM,BischL,TranVN,CookS,
.
acteristics,safety,andfeasibility:insightsfromalargeinternationalobservational .. ScharfC,BurriH.Leadlesspacingusingthetranscatheterpacingsystem(Micra
.
study.JCardiovascElectrophysiol2019;30:1984(cid:2)1993. . TPS) in the real world: initial Swiss experience from the Romandie region.
.
424. VijayaramanP,DandamudiG,ZanonF,SharmaPS,TungR,HuangW,Koneru . Europace2019;21:275(cid:2)280.
.
J,TadaH,EllenbogenKA,LustgartenDL.PermanentHisbundlepacing:recom- .. 446.DefayeP,KlugD,AnselmeF,GrasD,HermidaJS,PiotO,AlonsoC,Fauchier
mendations from a Multicenter His Bundle Pacing Collaborative Working .. L, Gandjbakhch E, Marijon E, Maury P, Taieb J, Boveda S, Sadoul N.
.
Groupforstandardizationofdefinitions,implantmeasurements,andfollow-up. . RecommendationsfortheimplantationofleadlesspacemakersfromtheFrench
.
HeartRhythm2018;15:460(cid:2)468. . WorkingGrouponCardiacPacingandElectrophysiologyoftheFrenchSociety
.
425. Burri H,Jastrzebski M, VijayaramanP. ECG analysis forHis bundle pacing at .. ofCardiology.ArchCardiovascDis2018;111:53(cid:2)58.
implantationandfollow-up.JACCClinElectrophysiol2020;6:883(cid:2)900. .. 447.Leadless cardiac pacemaker therapy: design of pre- and post-market clinical
.
426. Teigeler T, Kolominsky J, Vo C, Shepard RK, Kalahasty G, Kron J, Huizar JF, . studies. Recommendations from MHRA Expert Advisory Group. Version 3:
.
KaszalaK,TanAY,KoneruJN,EllenbogenKA,PadalaSK.Intermediateterm .. Updated January 2021. https://assets.publishing.service.gov.uk/government/
performanceandsafetyofHisbundlepacingleads:asinglecenterexperience. .. uploads/system/uploads/attachment_data/file/956252/Leadless-EAG-guidance.
.
HeartRhythm2021;18:743(cid:2)749. . pdf(25May2021)
.
427. Vijayaraman P, Naperkowski A, Subzposh FA, Abdelrahman M, Sharma PS, . 448.SteinwenderC,KhelaeSK,GarwegC,SunChanJY,RitterP,JohansenJB,Sagi
.
OrenJW,DandamudiG,EllenbogenKA.PermanentHis-bundlepacing:long- .. V,EpsteinLM,PicciniJP,PascualM,MontL,SheldonT,SplettV,StrombergK,
termleadperformanceandclinicaloutcomes.HeartRhythm2018;15:696(cid:2)702. . Wood N, Chinitz L. Atrioventricular synchronous pacing using a leadless
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 83 ---
ESCGuidelines 83
.
.
ventricular pacemaker: results from the MARVEL 2 study. JACC Clin . Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P,
.
Electrophysiol2019;6:94(cid:2)106. . Widimsk(cid:2)y P, ESC Scientific Document Group. 2017 ESC Guidelines for the
.
449. BeurskensNE,TjongFV,KnopsRE.End-of-lifemanagementofleadlesscardiac .. management of acute myocardial infarction in patients presenting with ST-
pacemakertherapy.ArrhythmElectrophysiolRev2017;6:129(cid:2)133. .. segment elevation: The Task Force for the management of acute myocardial
.
450. El-ChamiMF,JohansenJB,ZaidiA,FaerestrandS,ReynoldsD,Garcia-SearaJ, . infarction in patients presenting with ST-segment elevation of the European
.
MansouratiJ,PasquieJL,McElderryHT,RobertsPR,SoejimaK,StrombergK, .. SocietyofCardiology(ESC).EurHeartJ2018;39:119(cid:2)177.
PicciniJP.Leadlesspacemakerimplantinpatientswithpre-existinginfections: .. 470.Watson RD, Glover DR, Page AJ, Littler WA, Davies P, de Giovanni J,
.
results from the Micra postapproval registry. J Cardiovasc Electrophysiol . PentecostBL.TheBirminghamTrialofpermanentpacinginpatientswithintra-
.
2019;30:569(cid:2)574. . ventricularconductiondisordersafteracutemyocardialinfarction.AmHeartJ
.
451. ZimetbaumPJ,JosephsonME.Useoftheelectrocardiograminacutemyocardial .. 1984;108:496(cid:2)501.
infarction.NEnglJMed2003;348:933(cid:2)940. .. 471.Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR,
.
452. PejkovicB,KrajncI,AnderhuberF,KosuticD.Anatomicalaspectsofthearterial . Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK,
.
bloodsupplytothesinoatrialandatrioventricularnodesofthehumanheart.J . Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L. HRS/ACC/AHA
.
IntMedRes2008;36:691(cid:2)698. .. expertconsensusstatementontheuseofimplantablecardioverter-defibrillator
.
453. RitterWS,AtkinsJM,BlomqvistCG,MullinsCB.Permanentpacinginpatients . therapyinpatientswhoarenotincludedornotwellrepresentedinclinicaltri-
.
withtransienttrifascicularblockduringacutemyocardialinfarction.AmJCardiol . als.Circulation2014;130:94(cid:2)125.
. 1976;38:205(cid:2)208. .. 472.Brodell GK, Cosgrove D, Schiavone W, Underwood DA, Loop FD. Cardiac
454. GinksWR,SuttonR,OhW,LeathamA.Long-termprognosisafteracuteante- .. rhythmandconductiondisturbancesinpatientsundergoingmitralvalvesurgery.
.
riorinfarctionwithatrioventricularblock.BrHeartJ1977;39:186(cid:2)189. . CleveClinJMed1991;58:397(cid:2)399.
.
455. Feigl D, Ashkenazy J, Kishon Y. Early andlate atrioventricular block inacute . 473.Chung MK. Cardiac surgery: postoperative arrhythmias. Crit Care Med
.
inferiormyocardialinfarction.JAmCollCardiol1984;4:35(cid:2)38. .. 2000;28:N136(cid:2)N144.
456. JimMH,ChanAO,TseHF,BaroldSS,LauCP.Clinicalandangiographicfindings .. 474.JaegerFJ,TrohmanRG,BrenerS,LoopF.Permanentpacingfollowingrepeat
.
ofcompleteatrioventricularblockinacuteinferiormyocardialinfarction.Ann . cardiacvalvesurgery.AmJCardiol1994;74:505(cid:2)507.
.
AcadMedSingapore2010;39:185(cid:2)190. .. 475.Reade MC. Temporary epicardial pacing after cardiac surgery: a practical
457. SuttonR,DaviesM.Theconductionsysteminacutemyocardialinfarctioncom- .. review.Part1:generalconsiderationsinthemanagementofepicardialpacing.
.
plicatedbyheartblock.Circulation1968;38:987(cid:2)992. . Anaesthesia2007;62:264(cid:2)271.
.
458. GangUJ,HvelplundA,PedersenS,IversenA,JønsC,AbildstrømSZ,HaarboJ, . 476.Reade MC. Temporary epicardial pacing after cardiac surgery: a practical
.
Jensen JS, Thomsen PE. High-degree atrioventricular block complicating ST- .. review. Part 2: selection of epicardial pacing modes and troubleshooting.
segment elevation myocardial infarction in the era of primary percutaneous .. Anaesthesia2007;62:364(cid:2)373.
.
coronaryintervention.Europace2012;14:1639(cid:2)1645. . 477.Leyva F, Qiu T, McNulty D, Evison F, Marshall H, Gasparini M. Long-term
.
459. AuffretV,LoiratA,LeurentG,MartinsRP,FilippiE,CoudertI,HacotJP,Gilard . requirementforpacemaker implantation after cardiacvalve replacement sur-
.
M, Castellant P, Rialan A, Delaunay R, Rouault G, Druelles P, Boulanger B, .. gery.HeartRhythm2017;14:529(cid:2)534.
.
TreuilJ,AvezB,BedossaM,BoulmierD,LeGuellecM,DaubertJC,LeBreton . 478.MerinO,IlanM,OrenA,FinkD,DeebM,BitranD,SilbermanS.Permanent
.
H.High-degreeatrioventricularblockcomplicatingSTsegmentelevationmyo- . pacemakerimplantationfollowingcardiacsurgery:indicationsandlong-termfol-
.
cardialinfarctioninthecontemporaryera.Heart2016;102:40(cid:2)49. .. low-up.PacingClinElectrophysiol2009;32:7(cid:2)12.
460. Kim KH, Jeong MH, Ahn Y, Kim YJ, Cho MC, Kim W, Other Korea Acute .. 479.Glikson M, Dearani JA, Hyberger LK, Schaff HV, Hammill SC, Hayes DL.
.
MyocardialInfarctionRegistryInvestigators.Differentialclinicalimplicationsof . Indications,effectiveness,andlong-termdependencyinpermanentpacingafter
.
high-degreeatrioventricularblockcomplicatingST-segmentelevationmyocar- . cardiacsurgery.AmJCardiol1997;80:1309(cid:2)1313.
.
dialinfarctionaccordingtothelocationofinfarctionintheeraofprimaryper- .. 480.Kim MH, Deeb GM, Eagle KA, Bruckman D, Pelosi F, Oral H, Sticherling C,
cutaneouscoronaryintervention.KoreanCircJ2016;46:315(cid:2)323. .. Baker RL, Chough SP, Wasmer K, Michaud GF, Knight BP, Strickberger SA,
.
461. Kosmidou I, Redfors B, Dordi R, Dizon JM, McAndrew T, Mehran R, Ben- . MoradyF.Completeatrioventricularblockaftervalvularheartsurgeryandthe
.
YehudaO,MintzGS,StoneGW.Incidence,predictors,andoutcomesofhigh- .. timingofpacemakerimplantation.AmJCardiol2001;87:649(cid:2)651,A610.
gradeatrioventricularblockinpatientswithST-segmentelevationmyocardial .. 481.HillTE,KiehlEL,ShresthaNK,GordonSM,PetterssonGB,MohanC,Hussein
.
infarction undergoing primary percutaneous coronary intervention (from the . A,HussainS,WazniO,WilkoffBL,MenonV,TarakjiKG.Predictorsofperma-
.
HORIZONS-AMITrial).AmJCardiol2017;119:1295(cid:2)1301. . nent pacemaker requirement after cardiac surgery for infective endocarditis.
.
462. SinghSM,FitzGeraldG,YanAT,BriegerD,FoxKA,Lo(cid:2)pez-Sendo(cid:2)nJ,YanRT, .. EurHeartJAcuteCardiovascCare2021;10:329(cid:2)334.
EagleKA,StegPG,BudajA,GoodmanSG.High-gradeatrioventricularblockin .. 482.DiBiaseA,TseTM,SchnittgerI,WexlerL,StinsonEB,ValantineHA.Frequency
.
acute coronary syndromes: insights from the Global Registry of Acute . and mechanism of bradycardia in cardiac transplant recipients and need for
.
CoronaryEvents.EurHeartJ2015;36:976(cid:2)983. . pacemakers.AmJCardiol1991;67:1385(cid:2)1389. .
463. Meine TJ, Al-Khatib SM, Alexander JH, Granger CB, White HD, Kilaru R, .. 483.Melton IC, Gilligan DM, Wood MA, Ellenbogen KA. Optimal cardiac pacing
Williams K, Ohman EM, Topol E, Califf RM. Incidence, predictors, and out- .. afterhearttransplantation.PacingClinElectrophysiol1999;22:1510(cid:2)1527.
.
comes of high-degree atrioventricular block complicating acute myocardial . 484.Jacquet L, Ziady G, Stein K, Griffith B, Armitage J, Hardesty R, Kormos R.
. infarctiontreatedwiththrombolytictherapy.AmHeartJ2005;149:670(cid:2)674. .. Cardiacrhythmdisturbancesearlyafterorthotopichearttransplantation:prev-
464. HindmanMC,WagnerGS,JaRoM,AtkinsJM,ScheinmanMM,DeSanctisRW, .. alenceandclinicalimportanceoftheobservedabnormalities.JAmCollCardiol
.
HutterAH,YeatmanL,RubenfireM,PujuraC,RubinM,MorrisJJ.Theclinical . 1990;16:832(cid:2)837. .
significanceofbundlebranchblockcomplicatingacutemyocardialinfarction.1. . 485.Holt ND, McComb JM. Cardiac transplantation and pacemakers: when and
.
Clinical characteristics, hospital mortality, and one-year follow-up. Circulation .. whattoimplant.CardElectrophysiolRev2002;6:140(cid:2)151.
1978;58:679(cid:2)688. .. 486.BurgerH,PechaS,HakmiS,OpalkaB,SchoenburgM,ZiegelhoefferT.Five-
.
465. Melgarejo-MorenoA,Galcer(cid:2)a-Tom(cid:2)asJ,Garci(cid:2)a-AlberolaA,Valde´s-ChavarriM, . yearfollow-upoftransvenousandepicardialleftventricularleads:experience
.
Castillo-Soria FJ, Mira-S(cid:2)anchez E, Gil-S(cid:2)anchez J, Allegue-Gallego J. Incidence, .. withmorethan1000leads.InteractCardiovascThoracSurg2020;30:74(cid:2)80.
clinicalcharacteristics,andprognosticsignificanceofrightbundle-branchblock .. 487.Noheria A, van Zyl M, Scott LR, Srivathsan K, Madhavan M, Asirvatham SJ,
.
in acute myocardial infarction: a study in the thrombolytic era. Circulation . McLeodCJ.Single-siteventricularpacingviathecoronarysinusinpatientswith
.
1997;96:1139(cid:2)1144. . tricuspidvalvedisease.Europace2018;20:636(cid:2)642.
.
466. Vivas D, Pe´rez-Vizcayno MJ, Hern(cid:2)andez-Antol(cid:2)ın R, Fern(cid:2)andez-Ortiz A, .. 488.SharmaPS,SubzposhFA,EllenbogenKA,VijayaramanP.PermanentHis-bundle
Ba~nuelos C, Escaned J, Jime´nez-Quevedo P, De Agust(cid:2)ın JA, N(cid:2)u~nez-Gil I, .. pacinginpatientswithprostheticcardiacvalves.HeartRhythm2017;14:59(cid:2)64.
.
Gonz(cid:2)alez-Ferrer JJ, Macaya C, Alfonso F. Prognostic implications of bundle . 489.MartinsRP,GalandV,LeclercqC,DaubertJC.Cardiacelectronicimplantable
.
branchblockinpatientsundergoingprimarycoronaryangioplastyinthestent . devicesaftertricuspidvalvesurgery.HeartRhythm2018;15:1081(cid:2)1088.
.
era.AmJCardiol2010;105:1276(cid:2)1283. .. 490.LeonMB,SmithCR,MackM,MillerDC,MosesJW,SvenssonLG,TuzcuEM,
467. XiongY,WangL,LiuW,HankeyGJ,XuB,WangS.Theprognosticsignificance .. WebbJG,FontanaGP,MakkarRR,BrownDL,BlockPC,GuytonRA,Pichard
.
ofrightbundlebranchblock:ameta-analysisofprospectivecohortstudies.Clin . AD,BavariaJE,HerrmannHC,DouglasPS,PetersenJL,AkinJJ,AndersonWN,
.
Cardiol2015;38:604(cid:2)613. .. Wang D, Pocock S. Transcatheter aortic-valve implantation for aortic
468. SwartG,BradyWJ,DeBehnkeDJ,MAOJ,AufderheideTP.Acutemyocardial .. stenosis in patients who cannot undergo surgery. N Engl J Med
.
infarctioncomplicatedbyhemodynamicallyunstablebradyarrhythmia:prehospi- . 2010;363:1597(cid:2)1607.
.
talandEDtreatmentwithatropine.AmJEmergMed1999;17:647(cid:2)652. . 491.SmithCR,LeonMB,MackMJ,MillerDC,MosesJW,SvenssonLG,TuzcuEM,
.
469. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, .. WebbJG,FontanaGP,MakkarRR,WilliamsM,DeweyT,KapadiaS,Babaliaros
Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, . V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ,
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 84 ---
84 ESCGuidelines
.
.
AndersonWN,WangD,PocockSJ.Transcatheterversussurgicalaortic-valve . 504.RegueiroA,Abdul-JawadAltisentO,DelTrigoM,Campelo-ParadaF,PuriR,
.
replacementinhigh-riskpatients.NEnglJMed2011;364:2187(cid:2)2198. . UrenaM,PhilipponF,Rodes-CabauJ.Impactofnew-onsetleftbundlebranch
.
492. LeonMB,SmithCR,MackMJ,MakkarRR,SvenssonLG,KodaliSK,Thourani .. block and periprocedural permanent pacemaker implantation on clinical out-
VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ,Pichard AD, .. comesinpatientsundergoingtranscatheteraorticvalvereplacement:asystem-
.
Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, . aticreviewandmeta-analysis.CircCardiovascInterv2016;9:e003635.
.
Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, .. 505.Chamandi C, Barbanti M, Munoz-Garcia A, Latib A, Nombela-Franco L,
Brown DL,FearonWF,PibarotP,HahnRT, JaberWA,AndersonWN,Alu .. Gutierrez-IbanezE,Veiga-FernandezG,CheemaAN,Cruz-GonzalezI,SerraV,
.
MC, Webb JG. Transcatheter or surgical aortic-valve replacement in . TamburinoC,MangieriA,ColomboA,Jimenez-QuevedoP,ElizagaJ,Laughlin
.
intermediate-riskpatients.NEnglJMed2016;374:1609(cid:2)1620. . G, Lee DH, Garcia Del Blanco B, Rodriguez-Gabella T, Marsal JR, Cote M,
.
493. MackMJ,LeonMB,ThouraniVH,MakkarR,KodaliSK,RussoM,KapadiaSR, .. PhilipponF,Rodes-CabauJ.Long-termoutcomesinpatientswithnewperma-
MalaisrieSC,CohenDJ,PibarotP,LeipsicJ,HahnRT,BlankeP,WilliamsMR, .. nentpacemakerimplantationfollowingtranscatheteraorticvalvereplacement.
.
McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, . JACCCardiovascInterv2018;11:301(cid:2)310.
.
PershadA,PocockSJ,AluMC,WebbJG,SmithCR.Transcatheteraortic-valve . 506.Mohananey D, Jobanputra Y, Kumar A, Krishnaswamy A, Mick S, White JM,
.
replacementwithaballoon-expandablevalveinlow-riskpatients.NEnglJMed .. Kapadia SR. Clinical and echocardiographic outcomes following permanent
.
2019;380:1695(cid:2)1705. . pacemaker implantation after transcatheter aortic valve replacement: meta-
.
494. AdamsDH,PopmaJJ,ReardonMJ,YakubovSJ,CoselliJS,DeebGM,Gleason . analysisandmeta-regression.CircCardiovascInterv2017;10:e005046.
. TG,BuchbinderM,HermillerJJr,KleimanNS,ChetcutiS,HeiserJ,MerhiW, .. 507.UeshimaD,NaiFovinoL,MojoliM,NapodanoM,FraccaroC,TarantiniG.The
ZornG,TadrosP,RobinsonN,PetrossianG,HughesGC,HarrisonJK,Conte .. interplaybetweenpermanentpacemakerimplantationandmortalityinpatients
.
J, Maini B, Mumtaz M, Chenoweth S, Oh JK. Transcatheter aortic-valve . treated by transcatheter aortic valve implantation: a systematic review and
.
replacement with a self-expanding prosthesis. N Engl J Med . meta-analysis.CatheterCardiovascInterv2018;92:E159(cid:2)E167.
.
2014;370:1790(cid:2)1798. .. 508.Urena M, Webb JG, Tamburino C, Munoz-Garcia AJ, Cheema A, Dager AE,
495. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T, .. SerraV,Amat-SantosIJ,BarbantiM,ImmeS,BrialesJH,BenitezLM,AlLawati
.
Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, . H,CucalonAM,GarciaDelBlancoB,LopezJ,DumontE,DelarochelliereR,
.
AdamsDH,TeirsteinPS,ZornGL3rd,ForrestJK,TchetcheD,ResarJ,Walton .. RibeiroHB,Nombela-FrancoL,PhilipponF,Rodes-CabauJ.Permanentpace-
A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, .. makerimplantationaftertranscatheteraorticvalveimplantation:impactonlate
.
Boulware MJ, Qiao H, Mugglin AS, Reardon MJ. Transcatheter aortic-valve . clinicaloutcomesandleftventricularfunction.Circulation2014;129:1233(cid:2)1243.
.
replacement with a self-expanding valve in low-risk patients. N Engl J Med . 509.FujitaB,SchmidtT,BleizifferS,BauerT,BeckmannA,BekeredjianR,Mollmann
.
2019;380:1706(cid:2)1715. .. H,WaltherT,LandwehrS,HammC,BeyersdorfF,KatusHA,HarringerW,
496. ReardonMJ,VanMieghemNM,PopmaJJ,KleimanNS,SondergaardL,Mumtaz .. Ensminger S, Frerker C, GARY Executive Board. Impact of new pacemaker
.
M,AdamsDH,DeebGM,MainiB,GadaH,ChetcutiS,GleasonT,HeiserJ, . implantationfollowingsurgicalandtranscatheteraorticvalvereplacementon1-
.
Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, . yearoutcome.EurJCardiothoracSurg2020;57:151(cid:2)159.
.
YakubovSJ,GrubeE,MakkarR,LeeJS,ConteJ,VangE,NguyenH,ChangY, .. 510.ZhangXH,ChenH,SiuCW,YiuKH,ChanWS,LeeKL,ChanHW,LeeSW,
.
MugglinAS,SerruysPW,KappeteinAP.Surgicalortranscatheteraortic-valve . FuGS,LauCP,TseHF.New-onsetheartfailureafterpermanentrightventricu-
.
replacementinintermediate-riskpatients.NEnglJMed2017;376:1321(cid:2)1331. . larapicalpacinginpatientswithacquiredhigh-gradeatrioventricularblockand
.
497. BarbashIM,FinkelsteinA,BarsheshetA,SegevA,SteinvilA,AssaliA,BenGal .. normalleftventricularfunction.JCardiovascElectrophysiol2008;19:136(cid:2)141.
Y, Vaknin Assa H, Fefer P, Sagie A, Guetta V, Kornowski R. Outcomes .. 511.Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS, Kapadia S,
.
ofpatientsatestimatedlow,intermediate,andhighriskundergoingtranscath- . Babaliaros V, Herrmann HC, Szeto WY, Jilaihawi H, Fearon WF, Tuzcu EM,
.
eter aortic valve implantation for aortic stenosis. Am J Cardiol . PichardAD,MakkarR,WilliamsM,HahnRT,XuK,SmithCR,LeonMB,Kodali
.
2015;116:1916(cid:2)1922. .. SK. Chronic pacing and adverse outcomes after transcatheter aortic valve
498. BekeredjianR,SzaboG,BalabanU,BleizifferS,BauerT,EnsmingerS,Frerker .. implantation.Heart2015;101:1665(cid:2)1671.
.
C,HerrmannE,BeyersdorfF,HammC,BeckmannA,MollmannH,KarckM, . 512.AbramowitzY,KazunoY,ChakravartyT,KawamoriH,MaenoY,AndersonD,
.
KatusHA,WaltherT.PatientsatlowsurgicalriskasdefinedbytheSocietyof .. Allison Z, Mangat G, Cheng W, Gopal A, Jilaihawi H, Mack MJ, Makkar RR.
ThoracicSurgeonsScoreundergoingisolatedinterventionalorsurgicalaortic .. Concomitantmitralannularcalcificationandsevereaorticstenosis:prevalence,
.
valveimplantation:in-hospitaldataand1-yearresultsfromtheGermanAortic . characteristicsandoutcomefollowingtranscatheteraorticvalvereplacement.
.
ValveRegistry(GARY).EurHeartJ2019;40:1323(cid:2)1330. . EurHeartJ2017;38:1194(cid:2)1203.
.
499. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, .. 513.Al-AzzamF,GreasonKL,KrittanawongC,WilliamsonEE,McLeodCJ,KingKS,
Leprince P, Leguerrier A, Lievre M, Prat A, TeigerE, Lefevre T, HimbertD, .. MathewV.Theinfluenceofnativeaorticvalvecalciumandtranscathetervalve
.
TchetcheD,CarrieD,AlbatB,CribierA,RioufolG,SudreA,BlanchardD, . oversize on the need for pacemaker implantation after transcatheter aortic
.
Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, . valveinsertion.JThoracCardiovascSurg2017;153:1056(cid:2)1062.e1051. .
BoschatJ,LeBretonH,CollartF,HouelR,DelpineS,SouteyrandG,Favereau .. 514.Bagur R, Rodes-Cabau J, Gurvitch R, Dumont E, Velianou JL, Manazzoni J,
X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, .. Toggweiler S, Cheung A, Ye J, Natarajan MK, Bainey KR, DeLarochelliere R,
.
BertrandB,VanBelleE,LaskarM.Registryoftranscatheteraortic-valveimplan- . DoyleD,PibarotP,VoisineP,CoteM,PhilipponF,WebbJG.Needforperma-
. tationinhigh-riskpatients.NEnglJMed2012;366:1705(cid:2)1715. .. nent pacemaker as a complication of transcatheter aortic valve implantation
500. MoatNE,LudmanP,deBelderMA,BridgewaterB,CunninghamAD,Young .. and surgical aortic valve replacement in elderly patients with severe aortic
.
CP,ThomasM,KovacJ,SpytT,MacCarthyPA,WendlerO,Hildick-SmithD, . stenosisandsimilarbaselineelectrocardiographicfindings.JACCCardiovascInterv .
DaviesSW,TrivediU,BlackmanDJ,LevyRD,BreckerSJ,BaumbachA,Daniel . 2012;5:540(cid:2)551.
.
T, Gray H, Mullen MJ. Long-term outcomes after transcatheter aortic valve .. 515.Boerlage-Van Dijk K, Kooiman KM, Yong ZY, Wiegerinck EM, Damman P,
implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI .. BoumaBJ,TijssenJG,PiekJJ,KnopsRE,BaanJJr.Predictorsandpermanencyof
.
(UnitedKingdomTranscatheterAorticValveImplantation)Registry.JAmColl . cardiacconductiondisordersandnecessityofpacingaftertranscatheteraortic
.
Cardiol2011;58:2130(cid:2)2138. .. valveimplantation.PacingClinElectrophysiol2014;37:1520(cid:2)1529.
501. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, .. 516.CalviV,ContiS,PruitiGP,CapodannoD,PuzzangaraE,TempioD,DiGrazia
.
EggebrechtH,RubinoP,MichevI,LangeR,AndersonWN,WendlerO.Thirty- . A,UssiaGP,TamburinoC.Incidencerateandpredictorsofpermanentpace-
.
dayresultsoftheSAPIENaorticBioprosthesisEuropeanOutcome(SOURCE) . maker implantation after transcatheter aortic valve implantation with self-
.
Registry: a European registry of transcatheter aortic valve implantation using .. expandingCoreValveprosthesis.JIntervCardElectrophysiol2012;34:189(cid:2)195.
theEdwardsSAPIENvalve.Circulation2010;122:62(cid:2)69. .. 517.De Carlo M, Giannini C, Bedogni F, Klugmann S, Brambilla N, De Marco F,
.
502. Werner N, Zahn R, Beckmann A, Bauer T, Bleiziffer S, Hamm CW, . ZucchelliG,TestaL,OregliaJ,PetronioAS.Safetyofaconservativestrategyof
.
BerkeredjianR,BerkowitschA,MohrFW,LandwehrS,KatusHA,Harringer . permanent pacemaker implantation after transcatheter aortic CoreValve
.
W, Ensminger S, Frerker C, Mollmann H, Walther T, Schneider S, Lange R. .. implantation.AmHeartJ2012;163:492(cid:2)499.
Patientsatintermediatesurgicalriskundergoingisolatedinterventionalorsurgi- .. 518.FraccaroC,BujaG,TarantiniG,GasparettoV,LeoniL,RazzoliniR,Corrado
.
cal aortic valve implantation for severe symptomatic aortic valve stenosis. . D,BonatoR,BassoC,ThieneG,GerosaG,IsabellaG,IlicetoS,NapodanoM.
.
Circulation2018;138:2611(cid:2)2623. .. Incidence,predictors,andoutcomeofconductiondisordersaftertranscatheter
503. FadahunsiOO,OlowoyeyeA,UkaigweA,LiZ,VoraAN,VemulapalliS,Elgin .. self-expandableaorticvalveimplantation.AmJCardiol2011;107:747(cid:2)754.
.
E, Donato A. Incidence, predictors, and outcomes of permanent pacemaker . 519.GaedeL,KimWK,LiebetrauC,DorrO,SperzelJ,BlumensteinJ,Berkowitsch
.
implantationfollowingtranscatheteraorticvalvereplacement:analysisfromthe . A,WaltherT,HammC,ElsasserA,NefH,MollmannH.Pacemakerimplanta-
.
U.S. Society of Thoracic Surgeons/American College of Cardiology TVT .. tion after TAVI: predictors of AV block persistence. Clin Res Cardiol
Registry.JACCCardiovascInterv2016;9:2189(cid:2)2199. . 2018;107:60(cid:2)69.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 85 ---
ESCGuidelines 85
.
.
520. GuettaV,GoldenbergG,SegevA,DvirD,KornowskiR,FinckelsteinA,HayI, . 535.MouilletG,LelloucheN,LimP,MeguroK,YamamotoM,DeuxJF,MoninJL,
.
GoldenbergI,GliksonM.Predictorsandcourseofhigh-degreeatrioventricular . BergoendE,Dubois-RandeJL,TeigerE.PatientswithoutprolongedQRSafter
.
block after transcatheter aortic valve implantation using the CoreValve .. TAVI withCoreValvedevice donotexperience high-degree atrio-ventricular
RevalvingSystem.AmJCardiol2011;108:1600(cid:2)1605. .. block.CatheterCardiovascInterv2013;81:882(cid:2)887.
.
521. MangieriA,LanzilloG,BertoldiL,JabbourRJ,RegazzoliD,AnconaMB,Tanaka . 536.Rodes-Cabau J, Urena M, Nombela-Franco L, Amat-Santos I, Kleiman N,
.
A, Mitomo S, Garducci S, Montalto C, Pagnesi M, Giannini F, Giglio M, .. Munoz-GarciaA,AtienzaF,SerraV,DeyellMW,Veiga-FernandezG,Masson
MontorfanoM,ChieffoA,Rodes-CabauJ,MonacoF,PaglinoG,DellaBellaP, .. JB,Canadas-GodoyV,HimbertD,CastrodezaJ,ElizagaJ,FranciscoPascualJ,
.
ColomboA,LatibA.Predictorsofadvancedconductiondisturbancesrequiring . Webb JG, de la Torre JM, Asmarats L, Pelletier-Beaumont E, Philippon F.
.
a late (>_48 h) permanent pacemaker following transcatheter aortic valve . Arrhythmicburdenasdeterminedbyambulatorycontinuouscardiacmonitor-
.
replacement.JACCCardiovascInterv2018;11:1519(cid:2)1526. .. ing in patients with new-onset persistent left bundle branch block following
522. MauriV,ReimannA,SternD,SchernerM,KuhnE,RudolphV,RosenkranzS, .. transcatheteraorticvalvereplacement:theMAREstudy.JACCCardiovascInterv
.
Eghbalzadeh K, Friedrichs K, Wahlers T, Baldus S, Madershahian N, Rudolph . 2018;11:1495(cid:2)1505.
.
TK.Predictorsofpermanentpacemakerimplantationaftertranscatheteraortic . 537.UrenaM,WebbJG,EltchaninoffH,Munoz-GarciaAJ,BouletiC,TamburinoC,
.
valve replacement with the SAPIEN 3. JACC Cardiovasc Interv .. Nombela-FrancoL,NietlispachF,MorisC,RuelM,DagerAE,SerraV,Cheema
.
2016;9:2200(cid:2)2209. . AN, Amat-Santos IJ, de Brito FS, Lemos PA, Abizaid A, Sarmento-Leite R,
.
523. MouilletG,LelloucheN,YamamotoM,OguriA,Dubois-RandeJL,VanBelleE, . RibeiroHB,DumontE,BarbantiM,DurandE,AlonsoBrialesJH,HimbertD,
. GilardM,LaskarM,TeigerE.Outcomesfollowingpacemakerimplantationafter .. VahanianA,ImmeS,GarciaE,MaisanoF,delValleR,BenitezLM,Garciadel
transcatheteraorticvalveimplantationwithCoreValveVR devices:resultsfrom .. BlancoB,GutierrezH,PerinMA,SiqueiraD,BernardiG,PhilipponF,Rodes-
.
theFRANCE2Registry.CatheterCardiovascInterv2015;86:E158(cid:2)E166. . Cabau J. Late cardiac death in patients undergoing transcatheter aortic valve
.
524. NazifTM,DizonJM,HahnRT,XuK,BabaliarosV,DouglasPS,El-ChamiMF, . replacement: incidence and predictors of advanced heart failure and sudden
.
Herrmann HC,MackM,MakkarRR,MillerDC,PichardA,TuzcuEM,Szeto .. cardiacdeath.JAmCollCardiol2015;65:437(cid:2)448.
WY, Webb JG, Moses JW, Smith CR, Williams MR, Leon MB, Kodali SK. .. 538.Auffret V, Puri R, Urena M, Chamandi C, Rodriguez-Gabella T, Philippon F,
.
Predictors and clinical outcomes of permanent pacemaker implantation after . Rodes-Cabau J. Conduction disturbances after transcatheter aortic valve
.
transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic .. replacement: current status and future perspectives. Circulation
TraNscathetERValves)trialandregistry.JACCCardiovascInterv2015;8:60(cid:2)69. .. 2017;136:1049(cid:2)1069.
.
525. SiontisGC,JuniP,PilgrimT,StorteckyS,BullesfeldL,MeierB,WenaweserP, . 539.RogersT,DevrajM,ThomaidesA,SteinvilA,LipinskiMJ,BuchananKD,Alraies
.
WindeckerS.Predictorsofpermanentpacemakerimplantationinpatientswith . MC,KoifmanE,GaiJ,TorgusonR,OkubagziP,Ben-DorI,PichardAD,Satler
.
severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol .. LF, Waksman R. Utility of invasive electrophysiology studies in patients with
2014;64:129(cid:2)140. .. severeaorticstenosisundergoingtranscatheteraorticvalveimplantation.AmJ
.
526. van der Boon RM, Houthuizen P, Urena M, Poels TT, van Mieghem NM, . Cardiol2018;121:1351(cid:2)1357.
.
BruerenGR,AltintasS,NuisRJ,SerruysPW,vanGarsseLA,vanDomburgRT, . 540.Tovia-BrodieO,Ben-HaimY,JoffeE,FinkelsteinA,GlickA,RossoR,Belhassen
.
CabauJR,deJaegerePP,PrinzenFW.Trendsintheoccurrenceofnewconduc- .. B, Michowitz Y. The value of electrophysiologic study in decision-making
.
tion abnormalities after transcatheter aortic valve implantation. Catheter . regarding the need for pacemaker implantation after TAVI. J Interv Card
.
CardiovascInterv2015;85:E144(cid:2)E152. . Electrophysiol2017;48:121(cid:2)130.
.
527. GonskaB,SeegerJ,KesslerM,vonKeilA,RottbauerW,WohrleJ.Predictors .. 541.RivardL,SchramG,AsgarA,KhairyP,AndradeJG,BonanR,DubucM,Guerra
for permanent pacemaker implantation in patients undergoing transfemoral .. PG,IbrahimR,MacleL,RoyD,TalajicM,DyrdaK,ShohoudiA,lePolainde
.
aortic valve implantation with the Edwards Sapien 3 valve. Clin Res Cardiol . WarouxJB,ThibaultB.Electrocardiographicandelectrophysiologicalpredictors
.
2017;106:590(cid:2)597. . of atrioventricular block after transcatheter aortic valve replacement. Heart
.
528. MaenoY,AbramowitzY,KawamoriH,KazunoY,KuboS,TakahashiN,Mangat .. Rhythm2015;12:321(cid:2)329.
G,OkuyamaK,KashifM,ChakravartyT,NakamuraM,ChengW,FriedmanJ, .. 542.Lilly SM, Deshmukh AJ, Epstein AE, Ricciardi MJ, Shreenivas S, Velagapudi P,
.
BermanD,MakkarRR,JilaihawiH.Ahighlypredictiveriskmodelforpacemaker . WymanJF.2020ACCExpertconsensusdecisionpathwayonmanagementof
.
implantationafterTAVR.JACCCardiovascImaging2017;10:1139(cid:2)1147. .. conduction disturbances in patients undergoing transcatheter aortic valve
529. Giustino G, Van der Boon RM, Molina-Martin de Nicolas J, Dumonteil N, .. replacement: a report of the American College of Cardiology Solution Set
.
ChieffoA,deJaegerePP,TchetcheD,MarcheixB,MillischerD,CassagneauR, . OversightCommittee.JAmCollCardiol2020;76:2391(cid:2)2411.
.
CarrieD,VanMieghemNM,ColomboA.Impactofpermanentpacemakeron . 543.Rodes-CabauJ,EllenbogenKA,KrahnAD,LatibA,MackM,MittalS,Muntane-
.
mortality after transcatheter aortic valve implantation: the PRAGMATIC .. Carol G, Nazif TM, Sondergaard L, Urena M, Windecker S, Philippon F.
(Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy. .. Management of conduction disturbances associated with transcatheter aortic
.
EuroIntervention2016;12:1185(cid:2)1193. . valve replacement: JACC Scientific Expert Panel. J Am Coll Cardiol
.
530. HamdanA,GuettaV,KlempfnerR,KonenE,RaananiE,GliksonM,GoiteinO, . 2019;74:1086(cid:2)1106. .
SegevA,BarbashI,FeferP,SpiegelsteinD,GoldenbergI,SchwammenthalE. .. 544.Costa G, Zappulla P,BarbantiM, Cirasa A, Todaro D, Rapisarda G, Picci A,
Inverserelationshipbetweenmembranousseptallengthandtheriskofatrio- .. PlataniaF,TostoA,DiGraziaA,SgroiC,TamburinoC,CalviV.Pacemaker
.
ventricularblockinpatientsundergoingtranscatheteraorticvalveimplantation. . dependencyaftertranscatheteraorticvalveimplantation:incidence,predictors
. JACCCardiovascInterv2015;8:1218(cid:2)1228. .. andlong-termoutcomes.EuroIntervention2019;15:875(cid:2)883.
531. LedwochJ,FrankeJ,GerckensU,KuckKH,LinkeA,NickenigG,Krulls-Munch .. 545.KaplanRM,YadlapatiA,CanteyEP,PassmanRS,GajjarM,KnightBP,SweisR,
.
J,VohringerM,HambrechtR,ErbelR,RichardtG,HorackM,ZahnR,SengesJ, . Ricciardi MJ, Pham DT, Churyla A, Malaisrie SC, Davidson CJ, Flaherty JD. .
SievertH.Incidenceandpredictorsofpermanentpacemakerimplantationfol- . Conduction recovery following pacemaker implantation after transcatheter
.
lowingtranscatheteraorticvalveimplantation:analysisfromtheGermantrans- .. aorticvalvereplacement.PacingClinElectrophysiol2019;42:146(cid:2)152.
catheter aortic valve interventions registry. Catheter Cardiovasc Interv .. 546.Junquera L, Freitas-Ferraz AB, Padron R, Silva I, Nunes Ferreira-Neto A,
.
2013;82:E569(cid:2)E577. . Guimaraes L, Mohammadi S, Moris C, Philippon F, Rodes-Cabau J.
.
532. HusserO,PellegriniC,KesslerT,BurgdorfC,ThallerH,MayrNP,KaselAM, . Intraproceduralhigh-degreeatrioventricularblockorcompleteheartblockin
.
KastratiA,SchunkertH,HengstenbergC.Predictorsofpermanentpacemaker .. transcatheteraorticvalvereplacementrecipientswithnopriorintraventricular
.
implantations and new-onset conduction abnormalities with the SAPIEN 3 . conductiondisturbances.CatheterCardiovascInterv2019;95:982(cid:2)990.
.
balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv . 547.AuffretV,WebbJG,EltchaninoffH,Munoz-GarciaAJ,HimbertD,Tamburino
.
2016;9:244(cid:2)254. .. C, Nombela-Franco L, Nietlispach F, Moris C, Ruel M, Dager AE, Serra V,
533. ToggweilerS,StorteckyS,HolyE,ZukK,CuculiF,NietlispachF,SabtiZ,Suciu .. CheemaAN,Amat-SantosIJ,deBritoFSJr,LemosPA,AbizaidA,Sarmento-
.
R, Maier W, Jamshidi P, Maisano F, Windecker S, Kobza R, Wenaweser P, . Leite R, Dumont E, Barbanti M, Durand E, Alonso Briales JH, Vahanian A,
.
LuscherTF,BinderRK.Theelectrocardiogramaftertranscatheteraorticvalve . BouletiC,ImmeS,MaisanoF,DelValleR,BenitezLM,GarciaDelBlancoB,
.
replacementdeterminestheriskforpost-proceduralhigh-degreeAVblockand .. PuriR,PhilipponF,UrenaM,Rodes-CabauJ.Clinicalimpactofbaselineright
theneedfortelemetrymonitoring.JACCCardiovascInterv2016;9:1269(cid:2)1276. .. bundlebranchblockinpatientsundergoingtranscatheteraorticvalvereplace-
.
534. UrenaM,WebbJG,CheemaA,SerraV,ToggweilerS,BarbantiM,CheungA, . ment.JACCCardiovascInterv2017;10:1564(cid:2)1574.
.
Ye J, Dumont E, DeLarochelliere R, Doyle D, Al Lawati HA, Peterson M, .. 548.Jorgensen TH, De Backer O, Gerds TA, Bieliauskas G, Svendsen JH,
ChisholmR,IgualA,RibeiroHB,Nombela-FrancoL,PhilipponF,GarciaDel .. SondergaardL.Immediatepost-procedural12-leadelectrocardiographyaspre-
.
Blanco B, Rodes-Cabau J. Impact of new-onset persistent left bundle branch . dictoroflateconductiondefectsaftertranscatheteraorticvalvereplacement.
.
blockonlateclinicaloutcomesinpatientsundergoingtranscatheteraorticvalve . JACCCardiovascInterv2018;11:1509(cid:2)1518.
.
implantation with a balloon-expandable valve. JACC Cardiovasc Interv .. 549.ReamK,SandhuA,ValleJ,WeberR,KaizerA,WiktorDM,BorneRT,Tumolo
2014;7:128(cid:2)136. . AZ,KunkelM,ZipseMM,SchullerJ,TompkinsC,RosenbergM,NguyenDT,
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 86 ---
86 ESCGuidelines
.
.
ClevelandJCJr,FullertonD,CarrollJD,MessengerJ,SauerWH,AleongRG, . 570.GrossGJ,ChiuCC,HamiltonRM,KirshJA,StephensonEA.Naturalhistoryof
.
TzouWS.Ambulatoryrhythmmonitoringtodetectlatehigh-gradeatrioven- . postoperative heart block in congenital heart disease: implications for pacing
.
tricularblockfollowingtranscatheteraorticvalvereplacement.JAmCollCardiol .. intervention.HeartRhythm2006;3:601(cid:2)604.
2019;73:2538(cid:2)2547. .. 571.MurphyD.Prognosisofcompleteatrioventriculardissociationinchildrenafter
.
550. Kostopoulou A, Karyofillis P, Livanis E, Thomopoulou S, Stefopoulos C, . open-heartsurgery.Lancet1970;295:750(cid:2)752.
.
DoudoumisK,TheodorakisG,VoudrisV.Permanentpacingaftertranscatheter .. 572.KrongradE.Prognosisforpatientswithcongenitalheartdiseaseandpostopera-
aorticvalveimplantationofaCoreValveprosthesisasdeterminedbyelectro- .. tiveintraventricularconductiondefects.Circulation1978;57:867(cid:2)870.
.
cardiographic and electrophysiological predictors: a single-centre experience. . 573.VillainE.Indicationsforpacinginpatientswithcongenitalheartdisease.Pacing
.
Europace2016;18:131(cid:2)137. . ClinElectrophysiol2008;31Suppl1:S17-20.
.
551. KhairyP,LandzbergMJ,GatzoulisMA,MercierL-Ae,FernandesSM,Coˆte´J-M, .. 574.DillerGP,OkonkoD,UebingA,HoSY,GatzoulisMA.Cardiacresynchroniza-
Lavoie J-P, Fournier A, Guerra PG, Frogoudaki A, Walsh EP, Dore A. .. tion therapy for adult congenital heart disease patients with a systemic right
.
Transvenouspacingleadsandsystemicthromboemboliinpatientswithintra- . ventricle: analysis of feasibility and review of early experience. Europace
.
cardiacshunts.Circulation2006;113:2391(cid:2)2397. .. 2006;8:267(cid:2)272.
552. AnandN.Chronotropicincompetenceinyoungpatientswithlatepostopera- .. 575.Rapezzi C, Arbustini E, Caforio ALP, Charron P, Gimeno-Blanes J, Helio T,
.
tiveatrialflutter:acase(cid:2)controlstudy.EurHeartJ2006;27:2069(cid:2)2073. . Linhart A, Mogensen J, Pinto Y, Ristic A, Seggewiss H, Sinagra G, Tavazzi L,
.
553. Fishberger SB, Wernovsky G, Gentles TL, Gauvreau K, Burnetta J, Mayer JE, . ElliottPM.Diagnosticwork-upincardiomyopathies:bridgingthegapbetween
. Walsh EP. Factors that influence the development of atrial flutter after the .. clinical phenotypes and final diagnosis. A position statement from the ESC
Fontanoperation.JThoracCardiovascSurg1997;113:80(cid:2)86. .. Working Group on Myocardial and Pericardial Diseases. Eur Heart J
.
554. GillettePC,ShannonC,GarsonA,PorterC-BJ,OttD,CooleyDA,McNamara . 2012;34:1448(cid:2)1458.
.
DG.Pacemakertreatmentofsicksinussyndromeinchildren.JAmCollCardiol . 576.Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P,
.
1983;1:1325(cid:2)1329. .. HagegeAA,LafontA,LimongelliG,MahrholdtH,McKennaWJ,MogensenJ,
555. KayR,EstiokoM,WienerI.Primarysicksinussyndromeasanindicationfor .. Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH,
.
chronic pacemaker therapy in young adults: incidence, clinical features, and . TillmannsC,WatkinsH.2014ESCGuidelinesondiagnosisandmanagementof
.
long-termevaluation.AmericanHeartJournal1982;103:338(cid:2)342. .. hypertrophic cardiomyopathy: the Task Force for the Diagnosis and
556. Ragonese P, Drago F, Guccione P, Santilli A, Silvetti MS, Agostino DA. .. Management of Hypertrophic Cardiomyopathy of the European Society of
.
Permanent overdrive atrial pacing in the chronic management of recurrent . Cardiology(ESC).EurHeartJ2014;35:2733(cid:2)2779.
.
postoperativeatrialreentranttachycardiainpatientswithcomplexcongenital . 577.Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SN,
.
heartdisease.PacingClinElectrophysiol1997;20:2917(cid:2)2923. .. AllisonTG,TajikAJ.Dual-chamberpacingforhypertrophiccardiomyopathy:
557.OpicP,YapSC,VanKranenburgM,VanDijkAP,BudtsW,VliegenHW,VanErven .. a randomized, double-blind, crossover trial. J Am Coll Cardiol
.
L,CanA,SahinG,DeGrootNM,WitsenburgM,Roos-HesselinkJW.Atrial-based . 1997;29:435(cid:2)441.
.
pacinghasnobenefitoverventricularpacinginpreventingatrialarrhythmiasinadults . 578.Kappenberger L, Linde C, Daubert C, McKenna W, Meisel E, Sadoul N,
.
withcongenitalheartdisease.Europace2013;15:1757(cid:2)1762. .. ChojnowskaL,GuizeL,GrasD,JeanrenaudX,RydenL.Pacinginhypertrophic
.
558. SkanesAC,KrahnAD,YeeR,KleinGJ,ConnollySJ,KerrCR,GentM,Thorpe . obstructive cardiomyopathy: a randomized crossover study. Eur Heart J
.
KE, Roberts RS, Canadian Trial of Physiologic Pacing.Progressionto chronic . 1997;18:1249(cid:2)1256.
.
atrialfibrillationafterpacing:theCanadianTrialofPhysiologicPacing.CTOPP .. 579.MaronBJ,NishimuraRA,McKennaWJ,RakowskiH,JosephsonME,KievalRS.
Investigators.JAmCollCardiol2001;38:167(cid:2)172. .. Assessment of permanent dual-chamber pacing as a treatment for drug-
.
559. KusumotoFM,SchoenfeldMH,BarrettC,EdgertonJR,EllenbogenKA,Gold . refractorysymptomaticpatientswithobstructivehypertrophiccardiomyopathy.
.
MR, Goldschlager NF, Hamilton RM, Joglar JA, Kim RJ, Lee R, Marine JE, . A randomized, double-blind, crossover study (M-PATHY). Circulation
.
McLeod CJ, Oken KR, Patton KK, Pellegrini CN, Selzman KA, Thompson A, .. 1999;99:2927(cid:2)2933.
VarosyPD.2018ACC/AHA/HRSGuidelineontheevaluationandmanagement .. 580.Slade AK, Sadoul N, Shapiro L, Chojnowska L, Simon JP, Saumarez RC,
.
ofpatientswithbradycardiaandcardiacconductiondelay:executivesummary: . DodinotB,CammAJ,McKennaWJ,AliotE.DDDpacinginhypertrophiccardi-
.
areportoftheAmericanCollege ofCardiology/AmericanHeartAssociation .. omyopathy:amulticentreclinicalexperience.Heart1996;75:44(cid:2)49.
Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. .. 581.Megevand A, Ingles J, Richmond DR, Semsarian C. Long-term follow-up of
.
Circulation2019;140:e333-e381. . patients with obstructive hypertrophic cardiomyopathy treated with dual-
.
560. KramerCC,MaldonadoJR,OlsonMD,GingerichJC,OchoaLA,LawIH.Safety . chamberpacing.AmJCardiol2005;95:991(cid:2)993.
.
and efficacy of atrial antitachycardia pacing in congenital heart disease. Heart .. 582.Linde C, Gadler F, Kappenberger L, Ryden L. Placebo effect of pacemaker
Rhythm2018;15:543(cid:2)547. .. implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group.
.
561. StephensonEA,CasavantD,TuziJ,AlexanderME,LawI,SerwerG,StrieperM, . PacingInCardiomyopathy.AmJCardiol1999;83:903(cid:2)907.
.
WalshEP,BerulCI,ATTESTInvestigators.Efficacyofatrialantitachycardiapac- . 583.Ommen SR, Nishimura RA, Squires RW, Schaff HV, Danielson GK, Tajik AJ. .
ingusingtheMedtronicAT500pacemakerinpatientswithcongenitalheartdis- .. Comparisonofdual-chamberpacingversusseptalmyectomyforthetreatment
ease.AmJCardiol2003;92:871(cid:2)876. .. of patients with hypertrophic obstructive cardiomyopathy: a comparison of
.
562. JaeggiET,HamiltonRM,SilvermanED,ZamoraSA,HornbergerLK.Outcome . objective hemodynamic and exercise end points. J Am Coll Cardiol
. of children with fetal, neonatal, or childhood diagnosis of isolated congenital .. 1999;34:191(cid:2)196.
atrioventricularblock:asingleinstitution’sexperienceof30years.ACCCurrent .. 584.ArnoldAD,HowardJP,ChiewK,KerriganWJ,deVereF,JohnsHT,Churlilov
.
JournalReview2002;11:95. . L,AhmadY,KeeneD,Shun-ShinMJ,ColeGD,KanagaratnamP,SohaibSMA, .
563. VillainE,Coastedoat-ChalumeauN,MarijonE,BoudjemlineY,PietteJC,Bonnet . VarnavaA,FrancisDP,WhinnettZI.Rightventricularpacingforhypertrophic
.
D.Presentation and prognosis ofcompleteatrioventricularblockinchildhood, .. obstructivecardiomyopathy:meta-analysisandmeta-regressionofclinicaltrials.
accordingtomaternalantibodystatus.JAmCollCardiol2006;48:1682(cid:2)1687. .. EurHeartJQualCareClinOutcomes2019;5:321(cid:2)333.
.
564. Dewey RC, Capeless MA, Levy AM. Use of ambulatory electrocardiographic . 585.ChangSM,NaguehSF,SpencerWH3rd,LakkisNM.Completeheartblock:
.
monitoringtoidentifyhigh-riskpatientswithcongenitalcompleteheartblock. . determinantsandclinicalimpactinpatientswithhypertrophicobstructivecardi-
.
NEnglJMed1987;316:835(cid:2)839. .. omyopathyundergoingnonsurgicalseptalreductiontherapy.JAmCollCardiol
.
565. Karpawich PP, Gillette PC, Garson A Jr, Hesslein PS, Porter CB, McNamara . 2003;42:296(cid:2)300.
.
DG.Congenitalcompleteatrioventricularblock:clinicalandelectrophysiologic . 586.Lawrenz T, Lieder F, Bartelsmeier M, Leuner C, Borchert B, Meyer zu
.
predictorsofneedforpacemakerinsertion.AmJCardiol1981;48:1098(cid:2)1102. .. VilsendorfD,Strunk-MuellerC,ReinhardtJ,FeuchtlA,StellbrinkC,KuhnH.
566. MichaelssonM,JonzonA,RiesenfeldT.Isolatedcongenitalcompleteatrioven- .. Predictorsofcompleteheartblockaftertranscoronaryablationofseptalhyper-
.
tricularblockinadultlife.Aprospectivestudy.Circulation1995;92:442(cid:2)449. . trophy: results of a prospective electrophysiological investigation in 172
.
567. Beaufort-KrolGC,Schasfoort-vanLeeuwenMJ,StienstraY,Bink-BoelkensMT. . patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol
.
Longitudinalechocardiographicfollow-upinchildrenwithcongenitalcomplete .. 2007;49:2356(cid:2)2363.
atrioventricularblock.PacingClinElectrophysiol2007;30:1339(cid:2)1343. .. 587.TopilskiI,SherezJ,KerenG,CoppermanI.Long-termeffectsofdual-chamber
.
568. BreurJM,UdinkTenCateFE,KapustaL,CohenMI,CrossonJE,Boramanand . pacing with periodic echocardiographic evaluation of optimal atrioventricular
.
N,LubbersLJ,FriedmanAH,BrennerJI,VetterVL,SreeramN,MeijboomEJ. .. delay in patients with hypertrophic cardiomyopathy >50 years of age. Am J
Pacemaker therapy in isolated congenital complete atrioventricular block. .. Cardiol2006;97:1769(cid:2)1775.
.
PacingClinElectrophysiol2002;25:1685(cid:2)1691. . 588.CuiH,SchaffHV,NishimuraRA,GeskeJB,DearaniJA,LahrBD,OmmenSR.
.
569. BonattiV,AgnettiA,SquarciaU.Earlyandlatepostoperativecompleteheart . Conductionabnormalitiesandlong-termmortalityfollowingseptalmyectomy
.
blockinpediatricpatientssubmittedtoopen-heartsurgeryforcongenitalheart .. in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol
disease.PediatrMedChir1998;20:181(cid:2)186. . 2019;74:645(cid:2)655.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 87 ---
ESCGuidelines 87
.
.
589. Rogers DP, Marazia S, Chow AW, Lambiase PD, Lowe MD, Frenneaux M, . 608.Sanna T. Cardiac features of Emery(cid:2)Dreifussmuscular dystrophy caused by
.
McKennaWJ,ElliottPM.Effectofbiventricularpacingonsymptomsandcardiac .. laminA/Cgenemutations.EurHeartJ2003;24:2227(cid:2)2236.
remodelling in patients with end-stage hypertrophic cardiomyopathy. Eur J .. 609.Haas J, Frese KS, Peil B, Kloos W, Keller A, Nietsch R, Feng Z, Muller S,
HeartFail2008;10:507(cid:2)513. .. Kayvanpour E, Vogel B, Sedaghat-Hamedani F, Lim WK, Zhao X, Fradkin D,
.
590. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, . KohlerD,FischerS,FrankeJ,MarquartS,BarbI,LiDT,AmrA,EhlermannP,
.
HungJ,JoglarJA, KantorP,Kimmelstiel C,KittlesonM,LinkMS,MaronMS, .. MerelesD,WeisT,HasselS,KremerA,KingV,WirszE,IsnardR,KomajdaM,
MartinezMW,MiyakeCY,SchaffHV,SemsarianC,SorajjaP.2020AHA/ACC .. SerioA,GrassoM,SyrrisP,WicksE,PlagnolV,LopesL,GadgaardT,Eiskjaer
.
Guidelineforthediagnosisandtreatmentofpatientswithhypertrophiccardio- . H, Jorgensen M, Garcia-Giustiniani D, Ortiz-Genga M, Crespo-Leiro MG,
.
myopathy: Executive Summary: a Report of the American College of . Deprez RH, Christiaans I, van Rijsingen IA, Wilde AA, Waldenstrom A,
.
Cardiology/American Heart Association Joint Committee on Clinical Practice .. Bolognesi M, Bellazzi R, Morner S, Bermejo JL, Monserrat L, Villard E,
Guidelines.Circulation2020;142:e533-e557. .. MogensenJ,PintoYM,CharronP,ElliottP,ArbustiniE,KatusHA,MederB.
.
591. CappelliF,MoriniS,PieragnoliP,TargettiM,StefanoP,MarchionniN,OlivottoI. . Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J
.
Cardiac resynchronization therapy for end-stage hypertrophic cardiomyopathy: .. 2015;36:1123(cid:2)1135.
theneedfordisease-specificcriteria.JAmCollCardiol2018;71:464(cid:2)466. .. 610.Gigli M, Merlo M, Graw SL, Barbati G, Rowland TJ, Slavov DB, Stolfo D,
.
592. KilluAM,ParkJY,SaraJD,HodgeDO,GershBJ,NishimuraRA,AsirvathamSJ, . HaywoodME,DalFerroM,AltinierA,RamaniF,BrunF,CoccioloA,PuggiaI,
.
McLeod CJ. Cardiac resynchronization therapy in patients with end-stage . Morea G, McKenna WJ, La Rosa FG, Taylor MRG, Sinagra G, Mestroni L.
. hypertrophiccardiomyopathy.Europace2018;20:82(cid:2)88. .. Geneticriskofarrhythmicphenotypesinpatientswithdilatedcardiomyopathy.
593. GuM,JinH,HuaW,FanXH,NiuHX,TianT,DingLG,WangJ,XueC,Zhang .. JAmCollCardiol2019;74:1480(cid:2)1490.
.
S.Clinicaloutcomeofcardiacresynchronizationtherapyindilated-phasehyper- . 611.vanBerloJH,deVoogtWG,vanderKooiAJ,vanTintelenJP,BonneG,Yaou
.
trophiccardiomyopathy.JGeriatrCardiol2017;14:238(cid:2)244. . RB,DubocD,RossenbackerT,HeidbuchelH,deVisserM,CrijnsHJ,PintoYM.
.
594. Fruh A, Siem G, Holmstrom H, Dohlen G, Haugaa KH. The Jervell and .. Meta-analysisofclinicalcharacteristicsof299carriersofLMNAgenemutations:
Lange(cid:2)Nielsen syndrome; atrial pacing combined with b-blocker therapy, a .. dolaminA/Cmutationsportendahighriskofsuddendeath?JMolMed(Berl)
.
favorableapproachinyounghigh-riskpatientswithlongQTsyndrome?Heart . 2005;83:79(cid:2)83.
.
Rhythm2016;13:2186(cid:2)2192. .. 612.MeuneC,VanBerloJH,AnselmeF,BonneG,PintoYM,DubocD.Primarypre-
595. AzizPF,TanelRE,ZelsterIJ,PassRH,WieandTS,VetterVL,VogelRL,Shah .. ventionofsuddendeathinpatientswithlaminA/Cgenemutations.NEnglJ
.
MJ.CongenitallongQTsyndromeand2:1atrioventricularblock:anoptimistic . Med2006;354:209(cid:2)210.
.
outcomeinthecurrentera.HeartRhythm2010;7:781(cid:2)785. . 613.AnselmeF,MoubarakG,SavoureA,GodinB,BorzB,Drouin-GarraudV,Gay
.
596. FeingoldB,MahleWT,AuerbachS,ClemensP,DomenighettiAA,JefferiesJL, .. A. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with
Judge DP, Lal AK, Markham LW, Parks WJ, Tsuda T, Wang PJ, Yoo SJ, .. cardiacconductiondisorders.HeartRhythm2013;10:1492(cid:2)1498.
.
AmericanHeartAssociationPediatricHeartFailureCommitteeoftheCouncil . 614.Hasselberg NE, Haland TF, Saberniak J, Brekke PH, Berge KE, Leren TP,
.
on Cardiovascular Disease in the Young, Council on Clinical Cardiology, . EdvardsenT,HaugaaKH.LaminA/Ccardiomyopathy:youngonset,highpene-
.
Council on Cardiovascular Radiology Intervention, Council on Functional .. trance, and frequent need for heart transplantation. Eur Heart J
.
Genomics Translational Biology, Stroke Council. Management of cardiac . 2018;39:853(cid:2)860.
.
involvement associated with neuromuscular diseases: a Scientific Statement . 615.Becane HM, Bonne G, Varnous S, Muchir A, Ortega V, Hammouda EH,
.
fromtheAmericanHeartAssociation.Circulation2017;136:e200-e231. .. UrtizbereaJA,LavergneT,FardeauM,EymardB,WeberS,SchwartzK,Duboc
597. ArbustiniE,DiToroA,GiulianiL,FavalliV,NarulaN,GrassoM.Cardiacphe- .. D.Highincidenceofsuddendeathwithconductionsystemandmyocardialdis-
.
notypes in hereditary muscle disorders: JACC State-of-the-Art Review. J Am . ease due to lamins A and C gene mutation. Pacing Clin Electrophysiol
.
CollCardiol2018;72:2485(cid:2)2506. . 2000;23:1661(cid:2)1666.
.
598. Groh WJ. Arrhythmias in the muscular dystrophies. Heart Rhythm .. 616.WahbiK,BenYaouR,GandjbakhchE,AnselmeF,GossiosT,LakdawalaNK,
2012;9:1890(cid:2)1895. .. StalensC,SacherF,BabutyD,TrochuJN,MoubarakG,SavvatisK,PorcherR,
.
599. BhaktaD,ShenC,KronJ,EpsteinAE,PascuzziRM,GrohWJ.Pacemakerand . LaforetP,FayssoilA,MarijonE,StojkovicT,BehinA,Leonard-LouisS,SoleG,
.
implantable cardioverter-defibrillator usein a US myotonic dystrophy type 1 .. LabombardaF,RichardP,MetayC,Quijano-RoyS,DabajI,KlugD,Vantyghem
population.JCardiovascElectrophysiol2011;22:1369(cid:2)1375. .. MC,ChevalierP,AmbrosiP,SalortE,SadoulN,WaintraubX,ChikhaouiK,
.
600. WahbiK,MeuneC,PorcherR,BecaneHM,LazarusA,LaforetP,StojkovicT, . Mabo P, Combes N, Maury P, Sellal JM, Tedrow UB, Kalman JM, Vohra J,
.
BehinA,Radvanyi-HoffmannH,EymardB,DubocD.Electrophysiologicalstudy . AndroulakisAFA,ZeppenfeldK,ThompsonT,BarneriasC,BecaneHM,Bieth
.
with prophylactic pacing and survival in adults with myotonic dystrophy and .. E,BoccaraF,BonnetD,BouhourF,BouleS,BrehinAC,ChaponF,CintasP,
conductionsystemdisease.JAMA2012;307:1292(cid:2)1301. .. Cuisset JM, Davy JM, De Sandre-Giovannoli A, Demurger F, Desguerre I,
.
601. LazarusA,VarinJ,BabutyD,AnselmeF,CosteJ,DubocD.Long-termfollow- . DieterichK,DurigneuxJ,Echaniz-LagunaA,EschalierR,FerreiroA,FerrerX,
.
upofarrhythmiasinpatientswithmyotonicdystrophytreatedbypacing:amul- . FrancannetC,FradinM,GaboritB,GayA,HagegeA,IsapofA,JeruI,Juntas .
ticenterdiagnosticpacemakerstudy.JAmCollCardiol2002;40:1645(cid:2)1652. .. Morales R, Lagrue E, Lamblin N, Lascols O, Laugel V, Lazarus A, Leturcq F,
602. Laurent V, Pellieux S, Corcia P, Magro P, Pierre B, Fauchier L, Raynaud M, .. LevyN,MagotA,ManelV,MartinsR,MayerM,MercierS,MeuneC,Michaud
.
BabutyD.Mortalityinmyotonicdystrophypatientsintheareaofprophylactic . M,Minot-MyhieMC,MuchirA,Nadaj-PaklezaA,PereonY,PetiotP,PetitF,
. pacingdevices.IntJCardiol2011;150:54(cid:2)58. .. PralineJ,RollinA,SabouraudP,SarretC,SchaefferS,TaitheF,TardC,Tiffreau
603. GrohWJ,GrohMR,SahaC,KincaidJC,SimmonsZ,CiafaloniE,PourmandR, .. V,ToutainA,VatierC,Walther-LouvierU,EymardB,CharronP,VigourouxC,
.
Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM. . BonneG,KumarS,ElliottP,DubocD.Developmentandvalidationofanew .
Electrocardiographic abnormalities and sudden death in myotonic dystrophy . riskpredictionscoreforlife-threateningventriculartachyarrhythmiasinlamino-
.
type1.NEnglJMed2008;358:2688(cid:2)2697. .. pathies.Circulation2019;140:293(cid:2)302.
604. Ha AH, Tarnopolsky MA, Bergstra TG, Nair GM, Al-Qubbany A, Healey JS. .. 617.vanRijsingenIA,ArbustiniE,ElliottPM,MogensenJ,Hermans-vanAstJF,van
.
Predictors of atrio-ventricular conduction disease, long-term outcomes in . derKooiAJ,vanTintelenJP,vandenBergMP,PilottoA,PasottiM,JenkinsS,
.
patients with myotonic dystrophy types I and II. Pacing Clin Electrophysiol . Rowland C, Aslam U, Wilde AA, Perrot A, Pankuweit S, Zwinderman AH,
.
2012;35:1262(cid:2)1269. .. CharronP,PintoYM.Riskfactorsformalignantventriculararrhythmiasinlamin
.
605. FatkinD,MacRaeC,SasakiT,WolffMR,PorcuM,FrenneauxM,AthertonJ, . A/C mutation carriers a European cohort study. J Am Coll Cardiol
.
VidailletHJJr,SpudichS,DeGirolamiU,SeidmanJG,SeidmanC,MuntoniF, . 2012;59:493(cid:2)500.
.
MuehleG,JohnsonW,McDonoughB.Missensemutationsintheroddomain .. 618.Kumar S, Baldinger SH, Gandjbakhch E, Maury P, Sellal JM, Androulakis AF,
of the lamin A/C gene as causesof dilated cardiomyopathy and conduction- .. WaintraubX,CharronP,RollinA,RichardP,StevensonWG,MacintyreCJ,Ho
.
systemdisease.NEnglJMed1999;341:1715(cid:2)1724. . CY,ThompsonT,VohraJK,KalmanJM,ZeppenfeldK,SacherF,TedrowUB,
.
606. ArbustiniE,PilottoA,RepettoA,GrassoM,NegriA,DiegoliM,CampanaC, . LakdawalaNK.Long-termarrhythmicandnonarrhythmicoutcomesoflaminA/
.
ScelsiL,BaldiniE,GavazziA,TavazziL.Autosomaldominantdilatedcardiomy- .. Cmutationcarriers.JAmCollCardiol2016;68:2299(cid:2)2307.
opathywithatrioventricularblock:alaminA/Cdefect-relateddisease.JAmColl .. 619.PasottiM,KlersyC,PilottoA,MarzilianoN,RapezziC,SerioA,MannarinoS,
.
Cardiol2002;39:981(cid:2)990. . GambarinF,FavalliV,GrassoM,AgozzinoM,CampanaC,GavazziA,FeboO,
.
607. Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di .. MariniM,LandolinaM,MortaraA,PiccoloG,ViganoM,TavazziL,ArbustiniE.
Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, Boucek MM, Lascor J, .. Long-termoutcomeandriskstratificationindilatedcardiolaminopathies.JAm
.
Moss AC, Li WL, Stetler GL, Muntoni F, Bristow MR, Mestroni L, Familial . CollCardiol2008;52:1250(cid:2)1260.
.
Dilated Cardiomyopathy Registry ResearchGroup. Natural historyof dilated . 620.Hasselberg NE, Edvardsen T, Petri H, Berge KE, Leren TP, Bundgaard H,
.
cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol .. HaugaaKH.Riskpredictionofventriculararrhythmiasandmyocardialfunction
2003;41:771(cid:2)780. . inLaminA/Cmutationpositivesubjects.Europace2014;16:563(cid:2)571.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 88 ---
88 ESCGuidelines
.
.
621. LimongelliG,Tome-EstebanM,DejthevapornC,RahmanS,HannaMG,Elliott . U, Starck C, Tascini C, Strathmore N. European Heart Rhythm Association
.
PM.Prevalenceandnaturalhistoryofheartdiseaseinadultswithprimarymito- . (EHRA)internationalconsensusdocumentonhowtoprevent,diagnose,and
.
chondrialrespiratorychaindisease.EurJHeartFail2010;12:114(cid:2)121. .. treat cardiac implantable electronic device infections-endorsed by the Heart
622. Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, Osame M, .. Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the
.
TanakaH.Cardiacinvolvementinmitochondrialdiseases.Astudyon17patients . Latin American Heart Rhythm Society (LAHRS), International Society for
.
withdocumentedmitochondrialDNAdefects.Circulation1995;91:955(cid:2)961. .. Cardiovascular Infectious Diseases (ISCVID), and the European Society of
623. KhambattaS,NguyenDL,BeckmanTJ,WittichCM.Kearns(cid:2)Sayresyndrome:a .. ClinicalMicrobiologyandInfectiousDiseases(ESCMID)incollaborationwith
.
caseseriesof35adultsandchildren.IntJGenMed2014;7:325(cid:2)332. . the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J
.
624. Kabunga P,Lau AK, PhanK, Puranik R,LiangC,Davis RL, SueCM, Sy RW. . 2020;41:2012(cid:2)2032.
.
SystematicreviewofcardiacelectricaldiseaseinKearns(cid:2)Sayresyndromeand .. 643.de Oliveira JC, Martinelli M, Nishioka SA, Varejao T, Uipe D, Pedrosa AA,
mitochondrialcytopathy.IntJCardiol2015;181:303(cid:2)310. .. Costa R, D’Avila A, Danik SB. Efficacy of antibiotic prophylaxis before the
.
625. PolakPE,ZijlstraF,RoelandtJR.Indicationsforpacemakerimplantationinthe . implantation of pacemakers and cardioverter-defibrillators: results of a large,
.
Kearns(cid:2)Sayresyndrome.EurHeartJ1989;10:281(cid:2)282. .. prospective,randomized,double-blinded,placebo-controlledtrial.CircArrhythm
626. NordenswanHK,LehtonenJ,EkstromK,KandolinR,SimonenP,MayranpaaM, .. Electrophysiol2009;2:29(cid:2)34.
.
Vihinen T, Miettinen H, Kaikkonen K, Haataja P, Kerola T, Rissanen TT, . 644.Madadi S, Kafi M, Kheirkhah J, Azhari A, Kiarsi M, Mehryar A, Fazelifar A,
.
KokkonenJ,AlataloA,Pietila-EffatiP,UtriainenS,KupariM.Outcomeofcar- . AlizadehdizA,EmkanjooZ,HaghjooM.Postoperativeantibioticprophylaxisin
. diacsarcoidosispresentingwithhigh-gradeatrioventricularblock.CircArrhythm .. the prevention of cardiac implantable electronic device infection. Pacing Clin
Electrophysiol2018;11:e006145. .. Electrophysiol2019;42:161(cid:2)165.
.
627. Nery PB, Beanlands RS, Nair GM, Green M, Yang J, McArdle BA, Davis D, . 645.KrahnAD,LongtinY,PhilipponF,BirnieDH,ManlucuJ,AngaranP,RinneC,
.
OhiraH,GollobMH,LeungE,HealeyJS,BirnieDH.Atrioventricularblockas . Coutu B, Low RA, Essebag V, Morillo C, Redfearn D, Toal S, Becker G,
.
theinitialmanifestationofcardiacsarcoidosisinmiddle-agedadults.JCardiovasc .. Degrace M, Thibault B, Crystal E, Tung S, LeMaitre J, Sultan O, Bennett M,
Electrophysiol2014;25:875(cid:2)881. .. BashirJ,Ayala-ParedesF,GervaisP,RiouxL,HemelsMEW,BouwelsLHR,van
.
628. YoshidaY,MorimotoS,HiramitsuS,TsuboiN,HirayamaH,ItohT.Incidence . Vlies B, Wang J, Exner DV, Dorian P, Parkash R, Alings M, Connolly SJ.
.
of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular .. Preventionofarrhythmiadeviceinfectiontrial:thePADITtrial.JAmCollCardiol
block.AmHeartJ1997;134:382(cid:2)386. .. 2018;72:3098(cid:2)3109.
.
629. Mankad P, Mitchell B, Birnie D, Kron J. Cardiac sarcoidosis. Curr Cardiol Rep . 646.HainesDE,BeheiryS,AkarJG,BakerJL,BeinbornD,BeshaiJF,BrysiewiczN,
.
2019;21:152. . Chiu-ManC,CollinsKK,DareM,FetterlyK,FisherJD,HongoR,IrefinS,Lopez
.
630. SadekMM,YungD,BirnieDH,BeanlandsRS,NeryPB.Corticosteroidtherapy .. J, Miller JM, Perry JC, Slotwiner DJ, Tomassoni GF, Weiss E. Heart Rythm
forcardiacsarcoidosis:asystematicreview.CanJCardiol2013;29:1034(cid:2)1041. .. Societyexpertconsensusstatementonelectrophysiologylaboratorystandards:
.
631. BirnieDH,SauerWH,BogunF,CooperJM,CulverDA,DuvernoyCS,Judson . process,protocols,equipment,personnel,andsafety.HeartRhythm2014;11:e9-
.
MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T, Raatikainen P, . 51.
.
SoejimaK.HRSexpertconsensusstatementonthediagnosisandmanagement .. 647.Mimoz O, Lucet J-C, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A,
.
of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm . BouadmaL,LasockiS,AlfandariS,FriggeriA,WalletF,AllouN,RucklyS,Balayn
.
2014;11:1305(cid:2)1323. . D,LepapeA,TimsitJ-F.Skinantisepsiswithchlorhexidine(cid:2)alcoholversuspovi-
.
632. Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel AR, Sweiss NJ, .. done iodine(cid:2)alcohol, with and without skin scrubbing, for prevention of
NguyenDT,AleongRG,VarosyPD,WeinbergerHD,SauerWH.Implantable .. intravascular-catheter-relatedinfection(CLEAN):anopen-label,multicentre,rand-
.
cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J . omised,controlled,two-by-twofactorialtrial.Lancet2015;386:2069(cid:2)2077.
.
CardiovascElectrophysiol2012;23:925(cid:2)929. . 648.Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM,
.
633. KronJ,SauerW,SchullerJ,BogunF,CrawfordT,SarsamS,RosenfeldL,Mitiku .. Miller HJ, Awad SS, Crosby CT, Mosier MC, Alsharif A, Berger DH.
TY,CooperJM,MehtaD,GreensponAJ,OrtmanM,DelurgioDB,ValadriR, .. Chlorhexidine(cid:2)alcohol versus povidone-iodine for surgical-site antisepsis. N
.
Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, . EnglJMed2010;362:18(cid:2)26.
.
KrahnAD,WolfeLG,FeinsteinS,EllenbogenKA.Efficacyandsafetyofimplant- .. 649.EssebagV,VermaA,HealeyJS,KrahnAD,KalfonE,CoutuB,Ayala-ParedesF,
able cardiacdefibrillatorsfortreatment ofventriculararrhythmiasinpatients .. Tang AS, Sapp J, Sturmer M, Keren A, Wells GA, Birnie DH, BRUISE
.
withcardiacsarcoidosis.Europace2013;15:347(cid:2)354. . CONTROLInvestigators.Clinicallysignificantpockethematomaincreaseslong-
.
634. BirnieDH,SauerWH,JudsonMA.Consensusstatementonthediagnosisand . termriskofdeviceinfection:BRUISECONTROLINFECTIONStudy.JAmColl
.
management of arrhythmias associated with cardiac sarcoidosis. Heart .. Cardiol2016;67:1300(cid:2)1308.
2016;102:411(cid:2)414. .. 650.BirnieDH,HealeyJS,WellsGA,VermaA,TangAS,KrahnAD,SimpsonCS,
.
635. Regitz-ZagrosekV,Roos-HesselinkJW,BauersachsJ,Blomstrom-LundqvistC, . Ayala-Paredes F, Coutu B, Leiria TLL, Essebag V, BRUISE CONTROL
.
CifkovaR,DeBonisM,IungB,JohnsonMR,KintscherU,KrankeP,LangIM, . Investigators.Pacemakerordefibrillatorsurgerywithoutinterruptionofantico- .
MoraisJ,PieperPG,PresbiteroP,PriceS,RosanoGMC,SeelandU,Simoncini .. agulation.NEnglJMed2013;368:2084(cid:2)2093.
T,SwanL,WarnesCA,ESCScientificDocumentGroup.2018ESCGuidelines .. 651.Malagu M, Trevisan F, Scalone A, Marcantoni L, Sammarco G, Bertini M.
.
for the management of cardiovascular diseases during pregnancy. Eur Heart J . Frequencyof‘pocket’hematomainpatientsreceivingvitaminKantagonistand
. 2018;39:3165(cid:2)3241. .. antiplatelet therapy at the time of pacemaker or cardioverter defibrillator
636. Tuzcu V, Gul EE, Erdem A, Kamali H, Saritas T, Karadeniz C, Akdeniz C. .. implantation(fromthePOCKETStudy).AmJCardiol2017;119:1036(cid:2)1040.
.
Cardiacinterventionsinpregnantpatientswithoutfluoroscopy.PediatrCardiol . 652.BirnieDH,HealeyJS,WellsGA,Ayala-ParedesF,CoutuB,SumnerGL,Becker .
2015;36:1304(cid:2)1307. . G,VermaA,PhilipponF,KalfonE,EikelboomJ,SandhuRK,NeryPB,Lellouche
.
637. GudalM,KervanciogluC,OralD,GurelT,ErolC,SonelA.Permanentpace- .. N,ConnollySJ,SappJ,EssebagV.Continuedvs.interrupteddirectoralanticoa-
makerimplantationinapregnantwomanwiththeguidanceofECGandtwo- .. gulantsatthetimeofdevicesurgery,inpatientswithmoderatetohighriskof
.
dimensionalechocardiography.PacingClinElectrophysiol1987;10:543(cid:2)545. . arterial thrombo-embolic events (BRUISE CONTROL-2). Eur Heart J
.
638. TraykovV,BongiorniMG,BorianiG,BurriH,CostaR,DagresN,DeharoJC, .. 2018;39:3973(cid:2)3979.
EpsteinLM,ErbaPA,Snygg-MartinU,NielsenJC,PooleJE,SaghyL,StarckC, .. 653.KutinskyIB,JarandillaR,JewettM,HainesDE.Riskofhematomacomplications
.
StrathmoreN,Blomstrom-LundqvistC.Clinicalpracticeandimplementationof . after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol
.
guidelinesfortheprevention,diagnosisandmanagementofcardiacimplantable . 2010;3:312(cid:2)318.
.
electronicdeviceinfections:resultsofaworldwidesurveyundertheauspices .. 654.TompkinsC,ChengA,DalalD,BrinkerJA,LengCT, MarineJE,NazarianS,
oftheEuropeanHeartRhythmAssociation.Europace2019;21:1270(cid:2)1279. .. Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H,
.
639. KlugD,BaldeM,PavinD,Hidden-LucetF,ClementyJ,SadoulN,ReyJL,LandeG, . Henrikson CA. Dual antiplatelet therapy and heparin ‘bridging’ significantly
.
LazarusA,VictorJ,BarnayC,GrandbastienB,KacetS,PeopleStudyGroup.Risk . increase the risk of bleeding complications after pacemaker or implantable
.
factors related to infections of implanted pacemakers and cardioverter- .. cardioverter-defibrillator device implantation. J Am Coll Cardiol
defibrillators:resultsofalargeprospectivestudy.Circulation2007;116:1349(cid:2)1355. .. 2010;55:2376(cid:2)2382.
.
640. EnzlerMJ,BerbariE,OsmonDR.Antimicrobialprophylaxisinadults.MayoClin . 655.ValgimigliM,BuenoH,ByrneRA,ColletJP,CostaF,JeppssonA,JuniP,Kastrati
.
Proc2011;86:686(cid:2)701. .. A,KolhP,MauriL,MontalescotG,NeumannFJ,PetricevicM,RoffiM,StegPG,
641. PolyzosKA,KonstanteliasAA,FalagasME.Riskfactorsforcardiacimplantable .. WindeckerS,ZamoranoJL,LevineGN,ESCScientificDocumentGroup,ESC
.
electronic device infection: a systematic review and meta-analysis. Europace . CommitteeforPracticeGuidelines,ESCNationalCardiacSocieties.2017ESC
.
2015;17:767(cid:2)777. . focusedupdateondualantiplatelettherapyincoronaryarterydiseasedevel-
.
642. Blomstrom-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni .. opedincollaborationwithEACTS:TheTaskForcefordualantiplatelettherapy
MG,PooleJ,BorianiG,CostaR,DeharoJC,EpsteinLM,SaghyL,Snygg-Martin . incoronaryarterydiseaseoftheEuropeanSocietyofCardiology(ESC)andof
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 89 ---
ESCGuidelines 89
.
.
the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J . quadripolarpassivefixationlead?AnItalianmulticenterexperience.JCardiovasc
.
2018;39:213(cid:2)260. . Med(Hagerstown)2019;20:192(cid:2)200.
.
656. Rossini R, Musumeci G, Visconti LO, Bramucci E, Castiglioni B, De Servi S, .. 670.ShimonyA,EisenbergMJ,FilionKB,AmitG.Beneficialeffectsofrightventricu-
Lettieri C, Lettino M, Piccaluga E, Savonitto S, Trabattoni D, Capodanno D, .. lar non-apical vs. apical pacing: a systematic review and meta-analysis of
.
Buffoli F, Parolari A, Dionigi G, Boni L, Biglioli F, Valdatta L, Droghetti A, . randomized-controlledtrials.Europace2012;14:81(cid:2)91.
.
BozzaniA,SetacciC,RavelliP,CresciniC,StaurenghiG,ScaroneP,FrancettiL, .. 671.NgACT,AllmanC,VidaicJ,TieH,HopkinsAP,LeungDY.Long-termimpact
D’Angelo F, Gadda F, Comel A, Salvi L, Lorini L, Antonelli M, Bovenzi F, .. ofrightventricularseptalversusapicalpacingonleftventricularsynchronyand
.
CremonesiA,AngiolilloDJ,GuagliumiG,ItalianSocietyofInvasiveCardiology, . function in patients with second- or third-degree heart block. Am J Cardiol
.
ItalianAssociationofHospitalCardiologists,ItalianSocietyforCardiacSurgery, . 2009;103:1096(cid:2)1101.
.
Italian Society of Vascular and Endovascular Surgery, Italian Association of .. 672.HattoriM,NaruseY,OginosawaY,MatsueY,HanakiY,KowaseS,KurosakiK,
Hospital Surgeons, Italian Society of Surgery, Italian Society of Anaesthesia, .. MizukamiA,KohnoR,AbeH,AonumaK,NogamiA.Prognosticimpactoflead
.
Intensive Care Medicine, Lombard Society of Surgery, Italian Society of . tippositionconfirmedviacomputedtomographyinpatientswithrightventricu-
.
Maxillofacial Surgery, Italian Society of Reconstructive Plastic Surgery and .. larseptalpacing.HeartRhythm2019;16:921(cid:2)927.
Aesthetics, Italian Society of Thoracic Surgeons, Italian Society of Urology, .. 673.DomenichiniG,SunthornH,FleuryE,FoulkesH,StettlerC,BurriH.Pacingof
.
Italian Society of Orthopaedics and Traumatology, Italian Society of . the interventricular septum versus the right ventricular apex: a prospective,
.
Periodontology, Italian Federation of Scientific Societies of Digestive System . randomizedstudy.EurJInternMed2012;23:621(cid:2)627.
. Diseases Lombardia, Association of Obstetricians Gynaecologists Italian .. 674.MahapatraS,BybeeKA,BunchTJ,EspinosaRE,SinakLJ,McGoonMD,Hayes
HospitalLombardia,SocietyofOphthalmologyLombardia.Perioperativeman- .. DL.Incidenceandpredictorsofcardiacperforationafterpermanentpacemaker
.
agementofantiplatelettherapyinpatientswithcoronarystentsundergoingcar- . placement.HeartRhythm2005;2:907(cid:2)911.
.
diacandnon-cardiacsurgery:aconsensusdocumentfromItaliancardiological, . 675.BiffiM,deZanG,MassaroG,AngelettiA,MartignaniC,BorianiG,Diemberger
.
surgicalandanaesthesiologicalsocieties.EuroIntervention2014;10:38(cid:2)46. .. I, Ziacchi M. Is ventricular sensing always right, when it is left? Clin Cardiol
657. Essebag V, HealeyJS,Joza J,NeryPB, Kalfon E, Leiria TLL, Verma A, Ayala- .. 2018;41:1238(cid:2)1245.
.
ParedesF,CoutuB,SumnerGL,BeckerG,PhilipponF,EikelboomJ,Sandhu . 676.Burri H, Muller H, Kobza R, Sticherling C, Ammann P, Zerlik H, Stettler C,
.
RK, Sapp J, Leather R, Yung D, Thibault B, Simpson CS, Ahmad K, Toal S, .. KlersyC,PrinzenF,AuricchioA.RIghtVErsusLeftApicaltransvenouspacing
SturmerM,KavanaghK,CrystalE,WellsGA,KrahnAD,BirnieDH.Effectof .. for bradycardia: results of the RIVELA randomized study. Indian Pacing
.
direct oral anticoagulants, warfarin, and antiplatelet agents on risk of device . ElectrophysiolJ2017;17:171(cid:2)175.
.
pocket hematoma: combined analysis of BRUISE CONTROL 1 and 2. Circ . 677.TanabeK,KotodaM,NakashigeD,MitsuiK,IkemotoK,MatsukawaT.Sudden
.
ArrhythmElectrophysiol2019;12:e007545. .. onsetpacemaker-induceddiaphragmatictwitchingduringgeneralanesthesia.JA
658. Kirkfeldt RE, Johansen JB, Nohr EA, Moller M, Arnsbo P, Nielsen JC. .. ClinRep2019;5:36.
.
Pneumothorax in cardiac pacing: a population-based cohort study of 28 860 . 678.KhanAA,NashA,RingNJ,MarshallAJ.Righthemidiaphragmatictwitching:acom-
.
Danishpatients.Europace2012;14:1132(cid:2)1138. . plicationofbipolaratrialpacing.PacingClinElectrophysiol1997;20:1732(cid:2)1733.
.
659. LiuP,ZhouY-F,YangP,GaoY-S,ZhaoG-R,RenS-Y,LiX-L.Optimizedaxil- .. 679.Shali S, Su Y, Ge J. Interatrial septal pacing to suppress atrial fibrillation in
.
laryveintechniqueversussubclavianveintechniqueincardiovascularimplant- . patients with dual chamberpacemakers: a meta-analysis of randomized, con-
.
ableelectronicdeviceimplantation.ChinMedJ2016;129:2647(cid:2)2651. . trolledtrials.IntJCardiol2016;219:421(cid:2)427.
.
660. LiccardoM,NocerinoP,GaiaS,CiardielloC.Efficacyofultrasound-guidedaxil- .. 680.ZhangL,JiangH,WangW,BaiJ,LiangY,SuY,GeJ.Interatrialseptumversus
lary/subclavianvenousapproachesforpacemakeranddefibrillatorleadimplan- .. rightatrialappendagepacingforpreventionofatrialfibrillation:ameta-analysis
.
tation:arandomizedstudy.JIntervCardElectrophysiol2018;51:153(cid:2)160. . ofrandomizedcontrolledtrials.Herz2018;43:438(cid:2)446.
.
661. Chan NY, Kwong NP, Cheong AP. Venous access and long-term pacemaker . 681.Magnusson P, Wennstrom L, Kastberg R, Liv P. Placement Of Cardiac
.
lead failure: comparing contrast-guided axillary vein puncture with subclavian .. PacemaKEr Trial (POCKET)—rationale and design: a randomized controlled
punctureandcephaliccutdown.Europace2017;19:1193(cid:2)1197. .. trial.HeartInt2017;12:e8-e11.
.
662. DeharoJC,BongiorniMG,RozkovecA,BrackeF,DefayeP,Fernandez-Lozano . 682.Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated
.
I, Golzio PG, Hansky B, Kennergren C, Manolis AS, Mitkowski P, Platou ES, .. withpectoralcardioverter-defibrillatorimplantation:comparisonofsubcutane-
LoveC,WilkoffB.Pathwaysfortrainingandaccreditationfortransvenouslead .. ousandsubmuscularapproaches.JAmCollCardiol1996;28:1278(cid:2)1282.
.
extraction: a European Heart Rhythm Association position paper. Europace . 683.Lakshmanadoss U, Nuanez B, Kutinsky I, Khalid R, Haines DE, Wong WS.
.
2012;14:124(cid:2)134. . Incidence of pocket infection postcardiac device implantation using antibiotic
.
663. MiglioreF,ZorziA,BertagliaE,LeoniL,SicilianoM,DeLazzariM,IgnatiukB, .. versus saline solution for pocket irrigation. Pacing Clin Electrophysiol
VeroneseM,VerlatoR,TarantiniG,IlicetoS,CorradoD.Incidence,manage- .. 2016;39:978(cid:2)984.
.
ment, and prevention of right ventricular perforation by pacemaker and . 684.MuellerTC,LoosM,HallerB,MihaljevicAL,NitscheU,WilhelmD,FriessH,
.
implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol . KleeffJ,BaderFG.Intra-operativewoundirrigationtoreducesurgicalsiteinfec- .
2014;37:1602(cid:2)1609. .. tions after abdominal surgery: a systematic review and meta-analysis.
664. Segreti L, DiCori A, Soldati E, ZucchelliG, VianiS, Paperini L, De LuciaR, .. Langenbeck’sArchSurg2015;400:167(cid:2)181.
.
ColucciaG,ValsecchiS,BongiorniMG.Majorpredictorsoffibrousadherences . 685.TarakjiKG,MittalS,KennergrenC,CoreyR,PooleJE,SchlossE,GallasteguiJ,
. in transvenous implantable cardioverter-defibrillator lead extraction. Heart .. Pickett RA, Evonich R, Philippon F, McComb JM, Roark SF, Sorrentino D,
Rhythm2014;11:2196(cid:2)2201. .. SholevarD,CroninE,BermanB,RiggioD,BiffiM,KhanH,SilverMT,CollierJ,
.
665. Behar JM, Bostock J, Zhu Li AP, Chin HMS, Jubb S, Lent E, Gamble J, Foley . EldadahZ,WrightDJ,LandeJD,LexcenDR,ChengA,WilkoffBL,WRAP-IT .
PWX, Betts TR, Rinaldi CA, Herring N. Cardiac resynchronization therapy . Investigators. Antibacterial envelope to prevent cardiac implantable device
.
deliveredviaamultipolarleftventricularleadisassociatedwithreducedmor- .. infection.NEnglJMed2019;380:1895(cid:2)1905.
talityandeliminationofphrenicnervestimulation:long-termfollow-upfroma .. 686.Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A,
.
multicenterregistry.JCardiovascElectrophysiol2015;26:540(cid:2)546. . IsaazK,TouboulP.Antibioticprophylaxisforpermanentpacemakerimplanta-
.
666. ForleoGB,DiBiaseL,PanattoniG,ManticaM,ParisiQ,MartinoA,Pappalardo .. tion:ameta-analysis.Circulation1998;97:1796(cid:2)1801.
A,SergiD,TesauroM,PapavasileiouLP,SantiniL,Calo(cid:4)L,TondoC,NataleA, .. 687.Leyva F, Zegard A, Qiu T, Acquaye E, Ferrante G, Walton J, Marshall H.
.
Romeo F. Improved implant and postoperative lead performance in CRT-D . Cardiac resynchronization therapy using quadripolar versus non-quadripolar
.
patientsimplantedwithaquadripolarleftventricularlead.A6-monthfollow-up . left ventricular leads programmed to biventricular pacing with single-site left
.
analysis from a multicenter prospective comparative study. J Interv Card .. ventricular pacing: impact on survival and heart failure hospitalization. J Am
Electrophysiol2015;42:59(cid:2)66. .. HeartAssoc2017;6:e007026.
.
667. JacksonKP,FaerestrandS,PhilipponF,YeeR,KongMH,KloppeA,Bongiorni . 688.HenriksonCA,SohailMR,AcostaH,JohnsonEE,RosenthalL,PachulskiR,Dan
.
MG, Lee SF, Canby RC, Pouliot E, van Ginneken MME, Crossley GH. . D,PaladinoW,KhairallahFS,GleedK,HannaI,ChengA,LexcenDR,Simons
.
Performanceofanovelactivefixationquadripolarleftventricularleadforcar- .. GR.Antibacterialenvelopeisassociatedwithlowinfectionratesafterimplant-
diac resynchronization therapy: Attain Stability Quad Clinical Study results. J .. able cardioverter-defibrillator and cardiac resynchronization therapy device
.
CardiovascElectrophysiol2020;31:1147(cid:2)1154. . replacement: results of the Citadel and Centurion studies. JACC Clin
.
668. Ziacchi M, Diemberger I, Corzani A, Martignani C, Mazzotti A, Massaro G, .. Electrophysiol2017;3:1158(cid:2)1167.
ValzaniaC,RapezziC,BorianiG,BiffiM.Cardiacresynchronizationtherapy:a .. 689.GhanbariH,PhardWS,Al-AmeriH,LatchamsettyR,JongnarngsinK,Crawford
.
comparisonamongleftventricularbipolar,quadripolarandactivefixationleads. . T,GoodE,ChughA,OralH,BogunF,MoradyF,PelosiFJr.Meta-analysisof
.
SciRep2018;8:13262. . safetyandefficacyofuninterruptedwarfarincomparedtoheparin-basedbridg-
.
669. Ziacchi M, Giannola G, Lunati M, Infusino T, Luzzi G, Rordorf R, Pecora D, .. ing therapy during implantation of cardiac rhythm devices. Am J Cardiol
BongiorniMG,DeRuvoE,BiffiM.Bipolaractivefixationleftventricularleador . 2012;110:1482(cid:2)1488.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 90 ---
90 ESCGuidelines
.
.
690. UdoEO,ZuithoffNP,vanHemelNM,deCockCC,HendriksT,DoevendansPA, . studyofacuteandmid-termcomplicationswithleadlessandtransvenouscar-
.
Moons KG. Incidence and predictors of short- and long-termcomplicationsin . diacpacemakers.HeartRhythm2018;15:1023(cid:2)1030.
.
pacemakertherapy:theFOLLOWPACEstudy.HeartRhythm2012;9:728(cid:2)735. .. 710.ChahineJ,BaranowskiB,TarakjiK,GadMM,SalibaW,RickardJ,CantillonDJ,
691. KoneruJN,JonesPW,HammillEF,WoldN,EllenbogenKA.Riskfactorsand .. DiabM,KanjM,CallahanT,DresingT,BhargavaM,ChungM,NiebauerMJ,
.
temporaltrendsofcomplicationsassociatedwithtransvenousimplantablecar- . VarmaN,TchouP,WilkoffBL,WazniO,HusseinAA.Cardiacvenousinjuries:
.
diacdefibrillatorleads.JAmHeartAssoc2018;7:e007691. .. proceduralprofilesandoutcomesduringleftventricularleadplacementforcar-
692. EllenbogenKA,HellkampAS,WilkoffBL,CamunasJL,LoveJC,HadjisTA,Lee .. diacresynchronizationtherapy.HeartRhythm2020;17:1298(cid:2)1303.
.
KL,LamasGA.ComplicationsarisingafterimplantationofDDDpacemakers: . 711.SeifertM,SchauT,Moeller V,NeussM,Meyhoefer J,ButterC.Influenceof
.
theMOSTexperience.AmJCardiol2003;92:740(cid:2)741. . pacingconfigurations,bodymassindex,andpositionofcoronarysinusleadon
.
693. Parsonnet V, Bernstein AD, Lindsay B. Pacemaker-implantation complication .. frequency of phrenic nerve stimulation and pacing thresholds under cardiac
rates: an analysis of some contributing factors. J Am Coll Cardiol .. resynchronizationtherapy.Europace2010;12:961(cid:2)967.
.
1989;13:917(cid:2)921. . 712.BiffiM,MoschiniC,BertiniM,SaporitoD,ZiacchiM,DiembergerI,ValzaniaC,
.
694. RanasingheI,LabroscianoC,HortonD,GanesanA,CurtisJP,KrumholzHM, . DomenichiniG,CerviE,MartignaniC,SangiorgiD,BranziA,BorianiG.Phrenic
.
McGavigan A, Hossain S, Air T, Hariharaputhiran S. Institutional variation in .. stimulation: a challenge for cardiac resynchronization therapy. Circ Arrhythm
.
quality of cardiovascular implantable electronic device implantation: a cohort . Electrophysiol2009;2:402(cid:2)410.
.
study.AnnInternMed2019;171:309(cid:2)317. . 713.Rijal S, Wolfe J, Rattan R, Durrani A, Althouse AD, Marroquin OC, Jain S,
. 695. PooleJE,GlevaMJ,MelaT,ChungMK,UslanDZ,BorgeR,GottipatyV,Shinn .. MulukutlaS,SabaS.Leadrelatedcomplicationsinquadripolarversusbipolar
T,DanD,FeldmanLA,SeideH,WinstonSA,GallagherJJ,LangbergJJ,Mitchell .. leftventricularleads.IndianPacingElectrophysiolJ2017;17:3(cid:2)7.
.
K,HolcombR,REPLACERegistryInvestigators.Complicationratesassociated . 714.NicholsCI,VoseJG.Incidenceofbleeding-relatedcomplicationsduringprimary
.
with pacemaker or implantable cardioverter-defibrillator generator replace- . implantation and replacement of cardiac implantable electronic devices. J Am
.
mentsandupgradeprocedures:resultsfromtheREPLACEregistry.Circulation .. HeartAssoc2017;6:e004263.
2010;122:1553(cid:2)1561. .. 715.WiegandUKH,LeJeuneD,BoguschewskiF,BonnemeierH,EberhardtF,Schunkert
.
696. BiffiM,AmmendolaE,MenardiE,ParisiQ,NarducciML,DeFilippoP,Manzo . H,BodeF.Pockethematomaafterpacemakerorimplantablecardioverterdefibrilla-
.
M,StabileG,PotenzaDR,ZanonF,QuartieriF,RilloM,SaporitoD,ZacaV, .. torsurgery:influenceofpatientmorbidity,operationstrategy,andperioperativeanti-
BerissoMZ,BertiniM,TumiettoF,MalacridaM,Diemberger I.Real-lifeout- .. platelet/anticoagulationtherapy.Chest2004;126:1177(cid:2)1186.
.
come of implantable cardioverter-defibrillator and cardiac resynchronization . 716.VanDeHeyningCM,ElbarasiE,MasieroS,BrambattiM,GhazalS,Al-Maashani
.
defibrillatorreplacement/upgradeinacontemporarypopulation:observations . S, Capucci A, Leong D, Shivalkar B, Saenen JB, Miljoen HP, Morillo CA,
.
fromthemulticentreDECODEregistry.Europace2019;21:1527(cid:2)1536. .. DivarakarmenonS,AmitG,RibasS,BaioccoE,MaoloA,RomandiniA,MaffeiS,
697. HosseiniSM,MoazzamiK,RozenG,VaidJ,SalehA,HeistKE,VangelM,Ruskin .. ConnollySJ,HealeyJS,DokainishH.Prospectivestudyoftricuspidregurgitation
.
JN.Utilizationandin-hospitalcomplicationsofcardiacresynchronizationther- . associatedwithpermanentleadsaftercardiacrhythmdeviceimplantation.CanJ
.
apy: trends in the United States from 2003 to 2013. Eur Heart J . Cardiol2019;35:389(cid:2)395.
.
2017;38:2122(cid:2)2128. .. 717.ChoMS,KimJ,LeeJB,NamGB,ChoiKJ,KimYH.Incidenceandpredictorsof
.
698. Zeitler EP, Patel D, Hasselblad V, Sanders GD, Al-Khatib SM. Complications . moderate to severe tricuspid regurgitation after dual-chamber pacemaker
.
fromprophylacticreplacementofcardiacimplantableelectronicdevicegenera- . implantation.PacingClinElectrophysiol2019;42:85(cid:2)92.
.
torsinresponsetoUnitedStatesFoodandDrugAdministrationrecall:asys- .. 718.LeeRC,FriedmanSE,KonoAT,GreenbergML,PalacRT.Tricuspidregurgita-
tematicreviewandmeta-analysis.HeartRhythm2015;12:1558(cid:2)1564. .. tion following implantation of endocardial leads: incidence and predictors.
.
699. NowakB,TascheK,BarnewoldL,HellerG,SchmidtB,BordignonS,ChunKR, . PacingClinElectrophysiol2015;38:1267(cid:2)1274.
.
FurnkranzA,MehtaRH.Associationbetweenhospitalprocedurevolumeand . 719.Link MS, Hellkamp AS, Estes NA 3rd, Orav EJ, Ellenbogen KA, Ibrahim B,
.
early complications after pacemaker implantation: results from a large, unse- .. Greenspon A, Rizo-Patron C, Goldman L, Lee KL, Lamas GA, MOST Study
lected, contemporary cohort of the German nationwide obligatory external .. Investigators. High incidence of pacemaker syndrome in patients with sinus
.
qualityassuranceprogramme.Europace2015;17:787(cid:2)793. . nodedysfunctiontreatedwithventricular-basedpacingintheModeSelection
.
700. van Rees JB, de Bie MK, Thijssen J, Borleffs CJ, Schalij MJ, van Erven L. .. Trial(MOST).JAmCollCardiol2004;43:2066(cid:2)2071.
Implantation-related complications of implantable cardioverter-defibrillators .. 720.vanRoodenCJ,MolhoekSG,RosendaalFR,SchalijMJ,MeindersAE,Huisman
.
andcardiacresynchronizationtherapydevices:asystematicreviewofrandom- . MV.Incidenceandriskfactorsofearlyvenousthrombosisassociatedwithper-
.
izedclinicaltrials.JAmCollCardiol2011;58:995(cid:2)1000. . manentpacemakerleads.JCardiovascElectrophysiol2004;15:1258(cid:2)1262.
.
701. WiegandUK,BodeF,BonnemeierH,EberhardF,SchleiM,PetersW.Long- .. 721.Da Costa SSdC, Scalabrini Neto A, Costa R, Caldas JG, Martinelli Filho M.
termcomplicationratesinventricular,singleleadVDD,anddualchamberpac- .. Incidenceandriskfactorsofupperextremitydeepveinlesionsafterpermanent
.
ing.PacingClinElectrophysiol2003;26:1961(cid:2)1969. . transvenouspacemakerimplant:a6-monthfollow-upprospectivestudy.Pacing
.
702. OlsenT,JorgensenOD,NielsenJC,ThogersenAM,PhilbertBT,JohansenJB. . ClinElectrophysiol2002;25:1301(cid:2)1306. .
Incidenceofdevice-relatedinfectionin97750patients:clinicaldatafromthe .. 722.Ascoeta MS, Marijon E, Defaye P, Klug D, Beganton F, Perier M-C, Gras D,
completeDanishdevice-cohort(1982(cid:2)2018).EurHeartJ2019;40:1862(cid:2)1869. .. AlgalarrondoV,DeharoJ-C,LeclercqC,FauchierL,BabutyD,BordacharP,
.
703. GreensponAJ,PatelJD,LauE,OchoaJA,FrischDR,HoRT,PavriBB,Kurtz . SadoulN,BovedaS,PiotO,DAI-PPInvestigators.Impactofearlycomplications
. SM. 16-year trends in the infection burden for pacemakers and implantable .. onoutcomesinpatientswithimplantablecardioverter-defibrillatorforprimary
cardioverter-defibrillatorsintheUnitedStates1993to2008.JAmCollCardiol .. prevention.HeartRhythm2016;13:1045(cid:2)1051.
.
2011;58:1001(cid:2)1006. . 723.Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, .
704. Rennert-MayE,ChewD,LuS,ChuA,KuriachanV,SomayajiR.Epidemiology . SimonAW.Thefrequencyandincrementalcostofmajorcomplicationsamong
.
of cardiac implantable electronic device infections in the United States: a .. Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am
population-basedcohortstudy.HeartRhythm2020;17:1125(cid:2)1131. .. CollCardiol2006;47:2493(cid:2)2497.
.
705. Ozcan C,Raunso J,LambertsM, Kober L, LindhardtTB, BruunNE,Laursen . 724.SridharAR,YarlagaddaV,YeruvaMR,KanmanthareddyA,VallakatiA,DawnB,
.
ML,Torp-PedersenC,GislasonGH,HansenML.Infectiveendocarditisandrisk . LakkireddyD.ImpactofhaematomaafterpacemakerandCRTdeviceimplanta-
.
ofdeathaftercardiacimplantableelectronicdeviceimplantation:anationwide .. tiononhospitalizationcosts,lengthofstay,andmortality:apopulation-based
.
cohortstudy.Europace2017;19:1007(cid:2)1014. . study.Europace2015;17:1548(cid:2)1554.
.
706. DaiM,CaiC,VaibhavV,SohailMR,HayesDL,HodgeDO,TianY,Asirvatham . 725.Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F,
.
R, Cochuyt JJ, Huang C, Friedman PA, Cha YM. Trends of cardiovascular .. Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-
implantableelectronicdeviceinfectionin3decades:apopulation-basedstudy. .. GosciniakE,PriceS,Roos-HesselinkJ,Snygg-MartinU,ThunyF,TornosMasP,
.
JACCClinElectrophysiol2019;5:1071(cid:2)1080. . Vilacosta I, Zamorano JL, ESC Scientific Document Group. 2015 ESC
.
707. PalmisanoP,AccogliM,ZaccariaM,LuzziG,NacciF,AnaclerioM,FavaleS. . Guidelinesforthemanagement ofinfective endocarditis:TheTask Forcefor
.
Rate,causes,andimpactonpatientoutcomeofimplantabledevicecomplica- .. the Management of Infective Endocarditis of the European Society of
tions requiringsurgical revision:largepopulation surveyfromtwo centres in .. Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic
.
Italy.Europace2013;15:531(cid:2)540. . Surgery(EACTS),theEuropeanAssociationofNuclearMedicine(EANM).Eur
.
708. SohailMR,HenriksonCA,Braid-ForbesMJ,ForbesKF,LernerDJ.Mortalityand .. HeartJ2015;36:3075(cid:2)3128.
cost associated with cardiovascular implantable electronic device infections. .. 726.ClementyN,CarionPL,LeotoingL,LamarsalleL,Wilquin-BequetF,BrownB,
.
ArchInternMed2011;171:1821(cid:2)1828. . VerheesKJP,FernandesJ,DeharoJC.Infectionsandassociatedcostsfollowing
.
709. CantillonDJ,DukkipatiSR,IpJH,ExnerDV,NiaziIK,BankerRS,RashtianM, . cardiovascularimplantableelectronicdeviceimplantations:anationwidecohort
.
Plunkitt K, Tomassoni GF, Nabutovsky Y, Davis KJ, Reddy VY. Comparative .. study.Europace2018;20:1974(cid:2)1980.
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 91 ---
ESCGuidelines 91
.
.
727. RattanawongP,KewcharoenJ,MekraksakitP,MekritthikraiR,PrasitlumkumN, . 745.IndikJH,GimbelJR,AbeH,Alkmim-TeixeiraR,Birgersdotter-GreenU,Clarke
.
VutthikraivitW,PutthapibanP,DworkinJ.Deviceinfectionsinimplantablecar- . GD, Dickfeld TL, Froelich JW, Grant J, Hayes DL, Heidbuchel H, Idriss SF,
.
dioverterdefibrillatorsversuspermanentpacemakers:asystematicreviewand .. KanalE,LampertR,MachadoCE,MandrolaJM,NazarianS,PattonKK,Rozner
meta-analysis.JCardiovascElectrophysiol2019;30:1053(cid:2)1065. .. MA,RussoRJ,ShenWK,ShinbaneJS,TeoWS,UribeW,VermaA,WilkoffBL,
.
728. Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-KhatibSM, AggarwalS, Uslan . WoodardPK.2017HRSexpertconsensusstatementonmagneticresonance
.
DZ.Ratesofandfactorsassociatedwithinfectionin200909Medicareimplant- .. imagingandradiationexposureinpatientswithcardiovascularimplantableelec-
able cardioverter-defibrillator implants: results from the National .. tronicdevices.HeartRhythm2017;14:e97(cid:2)e153.
.
CardiovascularDataRegistry.Circulation2014;130:1037(cid:2)1043. . 746.Nazarian S, Hansford R, Rahsepar AA, Weltin V, McVeigh D, Gucuk Ipek E,
.
729. UslanDZ,SohailMR,StSauverJL,FriedmanPA,HayesDL,StonerSM,Wilson . KwanA,BergerRD,CalkinsH,LardoAC,KrautMA,KamelIR,Zimmerman
.
WR,SteckelbergJM,BaddourLM.Permanentpacemakerandimplantablecardi- .. SL,HalperinHR.Safetyofmagneticresonanceimaginginpatientswithcardiac
overter defibrillator infection: a population-based study. Arch Intern Med .. devices.NEnglJMed2017;377:2555(cid:2)2564.
.
2007;167:669(cid:2)675. . 747.BalmerC,GassM,DaveH,DuruF,LuechingerR.Magneticresonanceimaging
.
730. ChangJD,ManningWJ,EbrilleE,ZimetbaumPJ.Tricuspidvalvedysfunctionfol- . ofpatientswithepicardialleads:invitroevaluationoftemperaturechangesat
.
lowing pacemaker or cardioverter-defibrillator implantation. J Am Coll Cardiol .. theleadtip.JIntervCardElectrophysiol2019;56:321(cid:2)326.
.
2017;69:2331(cid:2)2341. . 748.HigginsJV,GardJJ,SheldonSH,EspinosaRE,WoodCP,FelmleeJP,ChaYM,
.
731. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long- . AsirvathamSJ,DalzellC,AckerN,WatsonREJr,FriedmanPA.Safetyandout-
. termsurvival.JAmCollCardiol2004;43:405(cid:2)409. .. comesofmagneticresonanceimaginginpatientswithabandonedpacemaker
732. HokeU,AugerD,ThijssenJ,Wolterbeek R,vanderVeldeET,HolmanER, .. anddefibrillatorleads.PacingClinElectrophysiol2014;37:1284(cid:2)1290.
.
Schalij MJ, Bax JJ, Delgado V, Marsan NA. Significant lead-induced tricuspid . 749.PadmanabhanD,KellaDK,MehtaR,KapaS,DeshmukhA,MulpuruS,JaffeAS,
.
regurgitationisassociatedwithpoorprognosisatlong-termfollow-up.Heart . Felmlee JP, Jondal ML, Dalzell CM, Asirvatham SJ, Cha YM, Watson RE Jr,
.
2014;100:960(cid:2)968. .. FriedmanPA.Safetyofmagneticresonanceimaginginpatientswithlegacypace-
733. MutlakD,AronsonD,LessickJ,ReisnerSA,DabbahS,AgmonY.Functionaltri- .. makersanddefibrillatorsandabandonedleads.HeartRhythm2018;15:228(cid:2)233.
.
cuspid regurgitation in patients with pulmonary hypertension: is pulmonary . 750.Horwood L, Attili A, Luba F, Ibrahim EH, Parmar H, Stojanovska J, Gadoth-
.
artery pressure the only determinant of regurgitation severity? Chest .. GoodmanS,FetteC,OralH,BogunF.Magneticresonanceimaginginpatients
2009;135:115(cid:2)121. .. withcardiacimplantedelectronicdevices:focusoncontraindicationstomag-
.
734. SchleiferJW,PislaruSV,LinG,PowellBD,EspinosaR,KoestlerC,ThomeT, . neticresonanceimagingprotocols.Europace2017;19:812(cid:2)817.
.
PolkL,LiZ,AsirvathamSJ,ChaYM.Effectofventricularpacingleadposition . 751.VuorinenAM,PakarinenS,JaakkolaI,HolmstromM,KivistoS,KaasalainenT.
.
on tricuspid regurgitation: a randomized prospective trial. Heart Rhythm .. Clinicalexperienceofmagneticresonanceimaginginpatientswithcardiacpac-
2018;15:1009(cid:2)1016. .. ingdevices:unrestrictedpatientpopulation.ActaRadiol2019;60:1414(cid:2)1421.
.
735. ChengY,GaoH,TangL,LiJ,YaoL.Clinicalutilityofthree-dimensionalecho- . 752.PulverAF,PuchalskiMD,BradleyDJ,MinichLL,SuJT,SaarelEV,WhitakerP,
.
cardiographyintheevaluationoftricuspidregurgitationinducedbyimplantable . EtheridgeSP.SafetyandimagingqualityofMRIinpediatricandadultcongenital
.
deviceleads.Echocardiography2016;33:1689(cid:2)1696. .. heart disease patients with pacemakers. Pacing Clin Electrophysiol
.
736. BeurskensNEG,TjongFVY,deBruin-BonRHA,DasselaarKJ,KuijtWJ,Wilde . 2009;32:450(cid:2)456.
.
AAM,KnopsRE.Impactofleadlesspacemakertherapyoncardiacandatrioven- . 753.Wilkoff BL, Bello D, Taborsky M, Vymazal J, Kanal E, Heuer H, Hecking K,
.
tricular valve function through 12 months of follow-up. Circ Arrhythm .. JohnsonWB,YoungW,RamzaB,AkhtarN,KuepperB,HunoldP,Luechinger
Electrophysiol2019;12:e007124. .. R, Puererfellner H, Duru F, Gotte MJ, Sutton R, Sommer T, EnRhythm MRI
.
737. AddetiaK,HarbSC,HahnRT,KapadiaS,LangRM.Cardiacimplantableelec- . SureScan Pacing System Study Investigators. Magnetic resonance imaging in
.
tronic device lead-induced tricuspid regurgitation. JACC Cardiovasc Imaging . patientswithapacemakersystemdesignedforthemagneticresonanceenvi-
.
2019;12:622(cid:2)636. .. ronment.HeartRhythm2011;8:65(cid:2)73.
738. Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger-Toller A, .. 754.ShentharJ,MilasinovicG,AlFagihA,GotteM,EngelG,WolffS,TseHF,Herr
.
Biasco L, Lurz P, Braun D, Brochet E, Connelly KA, de Bruijn S, Denti P, . J,CarrithersJ,CerkvenikJ,NahleCP.MRIscanninginpatientswithnewand
.
DeuschlF,Estevez-LoureiroR,FamN,FrerkerC,GavazzoniM,HausleiterJ, .. existing CapSureFix Novus 5076 pacemaker leads: randomized trial results.
Ho E, Juliard JM, Kaple R, Besler C, Kodali S, Kreidel F, Kuck KH, Latib A, .. HeartRhythm2015;12:759(cid:2)765.
.
Lauten A, Monivas V, Mehr M, Muntane-Carol G, Nazif T, Nickening G, . 755.GimbelJR,BelloD,SchmittM,MerkelyB,SchwitterJ,HayesDL,SommerT,
.
PedrazziniG,PhilipponF,PozzoliA,PrazF,PuriR,Rodes-CabauJ,SchaferU, . SchlossEJ,ChangY,WilleyS,KanalE.Randomizedtrialofpacemakerandlead
.
SchoferJ,SievertH,TangGHL,ThieleH,TopilskyY,RommelKP,DelgadoV, .. systemforsafescanningat1.5Tesla.HeartRhythm2013;10:685(cid:2)691.
VahanianA,VonBardelebenRS,WebbJG,WeberM,WindeckerS,WinkelM, .. 756.HomsiR,MellertF,LuechingerR,ThomasD,DoernerJ,LuetkensJ,SchildHH,
.
Zuber M, Leon MB, Hahn RT, Bax JJ, Enriquez-Sarano M, Maisano F. . NaehleCP.Safetyandfeasibilityofmagneticresonanceimagingofthebrainat
.
Transcatheter versus medical treatment of patients with symptomatic severe . 1.5 Tesla in patients with temporary transmyocardial pacing leads. Thorac .
tricuspidregurgitation.JAmCollCardiol2019;74:2998(cid:2)3008. .. CardiovascSurg2019;67:86(cid:2)91.
739. AuricchioA,GaspariniM,LindeC,DobreanuD,CanoO,SterlinskiM,Bogale .. 757.ZarembaT,JakobsenAR,SogaardM,ThogersenAM,JohansenMB,MadsenLB,
.
N, Stellbrink C, Refaat MM, Blomstrom-Lundqvist C, Lober C, Dickstein K, . RiahiS.Riskofdevicemalfunctionincancerpatientswithimplantablecardiac
. NormandC.Sex-relatedproceduralaspectsandcomplicationsinCRTSurvey .. device undergoing radiotherapy: a population-based cohort study. Pacing Clin
II:amulticenterEuropeanexperiencein11,088patients.JACCClinElectrophysiol .. Electrophysiol2015;38:343(cid:2)356.
.
2019;5:1048(cid:2)1058. . 758.HarmsW,BudachW,DunstJ,FeyerP,FietkauR,HaaseW,KrugD,Piroth .
740. WagnerEH,AustinBT,VonKorffM.Organizingcareforpatientswithchronic . MD,Sautter-BihlML,SedlmayerF,SouchonR,WenzF,SauerR,BreastCancer
.
illness.MilbankQ1996;74:511(cid:2)544. .. ExpertPaneloftheGermanSocietyofRadiationOncology.DEGROpractical
741. HendriksJM,deWitR,CrijnsHJ,VrijhoefHJ,PrinsMH,PistersR,PisonLA, .. guidelinesforradiotherapyofbreastcancerVI:therapyoflocoregionalbreast
.
BlaauwY,TielemanRG.Nurse-ledcarevs.usualcareforpatientswithatrial . cancerrecurrences.StrahlentherOnkol2016;192:199(cid:2)208.
.
fibrillation:resultsofarandomizedtrialofintegratedchroniccarevs.routine . 759.Zecchin M, Severgnini M, Fiorentino A, Malavasi VL, Menegotti L, Alongi F,
.
clinical care in ambulatory patients with atrial fibrillation. Eur Heart J .. Catanzariti D, Jereczek-Fossa BA, Stasi M, Russi E, Boriani G. Management of
.
2012;33:2692(cid:2)2699. . patientswithcardiacimplantableelectronicdevices(CIED)undergoingradiother-
.
742. GallagherC,ElliottAD,WongCX,RangnekarG,MiddeldorpME,MahajanR, . apy: a consensus document from Associazione Italiana Aritmologia e
.
LauDH,SandersP,HendriksJML.Integratedcareinatrialfibrillation:asystem- .. Cardiostimolazione(AIAC),AssociazioneItalianaRadioterapiaOncologica(AIRO),
aticreviewandmeta-analysis.Heart2017;103:1947(cid:2)1953. .. AssociazioneItalianaFisicaMedica(AIFM).IntJCardiol2018;255:175(cid:2)183.
.
743. WijtvlietE,TielemanRG,vanGelderIC,PluymaekersN,RienstraM,Folkeringa . 760.GrantJD,JensenGL,TangC,PollardJM,KrySF,KrishnanS,DoughertyAH,
.
RJ, Bronzwaer P,Elvan A, Elders J, Tukkie R, Luermans J, Van Asselt A, Van . Gomez DR, Rozner MA. Radiotherapy-induced malfunction in contemporary
.
KuijkSMJ,TijssenJG,CrijnsH,RACEInvestigators.Nurse-ledvs.usual-carefor .. cardiovascularimplantableelectronicdevices:clinicalincidenceandpredictors.
atrialfibrillation.EurHeartJ2020;41:634(cid:2)641. .. JAMAOncol2015;1:624(cid:2)632.
.
744. RussoRJ,CostaHS,SilvaPD,AndersonJL,ArshadA,BiedermanRW,Boyle . 761.ZarembaT,JakobsenAR,SøgaardM,ThøgersenAM,RiahiS.Radiotherapyin
.
NG,FrabizzioJV,Birgersdotter-GreenU,HigginsSL,LampertR,MachadoCE, .. patients with pacemakers and implantable cardioverter defibrillators: a litera-
Martin ET, Rivard AL, Rubenstein JC, Schaerf RH, Schwartz JD, Shah DJ, .. turereview.Europace2016;18:479(cid:2)491.
.
TomassoniGF,TominagaGT,TonkinAE,UretskyS,WolffSD.Assessingthe . 762.HurkmansCW,KnegjensJL,OeiBS,MaasAJ,UiterwaalGJ,vanderBordenAJ,
.
risksassociatedwithMRIinpatientswithapacemakerordefibrillator.NEnglJ . Ploegmakers MM, van Erven L, Dutch Society of Radiotherapy Oncology.
.
Med2017;376:755(cid:2)764. .. ManagementofradiationoncologypatientswithapacemakerorICD:anew
.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 92 ---
92 ESCGuidelines
.
.
comprehensive practical guideline in The Netherlands. Dutch Society of . Moorman LP, Thompson A. The Heart Rhythm Society (HRS)/American
.
RadiotherapyandOncology(NVRO).RadiatOncol2012;7:198. . SocietyofAnesthesiologists(ASA)ExpertConsensusStatementontheperio-
.
763. Gomez DR,PoenischF,PinnixCC,SheuT,ChangJY, MemonN,Mohan R, .. perative management of patients with implantable defibrillators, pacemakers
Rozner MA, Dougherty AH. Malfunctions of implantable cardiac devices in .. andarrhythmiamonitors:facilitiesandpatientmanagementthisdocumentwas
.
patientsreceivingprotonbeamtherapy:incidenceandpredictors.IntJRadiat . developed as a joint project with the American Society of Anesthesiologists
.
OncolBiolPhys2013;87:570(cid:2)575. .. (ASA),andincollaborationwiththeAmericanHeartAssociation(AHA),and
764. TjongFVY,deRuijterUW,BeurskensNEG,KnopsRE.Acomprehensivescop- .. theSocietyofThoracicSurgeons(STS).HeartRhythm2011;8:1114(cid:2)1154.
.
ing review on transvenous temporary pacing therapy. Neth Heart J . 788.HealeyJS,MerchantR,SimpsonC,TangT,BeardsallM,TungS,FraserJA,Long
.
2019;27:462(cid:2)473. . L,vanVlymenJM,ManninenP,RalleyF,VenkatraghavanL,YeeR,PrasloskiB,
.
765. Hynes JK, Holmes DR Jr, Harrison CE. Five-year experience with temporary .. Sanatani S, Philippon F, Canadian Cardiovascular Society, Canadian
pacemakertherapyinthecoronarycareunit.MayoClinProc1983;58:122(cid:2)126. .. Anesthesiologists’ Society, Canadian Heart Rhythm Society. Canadian
.
766. FerriLA,FarinaA,LenattiL,RuffaF,TibertiG,PiattiL,SavonittoS.Emergent . Cardiovascular Society/Canadian Anesthesiologists’ Society/Canadian Heart
.
transvenouscardiacpacingusingultrasoundguidance:aprospectivestudyver- . RhythmSocietyjointpositionstatementontheperioperativemanagementof
.
sus the standard fluoroscopy-guided procedure. Eur Heart J Acute Cardiovasc .. patients with implanted pacemakers, defibrillators, and neurostimulating devi-
.
Care2016;5:125(cid:2)129. . ces.CanJCardiol2012;28:141(cid:2)151.
.
767. LangR,DavidD,KleinHO,DiSegniE,LibhaberC,SareliP,KaplinskyE.The . 789.BorianiG,FauchierL,AguinagaL,BeattieJM,BlomstromLundqvistC,Cohen
. use of the balloon-tipped floating catheter in temporary transvenous cardiac .. A,DanGA,GenovesiS,IsraelC,JoungB,KalarusZ,LampertR,MalavasiVL,
pacing.PacingClinElectrophysiol1981;4:491(cid:2)496. .. Mansourati J, Mont L, Potpara T, Thornton A, Lip GYH, ESC Scientific
.
768.FergusonJD,BanningAP,BashirY.Randomisedtrialoftemporarycardiacpacing . Document Group. European Heart Rhythm Association (EHRA) consensus
.
withsemirigidandballoon-flotationelectrodecatheters.Lancet1997;349:1883. . documentonmanagementofarrhythmiasandcardiacelectronicdevicesinthe
.
769. AustinJL,PreisLK,CramptonRS,BellerGA,MartinRP.Analysisofpacemaker .. criticallyillandpost-surgerypatient,endorsedbyHeartRhythmSociety(HRS),
malfunctionandcomplicationsoftemporarypacinginthecoronarycareunit. .. Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of
.
AmJCardiol1982;49:301(cid:2)306. . SouthernAfrica(CASSA),andLatinAmericanHeartRhythmSociety(LAHRS).
.
770. Hill PE. Complications of permanent transvenous cardiac pacing: a 14-year .. Europace2019;21:7(cid:2)8.
review of all transvenous pacemakers inserted at one community hospital. .. 790.Schulman PM, Treggiari MM, Yanez ND, Henrikson CA, Jessel PM, Dewland
.
PacingClinElectrophysiol1987;10:564(cid:2)570. . TA,MerkelMJ,SeraV,HarukuniI,AndersonRB,KahlE,BinghamA,Alkayed
.
771. MurphyJJ.Currentpracticeandcomplicationsoftemporarytransvenouscar- . N,SteckerEC.Electromagneticinterferencewithprotocolizedelectrosurgery
.
diacpacing.BMJ1996;312:1134. .. dispersiveelectrodepositioninginpatientswithimplantablecardioverterdefib-
772. BjornstadCC,GjertsenE,ThorupF,GundersenT,TobiassonK,OtterstadJE. .. rillators.Anesthesiology2019;130:530(cid:2)540.
.
TemporarycardiacpacemakertreatmentinfiveNorwegianregionalhospitals. . 791.Gifford J, Larimer K, Thomas C, May P. ICD-ON Registry for perioperative
.
ScandCardiovascJ2012;46:137(cid:2)143. . management of CIEDs: most require no change. Pacing Clin Electrophysiol
.
773.LopezAyerbeJ,VilluendasSabateR,GarciaGarciaC,RodriguezLeorO,Gomez .. 2017;40:128(cid:2)134.
.
PerezM,CurosAbadalA,SerraFloresJ,LarrousseE,ValleV.[Temporarypace- . 792.Heidbuchel H, Panhuyzen-Goedkoop N, Corrado D, Hoffmann E, Biffi A,
.
makers:currentuseandcomplications].RevEspCardiol2004;57:1045(cid:2)1052. . DeliseP,Blomstrom-LundqvistC,VanheesL,IvarhoffP,DorwarthU,Pelliccia
.
774. NgACC,LauJK,ChowV,AdikariD,BriegerD,KritharidesL.Outcomesof .. A, Study Group on Sports Cardiology of the European Association for
4838 patients requiring temporary transvenous cardiac pacing: a statewide .. CardiovascularPreventionRehabilitation.Recommendationsforparticipationin
.
cohortstudy.IntJCardiol2018;271:98(cid:2)104. . leisure-timephysicalactivityandcompetitivesportsinpatientswitharrhythmias
.
775. MetkusTS,SchulmanSP,MarineJE,EidSM.Complicationsandoutcomesof . andpotentiallyarrhythmogenicconditionsPartI:supraventriculararrhythmias
.
temporary transvenous pacing: an analysis of >360,000 patients from the .. andpacemakers.EurJCardiovascPrevRehabil2006;13:475(cid:2)484.
NationalInpatientSample.Chest2019;155:749(cid:2)757. .. 793.LampertR.Managingwithpacemakersandimplantablecardioverterdefibrilla-
.
776. Lever N, Ferguson JD, Bashir Y, Channon KM. Prolonged temporary cardiac . tors.Circulation2013;128:1576(cid:2)1585.
.
pacing using subcutaneous tunnelled active-fixation permanent pacing leads. .. 794.PellicciaA,Fagard R,BjornstadHH,AnastassakisA,Arbustini E,AssanelliD,
Heart2003;89:209(cid:2)210. .. Biffi A, Borjesson M, Carre F, Corrado D, Delise P, Dorwarth U, Hirth A,
.
777. RastanAJ,DollN,WaltherT,MohrFW.Pacemakerdependentpatientswith . Heidbuchel H, Hoffmann E, Mellwig KP, Panhuyzen-Goedkoop N, Pisani A,
.
device infection—a modified approach. Eur J Cardiothorac Surg . Solberg EE, van-BuurenF, Vanhees L, Blomstrom-Lundqvist C, Deligiannis A,
.
2005;27:1116(cid:2)1118. .. Dugmore D, Glikson M, Hoff PI, Hoffmann A, Hoffmann E, Horstkotte D,
778. ZeiPC,EckartRE,EpsteinLM.Modifiedtemporarycardiacpacingusingtrans- .. Nordrehaug JE, Oudhof J, McKenna WJ, Penco M, Priori S, Reybrouck T,
.
venous active fixation leads and external re-sterilized pulse generators. J Am . SendenJ,SpataroA,ThieneG.Recommendationsforcompetitivesportspar-
.
CollCardiol2006;47:1487(cid:2)1489. . ticipationinathleteswithcardiovasculardisease:aconsensusdocumentfrom .
779. KawataH,PretoriusV,PhanH,MulpuruS,GadiyaramV,PatelJ,SteltznerD, .. the Study Group of Sports Cardiology of the Working Group of Cardiac
KrummenD,Feld G,Birgersdotter-Green U.Utilityandsafetyof temporary .. RehabilitationandExercisePhysiologyandtheWorkingGroupofMyocardial
.
pacingusingactivefixationleadsandexternalizedre-usable permanentpace- . and Pericardial Diseases of the European Society of Cardiology. Eur Heart J
. makersafterleadextraction.Europace2013;15:1287(cid:2)1291. .. 2005;26:1422(cid:2)1445.
780. Timothy PR, Rodeman BJ. Temporary pacemakers in critically ill patients: .. 795.HeidbuchelH,AdamiPE,AntzM,BraunschweigF,DeliseP,ScherrD,Solberg
.
assessmentandmanagementstrategies.AACNClinIssues2004;15:305(cid:2)325. . EE,WilhelmM,PellicciaA.Recommendationsforparticipationinleisure-time .
781. Abd Elaziz ME, Allama AM. Temporary epicardial pacing after valve replace- . physicalactivityandcompetitivesportsinpatientswitharrhythmiasandpoten-
.
ment:incidenceandpredictors.HeartSurgForum2018;21:E049(cid:2)E053. .. tiallyarrhythmogenicconditions:Part1:supraventriculararrhythmias.Aposi-
782. Lazarescu C,MertesPM,Longrois D.[Temporary epicardial pacingfollowing .. tion statement of the Section of Sports Cardiology and Exercise from the
.
cardiacsurgery:practicalaspects].AnnFrAnesthReanim2013;32:592(cid:2)601. . European Association of Preventive Cardiology (EAPC) and the European
.
783. BektasF,SoyuncuS.TheefficacyoftranscutaneouscardiacpacinginED.AmJ .. HeartRhythmAssociation(EHRA),bothassociationsoftheEuropeanSociety
EmergMed2016;34:2090(cid:2)2093. .. ofCardiology.EurJPrevCardiol2020;doi:10.1177/2047487320925635
.
784. QuastABE,BeurskensNEG,EbnerA,WasleyR,VehmeijerJT,MarcovecchioA, . 796.PellicciaA,SharmaS,GatiS,BackM,BorjessonM,CaselliS,ColletJP,Corrado
.
SangheraR,KnopsRE,BurkeMC.Feasibilityofanentirelyextracardiac,minimally . D, Drezner JA, Halle M, Hansen D, Heidbuchel H, Myers J, Niebauer J,
.
invasive,temporarypacingsystem.CircArrhythmElectrophysiol2019;12:e007182. .. Papadakis M, Piepoli MF, Prescott E, Roos-Hesselink JW, Graham Stuart A,
785. Sherbino J, Verbeek PR, MacDonald RD, Sawadsky BV, McDonald AC, .. Taylor RS, Thompson PD, Tiberi M, Vanhees L, Wilhelm M, ESC Scientific
.
MorrisonLJ.Prehospitaltranscutaneouscardiacpacingforsymptomaticbrady- . DocumentGroup.2020ESCGuidelinesonsportscardiologyandexercisein
.
cardia or bradyasystolic cardiac arrest: a systematic review. Resuscitation . patientswithcardiovasculardisease.EurHeartJ2020;42:17(cid:2)96.
.
2006;70:193(cid:2)200. .. 797.Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M,
786. AmericanSocietyofAnesthesiologists.Practiceadvisoryfortheperioperative .. CalkinsH,EstesNAM,LinkMS,MaronBJ,MarcusF,ScheinmanM,WilkoffBL,
.
management of patients with cardiac implantable electronic devices: pace- . ZipesDP,BerulCI,ChengA,JordaensL,LawI,LoomisM,WillemsR,BarthC,
.
makers and implantable cardioverter-defibrillators: an updated report by the .. Broos K, Brandt C, Dziura J, Li F, Simone L, Vandenberghe K, Cannom D.
AmericanSocietyofAnesthesiologiststaskforceonperioperativemanagement .. Safetyofsportsforathleteswithimplantablecardioverter-defibrillators:long-
.
of patients with cardiac implantable electronic devices. Anesthesiology . term results of a prospective multinational registry. Circulation
.
2011;114:247(cid:2)261. . 2017;135:2310(cid:2)2312.
.
787. Crossley GH, Poole JE, Rozner MA, Asirvatham SJ, Cheng A, Chung MK, .. 798.Heidbuchel H, Arbelo E, D’Ascenzi F, Borjesson M, Boveda S, Castelletti S,
Ferguson TB, Gallagher JD, Gold MR, Hoyt RH, Irefin S, Kusumoto FM, . MiljoenH,MontL,NiebauerJ,PapadakisM,PellicciaA,SaenenJ,Sanzdela
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 93 ---
ESCGuidelines 93
.
.
GarzaM,SchwartzPJ,SharmaS,ZeppenfeldK,CorradoD.Recommendations . Institute of Medicine of the National Academies; 2012. http://www.iom.edu/
.
for participation in leisure-time physical activity and competitive sports of . evidence.
.
patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: .. 816.HibbardJH,GreeneJ.Whattheevidenceshowsaboutpatientactivation:better
ventricular arrhythmias, channelopathies, and implantable defibrillators. .. health outcomes and care experiences; fewer data on costs. Health Aff
.
Europace2021;23:147(cid:2)148. . (Millwood)2013;32:207(cid:2)214.
.
799. Hauser RG, Hayes DL, Kallinen LM, Cannom DS, Epstein AE, Almquist AK, .. 817.CharlesC,GafniA,WhelanT.Shareddecision-makinginthemedicalencoun-
SongSL,TyersGF,VlaySC,IrwinM.Clinicalexperiencewithpacemakerpulse .. ter: what does it mean? (or it takes at least two to tango). Soc Sci Med
.
generators and transvenous leads: an 8-year prospective multicenter study. . 1997;44:681(cid:2)692.
.
HeartRhythm2007;4:154(cid:2)160. . 818.TowleA,GodolphinW.Frameworkforteachingandlearninginformedshared
.
800. Merchant FM, Tejada T, Patel A, El-Khalil J, Desai Y, Keeling B, Lattouf OM, .. decisionmaking.BMJ1999;319:766(cid:2)771.
LeonAR,El-ChamiMF.Proceduraloutcomesandlong-termsurvivalassociated .. 819.Makoul G, Clayman ML. An integrative model of shared decision making in
.
with lead extraction in patients with abandoned leads. Heart Rhythm . medicalencounters.PatientEducCouns2006;60:301(cid:2)312.
.
2018;15:855(cid:2)859. .. 820.PitcherD,SoarJ,HoggK,LinkerN,ChapmanS,BeattieJM,JonesS,GeorgeR,
801. DiembergerI,MazzottiA,GiuliaMB,BiffiM,CristianM,MassaroG,MatteoM, .. McCombJ,GlancyJ,PattersonG,TurnerS,HampshireS,LockeyA,BakerT,
.
Martignani C, Letizia ZM, Ziacchi M, Reggiani B, Reggiani ML, Battistini P, . MitchellS.Cardiovascularimplantedelectronicdevicesinpeopletowardsthe
.
BorianiG.Fromleadmanagementtoimplantedpatientmanagement:systematic . endoflife,duringcardiopulmonaryresuscitationandafterdeath:guidancefrom
. reviewandmeta-analysisofthelast15yearsofexperienceinleadextraction. .. the Resuscitation Council (UK), British Cardiovascular Society and National
ExpertRevMedDevices2013;10:551(cid:2)573. .. CouncilforPalliativeCare.Heart2016;102Suppl7:A1-a17.
.
802. Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA, . 821.The SHARE Approach. https://www.ahrq.gov/health-literacy/professional-train
.
Romano SL, Maggioni AP, Andarala M, Auricchio A, Kuck KH, Blomstro¨m- . ing/shared-decision/index.html(25May2021)
.
Lundqvist C, ELECTRa Investigators. The European Lead Extraction .. 822.International Patient Decision Aid Standards (IPDAS). IPDAS Collaboration
ConTRolled(ELECTRa)study:aEuropeanHeartRhythmAssociation(EHRA) .. BackgroundDocument,.ipdas.ohri.ca/IPDAS_Background.pdf(25May2021)
.
registry of transvenous lead extraction outcomes. Eur Heart J . 823.StaceyD,LegareF,LewisK,BarryMJ,BennettCL,EdenKB,Holmes-Rovner
.
2017;38:2995(cid:2)3005. .. M,Llewellyn-ThomasH,LyddiattA,ThomsonR,TrevenaL.Decisionaidsfor
803. SegretiL,RinaldiCA,ClaridgeS,SvendsenJH,Blomstrom-LundqvistC,Auricchio .. peoplefacinghealthtreatmentorscreeningdecisions.CochraneDatabaseSyst
.
A, Butter C, Dagres N, Deharo JC, Maggioni AP, Kutarski A, Kennergren C, . Rev2017;4:Cd001431.
.
Laroche C, Kempa M, Magnani A, Casteigt B, Bongiorni MG, ELECTRa . 824.DeOliveiraGSJr,McCarthyRJ,WolfMS,HollJ.Theimpactofhealthliteracy
.
Investigators.Proceduraloutcomesassociatedwithtransvenousleadextractionin .. in the care of surgical patients: a qualitative systematic review. BMC Surg
patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead .. 2015;15:86.
.
ExtractionConTRolled)registrysub-analysis.Europace2019;21:645(cid:2)654. . 825.Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Viera A, Crotty K,
.
804. Parthiban N, Esterman A, Mahajan R, Twomey DJ, Pathak RK, Lau DH, . HollandA,BrasureM,LohrKN,HardenE,TantE,WallaceI,ViswanathanM.
.
Roberts-ThomsonKC,YoungGD,SandersP,GanesanAN.Remotemonitoring .. Healthliteracyinterventionsandoutcomes:anupdatedsystematicreview.Evid
.
ofimplantablecardioverter-defibrillators:asystematicreviewandmeta-analysis . RepTechnolAssess(FullReport)2011:1(cid:2)941.
.
ofclinicaloutcomes.JAmCollCardiol2015;65:2591(cid:2)2600. . 826.WolfA,VellaR,ForsA.Theimpactofperson-centredcareonpatients’care
.
805. Garcia-FernandezFJ,OscaAsensiJ,RomeroR,FernandezLozanoI,Larrazabal .. experiencesinrelationtoeducationallevelafteracutecoronarysyndrome:sec-
JM, Martinez Ferrer J, Ortiz R, Pombo M, Tornes FJ, Moradi Kolbolandi M. .. ondaryoutcomeanalysisofarandomisedcontrolledtrial.EurJCardiovascNurs
.
Safetyandefficiencyofacommonandsimplifiedprotocolforpacemakerand . 2019;18:299(cid:2)308.
.
defibrillator surveillance based on remote monitoring only: a long-term . 827.MarcusC.Strategiesforimprovingthequalityofverbalpatientandfamilyedu-
.
randomizedtrial(RM-ALONE).EurHeartJ2019;40:1837(cid:2)1846. .. cation:areviewoftheliteratureandcreationoftheEDUCATEmodel.Health
806. MaboP,VictorF,BazinP,AhresS,BabutyD,DaCostaA,BinetD,DaubertJC, .. PsycholBehavMed2014;2:482(cid:2)495.
.
COMPAS Trial Investigators. A randomized trial of long-term remote . 828.Friedman AJ, Cosby R, Boyko S, Hatton-Bauer J, Turnbull G. Effective
.
monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J .. teaching strategies and methods of delivery for patient education: a
2012;33:1105(cid:2)1111. .. systematic review and practice guideline recommendations. J Cancer Educ
.
807. Vogtmann T, Stiller S, Marek A, Kespohl S, Gomer M, Ku¨hlkamp V, Zach G, . 2011;26:12(cid:2)21.
.
Lo¨scher S, Baumann G. Workload and usefulness of daily, centralized home . 829.Sustersic M, Gauchet A, Foote A, Bosson JL. How best to use and evaluate
.
monitoring for patients treated with CIEDs: results of the MoniC (Model .. PatientInformationLeafletsgivenduringaconsultation:asystematicreviewof
Project Monitor Centre) prospective multicentre study. Europace .. literaturereviews.HealthExpect2017;20:531(cid:2)542.
.
2013;15:219(cid:2)226. . 830.Elwyn G, Lloyd A, Joseph-Williams N, Cording E, Thomson R, Durand MA,
.
808. Nielsen JC, Kautzner J, Casado-Arroyo R, Burri H, Callens S, Cowie MR, . Edwards A. Option grids: shared decision making made easier. Patient Educ .
DicksteinK,DrossartI,GenesteG,ErkinZ,HyafilF,KrausA,KutyifaV,Marin .. Couns2013;90:207(cid:2)212.
E, Schulze C, Slotwiner D, Stein K, Zanero S, Heidbuchel H, Fraser AG. .. 831.DwamenaF,Holmes-RovnerM,GauldenCM,JorgensonS,SadighG,Sikorskii
.
Remotemonitoringofcardiacimplantedelectronicdevices:legalrequirements . A,LewinS,SmithRC,CoffeyJ,OlomuA.Interventionsforproviderstopro-
. and ethical principles—ESC Regulatory Affairs Committee/EHRA joint task .. mote a patient-centred approach in clinical consultations. Cochrane Database
forcereport.Europace2020;22:1742(cid:2)1758. .. SystRev2012;12:Cd003267.
.
809. PerlS,StieglerP,RotmanB,PrennerG,LercherP,Anelli-MontiM,SereiniggM, . 832.OlssonLE,JakobssonUngE,SwedbergK,EkmanI.Efficacyofperson-centred .
RiegelnikV,KvasE,KosC,HeinzelFR,TscheliessniggKH,PieskeB.Socio-eco- . care as an intervention in controlled trials—a systematic review. J Clin Nurs
.
nomiceffectsandcostsavingpotentialofremotepatientmonitoring(SAVE- .. 2013;22:456(cid:2)465.
HMtrial).IntJCardiol2013;169:402(cid:2)407. .. 833.McMillanSS,KendallE,SavA,KingMA,WhittyJA,KellyF,WheelerAJ.Patient-
.
810. RicciRP,MorichelliL,SantiniM.Remotecontrolofimplanteddevicesthrough . centeredapproachestohealthcare:asystematicreviewofrandomizedcon-
.
HomeMonitoringtechnologyimprovesdetectionandclinicalmanagementof .. trolledtrials.MedCareResRev2013;70:567(cid:2)596.
atrialfibrillation.Europace2009;11:54(cid:2)61. .. 834.EkmanI,WolfA,OlssonLE,TaftC,DudasK,SchaufelbergerM,SwedbergK.
.
811. McCanceT,McCormackB,DewingJ.Anexplorationofperson-centrednessin . Effectsofperson-centredcareinpatientswithchronicheartfailure:thePCC-
.
practice.OnlineJIssuesNurs2011;16:1. . HFstudy.EurHeartJ2012;33:1112(cid:2)1119.
.
812. Kitson A, Marshall A, Bassett K, Zeitz K. What are the core elements of .. 835.UlinK,OlssonLE,WolfA,EkmanI.Person-centredcare—anapproachthat
patient-centred care?Anarrativereview andsynthesisofthe literaturefrom .. improvesthedischargeprocess.EurJCardiovascNurs2016;15:e19(cid:2)e26.
.
healthpolicy,medicineandnursing.JAdvNurs2013;69:4(cid:2)15. . 836.DudasK,OlssonLE,WolfA,SwedbergK,TaftC,SchaufelbergerM,EkmanI.
.
813. Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, Carlsson J, . Uncertainty in illness among patients with chronic heart failure is less
.
Dahlin-IvanoffS,JohanssonIL,KjellgrenK,LidenE,OhlenJ,OlssonLE,Rosen .. in person-centred care than in usual care. Eur J Cardiovasc Nurs
H,RydmarkM,SunnerhagenKS.Person-centeredcare—readyforprimetime. .. 2013;12:521(cid:2)528.
.
EurJCardiovascNurs2011;10:248(cid:2)251. . 837.MinchinM,RolandM,RichardsonJ,RowarkS,GuthrieB.Qualityofcareinthe
.
814. KieslerDJ,AuerbachSM.Optimalmatchesofpatientpreferencesforinforma- .. United Kingdom after removal of financial incentives. N Engl J Med
tion,decision-makingandinterpersonalbehavior:evidence,modelsandinter- .. 2018;379:948(cid:2)957.
.
ventions.PatientEducCouns2006;61:319(cid:2)341. . 838.SongZ, Ji Y, Safran DG,Chernew ME.Healthcare spending, utilization,and
.
815. Alston C, Paget L, Halvorson G, Novelli B, Guest J, McCabe P, Hoffman K, . quality8yearsintoglobalpayment.NEnglJMed2019;381:252(cid:2)263.
.
KoepkeC,SimonM,SuttonS,OkunS,WicksP,UndemT,RohrbachV,von .. 839.Aktaa S, Batra G, Wallentin L, Baigent C, Erlinge D, James S, Ludman P,
KohornI.CommunicatingwithPatientsonHealthCareEvidence.Washington,DC: . Maggioni AP, Price S, Weston C, Casadei B, Gale CP. European Society of
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
--- Страница 94 ---
94 ESCGuidelines
.
.
Cardiology methodology for the development of quality indicators for the . senting without persistent ST-segment elevation. Eur Heart J
.
quantificationofcardiovascularcareandoutcomes.EurHeartJQualCareClin . 2021;42:1289(cid:2)1367.
.
Outcomes2020;TOBEUPDATED:doi:10.1093/ehjqcco/qcaa1069.Onlineahead .. 842.WallentinL,GaleCP,MaggioniA,BardinetI,CasadeiB.EuroHeart:European
ofprint. .. unified registries on heart care evaluation and randomized trials. Eur Heart J
.
840. Arbelo E, Aktaa S, Bollmann A, D’Avila A, Drossart I, Dwight J, Hills MT, . 2019;40:2745(cid:2)2749.
.
HindricksG,KusumotoFM,LaneDA,LauDH,LettinoM,LipGYH,LobbanT, .. 843.Zhang S, Gaiser S, Kolominsky-Rabas PL. Cardiac implant registries
PakHN,PotparaT,SaenzLC,VanGelderIC,VarosyP,GaleCP,DagresN, .. 2006(cid:2)2016:asystematicreviewandsummaryofglobalexperiences.BMJOpen
.
Reviewers,BovedaS,DenekeT,DefayeP,ConteG,LenarczykR,Providencia . 2018;8:e019039.
.
R,GuerraJM,TakahashiY,PisaniC,NavaS,SarkozyA,GlotzerTV,Martins . 844.Aktaa S, Abdin A, Arbelo E, Burri H, Vernooy K, Blomstro¨m-Lundqvist C,
.
OliveiraM.Qualityindicatorsforthecareandoutcomesofadultswithatrial .. BorianiG,DefayeP,DeharoJ-C,DrossartI,FoldagerD,GoldMR,JohansenJB,
fibrillation.Europace2021;23:494(cid:2)495. .. LeyvaF,LindeC,MichowitzY,KronborgMB,SlotwinerD,SteenT,Tolosana
.
841. ColletJP,ThieleH,BarbatoE,BarthelemyO,BauersachsJ,BhattDL,Dendale . JM,TzeisS,VarmaN,GliksonM,NielsenJ-C,GaleCP.EuropeanSocietyof
.
P,DorobantuM,EdvardsenT,FolliguetT,GaleCP,GilardM,JobsA,JuniP, . Cardiology Quality Indicators for the care and outcomes of cardiac pacing
.
Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, .. DevelopedbytheWorkingGroupforCardiacPacingQualityIndicatorsincol-
.
RuttenFH,SibbingD,SiontisGCM,ESCScientificDocumentGroup.2020ESC . laboration with the European Heart Rhythm Association of the European
.
Guidelinesforthemanagementofacutecoronarysyndromesinpatientspre- . SocietyofCardiology.Europace2021;doi:10.1093/europace/euab193.
Downloaded
from
https://academic.oup.com/eurheartj/article/42/35/3427/6358547
by
guest
on
22
January
2026
